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Abstract 
 
 
Since 1994 there have been considerable additions to the range of health care professionals (HCPs) 
that can prescribe in the United Kingdom (UK). These HCPs include nurses, pharmacists, 
radiographers, physiotherapists, podiatrists, chiropodists and optometrists. After a period of 
specific prescribing training these HCPs are often referred to as non-medical prescribers (NMPs). 
There has been a limited amount of research that has investigated the influences on the prescribing 
behaviour of NMPs. Additional research with NMPs would be beneficial to contribute to the 
currently limited understanding of the prescribing behaviour of NMPs. Knowledge about the 
influences on NMPs’ decisions will also provide further insight into the training and support 
requirements of these HCPs. 
 
A programme of research was conducted to explore the influences on the prescribing behaviour of 
nurse and pharmacist independent and/or supplementary prescribers working in primary and 
community care. The research utilised a range of qualitative data collection techniques including 
interviews, semi-structured interviews, focus groups and the critical incident technique. The Q-
method was also used. This allowed perspectives amongst NMPs about prescribing influences to be 
identified. In total, 104 NMPs took part in this research. This included 31 pharmacist prescribers 
and 73 nurse prescribers. NMPs were mainly recruited via their primary care trust prescribing lead 
but pharmacist prescribers were also contacted using the details they provided to their professional 
body. NMPs in this research occupied a wide range of roles and had diverse demographic 
characteristics. Relevant ethical approval was obtained before conducting this research. 
 
NMPs were motivated by their desire to feel safe, keep it simple and fit in with prescribing culture 
when prescribing. They also had a code of practice which underlined their rejection of some 
influences, such as patient pressure and logistical influences, and their acceptance of others, such as 
guidelines and formularies. The research found that the influences on NMPs’ prescribing decisions 
can be best understood through identifying how and in what circumstances NMPs take 
responsibility for issuing prescriptions and making prescribing decisions. As well as providing 
insights into the training and support requirements of NMPs the findings of this research are 
important to others that may want to research the prescribing influences on NMPs in the future.  
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Chapter One - Introduction 
_________________________________________________________________________ 
 
The purpose of this chapter is to introduce the topic of this programme of research and provide an 
outline of the organisation of this thesis. 
_________________________________________________________________________ 
 
1.1 Introduction 
‘Medicines offer so much help, can deliver so much harm, and are the most expensive element in 
health care after staff costs’ (Barber et al. 2003, pg. 51). In 2009 alone, over £12.3 billion worth of 
National Health Service (NHS) expenditure in England was spent on the prescription of medicine, 
appliances and dressings1 (The NHS Information Centre 2010a). This accounted for approximately 
10% of total NHS expenditure in England that year (House of Commons Health Committee 2010). 
Given the associated costs, it is unsurprising that prescribing behaviour has attracted so much 
attention from researchers and policy makers over the last few decades. A large volume of research 
has set about identifying and understanding the influences on prescribing behaviour. This              
research has identified a wide range of factors that influence prescribing behaviour.    
 
Much of the United Kingdom (UK) based research investigating prescribing behaviour has focused 
on the prescribing decisions of doctors and dentists. This is because, prior to 1994, only doctors 
and dentists could prescribe in the UK. Furthermore, with dentists’ prescribing limited (The NHS 
Information Centre 2010b), the majority of this research has examined doctors’ prescribing only. 
Since 1994 there have been considerable additions to the range of health care professionals (HCPs) 
that can prescribe in the UK. Additional prescribing authority was first extended to community 
nurses in 1994. This move gave community nurse prescribers (CNPs) the legal authority to 
prescribe a limited range of products to patients. Since then, prescribing authority has been 
periodically extended to a wide range of other HCPs, including all nurses, pharmacists, 
radiographers, physiotherapists, podiatrists, chiropodists and optometrists. The term ‘non-medical 
prescribing’ is often used to refer to prescribing by this group of HCPs. 
 
Though non-medical prescribing is still in its infancy, to the year September 2010, almost 14 
million prescription items were prescribed by non-medical prescribers (NMPs) in general practice 
in England2. This accounted for 1.6% of all prescriptions written in the same period in primary 
                                                 
1
 Figure includes prescriptions issued the by the hospital pharmacy, prescriptions issued in primary care and hospital prescribing 
dispensed in the community.  
2
 Figures include prescriptions written in England but dispensed elsewhere. It does not include prescriptions written by prescribers in 
hospitals. 
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care, representing a 12% increase on the year to September 2009 (NHS Prescription Services 2009; 
NHS Prescription Services 2011). Only a small amount of research has sought to understand the 
factors influencing the prescribing behaviour of NMPs. Most of the research that does exist has 
focused on CNPs only. In contrast, a great deal of research has explored the prescribing behaviour 
of doctors. Given non-medical prescribing is increasing there is a need for further understanding of 
the influences on NMPs’ prescribing behaviour. Such research will contribute to the currently 
limited understanding of the prescribing decision-making process of NMPs. Further knowledge 
about the influences on NMPs’ decisions will also provide further insight into the training and 
support requirements of these HCPs. 
 
1.2 Organisation of Thesis 
Chapter Two provides background information about prescribing and non-medical prescribing, an 
overview of the current literature relating to prescribing influences and outlines the current gap in 
knowledge that this programme of research seeks to address.  
 
Chapter Three provides an overview of the entire programme of research. Methodological issues 
are discussed along with the ethical considerations of this research.  
 
Chapter Four provides a rationale for Study One, outlines the aim and objectives of the study and 
describes the method employed. It then describes the key findings, discusses these key findings in 
light of relevant literature and summarises the implications of the findings for the remainder of this 
programme of research.  
 
Chapter Five outlines the aim and objectives of Study Two and Study Three, the methods 
employed and the data analysis procedures. Study Two and Study Three were designed based on 
the findings of Study One. Study Two examined the factors that influence whether NMPs take 
responsibility for prescribing. Study Three furthered the understanding, developed in Study One, of 
the factors that influence NMPs’ prescribing decisions. In Study Three perspectives about 
prescribing influences amongst NMPs were generated by asking prescribers to order statements 
about prescribing influences according to their agreement with the statement.  
 
Chapter Six describes the factors that influence whether NMPs take responsibility for prescribing. 
The chapter combines relevant findings from both Study One and Study Two. The chapter begins 
by describing NMPs’ cautious approach to prescribing responsibility. The factors that influence 
whether NMPs take responsibility for prescribing are discussed under four main headings: 
competency, role, practical and legal considerations, and risk. The pressures that NMPs face in 
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relation to taking prescribing responsibility are also outlined. The chapter then discusses the 
findings in relation to the available literature. 
 
Chapter Seven explores the factors influencing the prescribing decisions of NMPs. This chapter 
draws on relevant findings from Study One. An overview of these findings are introduced in 
Chapter Three in order to provide a rationale for the entire programme of research, but are 
presented in more depth in this chapter. The findings are described under seven main headings: 
regulatory factors, patient factors, colleague factors, prescribing culture and professional 
experience, training and information sources, logistical factors the pharmaceutical industry. The 
results are then discussed in terms of the prescribing influences literature.  
 
Chapter Eight describes the findings of Study Three which identified the range of perspectives 
amongst NMPs about the sources of influence on their prescribing decisions. A reflection of the 
key aspects of these perspectives in terms of the current literature, with a particular emphasis on the 
principles of evidence-based medicine and patient-centred medicine, is then provided.  
 
Chapter Nine draws the programme of research to a conclusion, discusses the limitations of the 
research, outlines the recommendations from the research and suggests areas for further research. It 
ends with some final thoughts about this thesis. 
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Chapter Two – Background 
_________________________________________________________________________ 
 
The purpose of this chapter is to provide the necessary background information about prescribing 
and non-medical prescribing, provide a description and critique of the current literature in the area 
of prescribing influences and state the current gap in knowledge that this programme of research 
seeks to address.  
_________________________________________________________________________ 
 
2.1 Preparing the Prescribing and Non-Medical Prescribing Background Sections 
The initial part of this chapter provides an overview of prescribing and non-medical prescribing in 
the UK. This background information was produced partly by searching grey literature sources 
such as the Department of Health (DoH) website (see Appendix 1.0 for the list of grey literature 
sources). A literature search also helped to inform the background sections of this chapter. A 
number of key search terms associated with non-medical prescribing (see Box 2-1) were applied in 
various combinations and iterations to relevant databases (see Appendix 2.0 for list of databases). 
Recent information generated from the search was favoured because it provided a more accurate 
reflection of the current situation in relation to non-medical prescribing. However, older 
information sources were sometimes used to help uncover the history of non-medical prescribing in 
the UK. 
 
 
 
 
 
 
2.2 Background to Prescribing 
Before discussing non-medical prescribing in further detail, it is appropriate to define some key 
prescribing terms, overview the laws that govern prescribing in the UK and provide some 
information about the total cost and volume of prescribing.  
 
2.2.1 Definition and Legal Basis of Prescribing 
The Oxford Dictionary offers a definition of ‘prescribe’ which is as follows:  
 
‘(Of a medical practitioner). Advise and authorise the use of a medicine of treatment for someone 
else, especially in writing’ (Oxford dictionary of English 2005) 
 
 
Box 2-1: Key Search Terms used to Prepare Prescribing and Non-Medical Prescribing Background 
Sections 
Community Nurse Prescriber, Nurse, Pharmacist, Supplementary, Independent, Nurse Practitioner, 
Optometrist, Physiotherapist, Chiropodist, Podiatrist, Radiographer, District Nurse, Health Visitor, 
Prescribing, Prescriber, Non-Medical Prescribing, Implementation, Use, Background, Development, 
History 
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Whilst the definition is somewhat outdated, given the range of HCPs that can now prescribe, 
‘prescription’ is defined by the British Medical Association (BMA) as:  
 
‘An instruction written by a doctor, dentist or a specifically trained nurse that directs a pharmacist 
to dispense a particular drug at a specific dose. A prescription details how often the drug must be 
taken, how much is to be dispensed and other relevant facts’ (British Medical Association 2007) 
 
A prescriber is anyone who can issue a valid prescription. In the UK, doctors, dentists and 
appropriately trained nurses, pharmacists, radiographers, physiotherapists, podiatrists, chiropodists 
and optometrists can be prescribers. Doctors and dentists gain the authority to prescribe once 
registered with their professional body. Nurses, pharmacists, radiographers, physiotherapists, 
podiatrists, chiropodists and optometrists can gain prescribing authority through completion of a 
period of specific training. Prescribers are governed by strict laws and regulation. In the UK there 
are three major acts that govern the prescription and supply of medicines and poisons: (1) Poisons 
Act (1972), (2) Medicines Act (1968) and (3) Misuse of Drugs Act 1971 (Together with the Misuse 
of Drugs Regulations 1973) (Knight 1992). 
 
2.2.2 Total Volume and Cost of Prescribing 
In 2009, the total cost of prescribing in England accounted for £12.3 billion. In total, 69% of this 
cost (£8.3 billion) was as a result of primary care prescribing and 31% (£4.0 billion) was as a result 
of hospital or secondary care prescribing. The cost of prescribing to the NHS is increasing each 
year. There was a 5.6% increase in the cost of prescribing in 2009 compared with the previous year 
(The NHS Information Centre 2010a). Dentists’ prescribing accounts for a small proportion of the 
entire prescribing budget in England. In 2009, prescription items written by dentists and dispensed 
in the community accounted for £4.9 million worth of expenditure. The vast majority of the 
prescriptions written by dentists came under the British National Formulary (BNF) Section 5.1 
antibacterial drugs (The NHS Information Centre 2010b).  
 
2.3 Background to Non-Medical Prescribing 
The purpose of this section of the chapter is to describe non-medical prescribing in further detail by 
providing a historical account of non-medical prescribing in the UK. For the purposes of this thesis 
the term allied healthcare professionals (AHCPs) is used to refer to radiographers, physiotherapists, 
podiatrists, chiropodists and optometrists.  
 
 
 22 
2.3.1 Implementation of Non-Medical Prescribing 
2.3.1.1 Prescribing for Community Nurses 
In the 1980s reports by Julia Cumberledge and Dr June Crown highlighted the potential benefits of 
extending prescribing authority from doctors and dentists to community nurses (Department of 
Health 1989; DHSS. 1986). The reports suggested that allowing community nurses to prescribe a 
limited number of items would improve the efficiency of healthcare provision for patients. 
Community nurses included nurses with a district nurse (DN) qualification, a health visitor (HV) 
qualification, or a practice nurse with either a DN or HV qualification. It was felt that allowing 
community nurse prescribing would serve to legitimise current practice as nurses were already 
informally prescribing by asking doctors to sign pre-written prescriptions on their behalf. In 1994 a 
pilot of 58 community nurses specifically trained to prescribe were permitted to prescribe from the 
Nurse Prescribers’ Formulary (NPF) for HVs and DNs. The formulary included a limited range of 
medicines, dressings and appliances. The initial pilot was extended in 1996 to include an additional 
site which allowed evaluation of a further 150 nurses. Evaluation of this additional pilot phase was 
deemed a success and in April 1998 it was announced that community nurse prescribing would be 
fully implemented throughout the UK.   
 
In April 2011, 33,899 community nurses were qualified to prescribe from the ‘NPF for Community 
Practitioners’ (Nursing and Midwifery Council 2011) (renamed from NPF for HVs and DNs in 
2005). The formulary consists of a range of dressings, appliances, 13 prescription only medicines 
(POMs), some general sales list (GSL) medicines and pharmacy (P) medicines3. The formulary 
allows access to a range of wound management products, catheter care products, emollients, 
laxatives and head lice products. Prescribing training for CNPs is now integrated into community 
nurse specialist practitioner degree programmes. This means all newly qualified community nurses 
can prescribe (Department of Health 2006b).  
 
2.3.1.2 Prescribing for other HCPs (Crown Report II) 
Whilst prescribing rights for community nurses were being introduced the government set up 
another review under the direction of Dr June Crown. The purpose of this review, which was 
published in two reports (Department of Health 1998; Department of Health 1999), was to appraise 
the current situation in relation to group protocols, and to determine in what circumstances HCPs 
could undertake new roles with regards to the prescribing, supply, and administration of medicines. 
 
                                                 
3
 A prescription only medication is a licensed medicine that is regulated by legislation to require a prescription before it can be obtained. 
Only pharmacies may sell pharmacy medicine and a pharmacist must make or supervise the sale. General sales list medicines can be 
sold by a wide range of shops, such as newsagents, supermarkets and petrol stations. They do not require a prescription or a pharmacist 
to sell them. 
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Patient Group Directions (Crown Report II – Part 1: 1998) 
The first part of the Crown report, published in 1998, issued guidance on the supply and 
administration of medicines under group protocols. At the time there was concern about the legality 
of group protocols as it was thought that they were not meeting the requirements in some sections 
of the Medicines Act 1968 for the supply and administration of medicines to be in accordance with 
the directions of a doctor. It was thought that in order to meet these requirements protocols should 
leave the minimum of discretion for the HCPs involved (Baird 2003; Department of Health 1998). 
The report recommended that the current practice be continued, but with more stringent criteria in 
the form of Patient Group Directions (PGDs) (Department of Health 1998). First implemented in 
2000, a PGD enables the supply or administration of medicine in situations such as vaccinations 
and routine treatments. PGDs do not authorise the prescribing of medicine. There is no specific 
training for PGDs but organisations must ensure HCPs using PGDs are competent to do so 
(Department of Health 2006b).   
 
Independent Prescribing (IP) and Supplementary Prescribing (SP) (Crown Report II Part 2: 1999) 
The second part of Crown’s report, published in 1999, recommended that prescribing authority 
should be extended to other HCPs through two models of prescribing: independent prescribing and 
dependent prescribing. In the report an independent prescriber was described as a professional who 
is responsible for the initial assessment of the patient and for devising the broad treatment plan, 
with the authority to prescribe as part of that plan. A dependent prescriber (subsequently renamed 
as a supplementary prescriber) was defined as a professional who is authorised to prescribe certain 
medicines for patients whose condition has been diagnosed or assessed by a doctor or dentist 
within an agreed assessment and treatment plan. 
 
The implementation of Crown’s recommendations began with the introduction of IP for nurses in 
2002. Figure 2-1 presents a summary timeline of the implementation of non-medical prescribing in 
the UK. At the time, this type of prescribing was termed ‘Extended Nurse Prescribing’. It enabled 
all registered nurses and midwives with three years post registration clinical nursing experience to 
train to prescribe a limited range of medicines from the Extended Nurse Prescribers’ Formulary 
(ENPF). Initially the products listed in the ENPF were limited. However, in the years following 
2002 the ENPF expanded considerably and by May 2005 the ENPF included a list of around 240 
POMs, all GSL medicines and all P medicines (Department of Health 2006a). Training for nurses 
comprised 25 days taught theory over a three month period as well as 12 days of a period of 
learning in practice (PLP) with a designated medical practitioner (DMP). The purpose of the PLP 
was to provide the student with supervision, support and opportunities to develop competence in 
prescribing. 
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Figure 2-1: Summary Timeline of the Implementation of Non-Medical Prescribing in the UK 
Date 
 
Nurses and Midwives 
 
Pharmacists Allied Health Care  Professionals 
1986 Neighbourhood Nursing Review (Cumberledge Report) 
1989 Crown Report I - Community Nurse Prescribing 
1994 
 
Community nurses with 
appropriate qualification able 
to prescribe from the Nurse 
Prescribers’ Formulary 
(NPF) for District Nurses 
and Health Visitors (now 
NPF for Community 
Practitioners) in eight 
demonstration sites 
 
  
1996 
Pilots for community nurse 
prescribing extended to  
further sites 
  
1998 Crown Report II, Part 1 - Patient Group Directives 
 
December 
1998 
 
 
CNP is extended to all parts 
of the UK 
 
  
1999 Crown Report II, Part 2 - Independent and Supplementary Prescribing 
2002 
 
 
Extended nurse prescribing 
introduced 
 
  
 
April 2003 
 
SP introduced SP introduced  
April 2005   
 
SP introduced for 
Physiotherapists, 
Chiropodists, 
Podiatrists, 
Radiographers 
 
July 2005   SP introduced for Optometrists 
May 2006 IP introduced IP introduced  
June 2008   IP introduced for Optometrists 
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In April 2003, SP was introduced to nurses and pharmacists. Later that year, officials at the DoH 
undertook informal consultation on proposals to extend SP to AHCPs. The appropriate legislation 
to allow SP by AHCPs was eventually changed in 2005 (Department of Health 2005). As proposed 
by Crown, SP allows suitably trained HCPs to prescribe in partnership with an independent 
prescriber (i.e. doctor or dentist). The independent prescriber is responsible for the initial diagnosis 
and for setting up the parameters of the clinical management plan (CMP). The supplementary 
prescriber then has discretion in the choice of dosage, frequency, product and other variables in 
relation to medicines within the limits specified by the CMP. Within SP there are no legal 
restrictions on the conditions that can be treated (Department of Health 2005) and a supplementary 
prescriber can prescribe any medicine (including controlled drugs4 [CDs]) within the parameters of 
the CMP (Department of Health 2010d).  
 
To prepare nurses for SP, additional modules, comprising of one days teaching, were incorporated 
into their existing prescribing training course. A SP conversion course was made available for 
nurses that had previously qualified to prescribe as an extended nurse prescriber. SP training for 
pharmacists and AHCPs consisted of 25 and 26 taught study days respectively and 12 days of a 
PLP with a DMP. The curriculum for pharmacists and AHCPs was based on that for extended 
nurse prescribing but with components specific to SP (Department of Health 2005). The training 
for optometrists included components more specific to the eye (Department of Health 2006a).  
 
The introduction of SP for nurses meant they could prescribe using extended nurse prescribing and 
SP. However, though the products in the ENPF expanded considerably from 2002 to 2005, research 
at the time highlighted how the limited formulary was restricting benefit to patients and was 
limiting the efficiency of practice as nurses still had to rely on doctors for some prescriptions 
(Latter et al. 2005). The most common medicine additions desired by nurses at the time were a 
greater number of antibiotics, asthma medicine and respiratory medicine (Latter et al. 2005). As a 
result, in October 2005 the Committee on Safety and Medicines recommended to health ministers 
that nurses qualified as an extended nurse prescriber should be able to prescribe any licensed 
medicine5 for any medical condition within their competence. The proposal was accepted, and from 
May 2006 nurses were able to prescribe any licensed medication as well as specified CDs from the 
Nurse Independent Formulary (NIF) (renamed from the ENPF) (Department of Health 2006a). 
                                                 
4
 CDs are medicines controlled under the Misuse of Drugs Act. Examples of CDs include benzodiazepines, morphine, pethidine and 
methadone. Stricter legal controls apply to controlled medicines to prevent them being misused, being obtained illegally and causing 
harm. (NHS Choices 2009).  
5
 Licensed medicines are medicines which have marketing authorisation (MA). MAs are issued by the Medicines and Healthcare 
Products Regulatory Agency in the UK. Unlicensed medicines are medicines without MA. 
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Nurses were also able to prescribe licensed medicines off-label6 but were required to take full 
professional responsibility for their actions (Department of Health 2006a). 
 
In 2006, IP rights were also extended to pharmacists. Like nurses, pharmacists could prescribe any 
licensed medicine for any medical condition within their competence as well as licensed medicines 
off-label (Department of Health 2006a). Changes to legislation in December 2009 also meant both 
nurse and pharmacist prescribers could prescribe unlicensed medicine independently (Department 
of Health 2010a; Department of Health 2010c). Changes to legislation allowing the prescription of 
CDs by pharmacist prescribers have not been made. However, changes are likely to be 
implemented in the near future (Department of Health 2010c). From June 2008, optometrists were 
able to independently prescribe any licensed medicine (excluding CDs) for ocular conditions 
(Department of Health 2010b).  
 
To train pharmacists for IP an additional day was added to the SP course to bring pharmacists’ 
training in line with nurses and AHCPs at 26 taught study days and 12 days of a PLP. Components 
were added to reflect the increase in professional autonomy, clinical assessment and responsibility, 
and the associated legal and ethical implications. Conversion courses were made available for 
pharmacists and optometrists trained as supplementary prescribers wanting to become independent 
prescribers. Currently, minimum entry requirements for non-medical prescribing courses are 
standardised across higher education institutions in accordance with DoH guidelines. Table 2-1 
provides a summary of these requirements. 
 
 
                                                 
6
 The prescription of licensed medicine in a different manner (e.g. different dose, for a different patient age group, different 
administration) from that approved by the Food and Drug Administration (FDA) body. 
Table 2-1: Minimum Entry Requirements for Non-medical Prescribing Courses 
 Nurses Pharmacists AHCPs 
Registration with professional 
body Yes Yes Yes 
Post-registration clinical 
experience 3 years 2 years 3 years 
Number of years experience in 
prescribing field 1 year 1 year 1 year 
Education level capable of 
studying for Degree 
Higher Education 
Level 3 Degree 
Other criteria Support from the sponsoring organisation confirming a service need, 
access to a prescribing budget and a specified DMP 
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2.3.2 Non-Medical Prescribing in Practice: Benefits, Concerns and Barriers  
The DoH states that non-medical prescribing should ‘improve patient care without compromising 
patient safety, make it easier and quicker for patients to get the medicines they need, increase 
patient choice in accessing medicines, make better use of the skills of health care professionals and 
contribute to the introduction of more flexible team working across the NHS’ (Department of 
Health n.d.).  
 
 The literature suggests that the DoH’s expectation of benefit to patients, doctors and NMPs is 
fulfilled. Supplementary pharmacist prescribers feel, as a result of their prescribing role, patients 
benefit from better management and increased satisfaction (George et al. 2007). Similarly, nurse 
and pharmacist independent prescribers perceive that patients receive higher quality care, have 
more choice, have opportunities for longer consultations, receive more continuous care, benefit 
from a more convenient and timely service and are given more information about medicines 
(Courtenay and Berry 2007; Latter et al. 2010). Doctors too perceive similar patient benefits of 
non-medical prescribing (Courtenay and Berry 2007; Stewart et al. 2009b).  
 
Research with patients has also evaluated non-medical prescribing. Patients report similar benefits 
to those perceived by nurse prescribers, pharmacist prescribers and doctors. In earlier work patients 
consulting CNPs said they benefited from the greater expertise of the CNPs compared with general 
practitioners (GPs), a more responsive, timely and convenient service, greater continuity in their 
care, an improved relationship with their HCP and more information during consultations (Brooks 
et al. 2001; Luker et al. 1998). In more recent research patients consulting nurse independent 
prescribers in a dermatology service cited similar benefits of nurse prescribing. Patients said they 
benefited from more appointments, more flexible care, increased access to prescribers, high quality 
information relating to their medicines, greater continuity of care and said they experienced 
increased concordance and adherence to treatment regimens (Courtenay et al. 2011). Diabetic 
patients consulting nurse independent prescribers in primary care have highlighted nurses’ ‘non-
hurried’ and caring consultation style as well as improved access to medicines and better continuity 
of care (Stenner et al. 2011). In early evaluation work with patients of pharmacist supplementary 
prescribers patients said they were generally satisfied with the consultations, would recommend 
seeing a pharmacist prescriber to others and agreed they were provided with all the necessary 
information about their treatment. Patients also said it was easier to arrange an appointment with 
the pharmacist than their doctor and felt they had more time to discuss health-related issues 
(Stewart et al. 2008). In another study, patients consulting nurse and pharmacist independent 
prescribers said their appointments were longer than with their doctor. Of the patients surveyed, 
45% agreed that their condition was controlled better and that they were happier with their 
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medicines since seeing the NMP. Patients also said they had better access to medicine from the 
NMP than their doctor (Latter et al. 2010)  
 
Despite the obvious benefits of non-medical prescribing there is inconsistency in the attitudes of 
patients. In Stewart et al.’s study, 67% of patients said they would prefer to consult a doctor than a 
pharmacist. An even higher percentage of patients said they would prefer to consult a doctor if their 
condition worsened (Stewart et al. 2008). In Latter et al.’s study, between one in five and one in 
three patients believed they received safer care from their doctor than the nurse or pharmacist 
prescriber respectively. Some patients also felt doctors provided them with more information about 
non-drug treatments, how any medicine would help them and the possible side effects of the 
medicine (Latter et al. 2010). This research suggests patients have concerns about some aspects of 
non-medical prescribing. 
 
NMPs perceive, as a result of their prescriptive authority, that doctors’ relationships with them is 
improved and doctors’ time is used more effectively (Courtenay and Berry 2007; Hacking and 
Taylor 2010; Latter et al. 2010). Research has found doctors’ experiences of supplementary 
prescribing pharmacists matches NMPs own perceptions. Doctors have reported pharmacist 
prescribing improved team work and freed up their own time to spend on more acute patient cases 
(Stewart et al. 2009b). Similarly doctors interviewed regarding their experiences of nurse 
prescribing reported a reduction in their own workload. This view was confirmed by GP surgery 
managers in the same study who felt doctors’ workload had reduced significantly as health 
promotion issues had been taken up by nurse prescribers (Watterson et al. 2009). Weiss et al. also 
reported that doctors working with pharmacist supplementary prescribers felt a portion of their 
workload had been transferred to pharmacists. However, doctors felt transferred work was simply 
replaced by other demands (Weiss et al. 2006). Interestingly, 82% of the doctors surveyed in 
another study agreed non-medical prescribing saves them time but 43%, of the same sample, 
agreed that working with NMPs adds significant time to their workload because of the support 
NMPs need from them (Hacking and Taylor 2010). Similarly some pharmacists working with nurse 
prescribers have reported an increase in their workload due to time needed to support nurse 
prescribers (Watterson et al. 2009).   
 
Extending prescriptive authority has reportedly had benefits to the HCPs themselves. Pharmacist 
prescribers have said prescribing authority increases their job satisfaction, increases their self-
confidence, makes them more independent and provides more recognition from other HCPs 
(George et al. 2007). Nurse prescribers have also said their job satisfaction is improved and said 
prescribing brings greater opportunities for professional development (Courtenay and Berry 2007; 
Watterson et al. 2009). Nurse and pharmacist independent prescribers in other research have cited 
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similar benefits and added that prescribing authority enables better use of their skills and means 
their time is used more effectively (Latter et al. 2010). However, whilst NMPs clearly benefit from 
prescribing authority, some nurse prescribers have highlighted the increased pressure and workload 
prescribing duties bring (Watterson et al. 2009). 
 
Doctors and patients have expressed concerns about both nurse and pharmacist non-medical 
prescribing. Doctors have expressed concerns about the adequacy of the prescribing training, feel 
nurses and pharmacists are unprepared to conduct medical diagnoses and believe some NMPs may 
struggle to manage uncertainty arising from clinical practice (Blenkinsopp et al. 2008; Courtenay 
and Berry 2007; Crown and Miller 2005; Fisher 2010; Lloyd et al. 2010; Stewart et al. 2009b; Tann 
et al. 2010; Watterson et al. 2009; Weiss et al. 2006). Patients, on the whole, feel comfortable with 
nurse and pharmacists having a prescribing role (Stewart et al. 2009a). In one research study 
patients consulting pharmacists did not express too much concern regarding the concept of 
pharmacist prescribing (Stewart et al. 2009b). However, in other research, patients have expressed 
doubts about whether pharmacists are as knowledgeable as a doctor in prescribing medicines and 
many feel that a doctor should be involved whenever a pharmacist prescribes (Stewart et al. 
2009a). Hobson et al. also found that patients have concerns about the training and monitoring 
systems that are in place for pharmacist prescribers (Hobson et al. 2010). Patients also wish there to 
be safeguards for nurse prescribers and suggest GPs could check prescriptions. Patients have also 
expressed concerns about nurses’ diagnostic ability and emphasise how they should receive 
sufficient training and supervision (Watterson et al. 2009). However, presumably patients would 
expect all HCPs to have sufficient training and supervision. The issues surrounding the concerns 
raised by patients and doctors are not necessarily borne out in practice as nurse and pharmacist 
independent prescribers have found to be prescribing in clinically appropriate ways (Latter et al. 
2010). However evaluation of the clinical appropriateness of non-medical prescribing is clearly an 
area that will need continuous research.     
 
Post-qualifying not all qualified NMPs go on and use their prescriptive authority. Hacking and 
Taylor reported that 14% of 537 NMPs had not prescribed at all since qualifying (Hacking and 
Taylor 2010). Often there are also delays in the issuing of the first prescription by NMPs. Latter et 
al. reported that only 23% of nurses and 37% of pharmacists prescribed within one month of 
completing prescribing training. Furthermore 15% of nurses and pharmacists took longer than six 
months to issue their first prescription (Latter et al. 2010). Delays receiving prescription pads, 
managerial responsibilities, difficulties accessing patients’ notes, the availability of more 
appropriate services, insufficient support from doctors and other HCPs and time constraints were 
found, in earlier research, to be barriers to the use of prescriptive authority amongst CNPs (Hall et 
al. 2006). Similarly, research with pharmacist supplementary prescribers found that organisational 
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barriers (e.g. local Trust procedures, university systems), lack of funding, delay in prescription 
pads, and role changes delayed their use of SP (George et al. 2007; Tully et al. 2007). Recent 
research with nurse and pharmacist independent prescribers has found similar barriers are still 
delaying or preventing prescribing in some cases (Hacking and Taylor 2010; Latter et al. 2010). 
 
2.3.3 Profile of NMPs 
2.3.3.1 Number of Prescribers 
In April 2011 there were 23,280 nurses holding a SP or IP qualification on the Nursing and 
Midwifery Council (NMC) register. This represented an 18% increase from April 2010. In addition 
there were 33,899 CNPs on the register. Independent and/or supplementary nurse prescribers 
accounted for 3.5% and CNPs 5.1% of all practising nurses on the NMC register (Nursing and 
Midwifery Council 2011). It is likely that some CNPs were also independent and/or supplementary 
prescribers. There were 1,208 pharmacist independent prescribers and 1,471 pharmacist 
supplementary prescribers on the Royal Pharmaceutical Society of Great Britain (RPSGB)7 register 
in 2009 (Seston and Hassell 2010). Due to the staggered introduction of prescribing training for 
pharmacists8 the figures suggest that in 2009 there were 1,208 pharmacists trained as both an 
independent and supplementary prescriber and 363 pharmacists qualified as a supplementary 
prescriber only. In 2009 pharmacist prescribers accounted for 3% of all practising pharmacists on 
the RPSGB register (Seston and Hassell 2010). According to NHS Prescription Services there were 
103 AHCPs actively prescribing in 2010. The majority of the AHCPs prescribing were 
physiotherapists, chiropodists and podiatrists (NHS Prescription Services 2011). Numbers of 
AHCPs with a prescribing qualification but not actually prescribing are not currently available. 
 
2.3.3.2 Work Settings and Prescribing Environments 
Research shows that nurse and pharmacist prescribers work in a wide range of health care settings. 
Independent and supplementary pharmacist prescribers reportedly work in secondary care, primary 
care and the community pharmacy setting (Seston and Hassell 2010). Recent research has reported 
that primary care is the predominant setting for pharmacist prescribing (Latter et al. 2010). The 
NMC does not produce a breakdown of the care settings that nurse prescribers work. However, 
Hacking and Taylor surveyed 546 NMPs including 515 nurses, 16 pharmacists and 15 AHCPs. Of 
those surveyed, 46% worked for a primary care trust (PCT) and 21% worked for a GP surgery. The 
remainder worked for either an acute trust, mental health trust or in another setting (Hacking and 
Taylor 2010). Latter et al. concluded that, as with pharmacists, nurse prescribing operates 
                                                 
7
 The RPSGB is now separated into two bodies: the General Pharmaceutical Council (GPhC), which is the regulator for pharmacists, 
pharmacy technicians and pharmacy premises, and the Royal Pharmaceutical Society (RPS) which is the dedicated professional body for 
pharmacists in England, Scotland and Wales. 
8
 As the current prescribing course for pharmacist prescribers combines training for IP and SP and because the IP qualification for 
pharmacists has never been offered alone almost certainly all pharmacist independent prescribers will be supplementary prescribers. 
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predominantly within the primary care setting (Latter et al. 2010). This supports Hacking and 
Taylor’s findings. Latter et al. also reported that pharmacists were prescribing within the NHS 
acute trust setting, during home visits to patients, in care homes, nursing homes, at sexual health 
clinics and for NHS mental health trusts. Specific environments where nurse prescribers prescribed 
included in the NHS acute trust setting, during home visits to patients, NHS walk-in centres 
(WICs), family planning clinics, care homes, nursing homes, sexual health clinics, NHS mental 
health trusts, community midwifery, prisons, private hospitals, hospices and private clinics (Latter 
et al. 2010). 
 
2.3.4 Volume and Nature of Prescribing 
In the year to September 2010 non-medical prescribing accounted for 1.6% of the total volume of 
all prescriptions written in general practice in England. In total, 13.6 million prescriptions were 
written by nurse prescribers and a further 308,000 items were written by pharmacist prescribers. 
Furthermore, nurse and pharmacist prescribing, in the year to September 2010, increased by 11% 
and 78% respectively from the year beginning September 2008. AHCP prescribing is still in its 
infancy with only 1,790 prescription items written in the year September 2009 to September 2010 
(NHS Prescription Services 2011). Nurse prescribers have been found to prescribe within a wide 
range of treatment areas, the five most predominant of which are infections, asthma, diabetes, 
chronic obstructive pulmonary disease (COPD) and family planning. In the same study, 
hypertension, cardiology, asthma, coronary heart disease prevention and care of older people were 
found to be the main areas that pharmacists prescribe (Latter et al. 2010). Only 4% of pharmacists’ 
prescribing was in the infection treatment area compared with 15% of nurse prescribing (Latter et 
al. 2010). This suggests that nurses are involved more in the treatment of acute conditions than 
pharmacist prescribers.  
 
2.3.5 Prescribing Competency 
The NMC states that nurse prescribers should only prescribe within their level of experience and 
competence and within the requirements of their role (Nursing and Midwifery Council 2006). 
Likewise, the RPSGB state that pharmacist prescribers should only prescribe within their 
professional and clinical competence and expertise (Royal Pharmaceutical Society of Great Britain 
2007). A Competency Framework is provided to NMPs (National Prescribing Centre 2006) to be 
used to ensure prescribers possess the relevant competency to undertake a prescribing role, to help 
prescribers and their employers identify training and development needs and to support prescribers’ 
continued professional development (CPD). The Competency Framework is split into three main 
sections, ‘the consultation’, ‘prescribing effectively’ and ‘prescribing in context’. The key aspects 
of the Competency Framework are summarised in Table 2-2. The rather limited research in this 
area suggests that NMPs are prescribing within their perceived competency. For instance, Bradley 
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et al. reported that nurse prescribers’ perception of their competency influenced the areas that they 
selected to prescribe (Bradley et al. 2007). Other research has found despite receiving requests to 
prescribe outside their competency both nurse and pharmacist prescribers report they rarely do in 
practice (Bissell et al. 2008). Research suggests that NMPs are adhering to guidance from their 
professional body regarding competency. However, very little else is known about how prescribers 
select to use their prescriptive authority.  
 
 
2.3.6 Independent Prescribing versus Supplementary Prescribing 
The DoH has stated that IP is more appropriate where the NMP is competent to assess, diagnose 
and make treatment decisions for the patient, for conditions that the prescriber is competent to treat 
independently, and where the NMP works remotely from a doctor (Department of Health 2006a). 
The use of SP is considered more appropriate in the management of long-term medical conditions, 
where prescribing is undertaken as part of a team, where CDs are prescribed, where the NMP is 
newly qualified as a prescriber and in mental health settings (Department of Health 2006b). 
Table 2-2: Outline of the Competency Framework for NMPs 
Competency Area Competency Overarching Statements 
1. Clinical and Pharmaceutical 
Knowledge 
Has up-to-date clinical and 
pharmaceutical knowledge relevant to 
own area of practice. 
 
2. Establishing Options 
 
Reviews diagnosis and generates 
treatment options for the patient within 
the clinical management plan. Always 
follows up treatment. 
 
1. The Consultation 
 
 
 
3. Communicating with Patients 
 
Establishes a relationship based on trust 
and mutual respect. Sees patients as 
partners in the consultation. Applies the 
principles of concordance. 
 
4. Prescribing Safely 
 
Is aware of own limitations. Does not 
compromise patient safety, justifies 
prescribing decisions. 
5. Prescribing Professionally Works within professional and 
organisational standards. 
 
2. Prescribing 
Effectively 
 
 
6. Improving Prescribing Practice 
 
Actively participates in the review and 
development of prescribing practice to 
improve patient care. 
 
7. Information in Context 
 
Knows how to access relevant 
information. Can critically appraise and 
apply information in practice. 
 
8. The NHS in Context 
 
Understands, and works with, local and 
national policies and services that 
impact on prescribing practice. Sees 
how own practice impacts on the wider 
NHS. 
 
3. Prescribing in 
Context 
 
 
9. The Team and Individual 
Context 
 
Works in partnership with colleagues 
for the benefit of patients. Is self-aware 
and confident in own ability as a 
prescriber. 
Source: (National Prescribing Centre 2006) 
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Evidence that the recommendations regarding the use of IP and SP are followed by NMPs in 
practice is inconclusive. Earlier research with mental health nurses found that three quarters of the 
sample were using SP rather than IP (Snowden 2008). However, more recently Latter et al. found 
that much of the prescribing by nurse and pharmacists independent prescribers was for conditions 
considered long-term (e.g. asthma, diabetes, COPD, hypertension) (Latter et al. 2010). Hacking and 
Taylor reported only 9% of the NMPs in their study were using SP only, 92% of the NMPs were 
using IP and SP and 67% of the NMPs were using IP only. The 15 AHCPs included in the sample 
are likely to account for some of those using SP only (Hacking and Taylor 2010). The research 
suggests prescribers that can are using IP rather than SP. Some prescribers view CMPs as 
restrictive, cumbersome and time consuming (Bissell et al. 2008). It may be these views that 
underlie prescribers’ preferences for IP rather than SP. If legislation allowing the prescription of 
CDs by pharmacists is changed the use of SP could be reduced further. In the forthcoming years it 
may be important to evaluate the usefulness of the SP model.  
 
2.4 Prescribing Influences 
This section of the chapter provides a description of the current literature relating to prescribing 
influences. 
 
2.4.1 Literature Search Strategy 
A literature search was conducted using the search terms provided in Box 2-2. The search terms 
were kept broad to avoid rejecting papers relevant to the topic. This search strategy was applied to 
those databases outlined in Appendix 2.0. Grey literature sources were also searched (see Appendix 
1.0). The dates selected for the search were 1994 to present for NMPs and 1975 to present for 
doctors. For the NMPs search it was felt that searching earlier than 1994 would be unlikely to yield 
any relevant papers as the first form of non-medical prescribing was not introduced until 1994 in 
the UK. Prescribing by dentists was not included in the literature search because prescribing by 
dentists accounts for a small percentage of the overall NHS prescribing cost (see Section 2.2.2). 
Dentists only prescribe a limited range of medicine for specific complaints and work and prescribe 
within a unique setting specific to dentistry. The broad aim of the literature search was to identify a 
wide range of papers relating to the factors influencing NMPs and doctors’ prescribing decisions. 
The aim of the non-medical prescribing literature review was to identify gaps in understanding 
concerning the influences on NMPs’ prescribing. 
 
The search yielded 14 relevant papers relating to the influences on non-medical prescribing. The 
vast majority of the papers identified through the search focused on CNPs or NMPs outside the 
UK. Two papers addressed some of the influences on nurse independent and/or supplementary 
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prescribers but did not specifically focus on this topic. No papers were identified that examined the 
influences on the prescribing of pharmacists or AHCPs. 
 
There were no strict inclusion and exclusion criteria for the papers about doctors’ prescribing. The 
author used research papers she felt were most relevant to the topic. No preference was given to 
papers in either primary or hospital and secondary care but it became evident that much of the 
research focusing on prescribing influences has been conducted with GPs. Generally, UK papers 
were used over non-UK papers and more recent papers were selected over less recent papers. 
However, where non-UK papers and older papers were considered to contribute to understanding 
prescribing influences, more than other papers, they have been included in the review. New 
references, identified through reading papers generated by the search, were also read and included 
in the review if they were relevant to the topic. 
 
 
 
 
 
 
 
 
2.4.2 Influences on Prescribing 
The main categories of prescribing influences, identified through the literature search, were as 
follows: regulatory factors (i.e. guidelines, formularies, healthcare managers), cost, patient factors, 
colleagues, professional and personal experience, others’ prescribing behaviour and prescribing 
culture, research findings, logistical factors, diagnostic uncertainty and the pharmaceutical industry. 
The literature, for both doctors and NMPs, within each of these areas is discussed in this section of 
the thesis. 
 
2.4.2.1 Guidelines, Formularies and Healthcare Managers 
Both GPs and hospital doctors report that guidelines influence their prescribing decisions. 
Examples of guidelines in the literature include National Institute for Health and Clinical 
Excellence (NICE) guidelines, surgery guidelines, PCT guidelines, protocols and treatment 
pathways. Wood et al. interviewed GPs in order to explore the reasons for their choice of 
prescribed antibiotic. Many GPs reported that what was stated in the guidelines in relation to 
antibiotics influenced their prescribing decisions (Wood et al. 2007). Hospital doctors of all 
experience levels also select medicine based on protocols and guidance (Higgins and Tully 2005). 
Box 2-2: Key Search Terms used for Literature Searches 
Factors influencing Non-Medical Prescribing Decisions: Search Terms 
Sources, Information, Influences, Impact, Pressure, Factors, Community Nurse, Nurse, Pharmacist, 
Supplementary, Independent, Nurse Practitioner, Optometrist, Physiotherapist, Chiropodist, Podiatrist, 
Radiographer, District Nurse, Health Visitor, Non-Medical,  Prescribing, Prescribing Behaviour. 
Factors influencing Doctors’ Prescribing Decisions: Search Terms 
 Sources, Information, Decision-making, Influences, Impact, Pressure, Factors, Medical, Doctor, 
Prescribing, Prescribing Behaviour 
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Swedish hospital doctors have said they are particularly influenced by guidelines if they are 
prescribing outside their area of clinical expertise (Ljungberg et al. 2007). Doctors do not, however, 
feel obligated to conform to guidelines and deviation is also common. GPs in Wood et al’s study, 
initially described above, stated that prescribing contrary to the recommendations of guidelines was 
justified when it coincided with the patient’s best interests (Wood et al. 2007). Wathen and Dean 
assessed the impact of five NICE technology appraisals on the prescribing patterns of GPs. They 
found that overall NICE guidance in isolation had minimal impact on GPs’ prescribing patterns. If 
NICE guidance was considered out-dated or if the GP had conflicting advice from other sources 
then NICE guidance had no perceived impact on prescribing (Wathen and Dean 2004).  
 
Although much is known about the influence of guidelines on doctors’ prescribing decisions there 
is a limited understanding about how guidelines influence NMPs. The only research that does exist 
is with CNPs. This research found CNPs are influenced by guidelines in most circumstances. CNPs 
stated that they only deviate from guidelines in ‘exceptional circumstances’ on the grounds of lack 
of efficacy, reduced treatment duration, patient compliance, and more appropriate product choice. 
However, CNPs deviating from guidelines were all experienced practitioners who prescribed more 
frequently (Hall et al. 2004). Further research is required, especially with NMPs with full 
prescriptive authority, to expand the understanding of how guidelines influence NMPs’ prescribing.   
 
A formulary is a list of medicine that doctors or other prescribers may prescribe from. Prescribers 
are normally requested or required by management to use only formulary medicine unless there are 
valid medical reasons to use non-formulary medicine. Formularies can be implemented at various 
levels, including national level (e.g. BNF), PCT level, hospital level or surgery level. Formularies 
can include recommendations in regards to prescribing as guidelines do. Formularies have been 
found to influence the prescribing behaviour of doctors. Schumock et al. asked 150 United States 
(US) doctors, clinical pharmacists and formulary committee members to rate the importance of a 
list of factors thought to influence drug prescribing. All respondents rated drug formulary status as 
highly influential (Schumock et al. 2004). Clearly the US respondents’ interpretation of the term 
‘formulary’ may be different from UK doctors. However, UK research has noted similar findings. 
For instance GPs based in the UK have described how their choice of antibiotics is influenced, 
amongst other reasons, by their practice formulary (Wood et al. 2007). However, whilst doctors do 
take formulary recommendations into consideration they also feel comfortable to prescribe 
medicine not on their formulary. Jacoby et al. found that in response to clinical circumstances GPs 
reported they chose medicine not available on the formulary (Jacoby et al. 2003). 
 
The BNF has been cited as a source of influence by CNPs (Hall et al. 2003) but the impact of 
formularies on NMPs has not been explored in-depth. In earlier research Hall et al. described the 
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inconsistency in the provision of local formularies for CNPs (Hall et al. 2004). However, with the 
expansion of non-medical prescribing, it might be that formularies for NMPs are now more 
prevalent. More research in this area is needed to understand whether the recommendations of 
formularies influence NMPs and if NMPs, like doctors, feel comfortable deviating from these 
recommendations.  
 
GPs describe how NHS managers make them more accountable for their prescribing behaviour 
which ultimately influences their decisions (Prosser and Walley 2007). Whilst some GPs have 
welcomed discussions with NHS managers and found them a useful source of support others have 
said they resent the advice they have been given. Some GPs refer to ‘advice’ from NHS managers 
as ‘political’, ‘managerial meddling’, ‘cost-cutting’ and ‘inspecting’ (Carthy et al. 2000; Prosser 
and Walley 2007). Some GPs have challenged managers authority to control their prescribing 
behaviour and regard managers as not possessing sufficient information to engage in clinical 
decision making processes (Prosser and Walley 2007). It is not clear how NMPs respond to advice 
from healthcare managers. The currently limited research suggests NMPs have positive attitudes 
towards NHS managers. Nurse independent and supplementary prescribers prescribing in acute and 
chronic pain have welcomed formal agreements with PCT managers, such as the ‘intent to 
prescribe’ agreement, because they considered them useful in helping them to resist patient 
pressure (Stenner and Courtenay 2008). Further research on this topic, particularly with pharmacist 
prescribers and AHCP prescribers, would be clearly beneficial. 
 
2.4.2.2 Cost 
Doctors report that medicine cost can influence their prescribing decisions. Greenfield et al. 
investigated the factors influencing GPs’, cardiologists’ and practice nurses’ decisions to prescribe 
preventative treatment for coronary heart disease. Approximately one quarter of the participants 
who took part in the study regarded medicine cost as an important influence on their prescribing 
decisions and others mentioned other cost factors (e.g. cost of long-term monitoring of patients) 
(Greenfield et al. 2005). GPs have also described prescribing generic and cheaper products in order 
to reduce drug costs (Jacoby et al. 2003). However, other factors sometimes take precedence over 
cost. In Ljungberg et al.’s study Swedish hospital doctors said they prioritised their knowledge and 
experience over cost considerations (Ljungberg et al. 2007). Similarly Prosser and Walley found 
hospital doctors were willing to adhere to initiatives to prescribe therapeutically equivalent 
substitutions to save cost but still wished to prescribe more expensive drugs if they felt they 
improved the quality of prescribing for their individual patients (Prosser and Walley 2006). Whilst 
cost can clearly influence doctors’ they reject an entirely cost orientated agenda.  
 
 37 
CNPs also take cost, as well as other factors associated with cost, into consideration when 
prescribing. Hall et al. reported that when DNs assessed the cost of prescribing wound management 
products they considered a range of issues including product cost, time required to heal the wound, 
the number of dressing changes and the likely adherence of the patient (Hall et al. 2003). Although 
cost is considered by CNPs, PCT prescribing leads have said controlling the cost of community 
nurse prescribing is not a high priority for them (Hall et al. 2004). However it would be 
unsurprising if, because of the changes in the volume and range of NMPs since this research was 
conducted, PCTs now place more emphasis on the cost associated with non-medical prescribing. It 
may be that NMPs now face more pressure in relation to cost. Whether this is the case and how this 
influences their prescribing needs to be explored with further research.  
 
2.4.2.3 Patients 
Clinical patient factors, such as patients’ age, clinical need for the medicine, the extent and nature 
of co-morbidities, patients’ family history, patients’ lifestyle habits and current medication have 
been reported to influence doctors’ prescribing decisions (Bendtsen et al. 1999a; Greenfield et al. 
2005; Tobin et al. 2008). Other, less clinical, patient factors, such as patients’ financial status, 
likely adherence, location, living conditions and character, have also been found to influence 
doctors’ prescribing (Bendtsen et al. 1999a; Buusman et al. 2007; Carthy et al. 2000; Greenfield et 
al. 2005; Kumar et al. 2003; Ljungberg et al. 2007; Tobin et al. 2008). CNPs have also said they are 
influenced by patients’ financial status and social situation (Hall et al. 2003; Luker et al. 1998). For 
instance CNPs have said they are more likely to prescribe, rather than recommend an over the 
counter (OTC) product, for those exempt from prescription charges and will recommend an OTC 
product, rather than prescribe, if it would work out cheaper for the patient (Luker et al. 1998). DNs, 
in Hall et al.’s study, described how they prescribed products that they believed would prevent non-
adherence and minimum disruption to the patient’s daily activities (Hall et al. 2003).  
 
Doctors have cited patient pressure as an influence on their prescribing decisions (Bradley 1992a; 
Petursson 2005; Stevenson et al. 1999). For instance, in Stevenson et al.’s study, GPs interviewed 
said they had experienced pressure for a prescription from patients and said that this pressure led 
them to prescribe when they would not otherwise have done so (Stevenson et al. 1999). 
Furthermore, patient expectation is often blamed for non-pharmacological or non evidence-based 
prescriptions (Petursson 2005). Petursson asked Icelandic GPs for the reasons behind their non-
pharmacological prescribing of antibiotics. All GPs cited pressure from patient or family as the 
main reason for their decision (Petursson 2005). Lewis and Tully used the critical incident 
technique to investigate the influences on hospital doctors’ prescribing decisions by exploring what 
they found uncomfortable when prescribing. In nearly half of incidents where the doctor reported 
patient pressure the patient was prescribed the medicine requested. In many of these incidents the 
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prescribing was considered inappropriate by the prescriber (Lewis and Tully 2011). Doctors report 
that other factors, such as insufficient time and uncertainty, make it particularly difficult to resist 
patient pressure (Carthy et al. 2000; Coenen et al. 2006; Miller et al. 1999). These issues are 
discussed further in Section 2.4.2.8 and Section 2.4.2.9 respectively. 
 
Research employing quantitative techniques has provided further insight into patient pressure. 
Evidence suggests when a patient expects a prescription they are more likely to be given a 
prescription by the doctor (Macfarlane et al. 1997; Webb and Lloyd 1994). Cockburn and Pit found 
that when a patient expected medication they were three times more likely to be prescribed a 
medication than when the patient did not expect any medication. However, when the GP thought 
that the patient expected medication they were 10 times more likely to be prescribed a medication 
than when the GP thought the patient did not expect any medication (Cockburn and Pit 1997). This 
suggests that doctors’ assessments of patients’ preferences have more influence than patients’ 
preferences themselves. Clearly this makes it all the more important that doctors’ perceptions are 
accurate. However, studies have found that in many cases doctors overestimate patients’ 
expectations for prescriptions (Little et al. 2004; Macfarlane et al. 1997). 
 
CNPs also experience patient pressure in relation to prescribing (Hall et al. 2003; Luker et al. 
1998). HVs in Hall et al.’s study reported they felt particular pressure to prescribe free supplies of 
OTC medicines to patients who were exempt from prescription charges (Hall et al. 2003). In one 
study CNPs reported that patient pressure led them to prescribe some items that they would not 
otherwise have prescribed (Luker et al. 1998). More recently Weiss et al. compared WIC nurses’ 
and GPs’ perceptions of the influence of patients on their supply of an antibiotic to patients with an 
acute respiratory tract infection. The study found that GPs were more likely than nurses to report 
that the patient expected an antibiotic and were more likely to report being influenced by patient 
expectations (Weiss et al. 2004). Whilst Weiss et al.’s findings are important it is unknown how 
applicable the findings are to NMPs because the nurses in the study were using PGDs and not 
actually prescribing. The study however lays foundations for further research about patient pressure 
with NMPs. Given that research has already been conducted with CNPs it is important that future 
research focuses on other NMPs. 
 
Doctors’ desire to stay on good terms with their patients also influences their prescribing. In some 
cases this leads to in inappropriate prescribing. For instance, Coenen et al. found that concern for 
the doctor-patient relationship and GPs’ wish to be ‘nice’ to their patients played a role in over 
40% of deviations from good general practice (Coenen et al. 2006). Butler et al. found that both 
patients and doctors saw the doctor-patient relationship as important and were keen to avoid 
conflict. In many situations where antibiotics were prescribed doctors knew that they offered 
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marginal effectiveness yet often prescribed to maintain good relationships with patients (Butler et 
al. 1998). In some cases doctors’ fear that they may ‘lose’ their patients to another GP or practice 
motivates them to prescribe unnecessary medicines (Dybwad et al. 1997). The fear of loosing 
patients to other GPs has found to be particularly influential on doctors in countries where GPs are 
paid to maintain a certain number of patients in their surgery (Hassell et al. 2003). It would be 
unsurprising if, like doctors, NMPs also want to maintain good relationships with their patients. 
However, further research is needed to explore if the desire for good patient relationships 
influences their prescribing.  
 
2.4.2.4 Colleagues 
Influence of GPs 
CNPs have said GPs have a limited influence on their prescribing decisions (Hall et al. 2003; Luker 
et al. 1998). In one study, CNPs said they use GPs as an information source for specific conditions, 
such as bowel management, but regarded their knowledge superior to GPs for many conditions that 
they treated (Hall et al. 2003). There is little research that has examined how GPs influence 
independent and supplementary NMPs. It may be that because NMPs now manage a wider range of 
conditions, for which they are not necessarily the expert like CNPs, they may consult GPs more 
than CNPs do when making prescribing decisions. Additional research is needed to explore this 
area in detail. 
 
Hospital and Secondary Care Practitioners 
Hospital doctors have been found to influence GPs’ prescribing behaviour (Buusman et al. 2007; 
Eccles et al. 1996). For instance, in a UK study, Eccles et al. found that hospital doctors were 
particularly influential on GPs’ prescribing in the areas of schizophrenia, diabetes, ischemic heart 
disease as well as other conditions (Eccles et al. 1996). Similarly, Buusman et al. investigated how 
Danish GPs choose between drugs in the same therapeutic drug group. In the study many of the 15 
GPs stated that recommendations from the local hospital had a significant impact on their 
prescribing habits (Buusman et al. 2007). CNPs have previously cited clinical specialists as a 
source of information (Hall et al. 2009). However, the relationship between NMPs in primary and 
community care and hospital and secondary care practitioners has not been explored at all. Further 
research is needed to understand more about this relationship and how, if at all, it influences 
NMPs’ prescribing. 
 
Influence of Pharmacists 
Doctors believe pharmacists exert little influence on their prescribing behaviour (Carthy et al. 
2000; Schumock et al. 2004). GPs acknowledge community pharmacists fail-safe role in 
identifying prescription errors but admit they rarely exploit pharmacists in terms of prescribing 
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decision-making support (Carthy et al. 2000). In the US context there is also evidence of nurse 
prescribers preferring other sources of drug information, such as research and pharmaceutical 
representatives, than pharmacists (Clauson et al. 2009). However, Hall et al. found CNPs receive 
support from community pharmacists in the form of information on products, drug interactions and 
OTC products (Hall et al. 2003). Independent and supplementary nurse prescribers have also said 
they value pharmacists as a source of information and advice on CDs and drug interactions 
(Stenner and Courtenay 2008). Whilst there is clearly evidence of a cooperative relationship 
between CNPs and community pharmacists it is unclear the extent to which NMPs use community 
pharmacists for help with medicine choice and selection. Future research needs to address this 
question specifically. It may also be interesting to explore the interaction between pharmacist 
prescribers and other pharmacists.  
 
Peers 
Doctors’ attitudes towards the influence of other doctors on their prescribing practice vary 
considerably. Hospital doctors seek the advice of colleagues they regard as more knowledgeable 
about a particular aspect of prescribing (Ljungberg et al. 2007) and those more experienced (Lewis 
and Tully 2009b). GPs interact with colleagues about medicine issues at surgery meetings (Prosser 
et al. 2003; Wood et al. 2007) and favour the advice of those they regard as more up-to-date due to 
more recent hospital experience (Armstrong et al. 1996). However, other GPs have described how 
they rarely meet with colleagues to compare prescribing. In Carthy et al.’s study GPs explained 
their reluctance to compare prescribing with their GP colleagues was due to confidence in 
prescribing ability and fear of criticism (Carthy et al. 2000). Similarly, in Prosser et al.’s study, GPs 
reported that colleagues had little influence on their prescribing of new drugs (Prosser et al. 2003). 
 
The literature points to a cooperative relationship between nurse prescribing colleagues. CNPs have 
stated that other nurse prescribers influence their prescribing behaviour through informal 
discussion and exchange of ideas (Luker et al. 1998). Nurse independent and supplementary 
prescribers have described how peer support from other nurse prescribers is an important source for 
gaining information and trouble shooting, provides encouragement, boosts confidence and helps 
with teamwork (Stenner and Courtenay 2008). Peer support appears to be more important to NMPs 
than it does for some GPs. However, it is unknown whether NMPs, other than CNPs, feel their 
prescribing decisions are influenced by their colleagues.    
 
Influence of Nurses 
Research suggests that nurses’ influence on doctors’ prescribing decisions is varied. On the one 
hand junior doctors rely on experienced nurses when making prescribing decisions in hospital 
(Pearson et al. 2002). Nurses too say they are actively involved in the prescribing process, by 
 41 
writing out prescriptions for doctors to sign, recommending treatment and discussing treatment 
options with doctors (Jutel and Menkes 2010). Indeed nurses doing everything but signing 
prescriptions was one of the reasons that non-medical prescribing was introduced. However, 
nurses’ involvement in prescribing is sometimes interpreted as pressure by doctors. In Wood-
Mitchell et al.’s study, psychiatrists described the pressure from nurses, as well as other care home 
staff, to prescribe medicine for patients with dementia (Wood-Mitchell et al. 2008). Hospital 
doctors report pressure from nurses for medicine as a cause of discomfort in their practice (Lewis 
and Tully 2009b). As yet no research has examined how the relationship between NMPs and nurses 
influences their prescribing. Research is needed to understand if NMPs experience similar 
pressures from nurses, as doctors do, and, if they do, how they respond to this pressure.  
 
2.4.2.5 Professional and Personal Experience 
Doctors report that their personal and professional experience influences their prescribing 
decisions. In Wood-Mitchell et al.’s study psychiatrists reported their prescribing decisions were 
based on familiarity and past experience of a drug. Psychiatrists reported using a small group of 
medications that they had experience of as well some common ‘preferred’ medications (Wood-
Mitchell et al. 2008). Where doctors’ professional experience contradicts scientific evidence 
doctors favour their experience. For instance, in Schwartz et al.’s study, doctors defended their use 
of vasodilators, despite contradictory research evidence suggesting that other products are more 
effective, on the grounds that their clinical experience, generated from years of practising ‘real-
world medicine’, was more applicable to clinical practice than academic studies (Schwartz et al. 
1989). Research also suggests that those with less experience are influenced by professional 
experience less when prescribing than more experienced colleagues. Dutch junior doctors have 
indicated that clinical experience influences them, but less so compared with more experienced 
colleagues such as consultants and GPs (Tichelaar et al. 2010). It may be that less experienced 
doctors use clinical experience less than more experienced doctors simply because they have less 
experience to draw upon.  
 
The study by Tichelaar et al., although of limited comparison with UK prescribers because of the 
Dutch sample, raises questions about how NMPs, as relatively inexperienced prescribers, are 
influenced by their own experience. Research with CNPs found that they draw on past professional 
experience when making prescribing decisions (Hall et al. 2008). Personal experience also 
influences US nurse prescribers’ prescribing decisions within the field of chronic pain (Fontana et 
al. 2000). Despite this research, there is clearly a rather limited understanding of this area. In 
further research it may be interesting to explore the question, relating to inexperienced prescribers, 
raised by Tichelaar et al.’s study.  
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2.4.2.6 Behaviour of Others and Prescribing Culture 
There is evidence that doctors’ prescribing behaviour is influenced by the prescribing behaviour of 
others as well as by prescribing culture. There are a number of examples of this in the literature. 
For instance, sometimes GPs can feel obliged to continue prescriptions of medicines initiated by a 
hospital consultant (Armstrong and Ogden 2006; Buusman et al. 2007; Cantrill et al. 2000). 
Hospital doctors have reported that they prescribe in accordance with ‘therapeutic traditions’ which 
are not necessarily evidence-based (Ljungberg et al. 2007). Bishop et al. and Cavazos et al. 
reported that aspects of decision making, including prescribing, were influenced by informal ‘rules’ 
which dictate practice (Bishop et al. 2011; Cavazos et al. 2008). GPs report that the use of a new 
medicine by a hospital consultant gives it acceptability and encourages them to use it themselves 
(Jones et al. 2001; Prosser et al. 2003).  
 
CNPs, like doctors, are reluctant to change prescriptions initiated by hospital consultants (Hall et 
al. 2009). CNPs also look to the prescribing patterns of their immediate colleagues to guide their 
own practice (Hall et al. 2008). US nurse prescribers have reported their prescribing decisions are 
influenced by the customary prescribing practices of others, even practices not clinically 
appropriate (Fontana et al. 2000). There is evidence of both doctors and CNPs following the 
prescribing behaviour of others and conforming to prescribing culture. However, as this topic has 
not been explored with NMPs in the UK with full prescribing authority there is a need for further 
research in this area. 
 
2.4.2.7 Research Findings 
Doctors claim that the prescribing decisions they make are influenced by evidence from journals 
and research findings (Wood et al. 2007; Wood-Mitchell et al. 2008). Evidence suggests specialists 
are influenced by such sources more than GPs. In Allery et al.’s study GPs and consultants were 
asked to give the reasons for the change in their clinical practice. In the study hospital consultants 
cited literature as a source of influence more than GPs did (Allery et al. 1997). Although Allery’s 
findings were for changes in all types of clinical practice, and not just prescribing, a Dutch study 
similarly found clinical specialists rated scientific literature as more important in their drug choice 
than GPs and medical students (Tichelaar et al. 2010). The use of research to inform prescribing 
decisions is aligned with the principles of evidence-based medicine (EBM). EBM has been defined 
as the ‘conscientious, explicit, and judicious use of current best evidence in making decisions about 
the care of individual patients’ (Sackett et al. 1996, pg. 71). Despite being encouraged to adhere to 
the principles of EBM not all prescribing decisions made by doctors are evidence-based (Miller et 
al. 1999; Petursson 2005). Some doctors reject research findings because the research sample does 
not reflect the patients they manage (Wood et al. 2007; Wood-Mitchell et al. 2008). Furthermore, 
when discrepancies between their own experiences and the research emerge some doctors favour 
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their own experience (Wood-Mitchell et al. 2008). Other factors such as patient pressure (see 
Section 2.4.2.3) and time pressures (see Section 2.4.2.8) can also lead doctors to prescribe against 
available evidence.  
 
Evidence suggests NMPs’ exposure to and use of research in their practice is varied. In one study 
independent nurse prescribers’ responses to the question of how frequently they used evidence in 
their prescribing practice ranged from ‘not very often’ to ‘fairly regularly’ (Banning 2005). Nearly 
half of US nurse prescribers in another study rated published studies in journals as their preferred 
drug information source (Clauson et al. 2009). Clearly more research is needed with NMPs to 
understand their use of research findings in their prescribing practice. More research is needed with 
pharmacists and AHCPs as there is currently no research with this group of HCPs. 
 
2.4.2.8 Logistical Factors 
Doctors admit that time and workload pressures influences their prescribing behaviour. In many 
studies GPs have described how insufficient time in consultations leads to unnecessary 
prescriptions of drugs and reduced prescribing quality (Buusman et al. 2007; Carthy et al. 2000). In 
one study Kumar et al. looked at why GPs prescribe antibiotics to patients. GPs in the study stated 
they often prescribed antibiotics to patients as a result of the daily pressure, to make the 
consultation quick and therefore catch-up on time or relieve stress of clinical practice, and because 
they did not have time during the consultation to explain to the patient why antibiotics were not 
necessary (Kumar et al. 2003). Petursson also suggests that GPs use prescriptions as a means to 
ending a consultation with a patient and managing their workload (Petursson 2005). Carthy et al. 
also found that GPs regard patient pressure to be a key influence on their prescribing behaviour and 
whether they resisted this pressure depended on the amount of time available (Carthy et al. 2000). 
Britten suggested that GPs simply do not have enough time to negotiate an alternative to a 
prescription with the patient (Britten 1995). The anticipated workload arising from certain 
prescribing decisions also influences GPs’ decisions. GPs have described how it is easier to 
prescribe benzodiazepines to patients than deal with the extra workload associated with dealing 
with the patient’s addiction to the drugs (Bendtsen et al. 1999b). Similarly, GPs have described 
how prescribing a broader spectrum antibiotic lessens the need for the patient to re-present due to 
treatment failure which reduces demand on the surgery as a whole (Wood et al. 2007).  
 
NMPs, like doctors, report experiencing time pressures in their practice. Nurse independent 
prescribers have highlighted the increased pressure and workload that prescribing authority brings 
(Watterson et al. 2009). HVs in Hall et al.’s study described the time and workload pressure they 
experienced during clinics meant that it was not feasible to prescribe. Some HVs managed this 
pressure by concealing the fact they could prescribe so they could avoid writing prescriptions (Hall 
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et al. 2009). Paradoxically, some CNPs also feel they have more time to spend with patients. Hall 
et al. reported that CNPs considered this extra time led to a reduction in unnecessary prescriptions 
because they were able to use this time to explain to patients why the prescription was not needed 
(Hall et al. 2003). More research is needed to understand whether NMPs with full prescriptive 
authority feel time pressure and how any pressure influences their prescribing.  
 
2.4.2.9 Uncertainty  
Research indicates that diagnostic uncertainty can cause over prescribing. Studies have suggested 
that when doctors are unsure about a diagnosis their prescribing threshold is lowered making them 
more susceptible to factors such as patient, time and workload pressure (Miller et al. 1999; 
Petursson 2005). In one US study, Miller et al. investigated the influence of perceived patient 
demand on doctors’ prescribing of anti-infective drugs. Doctors reported that patient demand had 
little influence on their prescribing behaviour but when uncertain about clinical need for an anti-
effective over one third of patients were prescribed one and doctors reported that they were 
influenced by patients in over half of these cases (Miller et al. 1999). Petursson found that lack of 
continuity in medical care and uncertainties regarding diagnosis are factors that tend to be 
conducive to a doctor feeling insecure or anxious. Petursson suggested that this insecurity, 
uncertainty or anxiety then contributes to non-pharmacological prescriptions (Petursson 2005).  
 
Doctors have been found to manage uncertainty in a number of ways. Di Caccavo and Reid termed 
the management strategy, whereby doctors use a prescription to reduce clinical uncertainty, as 
‘hypervigilance’. Di Caccavo and Reid also highlighted how doctors use ‘defensive avoidance’, 
where they pass the decision on to another person, to mange their uncertainty (Di Caccavo and 
Reid 1995). Similarly Bendsten et al. found that Swedish doctors managed dilemmas relating to 
prescribing opiods by either seeking agreement with the patient or consulting external resources 
(e.g. discussion with a colleague, referral to a clinic) (Bendtsen et al. 1999a). There is little 
discussion in the literature about how NMPs manage uncertainty in their prescribing practice which 
highlights the need for further research in this area.   
 
2.4.2.10 Pharmaceutical Industry 
Pharmaceutical companies, and more specifically pharmaceutical representatives, seek to 
encourage HCPs with prescriptive authority to use and prescribe their company’s products to 
generate maximum profit for their company. The activities of pharmaceutical companies may 
include the following: promotional visits, presentations by representatives, sponsored training or 
conferences, personal gifts, gifts for the hospital or practice and free samples. On the one hand 
research illustrates that doctors value the activities of the pharmaceutical companies. Both GPs and 
hospital doctors find representatives convenient and an up-to-date information source (Ljungberg et 
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al. 2007; Prosser and Walley 2003; Tobin et al. 2008). However, although doctors recognise the 
value of the activities of the pharmaceutical industry they believe that some of the information 
provided by the industry is ‘biased’, ‘selective’ and ‘exaggerated’ (Prosser and Walley 2003). 
Evidence suggests that the activities of the pharmaceutical industry influence doctors’ prescribing 
behaviour (Muijrers et al. 2003; Watkins et al. 2003). However, when asked, doctors play down the 
impact of the pharmaceutical industry on their prescribing. GPs express confidence in their ability 
to withstand commercial sales pressure (Carthy et al. 2000) and feel they can resist pressure from 
sales representatives by selecting only relevant information (Prosser and Walley 2003).  
 
The available research relating to the influence of the pharmaceutical industry on NMPs provides a 
similar picture to that of doctors. Early research with CNPs reported that the majority had only 
limited contact with representatives (Luker et al. 1998). Those that did have contact considered the 
pharmaceutical industry a helpful source of information (Hall et al. 2003). Like doctors, CNPs and 
nurse independent/supplementary prescribers have expressed their resolve to withstand any 
pressure from pharmaceutical representatives and maintain evidence-based prescribing (Lewis-
Evans and Jester 2004). In contrast, nurse prescribers in the US admit that the activities of the 
pharmaceutical industry influence their prescribing in some manner (Kessenich and Westbrook 
1999; Ladd 2005). However, this difference in attitude may be a reflection of the US healthcare 
system which may have different regulations regarding marketing of medicine to HCPs. Clearly, 
further research with UK NMPs is warranted. Research with a sample larger and more diverse than 
that in Lewis-Evans and Jester’s study, of only seven nurses, would improve the understanding of 
this area. 
 
2.5 Summary 
Due to the differences in training that NMPs and doctors receive, both in terms of prescribing 
training and professional training, it is unknown how applicable the literature relating to doctors’ 
prescribing is to NMPs’ prescribing. However, since this earlier work was conducted there has 
been an extension of full prescribing rights to an even broader range of HCPs. It is difficult to 
generalise the findings of research with CNPs to other NMPs because CNPs only have limited 
prescribing authority, they receive different training and because they are managing patients in a 
very specific environment (i.e. in the patients’ homes). In contrast, newer NMPs train for longer, 
can prescribe virtually any medicine from the BNF within their competency and manage a wide 
range of patients in a wide range of settings (See Section 2.3.3.2). Therefore, to understand the 
influences on NMPs’ behaviour it is important to conduct research with these HCPs. The purpose 
of this programme of research was to address this current gap in research. In this thesis the term 
non-medical prescriber (NMP) refers to any prescriber, other than doctors and dentists, who can 
prescribe (i.e. nurses [including community nurses], pharmacists, radiographers, physiotherapists, 
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podiatrists, chiropodists and optometrists). When discussing the findings of the research, the term 
non-medical prescriber (NMP) is also used to refer to the participants who took part in the research. 
As will be discussed, the sample did not include community nurse prescribers, radiographers, 
physiotherapists, podiatrists, chiropodists or optometrists. 
 
Before specifying the overall aim of the research it is important to outline the two key decisions 
that were made by the author about the programme of research. Firstly, as a result of low 
prescribing volume by AHCPs, it was decided that this programme of research would concentrate 
on the decisions of nurse prescribers and pharmacist prescribers only. Secondly, it was decided that 
it would not be within the practical limitations of a PhD to study all the sectors that NMPs operate 
within. Instead it was decided that the research should focus on either primary and community care 
or hospital and secondary care. It was hoped this would make the research practically more 
manageable and more in-depth as all efforts could be devoted to one main sector of prescribing. As 
the majority of prescribing in the NHS is in primary care (The NHS Information Centre 2010a) and 
because nurse and pharmacists independent prescribers operate within primary care (Latter et al. 
2010) it was decided that the research would be conducted with prescribers working in primary and 
community care only. These two decisions led to the overall aim of this programme of research to 
be set as follows: 
 
To explore the influences on the prescribing behaviour of nurse and pharmacist independent 
and/or supplementary prescribers working in primary and community care. 
 
A programme of research consisting of three studies was conducted in order to address this overall 
research aim. The structure of this programme of research is discussed in Chapter Three. 
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Chapter Three – Overview of Programme of Research 
_________________________________________________________________________ 
 
The purpose of this chapter is to provide an overview of the entire programme of research. 
Methodological issues, such as validity and reliability, will be discussed along with the ethical 
considerations of this research.  
_________________________________________________________________________ 
 
3.1 Structure of Programme of Research 
A programme of research was conducted to address the overall aim of this PhD (see Section 2.5). 
The programme of research commenced in December 2008 and ended in December 2010. The 
research began with an exploratory study (Study One) in which 18 NMPs took part in an in-depth 
interview about prescribing influences. The aim of Study One was to develop the future 
programme of research by exploring the influences on NMPs’ prescribing, understanding the role 
of NMPs, identifying practical issues with conducting research with this group of HCPs, and 
formulating ideas about appropriate data collection techniques. An overview of the findings from 
Study One are presented in Chapter Four to explain the rationale for other aspects of the 
programme of research. The findings are then discussed in more detail in Chapter Six and Chapter 
Seven. Based on the findings of Study One it was decided that two further studies would be 
conducted.   
 
The aim of Study Two was to identify and explore the factors that influence whether NMPs take 
responsibility making a prescribing decision for a patient or issuing a prescription. The specific 
objectives of Study Two are outlined in Chapter Five (see Section 5.1.1). Study Two employed the 
critical incident technique which was facilitated in 20 semi-structured interviews with NMPs. 
Three focus groups were also conducted with 10 nurse prescribers. The findings of Study Two, 
with the relevant findings from Study One, are presented and discussed in Chapter Six. Study 
Three built on the findings of Study One by identifying similarities and differences between NMPs 
in relation to the factors they perceive influence their prescribing decisions. The Q-method was 
facilitated by an internet survey which was completed by 56 NMPs. The findings of Study Three 
are presented and discussed in Chapter Eight. A summary of this programme of research is 
provided in Figure 3-1. 
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Figure 3-1: Summary of Programme of Research 
Study One – Exploratory Study 
 
Aim: To develop the future programme of research by exploring the 
influences on non-medical prescribers’ prescribing, understanding the 
role of NMPs, identifying practical issues with conducting research 
with this group of HCPs, and formulating ideas about the 
appropriateness of data collection techniques 
Method: In-depth interviews with a purposively selected sample of 
nurse and pharmacist NMPs. The sample comprised 14 nurse 
prescribers and four pharmacist prescribers 
Study Three – Q-method 
 
Aim: To identify the similarities and 
differences between NMPs in relation to 
the factors they perceive influence their 
prescribing decisions  
 
Method: An internet survey designed 
using the principles of the Q-method. 
Participants were asked to arrange 
statements that started with ‘my 
prescribing decisions are influenced by…’ 
and then went on to describe a factor that 
could influence prescribing decisions (e.g. 
guidelines) on a grid according to their 
agreement with the statement. The data 
was analysed according to the principles of 
Q-method to reveal ‘perspectives’ amongst 
NMPs about prescribing influences. 
Participants were purposively selected. 
The sample comprised 34 nurse prescribers 
and 22 pharmacist prescribers 
Study Two – Responsibility 
 
Aim: To identify and explore the factors 
that influence whether nurse and 
pharmacist NMPs take responsibility for 
making a prescribing decision for a patient 
or issuing a prescription 
 
Methods: The critical incident technique 
facilitated using semi-structured 
interviews, and focus groups. Participants 
in the interviews were asked to think of 
two incidents: (1) where they did not take 
responsibility for prescribing, (2) where 
they felt uncomfortable or uneasy taking 
responsibility for prescribing. Themes 
generated from the incidents were then 
validated in focus groups. Participants 
were purposively selected to the study. The 
total sample comprised 25 nurse 
prescribers and five pharmacist prescribers 
All three studies addressed the overall aim of the programme of research: 
To explore the influences on the prescribing behaviour of nurse and pharmacist independent 
and/or supplementary prescribers working in primary and community care 
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3.2 Key Issues in the Programme of Research 
3.2.1 Methodological Issues 
This section is dedicated to discussing the concepts of reliability and validity in relation to this 
programme of research. 
 
3.2.1.1 Reliability 
Study One and Study Two 
Study One and Study Two used qualitative data collection methods (i.e. in-depth interviews, semi-
structured interviews, the critical incident technique, focus groups). The aim of qualitative research 
is to study people in their natural settings and to collect data naturally. The focus ‘is on the 
meanings that participants in the study attach to their social world’ (Bowling 2002, pg.352). In 
quantitative research, a measure is often considered reliable if it provides the same ‘reading’ 
repeatedly overtime (de Vaus 1996). However, in qualitative research, the application of reliability 
is uncertain. Kirk and Miller argued statements repeated consistently may only reflect the 
stereotyped view of events and that the need for observations to be repeated overtime is 
problematic as it is based on the assumption that the topic under consideration will not undergo any 
changes (Kirk and Miller 1986). Flick recommends that the focus in qualitative research should be 
on ‘checking the dependability of the data and procedures’ (Flick 2009). Merriam states that ‘what 
one strives for is consistency and dependability, a sort of internal reliability in which the findings 
of an investigation reflect, to the best of the researcher’s ability the data collected’ (Merriam 1995, 
pg. 57). In line with these recommendations, the researcher kept an audit trail which detailed how 
the data were collected, how the themes emerging from the data were formed and how other 
decisions were made during the research process. Secondly, the researcher checked the plausibility 
of the themes emerging from the analysis with her supervisors who have also conducted similar 
research.  
 
Study Three 
As described previously, Study Three used an internet survey administered using the principles of 
Q-method. Participants were asked to order statements about prescribing influences on a grid 
according to their extent of agreement with the statement. It was concluded, as for qualitative 
research, that traditional measures of reliability are difficult to apply to the Q-method. In 
conventional tests reliability can be assessed by administering the same test twice, say at intervals 
of two to four weeks. If the results from the first test correlate highly with the results of the second 
test then the measure can be considered ‘sound’ (de Vaus 1996). de Vaus highlights how this is a 
difficult measure of reliability to use because it can be difficult to administer the same test twice 
(de Vaus 1996). Indeed, in this research it would have been difficult to get participants to complete 
the survey on two separate occasions. Furthermore, participants may have simply remembered how 
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they responded on the first occasion and answered the same way on the second occasion. One way 
to overcome this would be to leave a longer time period between applying the tests. However, in 
this research, it is conceivable that prescribers’ attitudes to the influences on their prescribing could 
change overtime. A change in participants’ attitudes might suggest the test has lower reliability 
than it does. Furthermore, even if a view is repeated overtime it might only represent a stereotyped 
view. It was decided that the strategies for maximising reliability in Study Three would focus on 
checking the ‘dependability of the data and procedures’ as discussed previously. 
 
3.2.1.2 Internal Validity 
Study One and Study Two 
Internal validity concerns ‘the extent to which the instrument is really measuring what it purports to 
measure’ (Bowling 2002, pg. 438). Whilst the internal validity of the ‘measurement’ is a prime 
concern in quantitative research the extent to which the concept of validity should be applied to 
qualitative research and the best way it should be established is the subject of much debate. There 
remains no standard definition, but numerous authors have recommended strategies for maximising 
internal validity. Some authors encourage the use of member checking where the initial data and 
interpretations are taken back to participants for reflection (Lewis and Ritchie 2003). In Study Two 
member checking was conducted with the use of focus groups. Examples of prescribing scenarios 
provided by participants in the semi-structured interviews were presented back to other participants 
in focus groups for discussion. This allowed the author’s initial interpretation of the incidents to be 
explored and also the ‘frequency’ of the incidents to be tested (see Section 5.1.2.5 for further 
discussion).   
 
Another strategy for maximising internal validity, also used in this programme of research, 
includes peer review. This is where colleagues are asked to comment on the themes generated from 
the data to assess their plausibility and interpretation (Merriam 1995). In this research the data was 
analysed and interpreted initially by the author of the thesis. This initial interpretation was 
presented to the author’s PhD supervisors who reflected on the plausibility and breadth of the 
themes emerging. After reflecting on this initial interpretation with her supervisors the author 
revisited the data to explore any questions or comments raised. This process was repeated until all 
were satisfied with the interpretation of the data. The researcher also reflected throughout the 
research process on how her biases, experiences and assumptions may have impacted on how the 
data were interpreted.  
 
Study Three 
With the exception of member checking the strategies described above for maximising internal 
validity were also employed in Study Three. However, in addition to this, the content validity of 
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the Q-method survey was also assessed. Content validity refers to judgements, which are typically 
made by a panel of experts, about the extent to which the survey appears to measure what it claims 
to measure. In this study the content validity was assessed through cognitive interviews with 
NMPs. In the cognitive interviews prescribers completed the survey whilst ‘thinking aloud’. The 
researcher then inspected the transcripts made of the interviews and compared the meaning that the 
participants attributed to the instructions, wording of the questions and the statements to the 
meaning that was intended by the researcher. If problems became evident changes were made to 
the survey and these were re-tested in other interviews. 
 
3.2.1.3 External Validity 
Study One and Study Two 
External validity, sometimes referred to as generalisation, concerns the ‘extent to which the 
research findings can be generalised to the wider population of interest and applied to different 
settings’ (Bowling 2002, pg. 438). Merriam states that it is generally concluded that one cannot 
generalise from qualitative research because of the often small non-random sample used (Merriam 
1995). Much has been written about the applicability of the concept of external validity to 
qualitative research. Lewis and Ritchie, as well as others, have highlighted how the purpose of 
qualitative research is to understand the range of opinion rather than the prevalence of these 
opinions in the population (Lewis and Ritchie 2003). They suggest that external validity in 
qualitative research can be strengthened by providing a ‘thick description’ of the data interpretation 
process to allow others to confirm that the conclusions reached hold ‘validity’ and to allow others 
to assess the transferability of the findings to other settings. They also suggest providing a detailed 
description of the design and conduct of the research to allow others to assess the methods used and 
to evaluate the limitations of the research. In line with these recommendations a ‘thick description’ 
of all aspects of the research has been provided in this thesis. This involves a detailed account of 
the methods, data analysis procedures and an in-depth presentation of the findings. Merriam also 
highlighted how including a wide range of cases in the research will allow the results to be applied 
to a range of other situations (Merriam 1995). Therefore, this programme of research set out to 
include a wide range of NMPs from different settings.    
 
Study Three 
The Q-method can be considered a small investigation of human subjectivity. Like qualitative 
research, Q-method studies use small non-random samples. As a result, the ability to generalise the 
results of a Q-method sample to a wider population has been called into question. Brown argued 
that only a limited number of distinct perspectives exist on any topic and was confident that any 
well designed Q-method study would reveal any perspectives concerning the topic (Brown 1980). 
Furthermore, and in line with qualitative research thinking, Thomas and Baas highlighted how the 
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purpose of Q-method is to explore the range of perspectives about a topic rather than to identify the 
proportion of the sample or the general population that adheres to any of them (Thomas and Baas 
1992). Many of the strategies used to strength external validity in Study One and Study Two were 
used in Study Three. Thought was also given to whether NMPs had the necessary ‘tools’ to 
adequately express their perspective. If NMPs did not then the research might have failed to 
identify perspectives that exist in the wider population of NMPs. Therefore cognitive interviews 
were used to test whether any statements about prescribing influences were missing from the 
survey (see Section 5.2.2.5 for further discussion of the cognitive interviews). 
 
3.2.2 Ethical Considerations 
3.2.2.1 Ethics Issues 
A number of ethical issues were considered during the design and conduct of this programme of 
research. These included informed consent, confidentiality and recruitment issues. 
 
‘Informed consent by human participants is a necessary condition for ethically acceptable research. 
This means that all the risks involved in the investigation must be explained, as well as the possible 
benefits’ (Polgar and Thomas 2000, pg.34). To address this, in this programme of research 
participants were provided with a participant information sheet (PIS) when invited to take part in 
the study. The PIS outlined the purpose, nature, benefits and risks of the study. Participants were 
given other copies of the PIS when the interview or focus group time was confirmed (Study One 
and Study Two), immediately before the interview or focus group (Study One and Study Two) and 
before completing the survey (Study Three). To confirm the participant was satisfied with the 
information they had received and to confirm they were happy to take part in the research they 
were asked to sign a consent form. In Study Three, participants were asked to press the ‘confirm’ 
button if they were happy to continue. The researcher ensured from the first contact that 
participants were aware of their right to withdraw from the research at any time without giving a 
reason.  
 
Ethical principles also state that ‘participants have the right to expect that when they give you 
consent to observe or interview, you will protect their confidence and preserve their anonymity’ 
(Glesne 1999, pg.122). In this study, participant confidentiality was assured by ensuring that all 
manual and electronic data was kept secure and where possible marked with a reference number 
rather than the participants’ names, not disclosing the participants’ participation or non-
participation in the study to anyone other than those in the research team, disguising participants’ 
identity when using quotations from transcripts and anonymising transcripts by removing any 
identifying features. Participants also have the right to be informed of any limitations on the 
confidentiality of what they may divulge to the researcher (Darlington and Scott 2002). Therefore 
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participants were informed on the PIS that, in the highly unlikely event they disclosed a serious 
patient safety issue, confidentiality will be broken to report the findings to the relevant authority. In 
Study Three this statement was not included as participants responded to a set of pre-determined 
questions and had no opportunity to disclose such information. 
 
A consideration of the manner by which participants were recruited to this study was also given 
particular attention when designing the programme of research. Research might be deemed 
unethical if recruitment is based on a dependent relationship between an individual and the 
potential participant. As NMPs in all aspects of this research were recruited via their PCT non-
medical prescribing lead (NMPL), who arguably they have a dependent relationship with, this issue 
was considered. After contemplation of this issue with the research team the involvement of 
NMPLs in the research process was deemed satisfactory as their role was to distribute information 
and not to recruit participants. Participants’ participation or non-participation in the research was 
not disclosed to NMPLs.  
 
3.2.2.2 Ethics Approval and R&D Approval 
NHS research ethics approval is required if the research involves NHS staff recruited as research 
participants by virtue of their professional role, or the use of, or potential access to, NHS premises 
or facilities (Central Manchester University Hospitals NHS Foundation Trust 2010). As all studies 
within the programme of research fulfilled this criterion an application for NHS ethics approval 
was sought individually for each study. After due process, NHS ethics approval was granted for 
each study. The original NHS approval letters for each study are available in Appendix 3.0, 
Appendix 4.0 and Appendix 5.0. In addition to NHS ethics approval, NHS Research and 
Development (R&D) approval was also sought and subsequently granted for each study.  
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Chapter Four – Study One 
_________________________________________________________________________ 
 
The purpose of this chapter is to describe Study One including the method employed, the main 
substantive findings and discussion of these findings, and the implications of the study on other 
aspects of the programme of research.  
_________________________________________________________________________ 
 
4.1 Rationale for Exploratory Study 
Blaikie summaries the overall purpose of exploratory research as the following: ‘…essentially 
exploratory research is used to get a better idea of what is going on and how it might be researched’ 
(Blaikie 2007, pg.70). Blaikie argues that exploratory research is beneficial to understand more 
about the social situation and group of people you are researching, to develop and refine the 
research question(s) and to understand more about how the research question(s) might be addressed 
(Blaikie 2007). As research in the field of non-medical prescribing is limited, from the outset it was 
decided that exploratory research would be useful to aid the development of this programme of 
research. 
 
It was anticipated that Study One would contribute to the development of the programme of 
research in four ways: 
 
(1) Development of research aim and objectives - It was felt that understanding more about how 
the overall research aim could be addressed would be beneficial. This was felt to be particularly 
important as there was a limited amount of research in this area and, as a result, limited knowledge 
from which to produce meaningful research objectives. This was achieved by beginning to explore 
the influences on NMPs’ prescribing. It was hoped this would identify avenues of enquiry not 
previously considered.  
 
(2) Understanding the role of NMPs – Knowledge gathered by asking NMPs about their role and 
use of prescribing was to feed in to the sample design in other aspects of the programme of 
research and help the researcher, who is not a pharmacist, nurse or prescriber, familiarise herself 
with the language and environment of NMPs. 
 
(3) Uncovering practical issues of conducting research with this group of HCPs - It was 
anticipated that practical issues would be identified by actually conducting research with this group 
of HCPs. Issues could be planned for so future research was easier and more efficient to conduct. 
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 (4) Formulate ideas about methods - It was anticipated that ideas about appropriate methods to 
be employed in this research could develop from exploring how NMPs discuss influences on their 
prescribing and by reflecting on the method used in Study One. It should be noted however that the 
intention was not to ‘test’ different methods as only one method was used. 
 
4.2 Aims and Objectives 
The aim of Study One was to develop the future programme of research by addressing the 
following objectives: 
1. To explore the influences on the prescribing behaviour of nurse and pharmacist prescribers in 
primary and community care thereby identifying worthwhile avenues of enquiry to pursue in 
the future programme of research 
2. To understand the role of NMPs and their use of prescribing in primary and community care 
3. To identify any practical issues regarding conducting research with this group of HCPs 
4. To formulate ideas about the appropriateness of particular data collection techniques in this 
field 
 
4.3 Method 
The purpose of this section of the chapter is to outline the method used in Study One. The section 
begins by explaining the overall approach taken to the study. 
 
4.3.1 Overall Approach 
The exploratory nature of Study One led to the use of an inductive reasoning approach. Inductive 
reasoning begins with observation and measurement of phenomena and then develops ideas and 
general theories about the universe of interest (Bowling 2002). Qualitative research techniques 
were considered most appropriate to address the objectives of the study. It was felt a qualitative 
approach would enable a more in-depth exploration of participants’ views and were preferred over 
quantitative methods because of their greater flexibility in data collection. For instance it would 
allow the researcher to follow-up themes emerging from the initial interviews in later interviews. 
The use of qualitative data collection techniques are consistent with Blaikie who argues for 
flexibility in the data collection techniques used in exploratory work (Blaikie 2007).  
 
4.3.2 Location of Sample 
It was decided that participants in Study One would be drawn from PCTs in the North West of 
England to reduce both the time spent travelling by the researcher and to limit travel costs. NMPLs 
in four PCTs in Greater Manchester were approached and informed about the research. The PCTs 
were selected based on their close proximity to the University of Manchester. All PCT NMPLs 
approached agreed that they would help facilitate the research in their PCT. The majority of 
 56 
participants recruited to the study were based in one of these four PCTs. However, through 
snowball sampling, which is discussed in Section 4.3.3, another participant was recruited to this 
study who was based in a PCT outside Greater Manchester. 
 
4.3.3 Sampling and Recruitment 
Purposive sampling was used to select participants for inclusion in the study. Purposive sampling is 
a commonly used sampling method in qualitative research which Bowling describes as a 
‘deliberately non-random method of sampling which aims to sample a group of people or settings 
with a particular characteristic’ (Bowling 2002, pg.187). This sampling technique allows 
participants to be selected on the basis of their relevance to the topic under investigation. In Study 
One participants were considered to be appropriate for inclusion if they were a registered nurse or 
pharmacist working in primary or community care, qualified as an independent and/or 
supplementary prescriber and were prescribing as part of their role  
 
If participants wished to take part in the research they were asked to fill in the participant form (see 
Appendix 6.0). The form asked participants for the date of their prescribing qualification(s), type of 
prescribing qualification, use of prescribing and job title(s). Data collected on these forms were 
used to select participants for interviews. The aim was to have variety in the sample in terms of 
their prescribing demographic characteristics. Initially, it was hoped that the sample would include 
at least one participant employed as roles two to seven in Box 4-1 and two participants employed 
as role one. The information gained about NMPs’ roles through conducting Study One was used to 
modify the initial proposed sample. This led to some roles being merged and new roles added. No 
criteria regarding the number of prescriptions by participants were set because of the limited 
knowledge in this field. Potential participants decided themselves whether it was appropriate for 
them to take part in the study. Information collected in Study One was used to inform other parts of 
the programme of research. 
 
 
 
Box 4-1: Roles Occupied by NMPs intended to be Recruited to Study One 
1. Pharmacist running a clinic(s) for a chronic/long term condition (n=2) 
2. Pharmacist working in an out-of-hours centre (n=1) 
3. Practice nurse/Nurse practitioner (n=1) 
4. Nurse working in WIC (n=1) 
5. Specialist nurse running a clinic(s) for a chronic/long term condition  (n=1) 
6. Specialist nurse running for 1 or more of the following sexual health clinic, family planning clinic, 
new born babies clinic, other clinic  (n=1) 
7. Palliative care specialist nurse  (n=1) 
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Participants were initially approached by their PCT NMPL via email. The NMPL emailed the 
invitation letter (see Appendix 7.0), participant form, (see Appendix 6.0) and PIS (see Appendix 
8.0) to all nurse and pharmacist independent and/or supplementary prescribers in their PCT. The 
number of NMPs who were sent invitation letters was not recorded in Study One or Study Two 
(see Section 5.1.2.3). As discussed, it was not intended that a random sample would be recruited to 
Study One. As a result, it was considered unnecessary to record the response rate of NMPs taking 
part in the research. If the NMP was interested in taking part in the research then they were asked 
to complete the participant form and return it to the researcher. Of those participants that filled in 
the form and returned it to the researcher all but two participants were interviewed. These 
participants were not included as it was felt their inclusion did not add to the diversity of the 
sample in Study One.   
 
Snowball sampling was also used in Study One. ‘Snowballing’ is a ‘technique used where no 
sampling frame exists and it cannot be created. Initial respondents are asked to suggest others 
whom they know are in the target group and who could be invited to take part, and so on’ (Bowling 
2002, pg.380).  In this study a further three participants were recruited using snowballing sampling. 
One of the participants was based in a PCT not initially approached by the researcher. Attempts to 
recruit participants to the study ceased when it was felt that ‘saturation’ of the core themes 
emerging from the data analysis had been reached and the widest range of NMPs, which was 
practical to recruit at the time, had been included in the sample.  
 
4.3.4 Sample of Study One 
In total, 18 NMPs were recruited to Study One. This included four pharmacist prescribers and 14 
nurse prescribers. The number of participants were split between the following PCTs, PCT 1 (n=8), 
PCT 2 (n=1), PCT 3 (n=4), PCT 4 (n=4) and PCT 5 (n=1). Participants taking part in Study One 
were employed in the roles listed in Table 4-1. Other demographic information about the 
participants taking part in Study One is presented in Appendix 9.0. Further information about the 
nature of participants’ roles (e.g. type of conditions treated, consultation setting) is available in 
Appendix 10.0.  
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Table 4-1: Sample of Study One 
Role  n= 
Advanced Practitioner 4 
Community Matron/Active Case Manager 
(including paediatric and adult) 1 
Palliative Care 2 Specialist Nurse 
(including paediatric 
and adult) All Other - 
Nurse Practitioner for GP Surgery 2 
WIC Nurse 3 
Out-of-Hours*/WIC Nurse 1 
Nurse (Practice Nurse, WIC Nurse and Specialist 
Nurse) 1 
Practice Pharmacist/Prescribing Support 
Pharmacist 3 
Pharmacist (practice pharmacist, intermediate 
care pharmacist and acute OoHs service) 1 
TOTAL 18 
*Out-of-Hours (OOHs)  
 
4.3.5 Data Collection Method 
Participants recruited to the study took part in an in-depth interview. It was felt that in-depth 
interviews were an appropriate data collection method for addressing the aim and objectives of 
Study One. In-depth interviews have been defined as ‘guided conversations’ (Lofland and Lofland 
2006). In in-depth or unstructured interviews minimal questions and prompts are set before the 
interview begins and instead the discussion is formed and adapted based on participants’ comments 
during the interview. This unstructured approach was felt to be particularly suited to the aims of the 
study as it would allow participants the opportunity to explain their own role, prescribing behaviour 
and attitudes in relation to prescribing influences in their own words. The researcher would also 
have the freedom to probe in-depth any comments made by participants and ask any follow up 
questions if needed. It was also hoped that in-depth interviews would enable any important themes 
not previously thought of by the researcher to emerge through the discussion.       
 
The in-depth interviews conducted lasted between 40 minutes and one-hour and 10 minutes. The 
interviews took place between March 2009 and August 2009. All interviews were conducted in the 
participants’ place of work and were recorded with the participants’ permission. Four main themes 
were set out to be covered during the interviews. These four themes were: the participant’s role, use 
of prescribing, how NMPs decided in what circumstances they should prescribe and factors 
influencing prescribing decisions. A number of prompts, based on the literature, were also set out 
to be used if the interview became stilted. Generally though the discussions were based around 
participants’ comments in line with the nature of in-depth interviewing. 
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4.4 Data Analysis 
The data analysis of Study One was performed with the aim to develop theory ‘grounded’ in the 
data rather than test preconceived hypotheses. Strict use of the grounded theory approach that is 
often used in qualitative data analysis was avoided and instead a modified version, referred to as 
the framework approach, was used. Ritchie and Spencer describe the framework approach as 
‘grounded’, ‘dynamic’, ‘systematic’ and ‘comprehensive’. The framework approach was 
considered suited to exploratory research as it enables flexibility and openness to new themes 
whilst at the same time providing a systematic approach to analysis. The framework approach 
described by Ritchie and Spencer consists of five steps: (1) Familiarisation, (2) Identifying a 
thematic framework, (3) Indexing, (4) Charting and (5) Mapping and interpretation (Ritchie and 
Spencer 1994).  
 
In this study, familiarisation (Step 1) with the data was achieved easily as the author conducted all 
the interviews and transcribed all the recordings herself. As Ritchie and Spencer predict, at this 
early stage the author developed hunches about key issues and themes. It was these hunches that 
formed the basis of the initial thematic framework (Step 2). The thematic framework was set up in 
the qualitative data analysis software Nvivo (QSR International Pty Ltd) (Step 2). The author began 
to apply the data set to this initial thematic framework (Step 3) and, as Ritchie and Spencer predict, 
the initial thematic framework was continually refined in light of the emerging data. In the next 
step (Step 4) the initial thematic framework was rearranged in order to explore the range of opinion 
on a broader set of themes and issues. These broader themes and issues were generated both from 
the objectives of the study and the emergence of overall themes from the data itself. In the final 
step (Step 5) the author reviewed the themes generated from the data, compared viewpoints of 
participants in relation to particular themes and looked for explanations of any differences of 
viewpoints within the data. Nvivo was used throughout the data analysis process The use of a 
computerised qualitative data analysis package made the process of indexing, charting and retrieval 
simpler and more systematic.  
 
4.5 Substantive Findings and Discussion 
The purpose of this section of the chapter is to outline the key substantive findings from Study One 
and to discuss them in light of the current literature. The findings will only be discussed in 
sufficient depth to provide a rationale for the nature of the remainder of the programme of research. 
A detailed description of the substantive findings will instead be presented in Chapter Six, along 
with the findings of Study Two, and also Chapter Seven. 
 
 60 
4.5.1 Findings 
The findings of Study One highlighted two important aspects of prescribing NMPs consider in their 
practice. The first aspect of prescribing NMPs described was whether they should take 
‘responsibility’ for prescribing in the first place. It is important to note NMPs did not necessarily 
use the term ‘responsibility’. However, this term is used throughout this thesis to refer to this aspect 
of prescribing and differentiate it from other aspects of NMPs’ prescribing. In this thesis the 
umbrella term prescribing ‘responsibility’ relates to two different aspects of prescribing 
‘responsibility’ described by participants. Firstly, the term refers to ‘responsibility’ for making a 
prescribing decision for a patient. A NMP can be, for example, considered not to take 
‘responsibility’ for a prescribing decision if they refer a patient to a colleague. NMPs can be 
considered not to take full ‘responsibility’ for making a prescribing decision for a patient if they 
seek colleagues’ advice. Even though NMPs might not take ‘responsibility’ for the prescribing 
decision, or at least complete ‘responsibility’ for the prescribing decision, they may go on, or not 
go on, to issue the prescription. Secondly, the umbrella term prescribing ‘responsibility’ includes 
whether the prescriber takes ‘responsibility’ for issuing or signing the prescription. NMPs can be 
considered not to take ‘responsibility’ for issuing the prescription if they ask another prescriber to 
issue the prescription on their behalf. This first aspect of prescribing, prescribing ‘responsibility’, is 
represented on the left hand side of Figure 4-1.  
 
NMPs in Study One discussed how they defined their area of clinical practice. For example, one 
WIC nurse described how she would refer a patient who was breathless and experiencing chest 
pains to accident and emergency rather than managing the patient herself. The line between 
prescribing responsibility and clinical practice is blurred as NMPs cannot generally prescribe 
unless they are managing the patient. The aim of Study One was to focus on prescribing and 
therefore more emphasis was placed on understanding the factors that influence whether NMPs 
take responsibility for prescribing. However, participants spontaneously talked about how they 
defined their areas of practice and discussion often skipped, sometimes unknowingly, between the 
two areas. The remainder of this programme of research focuses on how NMPs decide whether to 
take prescribing responsibility and not just how they define their practice. 
 
The second aspect of prescribing described by NMPs in Study One was the actual prescribing 
decision. NMPs described this aspect of prescribing as the choice between a pharmacological 
versus non-pharmacological approach, and if a pharmacological approach is required, the choice of 
specific medicine (e.g. generic vs. non-generic or specific brand), the choice of dosage and the 
choice of formulation. This aspect of prescribing is represented on the right hand side of Figure 4-
1. Issues of prescribing responsibility (Decision 1. on Figure 4-1) and the actual prescribing 
decision (Decision 2. on Figure 4-1) are discussed separately in parts of this thesis. However, it is 
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important to note that NMPs did not describe a two-step prescribing process where they first of all 
decided whether to take responsibility for prescribing and then made the prescribing decision. In 
many cases NMPs formulated ideas about the prescribing decision before deciding whether to take 
responsibility. For example, a WIC nurse decided not to take responsibility for prescribing for a 
patient with severe back pain, who was already taking co-codomol and diclofenac, because she felt 
the patent needed stronger strength pain relief. The patient was instead referred to a doctor. The 
NMP decided not to take responsibility for prescribing for this patient. However, without making a 
preliminary prescribing decision this nurse would have been unable to make this decision.  
 
 
 
 
 
 
 
 
 
 
The influences on whether NMPs take responsibility for prescribing and NMPs’ prescribing 
decisions were discussed during the interviews in Study One. As the sole purpose of this chapter is 
to provide a rationale for other aspects of this programme of research only a brief description of the 
themes emerging from Study One will be provided. The themes emerging from Study One, relating 
to the influences on whether NMPs take responsibility for prescribing, fell into the following 
categories: competency, role, risk, practical and legal issues and pressures. The factors influencing 
NMPs’ prescribing decisions were discussed under the following general themes: regulatory 
factors, patient factors, colleague factors, prescribing culture and professional experience, training 
and information sources, logistical factors the pharmaceutical industry. Clinical influences on 
prescribing decisions were also discussed in Study One. These findings are presented and discussed 
in Chapter Six and Chapter Seven along with the findings from Study Two where appropriate.  
 
4.5.2 Discussion 
The decision of whether to take responsibility for prescribing was clearly a major consideration for 
NMPs in their practice as it was discussed extensively during the interviews. NMPs’ perceptions of 
their competency and role influenced whether they took responsibility for prescribing. This 
behaviour is consistent with guidance for NMPs (Nursing and Midwifery Council 2006; Royal 
Pharmaceutical Society of Great Britain 2007). However, current understanding about NMPs’ 
decisions to take responsibility for prescribing is limited to only a few studies. Nurse independent 
1. Responsibility for Prescribing 
 
Responsibility for 
making prescribing 
decision for the patient 
 
Responsibility for 
issuing or signing 
prescription 
2. Prescribing Decision  
(e.g. pharmacological versus non-
pharmacological approach, the choice of 
specific medicine, the choice of dosage and 
the choice of formulation) 
 
Two Different Types of Prescribing Decision discussed in this 
Programme of Research 
Figure 4-1: Diagrammatic Representation of the Two aspects of Prescribing discussed in this Thesis 
 62 
prescribers’ perception of their competency has been found to influence the clinical areas they are 
prepared to prescribe in (Bradley et al. 2007). CNPs have expressed concern about prescribing for 
some patient groups including those at either end of the age spectrum, those with more complex 
poly pharmacy and those with multiple co-morbidities (Hall et al. 2003; Hall et al. 2006). Nurse 
and pharmacist supplementary prescribers have also indicated they do not feel confident 
prescribing for patients with co-morbidities (Bissell et al. 2008). CNPs have said they are more 
comfortable prescribing topical or OTC products than internal medicine (Hall et al. 2003; Luker et 
al. 1998). This attitude is also reflected in the behaviour of US nurse prescribers who prescribe 
more OTC medicine than doctors for patients with similar complaints (Running et al. 2006). The 
limited research in this area does not reflect the importance of the issue of prescribing 
responsibility to NMPs. Furthermore, the little research that does exist has been conducted with 
CNPs and US nurse prescribers. As a result, it was concluded that a more in-depth study of the 
influences on whether NMPs take responsibility for prescribing in any given scenario was required. 
 
The General Medical Council states that doctors should recognise and work within the limits of 
their competence (General Medical Council 2006). Therefore, like NMPs, doctors need to decide 
whether it is appropriate for them to take responsibility for prescribing in any given scenario. 
Despite this there is little discussion in the literature about how doctors decide whether to take 
prescribing responsibility. A small volume of research has examined the factors that contribute to 
discomfort amongst doctors when prescribing (Bradley 1992b; Lewis and Tully 2009a; Lewis and 
Tully 2009b). Other research has gone some way to exploring the factors that influence whether 
doctors prescribe. For instance, GPs have been found to refer older diabetes patients when they 
require insulin because of discomfort initiating treatment (Agarwal et al. 2008). GPs’ knowledge 
and expertise has also been found to influence whether they prescribe specialist medicine (Crowe et 
al. 2009). Clearly however this research does not constitute a detailed examination of how doctors 
choose to employ their prescriptive authority.  
 
The limited amount of research about the factors that influence whether NMPs take responsibility 
for prescribing in any given scenario is understandable as non-medical prescribing has only 
recently been introduced. However, the lack of literature about this aspect of prescribing for 
doctors raises the question of how relevant the issue of responsibility is for doctors and for 
researchers to study. Weiss and Sutton argue that, until very recently, the competency of doctors as 
prescribers has rarely merited a topic of discussion and that GPs would be unlikely, at least openly, 
to set limits on their practice. It is only recently, they argue, with the emergence of NMPs that 
those in the medical field have begun to talk about prescribing competency and that a culture of 
safety has arisen with the emphasis on self-limitation and boundaries (Weiss and Sutton 2009). One 
reason for this might be that, unlike NMPs, doctors are not taught to consider their competency in 
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different prescribing fields. This issue is clearly relevant for NMPs as they talked about issues 
relating to taking prescribing responsibility at length in Study One. The frequency by which NMPs 
discussed this aspect of prescribing suggested that this was a key aspect of their prescribing that 
required further exploration. 
 
4.6 Implications of Study One 
The purpose of this section is to reflect on the findings of Study One and its implications for the 
future programme of research. The discussion in this section will be based around the four 
objectives of Study One. 
 
4.6.1 Avenues of Enquiry 
Through Study One it became apparent that in order to understand the influences on NMPs’ 
prescribing behaviour, the factors that influence whether NMPs take responsibility for prescribing, 
and the factors that influence their prescribing decisions need to be understood. Study One 
provided initial insight into these two areas of prescribing but, because of a limited sample and 
time during the interviews, it was felt that further research was needed. As a result it was decided 
that the remainder of the programme of research would be split into two parts. The first part would 
focus on the factors that influence whether NMPs take responsibility for prescribing in any given 
scenario (Study Two). The second part would focus on the influences on prescribing decisions 
made by NMPs (Study Three). The research conducted in order to do this is outlined in Chapter 
Five of this thesis. 
 
4.6.2 Role of NMPs and their Use of Prescribing 
The information gained from participants who described their role and use of prescribing helped 
formulate ideas about the desired sample in Study Two and Study Three. The information 
participants provided about the roles of other prescribers they knew also helped to inform the 
sample in Study Two and Study Three. Based on the discussions in Study One it was decided that 
the future research would seek to include NMPs employed in a wide range of specialist roles (e.g. 
diabetes, asthma, epilepsy nurse). One specialist nurse took part in Study One but the participant 
highlighted that NMPs worked in a range of specialist fields. Involvement of NMPs managing 
paediatric patients only and pharmacist prescribers working in the community pharmacy setting 
was also sought. It was considered important to include these prescribers in case they had differing 
views on prescribing influences than those interviewed in Study One. 
 
4.6.3 Practical Issues Regarding Conducting Research with this Group of HCPs 
Another objective of Study One was to identify practical issues with conducting research with this 
group of HCPs. The study demonstrated that recruitment via the PCT NMPLs was an appropriate 
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method to recruit NMPs as a number of participants were successfully recruited this way. However, 
as fewer pharmacist prescribers were recruited via NMPLs, alternative means to recruit pharmacist 
prescribers were explored. One possible option that became apparent with regards to recruiting 
pharmacists was the use of details contained on the RPSGB register to post information about the 
research to pharmacist prescribers. This method was eventually used in Study Three and is 
therefore discussed more in Chapter Five.  
 
The researcher also explored the surroundings and environment where NMPs worked. This 
information was used to reflect on the feasibility of other data collection methods. It was clear from 
visiting NMPs in their work place that all NMPs, even those practising in the community, had 
access to a computer. This observation opened up the possibility of internet-based research. 
 
4.6.4 Ideas about the Appropriateness of Data Collection Techniques 
Another objective of Study One was to develop ideas about the suitability of data collection 
techniques to study the influences on NMPs’ prescribing. The interviews were appropriate to 
address the objectives of Study One but it was noted that participants spoke in general terms about 
the influences on all aspects of their prescribing. NMPs struggled, even when prompted, to provide 
examples of prescribing scenarios. It was felt that in order to understand the area of prescribing 
responsibility (Decision 1, Figure 4-1) further, a more in-depth discussion of the factors that 
influence this decision was required. Therefore an approach called the critical incident technique 
was used in Study Two. This technique asks participants to bring specific examples of prescribing 
‘incidents’ with them to the interview so they can be discussed in-depth. The nature of this 
technique, as well as the other issues relating to the use of this method, is discussed in Chapter 
Five.  
 
The general nature of the discussion about prescribing influences in Study One led to a different 
issue with regards to understanding the influences on NMPs’ prescribing decisions (Decision 2, 
Figure 4-1). Study One allowed an understanding of the breadth and nature of the influences on 
NMPs’ prescribing decisions but, from the discussion, it was apparent that almost any factor could 
influence NMPs. However, the general nature of the discussion made it difficult to ascertain the 
relative influence of certain factors on individual NMPs. Subsequently it was difficult to 
understand the differences between individual NMPs with regards to the factors they perceived 
influenced their prescribing decisions. To address these issues a method, called the Q-method, was 
employed in Study Three. The Q-method asks participants to order statements, in this case about 
prescribing influences, on a grid according to their extent of agreement with the statement. By 
ordering statements about prescribing influences participants indicate the relative influence of 
certain factors on their prescribing decisions. The analysis in Q-method studies group participants 
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together that rank the statements in a similar way. These groups of participants represent 
perspectives amongst your sample towards the topic. Exploration of these perspectives can identify 
similarities and differences, in a more systematic way than interviews, towards the topic. In Study 
Three these perspectives were explored to identify similarities and differences between participants 
about the factors they perceive influence their prescribing decisions. The Q-method is discussed in 
further detail in Chapter Five.  
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Chapter Five – Methods 
_________________________________________________________________________ 
 
The purpose of this chapter is to outline the aim and objectives, methods and data analysis 
procedures of Study Two and Study Three.  
_________________________________________________________________________ 
 
5.1 Study Two 
Study Two was developed with the aim to further understand the factors that influence whether 
NMPs take responsibility for prescribing in any given scenario (Decision 1, Figure 4-1). The 
purpose of this section is to outline the aims and objectives, methods and data analysis procedures 
of Study Two. 
 
5.1.1 Aims and Objectives 
The aim of Study Two was to identify and explore the factors that influence whether nurse and 
pharmacist NMPs take responsibility for making a prescribing decision for a patient or issuing a 
prescription. This was to be achieved by addressing the following objectives: 
1. To explore how perceived competency levels influence whether NMPs take responsibility for 
prescribing in any given scenario 
2. To identify and explore how other factors than competency influence whether NMPs take 
responsibility for prescribing in any given scenario 
3. To identify and explore factors that make NMPs uncertain or uneasy about taking prescribing 
responsibility in any given scenario 
 
5.1.2 Method 
5.1.2.1 Overview of Method 
Nurse and pharmacist NMPs working in primary and community care were purposively sampled to 
this study from PCTs in Greater Manchester as well as other regions of England. Eligible 
participants were initially provided with the study details by their PCT NMPL. NMPs were asked 
to contact the researcher if they were interested in taking part in the study. Interested participants 
took part in a face-to-face or telephone semi-structured interview used in conjunction with the 
critical incident technique (CIT). Some nurse prescribers took part in a focus group. Assignment to 
either an interview or focus group was based on the individual’s preference.  
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5.1.2.2 Location of Sample 
As for Study One, participants were drawn from PCTs in Greater Manchester to limit travel time 
and costs. The NMPLs from six PCTs were approached and informed of the research. These PCTs 
were selected because they had not been approached in Study One. All NMPLs from the PCTs 
approached agreed they would help facilitate the research in their PCT. As a result, the majority of 
nurse prescribers recruited to the study were based in one of these six PCTs. As a result of poor 
recruitment via the PCT route, snowballing sampling was used to recruit pharmacist prescribers 
from other regions of England.  
 
5.1.2.3 Sampling and Recruitment 
Purposive sampling was used to select participants for inclusion in the study. The same recruitment 
criteria outlined in Section 4.3.3 was also used in this study. As for Study One, the aim was to 
ensure that the final sample included a diverse range of NMPs. It was initially planned that at least 
one participant from each of the roles identified in Study One, listed in Box 5-1, would take part in 
a semi-structured interview and a focus group. However, during the recruitment process it became 
evident that this would not be possible as most participants were happy to take part in an interview 
but not a focus group. The plan was revised to include NMPs from a wide range of roles in the 
study as a whole irrespective of whether they took part in an interview or focus group. The sample 
of the focus groups consisted mainly of colleagues and friends which meant they were all 
employed in the same or similar roles.  
 
Participants were also recruited to Study Two with the aim to achieve as much variety in the 
sample, in terms of other demographic characteristics, as practically possible. As with Study One, 
participants’ demographic information relating to their role was collected on the participant form 
(see Appendix 11.0). This information was used to assign participants to one of the categories 
outlined in Box 5-2. This information was then monitored throughout the study to ensure a wide 
demographic in the final sample. The number of participants to fulfil each sub-category was not 
pre-set prior to the study commencing. However, it was anticipated that very few, if any, 
participants would be using SP, as a very low use of SP was observed during Study One.  
Box 5-1: NMPs intended to be Recruited to Study Two and Study Three 
 
• Palliative Care Specialist Nurse 
• Advanced Practitioner 
• Specialist Nurse (any field) 
• WIC Nurse and/or OOHs Nurse 
• Nurse Practitioner for GP Surgery/Practice Nurse  
• Active Case Manager/Community Matron 
• Practice Pharmacist 
• Community Pharmacist 
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The sample size of this study was determined by the number of interviews and focus groups that 
were required to reach ‘data saturation’. The data generated from this study was continuously 
analysed throughout the data collection period. Recruitment ceased when it was felt that data 
‘saturation’ had been reached. Morse stated that saturation can be thought of as ‘data adequacy’ 
and can be operationalised by collecting data until no new themes or information are obtained from 
the data (Morse 1995). Morse highlighted how it is the research team, rather than published 
guidelines or tests, which determine whether data saturation has been reached. In this study the 
themes emerging from the data were reviewed by the research team for their breadth and depth. 
When it was felt that there was enough data to build a comprehensive and convincing theory, data 
saturation was considered to be reached, and sampling ceased.   
 
The recruitment of NMPs to Study Two took the same form as that in Study One and will not be 
outlined again. The invitation email, participant form and PIS are available in Appendix 12.0, 
Appendix 11.0 and Appendix 13.0 respectively. NMPLs sent initial emails and reminders between 
February 2010 and June 2010. As with Study One, the number of NMPs to whom invitations were 
sent was not recorded (see Section 4.3.3 for further information). All participants recruited to the 
study were provided with the information about the critical incidents before taking part in the 
interview. The focus groups were arranged via one NMP who decided on the time, date and 
location of the focus group. Other NMPs in the PCT were then notified of the details of the group 
via the NMPL and were asked to notify the researcher if they wished to take part. As stated 
previously, recruitment of pharmacist prescribers via the PCT recruitment route was poor. 
However, four pharmacist prescribers and a further nurse prescriber were recruited to the study via 
snowball sampling. 
 
5.1.2.4 Sample of Study Two 
In total, 30 NMPs took part in either a semi-structured interview or a focus group. The sample 
consisted of 25 nurse prescribers and five pharmacist prescribers. Of the 30 participants, 10 took 
part in a focus group (over three focus groups) and 20 in a semi-structured interview. No 
pharmacist prescribers took part in a focus group. The NMPs were drawn from the following 
Box 5-2: Demographic Categories for Study Two and Three (Based on data from Study One) 
• Frequency of Prescribing: Low (<5 or less prescriptions per week), Moderate (>5 to <20 
prescriptions per week) and High (>20 or more prescriptions per week) 
• Use of Prescribing: Independent only, Independent and Supplementary, Supplementary only 
• Year of Prescribing Qualification: Before 2003, 2003 to 2005, 2006 to Present 
• Length of Time Working in Field: Low (<4 years), Moderate (> 4 years & <10 years) and High (> 
10 years) 
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locations: PCT 1 (n=3), PCT 2 (n=10), PCT 3 (n=6), PCT 4 (n=2), PCT 5 (n=1), PCT 6 (n=3) and 
Other Region (n=5). Participants taking part in Study Two were employed in the roles listed in 
Table 5-1. Other demographic information about the participants taking part in Study Two is 
presented in Appendix 14.0. Further information about the nature of the participants’ roles (e.g. 
type of conditions treated, consultation setting) is available in Appendix 10.0. 
 
Table 5-1: Sample of Study Two 
Role  n= 
Advanced Nurse Practitioner for Nursing Homes 3 
Advanced Practitioner for Schools Health  1 
Community Matron/ Active Case Manager 
(including paediatric and adult) 3 
Palliative Care 1 Specialist Nurse 
(including paediatric 
and adult) All Other 5 
Nurse Practitioner for GP Surgery  7 
Practice Nurse 1 
WIC Nurse 1 
Community Matron & WIC Nurse 1 
Specialist Nurse & WIC Nurse 1 
Other: Extended Scope Practitioner 1 
Practice Pharmacist/Prescribing Support 
Pharmacist 3 
Community Pharmacist 2 
TOTAL 30 
 
5.1.2.5 Data Collection Method 
Participants recruited to Study Two took part in a semi-structured interview using the CIT or a 
focus group. The use of these methods will now be discussed. 
 
Critical Incident Technique (Facilitated using Semi-Structured Interviews) 
As has been discussed previously, participants in Study One found it difficult to discuss specific 
prescribing events even when prompted. Instead, participants spoke in general terms about their 
prescribing behaviour. Flanagan, an early pioneer of the CIT, describes how the CIT ‘does not 
collect opinions, hunches and estimates but obtains a record of specific behaviours’ (Flanagan 
1954). It was intended that the technique would allow focus on participants’ actual prescribing 
behaviour rather than stereotyped views. In this study the CIT was facilitated by semi-structured 
interviews. Semi-structured interviews were selected, rather than in-depth interviews or structured 
interviews, as they allow both a framework for discussion to be set out prior to the interviews and 
flexibility to respond to participants’ comments and thoughts as they emerge during the interviews. 
By using semi-structured interviews themes identified in Study One could be explored but 
participants still had an opportunity to add their own thoughts.  
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In studies using the CIT participants are asked to bring to the interview an example of a ‘critical 
incident’. Flanagan describes a critical incident as ‘any observable human activity that is sufficient 
in itself to permit inferences and predictions to be made about the person performing the act’ 
(Flanagan 1954). In one example of a CIT study, hospital doctors were asked to think of 
prescribing decisions they had made that made them feel uncomfortable. The reason for this 
discomfort was then discussed during semi-structured interviews (Lewis and Tully 2009b). 
 
In this study participants were asked to think of two critical incidents:  
 
(1) A situation where they did not feel it was appropriate for them to take responsibility for 
making a prescribing decision for a patient or issuing a prescription.  
 
(2) A situation where they felt uncertain or uneasy about taking responsibility for making a 
prescribing decision for a patient or issuing a prescription. 
 
Incidents provided by participants were deemed to be suitable for inclusion in the data analysis if 
they enabled an understanding of the factors that influence whether NMPs take responsibility for 
prescribing in any given scenario. Two types of critical incidents were requested from participants 
to facilitate a greater understanding of the area. Participants were asked to think of these critical 
incidents before attending the interview. It was thought it might be difficult for participants to think 
of these situations as they were being asked to think of something that they did not actually do (i.e. 
not take responsibility for prescribing). Therefore, the additional time for reflection that the CIT 
allows, by asking the participants before the interview, was considered useful. 
 
Flanagan stated the CIT should be adapted in accordance with the topic under investigation 
(Flanagan 1954). It should be noted that three modifications to the CIT were made in this study. 
Firstly, in contrast to Flanagan’s preference, the critical incidents were not directly observed by the 
researcher. It was felt observation of these incidents would be inappropriate as many aspects of 
prescribing are non-verbalised and relevant incidents may only happen infrequently. Secondly, the 
nature of the study meant that it would be likely that only a small number of critical incidents 
would be collected. It was not intended that the incidents from this study would provide 
quantitative results. Instead it was intended that the CIT would be used as a tool to further the 
understanding of the topic under investigation by creating an environment where participants could 
describe their behaviour. Thirdly, a panel of experts were not used to classify the incidents. It was 
felt that the researcher, who conducted the interviews, transcribed the recordings and immersed 
herself in other aspects of the topic, would be suitably placed to do this. However, the 
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classifications were discussed with other members of the research team and the themes emerging 
from the critical incidents were discussed in focus groups. 
 
There are disadvantages associated with the CIT. Some authors have highlighted that the technique 
relies heavily on participants’ ability to remember the scenarios accurately (Flanagan 1954; 
Gremler 2004; Schluter et al. 2008). If participants fail to remember aspects of the scenario they 
may omit certain details or replace their memory will false events. To help address this issue 
participants were provided with an aide-memoire form, sent with the details of the interview, to be 
used to record key details of the incidents. A further disadvantage of the method might arise from 
participants misunderstanding the nature of the request in regards to thinking of the critical incident 
(Gremler 2004; Schluter et al. 2008). If participants misinterpret the request they might provide 
information about an aspect of prescribing not relevant to the topic under investigation. In this 
study this potential issue was addressed by clarifying the types of critical incident required on the 
aide-memoire form provided to participants and by encouraging participants to contact the 
researcher if they had any issues with understanding what they needed to do. Another potential 
disadvantage of the CIT is that participants self-select the incidents they wish to discuss. 
Participants might therefore select unusual incidents, incidents they regard as interesting or have a 
great personal motivation to discuss. To overcome this issue, and to add to data collection 
generally, it was decided that a small number of focus group discussions would take place. In the 
focus groups participants would be asked to feedback on some of the incidents that participants 
provided in the semi-structured interviews. The ‘frequency’ and the relevance of the incidents to 
other NMPs were therefore assessed. 
 
Initially all the semi-structured interviews took place face-to-face. However, due to the low 
response rate of pharmacist prescribers, a number of pharmacists were also eventually recruited to 
the study from areas outside Greater Manchester. It was not deemed practical to interview these 
participants face-to-face due to the considerable travel and time costs. As a result, five of the 20 
semi-structured interviews took place over the telephone. The interviews were conducted after an 
initial telephone interview was conducted to assess the appropriateness of using the CIT via 
telephone. The interview transcript was inspected for problems, but none, specifically relating to 
the use of the telephone, were found. 
 
The semi-structured interviews lasted between thirty minutes and one-hour and 10 minutes. The 
interviews took place between February 2010 and June 2010. All interviews taking place face-to-
face were conducted in the participants’ place of work. All but one interview were recorded. One 
participant did not want her interview recording, so instead, the researcher took notes of the 
discussion.  
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Focus Groups 
As discussed, a number of focus group discussions were also conducted in Study Two. Focus 
groups can be defined as ‘unstructured interviews will small groups of people who interact with 
each other and the group leader’ (Bowling 2002, pg.394). The main advantage of focus groups is 
that participants support each other in remembering events and feelings and this process can lead 
participants to beyond the answers of single interviews (Flick 2009). In this study, participants in 
the focus groups were presented with between four and five anonymised critical incidents 
generated from the semi-structured interviews. The incidents shown to participants were selected to 
represent the key themes emerging from the initial analysis of the critical incidents. Participants 
were asked whether they experienced a similar situation to that represented in the incident and were 
asked to describe this situation if they had, or if not, to reflect on the reasons why not. Participants’ 
comments helped the researcher to reflect on the meanings she initially attributed to the critical 
incidents and revise them if necessary. As discussed in Chapter Three, this technique is called 
member validation and is a way of improving the internal validity of the findings. 
 
One advantage of focus groups often cited by authors is that they provide a time and cost efficient 
means to generate rich data (Flick 2009). This is also true in this study as the focus groups enabled 
data to be generated from a larger number of participants more efficiently than interviews. In this 
way, the focus groups were thought to compliment the semi-structured interviews. Unfortunately 
the focus groups were only conducted with nurse prescribers as it was not possible to arrange any 
groups with pharmacist prescribers. However, as the incidents provided by pharmacists were 
similar to those provided by nurses their incidents were also presented to the nurses in the focus 
groups for further discussion.  
 
The focus group discussions lasted between 50 minutes and one-hour and 20 minutes. The focus 
groups were conducted in July 2010. All focus groups were conducted at a participants’ place of 
work and were recorded with permission.  
 
Discussion Guides 
The discussion guides for the semi-structured interviews and the focus groups (see Appendix 15.0 
and Appendix 16.0 respectively) were developed based on the findings of Study One, relevant 
literature and previous interviews or focus groups (if relevant). Both discussion guides started with 
questions about the participant’s role and use of prescribing which helped provide important 
contextual information for the rest of the discussion. The discussion guide for the semi-structured 
interviews then included questions about the critical incidents. Relevant questions were set out 
before the interviews but these were sometimes omitted, modified or added to, to reflect the 
incident being discussed. The discussion guide for the focus groups included questions about the 
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incidents shown to participants. Both discussion guides gave participants the opportunity to reflect 
spontaneously on other factors that influence whether they take responsibility for prescribing. 
These questions were asked at the beginning of the discussion in the focus groups, so that 
participants were not biased by the examples presented to them, but at the end of the semi-
structured interviews to give these participants the opportunity to add any additional comments 
they had. In the semi-structured interviews these general questions were used if the participant had 
not thought of any critical incidents. 
 
5.1.3 Data Analysis 
The analysis of the data generated from Study Two was similar to the analysis in Study One. This 
has been described in detail in Section 4.4 and will not be outlined again. As mentioned, Study 
Two was designed to build on the findings of Study One. However, the data from Study Two was 
initially analysed separately from Study One. After it became apparent that similar broad themes, to 
those identified in Study One, were emerging it was decided to combine the relevant data from 
Study One with the data from Study Two. The broad themes generated from the data of Study One 
and Study Two were similar. However, Study Two helped to provide a greater understanding of 
these themes, generate sub-themes and contribute to the richness of the data. In later chapters the 
data from Study One and Study Two are presented in unison.  
   
5.2 Study Three 
As discussed previously, the general nature of the discussion in Study One made it difficult to 
ascertain the relative influence of factors on NMPs’ prescribing decisions. Subsequently it was 
difficult to gauge, at least in a systematic way, whether they were any differences between 
individual NMPs with regards to the factors they perceived influenced their prescribing decisions. 
To address these issues a method, called the Q-method, was employed in Study Three. Through the 
Q-method it is possible to identify and explore perspectives amongst your sample towards the topic 
of interest. The aim of this section of the chapter is to outline the aim of Study Three, the method 
employed as well as the data analysis procedure.  
 
5.2.1 Aim 
The aim of Study Three was as follows:  
- To identify similarities and differences between NMPs in relation to the factors they 
perceive influence their prescribing decisions 
 
This was to be achieved by addressing the following objective: 
- To identify and explore NMPs’ perspectives on prescribing influences using Q-methodology 
 74 
5.2.2 Method 
5.2.2.1 Overview 
Nurse and pharmacist NMPs working in primary and community care were purposively sampled to 
this study from the North of England. Participants were informed of the research by their PCT 
NMPL or via a direct postal invitation. Participants recruited to the study completed an internet 
survey, based on the principles of the Q-method, where they were asked to order statements about 
prescribing influences according to the extent to which they agreed or disagreed with the statement. 
Participants were also asked demographic questions about their role and use of prescribing at the 
end of the survey. 
 
5.2.2.2 Location of Sample 
Initially five PCTs in the North West of England were approached and were asked for help 
facilitating this study in their PCT. The five PCTs were chosen based on the Office for National 
Statistics 2001 health area classification (ONS 2008). PCTs were selected to represent patients with 
diverse health characteristics so there would be maximum variety in the patients that NMPs 
managed and ultimately prescribed for. Only PCTs in the North West were initially selected for 
involvement in the study because it was felt there was enough variety in the North West, in terms 
of population characteristics, to be able to conduct the study exclusively in the region.  
 
The location of the sample of Study Three evolved from just five PCTs in the North West initially 
to other areas of Northern England. The response rate of pharmacist prescribers in the five PCTs 
approached was not sufficient to achieve the desired sample. As a result, pharmacists in additional 
areas were approached and invited to participate in the research. As discussed in Section 4.6.3, 
requests can be made to the RPSGB for access to the personal information of it members for the 
purposes of research. Using the information obtained from the RPSGB all pharmacists in the North 
of England registered as either an independent or supplementary prescriber and registered as 
working in primary or community care were sent a letter about the study (see Appendix 17.0). 
Nurse prescribers in these additional areas were not approached as a sufficient number of nurses 
had already been recruited to the study at this time. 
 
5.2.2.3 Sampling and Recruitment 
Brown states that for Q-method studies it is not required that the sample is randomly chosen but it 
should be a sample of participants who are theoretically relevant to the problem under 
consideration (Brown 1980). Similarly, purposive sampling allows participants to be selected on 
the basis of their relevance to the topic under investigation. People in this study were considered 
‘relevant to the problem under consideration’ if they were a registered nurse or pharmacist, had 
qualified as an independent or supplementary prescriber, were working in primary and/or 
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community care and were currently prescribing in their role. Q-method studies do not require a 
large number of participants (Brown 1980). The initial aim of Study Three was to recruit 30 nurse 
prescribers and 30 pharmacist prescribers. This was based on Brown’s recommendations that the 
overall aim should be to have four or five persons defining each anticipated perspective, which is 
often between two and four, but rarely more than six (Brown 1980). The desire for 30 nurse 
prescribers and 30 pharmacist prescribers was based on the worst case scenario of needing five 
participants for a maximum of six perspectives. 
 
It was intended that at least one participant from each of the roles previously outlined in Box 5-1 
would be recruited to Study Three to ensure that a diverse range of NMPs took part in the study. 
The exact proportion of participants in each of the roles was not however set-out prior to the study 
commencing. To ensure maximum variety in the sample, NMPs expressing interest in taking part in 
the study, but occupying roles other than those in Box 5-1, were recruited to the study. As with 
Study Two it was the intention to have as much variation in the sample, in terms of other 
demographic criteria (e.g. prescribing qualifications, use of prescribing, frequency of prescribing), 
as possible. As for Study Two the demographic profile of participants recruited to the study was 
monitored to ensure that there was sufficient variety in the final sample. 
 
The majority of participants recruited to the study were initially approached by their PCT NMPL 
via email. This recruitment method has been discussed in Chapter Three and will not be discussed 
again in this section. The invitation email, the expression of interest (EOI) form and PIS are 
available in Appendix 18.0, Appendix 19.0 and Appendix 20.0 respectively. The numbers of 
prescribers within each PCT approached about this study are provided in Table 5-2. However, like 
Study One and Study Two (see Section 4.3.3 and Section 5.1.2.3) the response rate of NMPs taking 
part in Study Three was not calculated. Participants expressed interest by completing the EOI form 
and returning it to the researcher. Interested participants were sent the link to the internet survey as 
well as a unique username and password. This unique username and password allowed the 
researcher to identify participants that expressed interest in taking part in the study but did not 
actually complete the survey. In these cases a reminder email was sent to the participant notifying 
them they still had the opportunity to complete the survey. A maximum of three reminder emails 
were sent to individual participants who had not completed the survey. In addition to this, the 
NMPLs were asked to send reminder emails to all prescribers in their PCT at regular intervals a 
maximum of three times. Invitations were sent by PCT NMPLs between June and September 2011. 
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Table 5-2: Number of Participants approached about Study Three by PCT 
Number of Participants Approached PCT Nurse Prescribers Pharmacist Prescribers 
PCT 1 94 2 
PCT 2 190 10 
PCT 3 86 7 
PCT 4 72 8 
PCT 5 57 11 
 
As a result of the PCT recruitment method, six pharmacist prescribers and 52 nurse prescribers 
expressed their interest in taking part in the survey. However, not all those who expressed interest 
went on to complete the survey. The main reason offered by some of those not completing the 
survey was that they did not have sufficient time. Although the PCT recruitment method resulted in 
a sufficient recruitment of nurse prescribers very few pharmacists expressed interest in taking part 
and even fewer completed the survey.  
 
To supplement the PCT recruitment method additional pharmacists were also individually notified 
of the study via post using personal details obtained from the RPSGB register. All pharmacist 
prescribers in the North of England registered as working in primary and/or community care were 
invited to take part in the research. This resulted in a further 219 pharmacist prescribers being 
invited to take part in the study. The invitations were sent to pharmacists between September and 
December 2010. Participants were sent a unique username and password with the initial invitation 
letter (see Appendix 17.0) so if they wished to participate they could access the survey 
immediately. As before, participants were sent reminder letters at regular intervals, a maximum of 
two times, should they not have completed the survey.  
 
Attempts to recruit pharmacist prescribers using postal invites resulted in interest from a further 20 
participants. Eight pharmacists emailed the researcher to ask if they were suitable to take part in the 
survey as they were not currently prescribing. These pharmacists were asked not to complete the 
survey but to notify the researcher if their prescribing status changed. Two pharmacists did 
complete the survey despite the fact they were not currently using their prescribing. These records 
were omitted from the data inline with the inclusion criteria of this study. 
 
The additional recruitment of pharmacists did not result in the 30 pharmacist prescribers that it was 
initially hoped would be recruited to the study. However, it was apparent that pharmacist 
prescribers occupied a much narrower range of prescribing roles in primary and community care 
than nurse prescribers. It was therefore decided that a slightly smaller sample of pharmacists would 
be sufficient to represent the range of pharmacist prescribers in this setting. The pharmacist 
prescribers’ data was combined with the nurse prescribers’ data for analysis purposes.  
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5.2.2.4 Sample of Study Three 
In total, 56 NMPs took part in the survey. This consisted of 22 pharmacist prescribers and 34 nurse 
prescribers. The 56 NMPs were drawn from the following locations PCT 1 (n=10), PCT 2 (n=10), 
PCT 3 (n=9), PCT 4 (n=3), PCT 5 (n=4), North of England (n=20). Participants taking part in 
Study Two were employed in the roles listed in Table 5-3. Other demographic information about 
the participants taking part in Study Three is presented in Appendix 21.0. Further information 
about the nature of the roles (e.g. type of conditions treated, consultation setting) is available in 
Appendix 10.0. 
 
Table 5-3: Sample of Study Three 
Role  n= 
Advanced Practitioner 2 
Advanced Nurse Practitioner for Nursing Homes 1 
Community Matron/ Active Case Manager 
(including paediatric and adult) 7 
Palliative Care 4 Specialist Nurse 
(including paediatric 
and adult) All Other 4 
Nurse Practitioner for GP Surgery  10 
Practice Nurse 3 
WIC Nurse 1 
Specialist Nurse and Practice Nurse 1 
Other 1 
OOHs Practitioner  1 
Practice Pharmacist/Prescribing Support 
Pharmacist 13 
Community Pharmacist 3 
Practice Pharmacist/Prescribing Support 
Pharmacists & Other 1 
Practice Pharmacist/Prescribing Support 
Pharmacists & OOHs Practitioner 3 
Other 1 
TOTAL 56 
 
5.2.2.5 Data Collection Method 
Background 
Participants recruited to Study Three completed an internet-based survey. In the survey participants 
were asked to order statements about prescribing influences on a grid in the shape of a quasi-
normal distribution (see Figure 5-1 for example) according to their extent of agreement with the 
statement. The survey was designed according to the principles of Q-method which was initially 
proposed by William Stephenson in 1935. Since then, Brown has described the Q-method as 
providing the foundation for a systematic study of subjectivity, a person’s viewpoint, opinion, 
beliefs, attitudes and the like (Brown 1993). In a Q-method study participants are typically 
presented with a set of statements concerning the topic of interest, referred to as the q-set. 
Participants, typically referred to as the p-set, are asked to arrange the statements from their own 
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point of view according to some criterion, such as extent of agreement. Each arrangement is 
typically referred to as a q-sort and the process of sorting the statements is referred to as q-sorting. 
The criterion by which participants sort the statements is often referred to as the condition of 
instruction. McKeown and Thomas described how each completed q-sort represents an individual 
point of view concerning the study topic (McKeown and Thomas 1988). Likewise, Brown and 
Ungs stated that through the ranking of statements the participant provides a replica or model of 
their attitude (Brown and Ungs 1970).  
 
 
 
 
 
 
 
 
 
 
 
The aim of the analysis in Q-method studies is to identify and explore the perspectives towards any 
given topic. The analysis takes the form of a by-person factor analysis. The data analysis procedure 
for Q-method studies is outlined in detail in Section 5.2.3. The purpose of the analysis is to group 
participants together who arranged the statements in a similar, although not necessarily identical, 
manner. Participants who arrange the statements in a similar way could be said to hold a similar 
viewpoint towards the topic of interest. These groupings of participants are often referred to as 
‘factors’ when analysing and presenting the data. Webler et al. describes how factors are taken to 
represent underlying discourses within the larger discourse about the topic (Webler et al. 2001). 
 
It is difficult for prescribers to categorically state the exact nature and extent of the influences on 
their prescribing decisions because they might not know themselves. However, they can offer a 
description of how they perceive their prescribing decisions to be influenced. The Q-method was 
considered a suitable method for this topic as it seeks to study a person’s subjectivity or viewpoint 
on any personal matter or matter of social importance (McKeown and Thomas 1988). In this study 
participants were asked to arrange statements on a grid according to the extent to which they agreed 
with the statement. Each statement began with ‘my prescribing decisions are influenced by’ and 
then went on to describe a source of influence on prescribing. More information about the 
condition of instruction, statements and the statement development is presented in Section 5.2.2.5.  
Figure 5-1: Shape of Quasi-Normal Distribution 
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The Q-method has a number of advantages over conventional survey methods. In most survey 
methods participants are typically asked to indicate their view towards isolated statements. For 
example, in Schumock et al.’s study, participants were asked to rate the importance of a number of 
factors on their prescribing decisions (Schumock et al. 2004). Participants rated the statements 
independently to other statements. This meant that participants could give all the statements the 
same rating if they wished. However, in the Q-method, statements are no longer treated as discrete 
information independent of one another. As a result of the ranking process in Q-method studies 
participants must make fine discriminations between statements they might otherwise not make in 
conventional survey methods (Brown and Ungs 1970). Participants in Study Three were asked to 
indicate which statements about prescribing influences they agreed with most and the statements 
they agreed with least. This led to an understanding of how NMPs ‘trade-off’ or prioritise some 
influences over others. It has been argued that this process of ranking the statements provides the 
researcher with a more holistic perspective of a person’s subjectivity or viewpoint (Dennis 1986). 
 
Dennis argues that during the process of ranking the statements there is a potential for participants 
to make mechanical rather than conceptual choices in order to complete the exercise (Dennis 
1986). On the whole there was little evidence of this problem in the cognitive interviews conducted 
as part of this research. There was no evidence of this problem for the statements participants 
placed in the most agree and most disagree columns of the grid. However, there was some evidence 
of this problem when participants were making fine discriminations between the statements in the 
middle of the grid. Therefore, during the interpretation of the perspectives emerging from the data, 
more attention was given to statements that were placed in significantly different positions on one 
perspective compared with the statements positioning on another perspective.  
 
The Q-method offers advantages in terms of sampling because, compared with other techniques 
employed in social research, large randomised samples are not necessary. Brown states that the 
sample of Q-method studies need to include enough participants to establish the existence of a 
perspective for the purposes of comparing one perspective with another. Brown also added that the 
p-set does not need to be random (Brown 1980). Instead, the participants are theoretically sampled, 
as in qualitative research, and are deliberately selected with the expectation that they will hold 
different and relevant points of view on the topic of interest (Dennis 1986). Whilst this has raised 
some questions about the external validity of the findings from Q-method studies, discussed 
initially in Chapter Three, the lack of need for a large randomised sample makes Q-method studies 
less time consuming and less costly. This was considered beneficial for a programme of research 
constrained, as much research is, by many logistical factors.   
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As well as acknowledging the advantages of the method, Dennis raises concerns about participants’ 
ability to complete the Q-method exercise (Dennis 1986). Dennis emphasises how a thorough 
comprehension of the instructions for the exercise is required if the participants are to represent 
their perspectives accurately and adequately. Dennis argues that if a lack of understanding about 
the exercise leads to a misrepresentation of the participant’s viewpoint, the validity of the study 
may be questioned (Dennis 1986). The clarity of the instructions in this study was tested in the 
cognitive interviews. Webler et al. believed that the quality of the data they collected was improved 
as a result of the participants in their study enjoying the Q-method exercise (Webler et al. 2001). In 
their study, Webler et al. reported participants enjoyed doing the exercise, mentioned it was fun, 
moderately difficult, and that it stimulated their thinking (Webler et al. 2001). It might be that the 
unique nature of the Q-method exercise is both an advantage and disadvantage of the method.  
 
Application of Q-method in Study Three 
The application of the Q-method in Study Three will now be discussed under three main headings: 
(1) The development of the q-set (2) Testing of the q-set and survey, (3) The administration of the 
survey.   
 
(1) Initial Development of the Q-set (Statements) 
This section describes the stages involved in the initial development of the q-set for the survey used 
in Study Three. As described previously, the q-set is the statements presented to participants in Q-
method surveys. McKeown and Thomas make a distinction between four types of q-sets; (1) 
Naturalistic q-sets, (2) Ready-made q-sets (3) Quasi-naturalistic q-sets and (4) Hybrid types. 
According to McKeown and Thomas ‘naturalistic q-sets’ are statements taken from respondents’ 
oral or written communication about the topic under study. ‘Ready-made q-sets’ are derived from 
sources other than respondents’ own words. Quasi-naturalistic q-sets are similar to those drawn 
from interviews but are drawn from external sources to the study. As the name suggests, hybrid q-
sets can be derived from naturalistic, quasi-naturalistic and ready-made sources combined 
(McKeown and Thomas 1988). In this study the q-set developed could be considered a hybrid q-
set, as the development of the statements was drawn from both naturalistic (interviews in Study 
One) and quasi-naturalistic sources (literature for NMPs and doctors). 
 
All sources, whether naturalistic, ready-made, quasi-naturalistic or hybrid, from which the q-set is 
developed are often termed the concourse. Brown defines concourse as the flow of 
communicability surrounding any topic in the ordinary conversation, commentary and discourse of 
everyday life (Brown 1993). Similarly, van Exel and de Graaf describe how concourse is a 
technical concept used in Q-method studies for the collection of all possible statements the 
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participants can make about the subject at hand (van Exel and de Graaf 2005). In this study, the 
concourse consisted of three sources: 
 
(1) Transcripts of the 18 in-depth interviews in Study One 
(2) Literature on prescribing influences for NMPs 
(3) Literature on prescribing influences for doctors 
 
The literature used to develop the statements in Study Three reflects that already discussed in 
Chapter Two of this thesis. As for the literature review only a small volume of literature was 
available for NMPs. In contrast, a large amount of research concerned doctors’ prescribing. 
Therefore, as with the literature review, the researcher selected papers she felt were more relevant 
to address the aim of the study. Starting with the transcripts of the 18 in-depth interviews the 
researcher reviewed each source for statements where a factor was described as a source of 
influence on prescribing or where a factor was mentioned as something that did not influence 
prescribing. For example “guidelines probably the central role, though… in my prescribing, I mean 
I tend to stick to guidelines fairly rigidly… well very rigidly” and “I must admit I don't always 
think about cost an awful lot”. All statements were copied electronically into a blank Microsoft 
Excel document. The statements were grouped under broad themes generated from Study One. 
This led to 978 statements grouped under eight broad categories. These categories were: (1) 
clinical, (2) regulatory factors, (3) patient factors, (4) colleague factors, (5) prescribing culture and 
professional experience, (6) training and information sources, (7) logistical factors, (8) 
pharmaceutical industry. The researcher than reviewed the 978 statements again and removed 
irrelevant or ambiguous statements. This reduced the number of statements to 850.  
 
In the next stage of q-set development the researcher reviewed each of the statements within the 
eight categories described above and grouped statements that dealt with a very similar or the same 
theme together. This produced 97 statement sub-groupings within the broader eight categories. One 
overall statement was then created for each of the sub-groups of statements by reviewing the 
statements that were contained within the grouping. Where possible the researcher copied the 
language of the participants taking part in Study One to ensure that the statements mirrored the 
language of NMPs. However, in a desire to replicate the language of NMPs the word 
‘concordance’ was used in one statement in a way that is not consistent with the official definition 
(see Chapter Eight for further discussion). The overall statements were reviewed by the wider 
research team and some minor changes to the statements were made. The aim of the next stage was 
to, if necessary, refine and reduce the 97 statements even further. In order to help evaluate the 97 
statements a checklist was produced by the researcher based on the literature for the Q-method. 
 82 
This checklist is provided in Box 5-3. This review of the statements, in terms of the checklist, 
reduced the 97 statements to 52 statements.  
 
 
 
 
 
 
 
 
The majority of the 45 statements deleted from the original 97 were deleted because they did not 
fulfil one or more of the evaluation criteria outlined in Box 5-3. Nine statements were removed 
because they focused on clinical influences (e.g. the anticipated efficacy of the treatment). It was 
felt that if clinical influences were included in the task there would be less opportunity to explore 
how other sources of influences impacted NMPs’ decisions, as participants may well have placed 
all the statements concerning clinical factors in the most agree columns of the grid. For this reason 
the statements relating to clinical influences were removed. For much the same, albeit opposite 
reason described above, an additional four statements, all relating to the pharmaceutical industry, 
were also removed at this stage. It was clear from Study One that NMPs felt the pharmaceutical 
industry had little impact on their prescribing. It was anticipated that the majority of NMPs would 
place all the pharmaceutical industry factors in the disagree columns. For this reason the majority 
of statements relating to the pharmaceutical industry were removed. However, one statement was 
kept to ‘test’ this assumption in the cognitive interviews. 
  
McKeown and Thomas make the distinction between unstructured and structured q-sets. In 
unstructured q-sets, items considered relevant to the subject are selected so to provide a reasonably 
accurate ‘survey’ of positions taken or likely to be taken on a given issue. In structured q-sets items 
are composed more systematically. McKeown and Thomas state the process of developing q-sets 
can be inductive, so that categories emerge from observations or statements collected, or deductive, 
so that categories are formed based on prior hypothetical considerations (McKeown and Thomas 
1988). In this study, the q-set was ‘structured’ and ‘inductive’ because statements represented the 
broader categories of influences identified in Study One. However, the final number of statements 
under each theme varied to reflect the depth to which the theme received coverage in the original 
concourse. There were more statements under the colleague theme than the cost theme because 
there were many different ways NMPs talked about the influences of colleagues (e.g. GPs, 
pharmacists, NMPs) but there was less variety in terms of how cost was discussed. The difference 
Box 5.3: Checklist for Statement Development for Study Three 
1. Is the statement potentially relevant to each type of prescriber? 
2. Does the statement include a source of influence that could influence prescribing decisions? 
3. Does the statement include one idea only? 
4. Can the statement be compared with the other statements for the purposes of ranking/sorting? 
5. Can the statement be ranked on the scale provided? 
6. Does the statement include an idea that could evoke mixed reactions from the participants? 
7. Is the statement unique to other statements? 
8. Is the statement clear? 
9. Is the statement worded using terms that are familiar? 
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in the number of the statements within each category could therefore be considered a direct 
reflection of how prescribers talk about prescribing influences. It was felt this method would 
provide the best means for participants to adequately replicate their viewpoint through the Q-
method exercise. Baker using a similar approach to this, describes this as a ‘loose’ structured 
approach to developing the q-set (Baker 2006). It is important to note that the statement categories 
did not represent a theory as to how NMPs would be differentiated after data analysis. Instead, it 
was intended that any perspectives amongst NMPs would emerge from the data. This distinction 
was also made by Baker et al. in their Q-method study (Baker 2006) and should be considered 
when interpreting the findings of this survey.  
 
(2) Testing of the Q-set and Survey Material 
The performance of the 52 statements, produced in the initial development stage, as well as other 
survey material was tested through six cognitive interviews with NMPs. Cognitive interviews are 
used to identify problems in questionnaires under development by asking a small number of pre-
test participants to respond to the draft survey (Conrad and Blair 2009). In cognitive interviews 
participants are asked to provide verbal reports about their thinking while responding to draft 
survey questions. During the interview the researcher may probe further for more information than 
the participant spontaneously provides. Once the interview is complete the researcher inspects the 
transcripts for any evidence of problems in the questionnaire (Conrad and Blair 2009). Those 
NMPs taking part in the cognitive interviews were initially approached using contacts of the 
research team and colleagues in the Pharmacy department at the University of Manchester. All 
were told that the information gained from their interviews would only be used to help develop the 
survey material and would not be used in any other capacity.   
 
Three nurse prescribers and three pharmacist prescribers took part in a cognitive interview. The 
researcher recorded the cognitive interviews with the prescribers’ permission. Initially, the 
cognitive interviews took place face-to-face, either at the prescribers place of work, home-address 
or in offices at the University of Manchester and used paper versions of the material. This was to 
maximise understanding of how NMPs responded to the q-set and survey material as the researcher 
could evaluate both verbal and non-verbal clues (e.g. facial expressions). The performance of the 
internet survey was later tested in telephone interviews after the prescriber had completed the 
internet-based survey. The aim of the cognitive interviews was to test the performance of the q-set 
and other survey materials. NMPs were provided with the paper survey and were asked to complete 
the exercise normally but to explain their decisions as they made them. Participants were also asked 
the questions outlined in Box 5-4 at relevant points during the interview. 
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Discussions with NMPs were transcribed and inspected for problems. Initially, the condition of 
instruction, that is the instruction that sets out the context for consideration of the q-set, asked 
participants to order the q-set according to the extent to which they used the factors, listed on each 
card, to help make treatment decisions. Each statement in the q-set contained one source of 
influence such as ‘information from the medicines management team’. The scale on the grid ranged 
from ‘most frequently’ on the right to ‘most infrequently’ on the left with ‘neutral’ in the middle. 
 
NMPs’ behaviour and comments during the initial interviews pointed to a number of problems with 
this initial survey material. NMPs’ behaviour suggested that they had difficulty ordering the 
statements according to the condition of instruction. NMPs appeared confused, read the condition 
of instruction mid-exercise and re-worded the instruction inaccurately. At the end of the interviews 
NMPs were asked directly about any difficulty with the condition of instruction. Most described 
some issues with the wording and felt other words such as ‘influence’ would be more appropriate. 
NMPs also felt ‘prescribing decision’ would be more appropriate than ‘treatment decision’ as the 
word ‘treatment’ is wide ranging and involves many different aspects of patient care other than 
prescribing. 
 
Following the initial interviews a number of changes were made to the survey material. Each of the 
statements in the q-set was changed to start with the phrase ‘my prescribing decisions are 
influenced by’. This was done to re-emphasise the condition of instruction and to encourage 
participants to reflect on the factors that influence the prescribing decisions they personally make. 
In the condition of instruction ‘treatment decision’ was replaced by ‘prescribing decision’ and 
participants were asked to think about the extent to which they ‘agreed’ or ‘disagreed’ with the 
statements. This was changed so the condition of instruction was consistent with the language of 
the statements. The scale was changed to ‘most agree’ on the right hand side and ‘most disagree’ 
on the left hand side. In addition to these changes, small wording and formatting changes were 
made to other aspects of the survey instructions in line with NMPs’ comments during the 
interviews. The changes made as a result of the findings from the initial cognitive interviews were 
tested and refined in the later cognitive interviews.  
 
Box 5-4: Questions Participants asked in Cognitive Interviews in Study Three 
- What do you think the instructions are telling you to do? 
- How would you rephrase the instructions in your own words? 
- Is there anything confusing in the instructions? 
- Overall how did you find the exercise? 
- Was there anything you found difficult about the exercise? 
- Was there any statements that you expected to see that were not there? 
- How easy/difficult was it to think about your prescribing decisions generally? What would make it 
easier? 
- Can you foresee any problems when others complete the exercise? 
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Following the cognitive interviews a number of changes were made to the 52 statements in the q-
set. These changes involved reducing the number of statements from 52 to 42, and some small 
editing changes to the remaining statements. Duplicate statements were removed along with those 
considered not relevant to the majority of NMPs. Vague or ambiguous statements were also 
removed. For example, the statement ‘whether I am certain with the diagnosis I have made’ elicited 
a wide range of responses from NMPs which could not be resolved with wording changes. One 
statement ‘the anticipated effect of the prescribing decision on the wider community’ was divided 
in to two statements to reflect the two meanings that prescribers attributed to the statement. The 
statement relating to the pharmaceutical industry was deleted because, as predicted, all NMPs 
placed this statement in the most disagree column. The changes made to the q-set as a result of the 
findings from the initial cognitive interviews were tested and refined further in the later cognitive 
interviews. These changes led to 42 statements remaining in the q-set. The final 42 statements are 
available in Appendix 22.0. 
 
As outlined, in the later cognitive interviews participants completed the internet version of the 
survey and discussed any problems they faced with the researcher via telephone. These interviews 
served to ‘test’ the performance of the on-going changes to the survey and evaluate whether the 
survey worked effectively via the internet. After the initial cognitive interviews the survey material 
was transferred to the internet. To aid this process the researcher used a freely available internet 
version of the Q-method survey (Hackert and Braehler 2007). A number of structural modifications 
were made to the survey so it could be used for this study. The NMPs in the later interviews 
reported that they had no problems accessing the survey using the link provided, completing the 
main q-sorting task, navigating through the survey and completing other aspects of the survey. 
Therefore, no changes were made to the survey material as a result of the feedback NMPs provided 
in the later cognitive interviews. 
 
(3) Administration of Q-method Survey 
A number of ways to administer the survey were considered for this study. These included focus-
groups, one-to-one interviews, mail administration and the internet. Q-method surveys 
administered in face-to-face situations can aid completion of the survey as participants can clarify 
any difficulties with the instructions. Face-to-face administration may also enable a deeper 
understanding of participants’ rationale for the choices they made. However, it was felt that face-
to-face administration of the Q-method survey would not be possible in this study due to the 
limited number of pharmacist prescribers in the immediate area that had not taken part in Study 
One or Study Two. Therefore, in this study, the Q-method survey was administered using the 
internet to enable participants to be drawn from a wider geographical distribution than if the 
exercise was conducted face-to-face. An internet administration was preferred over mail 
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administration because it was anticipated that data collection would be more consistent, quicker 
and more efficient.  
 
Participants were sent a unique username and password and the link to the internet survey. To enter 
the survey the participant needed to enter their username and password details on screen one. 
Participants were provided with introductory information about the study on screen two and screen 
three. If participants continued with the survey at this stage they were assumed to be consenting to 
take part in the survey, an additional consent form was not signed. However, participants could still 
exit the survey if they decided not to take part at any point. 
 
On screen four of the survey participants were provided with the condition of instruction for the 
survey (see Box 5-5) along with instructions for Step One. Step One of the survey involved 
participants sorting the 42 statements into three piles: (1) Statements they generally agreed with, 
(2) Statements they felt neutral about and (3) Statements they generally diagreed with. On screen 
five participants were provided with Step One. A summary of each screen of the survey is provided 
in Table 5-4. A summary of each step of the survey is provided in Table 5-5. A full version of the 
survey is available in Appendix 23.0 
 
On screen six participants were given instructions for Step Two. In Step Two participants were 
asked to sort the statements, still in ‘piles’ as per Step One, in the form of a quasi-normal 
distribution (see Figure 5-1). Although other distributions can be selected a conventional quasi-
normal distribution was selected for this study. Participants were asked to arrange the 42 statements 
in a distribution ranging from -4 (most disagree) on the left hand side to +4 (most agree) on the 
right hand side. Neutral was in the middle of the scale and was represented by the value 0. A -4 to 
+4 scale was selected as Dennis recommends that piles on the continuum are labelled in deviation 
form (e.g. -4 to +4) and that the orientations reflect a most to most situation (e.g. most like me to 
most unlike me) as people’s negative feelings can be just as strong as their positive ones (Dennis 
1986). On screen seven participants were provided with Step Two. 
 
On screen eight participants were given instructions for Step Three. In Step Three participants were 
asked to review their distribution from Step Two and make any corrections they wished to. On 
screen nine participants were provided with Step Three. On screen ten participants were presented 
Box 5-5. Condition of Instruction for Survey in Study Three 
‘In the first step of this exercise you will be presented with 42 statements. Each statement begins with 
“My prescribing decisions are influenced by…” and then describes a factor that could influence 
prescribing. Please think about the extent to which you agree or disagree with each of the statements in 
relation to the prescribing decisions you personally make’. 
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with the instructions for Step Four. In Step Four participants were asked to explain the reasons for 
placing the two statements they did in the -4 column (most disagree) and the two statements they 
did in the +4 column (most agree). The information captured in this stage was used to help with the 
interpretation of the perspectives at a later stage. On screen eleven participants were provided with 
Step Four. 
 
 
 
 
 
 
 
 
 
 
 
 
On screen twelve participants were given instructions to complete Step Five. In Step Five 
participants were asked to complete questions relating to their role, number of years working in the 
field they are prescribing in, type of prescribing qualification achieved, use of different types of 
prescribing, year of first prescribing qualification and number of prescriptions issued per week. On 
screen thirteen participants were provided with Step Five. 
 
On screen fourteen participants were thanked for their participation and were asked to submit their 
data. On screen fourteen and screen fifteen participants were invited to leave any negative, positive 
or general comments they had about completing the survey.  
 
The data from the survey was automatically saved to a secure server. The saved data did not 
contain participants’ names or any other personal contact details but could be linked back to the 
name of the participant using the unique username that was saved with the data. The period of data 
collection was June 2010 to November 2010. Three participants had issues completing the survey 
via the internet and another participant wished to complete the survey using a manual, rather than 
an electronic version of the survey. To accommodate these participants a paper version of the 
survey, almost identical to the electronic version, was created and sent to these participants. Two of 
the four participants completed the survey and returned it to the researcher. The data of another 
participant, who returned a partially completed survey, was not used. 
 
Table 5-4: Summary of Each Screen in Survey used in Study Three 
Screen One, Two and Three Username and Password Login Introductory Information 
Screen Four Condition of Instruction Instructions for Step One 
Screen Five Step One Exercise 
Screen Six Instructions for Step Two 
Screen Seven Step Two Exercise 
Screen Eight Instructions for Step Three 
Screen Nine Step Three Exercise 
Screen Ten Instructions for Step Four 
Screen Eleven Step Four Exercise 
Screen Twelve Instructions for Step Five 
Screen Thirteen Step Five Exercise 
Screen Fourteen Thank you and Data Submit 
Screen Fifteen and Sixteen Feedback and Comments  
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5.2.3 Data Analysis 
The analysis of the data in Study Three was facilitated by the use of a program called PCQ 
software (Stricklin and Almeida 2004). This is a freely available downloadable software program 
specifically for the analysis of Q-method studies. A summary of the data analysis process for Study 
Three is provided in Figure 5-2. In the first stage of the analysis, the data for each q-sort was 
entered into the PCQ software program. The PCQ software checks that the number of a statement 
has not been entered twice or not at all. If an error has been made the program alerts you to the 
problem and asks you to double check the data and re-enter it if necessary. However, because this 
accuracy check would not cover instances where two statements were entered in the wrong place 
an additional accuracy check was completed by another person.  
 
Once entered, the data was subjected to factor analysis. As discussed previously, in Q-method it is 
people that are being ‘factored’ and correlated as opposed to tests, traits and the like (van Exel and 
de Graaf 2005). Therefore, in Q-method a factor represents a group of people who hold a similar 
perspective on the topic of interest (indicated by similar arranged q-sorts). In the second stage of 
the analysis the data was subjected to principal components analysis (PCA). The aim of this stage 
was to identify the number of natural groupings of q-sorts by virtue of being similar or dissimilar to 
one another, that is, to examine how many basically different q-sorts are in evidence. The PCA 
produced a series of eigenvalues, a Pearson’s correlation matrix (where each q-sort was correlated 
with every other q-sort) and an unrotated factor loadings file (which presented the loadings for each 
q-sort onto the factors extracted from the correlation matrix). Factor loadings are in effect 
correlation coefficients. They indicate the extent to which each q-sort is similar or dissimilar to 
eigenvalues (and corresponding percentage figures) on screen.  
 
Table 5-5: Summary of Step One to Step Five in Survey used in Study Three 
Step One 
Participants asked to sort 42 statements about prescribing influences into three 
piles: Statements they generally agree with, (2) Statement they feel neutral about 
and (3) Statements they generally disagree with 
Step Two 
Participants were asked to sort the statements, still in ‘piles’ as per Step One, in the 
form of a quasi-normal distribution (see Figure 5-1). Participants were asked to 
arrange the 42 statements in a distribution ranging from -4 (Most Disagree) on the 
left hand side to +4 (Most Agree) on the right hand side 
Step Three Participants were asked to review their distribution from Step Two and make any 
corrections they wished to 
Step Four 
Participants were asked to explain the reasons for placing the two statements they 
did in the -4 column (Most Disagree) and the two statements they did in the +4 
column (Most Agree) 
Step Five 
Participants were asked to complete questions relating to their role, number of years 
working in the field they are prescribing in, type of prescribing qualification 
achieved, use of different types of prescribing, year of first prescribing qualification 
and number of prescriptions issued per week 
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The aim of the third stage of the analysis was to determine the significance of the unrotated factors 
generated from PCA. This was achieved partly by examining the eigenvalues and producing a scree 
plot of the eigenvalues. However, other criteria for assessing the significance of the unrotated 
factors was also used. This is discussed further in Chapter Eight. Once it was decided how many  
 unrotated factors were significant, varimax rotation analysis was performed (fourth stage). The 
aim of this fourth stage was to yield interpretable factors by rotating the selected factors. To do this 
it is first necessary to derive a best estimate of that factor in terms of a weighted average of the q-
sorts in terms of their loadings on that factor. To achieve this it is required that the loadings of each 
q-sort should be large on one factor and trivial on the other. In factor analysis this is called ‘simple 
structure’ (van Exel and de Graaf 2005). Each resulting final factor represents a group of individual 
points of view that are highly correlated with each other and uncorrelated with others (van Exel and 
de Graaf 2005). This process is achieved automatically based on mathematical criterion in the PCQ 
software be selecting the varimax rotation option but this can also be achieved with qrotation, 
which is a visual procedure or hand rotation. Hand rotation was used more before the introduction 
of computers but is rarely used today. Instead, varimax is now the rotation of choice (van Exel and 
de Graaf 2005) and was therefore used in this study. 
 
The output of the varimax rotation analysis is a rotated factor loadings file. This file indicates the 
extent to which each participant’s q-sort is similar or dissimilar to the composite factor array for 
that type. In the fifth stage of analysis the q-sorts that load significantly on to each rotated factor 
were marked. These are termed ‘defining’ sorts. In the PCQ software there is an automatic function 
to mark defining sorts. However, in this study, this automatic function was overridden so an 
alternative formula could be applied. This is discussed further in Chapter Eight of the thesis. In the 
sixth stage of the analysis a final report is produced by selecting the qanalyse function in the PCQ 
software. This re-expresses the factors as a best estimate of the q-sorts or defining sorts that 
represent them. The final report includes the factor matrix with an ‘X’ indicating a defining sort, a 
list of statements that differentiates each factor from each of the other factors (along with 
significance levels) and the z-score for each statement and factor. In the seventh stage of the 
analysis factors generated from the study were interpreted using the final report, generated from the 
PCQ software, and the open-ended comments provided by participants in Step Four of the survey. 
The open-ended comments provided by participants were entered in to NVivo and organised 
according to the statement to which the comment related. 
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AIM 
- To identify the number of 
natural groupings of q-sorts 
by virtue of being similar 
or dissimilar to one another 
 
OUTPUT 
- Pearson’s Correlation 
Matrix, Unrotated factor 
loadings file and 
Eigenvalues  
 
Data subjected to Principal Component Analysis (PCA) 
 
Varimax Rotation Analysis 
AIM 
- To yield interpretable 
factors by rotating selected 
factors 
 
OUTPUT 
- Rotated Factor Loadings 
File  
 
Q-sorts for each participant entered into PCQ Software. 
Data entry checked 
INTERPRETATION OF PCA 
AIM – To determine significance of unrotated factors 
generated in PCA 
INTERPRETATION– Examination of Eigenvalues, Scree 
Plot of Eigenvalues along with other interpretation  
RESULT – Decide how many unrotated ‘factors’ are taken 
forward for further analysis 
INTERPRETATION OF Varimax 
AIM -  To specify which participants load significantly to 
each rotated factor (Defining Sort) 
INTERPRETATION– Examination of rotated factor 
loadings file. Significance level (99%) determined by using 
formula.  
 
Final Report (Qanalyse) 
Factor Interpretation 
- Labelling of factors based on final report and open-
ended comments 
 
AIM 
- To re-express factors as 
the best estimate of q-sorts 
that represent them 
 
OUTPUT 
- Report including key 
details  
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4 
5 
6 
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Data Entry 
and Data 
Checking 
Principal 
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Analysis 
Varimax 
Analysis 
QANALYSE 
Figure 5-2: Summary of Data Analysis and Interpretation process for Study Three 
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Chapter Six – Responsibility 
_________________________________________________________________________ 
 
The purpose of this chapter is to describe the factors that influence whether NMPs take 
responsibility for prescribing. This includes a discussion of the factors that influence whether 
NMPs take responsibility for issuing a prescription and the factors that influence whether they take 
responsibility for making a prescribing decision for a patient. The chapter draws on findings from 
both Study One and Study Two. Study One began to explore the influences on whether NMPs take 
responsibility for prescribing using in-depth interviews. The topic was then explored further in 
Study Two using the CIT, facilitated through semi-structured interviews, and focus groups. The 
chapter begins with an overview of the critical incidents provided by NMPs in Study Two. 
_________________________________________________________________________ 
6.1 Overview of Critical Incidents 
The NMPs taking part in Study Two were asked to think about two incidents before attending the 
interview: 
 
(1) A situation where they did not feel it was appropriate for them to issue a prescription or 
take responsibility for making a prescribing decision for a patient (for a non-clinical 
reason) 
 
(2) A situation where they felt uncertain or uneasy about issuing a prescription or taking 
responsibility for making a prescribing decision for a patient (for a non-clinical reason) 
 
The 20 NMPs taking part in a semi-structured interview in Study Two described 52 incidents. 
Nurse prescribers provided 40 incidents and pharmacist prescribers provided 12 incidents. Nine out 
of the 52 incidents concerned repeat prescribing. Analysis of these incidents was conducted. This 
analysis is presented in Section 6.5 of this chapter. In 24 of the remaining 43 incidents, the NMP 
decided not to take responsibility for prescribing. In 15 of these incidents the patient was formally 
referred to another HCP. In seven of these incidents the NMP did not take responsibility for 
prescribing and the patient was not referred. In two of these 24 incidents a doctor was asked to 
issue the prescription on behalf of the NMP. In 13 of the 43 incidents, the NMP took responsibility 
for prescribing in conjunction with another HCP. The NMPs eventually took responsibility for the 
prescribing decision in eight of these 13 cases. A doctor issued the prescription in two incidents. 
No prescription was issued by anyone in a further three incidents. Six of the 43 critical incidents 
collected concerned a scenario where the NMP felt uneasy or uncertain about taking responsibility 
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for prescribing. There were only six incidents in this category as NMPs brought incidents that 
covered both types of incidents outlined above. Figure 6-1 provides a summary of this data. 
 
Seven NMPs came to the interviews having not thought of any incidents at all. These NMPs were 
reminded of the request at the beginning of the interview and asked to think of these incidents 
during the discussion. Following this request all prescribers managed to recall incidents appropriate 
to the discussion. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NMPs often described many factors that impacted their eventual decision. It was therefore difficult 
to categorise the incidents based purely on the factors influencing the incident. This chapter will 
instead provide an overview of all the influences that NMPs discussed. The findings will be 
presented in conjunction with the appropriate findings from Study One and the focus groups in 
Study Two. The key factors influencing whether NMPs took responsibility for prescribing in any 
given scenario fell under four categories: competency, role, practical and legal issues, and degree 
of risk. NMPs also reported a number of factors that exerted pressure on them to take prescribing 
9 incidents relating 
to repeat prescribing 
(see Section 6.5) 
40 
 incidents 
from  
nurses 
12 incidents 
from  
pharmacists 6 incidents relating 
where prescriber felt 
uncertain or uneasy 
24 incidents where 
the prescriber did 
not take 
responsibility for 
prescribing 
13 incidents where 
the prescriber took 
responsibility for 
prescribing in 
conjunction with 
another HCP 
15 incidents where patient was formally referred to 
another HCP 
7 where the prescriber did not take responsibility but 
the patient was not referred 
3 incidents where no prescription issued by anyone 
2 incidents where a doctor issued the prescription 
8 incidents where the prescriber took responsibility 
for issuing the prescription. 
52 
CRITICAL 
INCIDENTS 
Figure 6-1: Summary of Critical Incidents collected in Study Two 
2 incidents where a doctor issued the prescription 
6 incidents where the prescriber took responsibility 
for prescribing 
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responsibility. These factors are discussed later in Section 6.4. NMPs’ overall approach to taking 
responsibility for prescribing is discussed in the next section of this chapter. 
 
6.2 Overall Approach to taking Responsibility 
It was evident from the discussion in both Study One and Study Two that most nurse and 
pharmacist prescribers adopted a cautious approach to taking prescribing responsibility. NMPs in 
this research stated they were cautious about taking responsibility. A quote from one palliative care 
specialist nurse (Nurse 010, Study One) illustrated the attitude of many interviewed that “I think 
it’s a case of if in doubt, do nowt”. This view was also replicated by one community matron (Nurse 
017, Study Two) in Study Two who said “If I’ve got a doubt then I have to find out”. This 
sentiment was also repeated amongst pharmacist prescribers. For example, one practice pharmacist 
(Pharmacist 001, Study One) said “If I am in any doubt whatsoever then I just buzz through to the 
GP”. Additionally, another practice pharmacist (Pharmacist 004, Study One) said “If I felt that my 
knowledge wasn’t up to, up to scratch, or there was any doubt in my mind, then I would refer”. 
These sentiments reflect the general cautious attitude of those taking part in this programme of 
research.  
 
NMPs also described behaviour that reflected a cautious approach to prescribing. For instance, 
NMPs described how they would only take responsibility for prescribing when the decision falls 
within their perceived competency levels. In this research, where competency was in question, but 
not altogether lacking, NMPs were quick to seek advice of colleagues. Competency is discussed 
further in Section 6.3.1. NMPs were also less keen to take responsibility for prescribing in 
situations they deemed high ‘risk’. High ‘risk’ was associated with deviation from guidelines or 
formularies, prescribing medicines off-label and prescribing high ‘risk’ medicines or for high ‘risk’ 
patients. Further evidence of NMPs’ cautiousness was reflected in their attitude to repeat 
prescribing. This is discussed in Section 6.5. NMPs drew a comparison between their careful 
approach to issuing repeat prescriptions and that of their GP counterparts who they believed would 
“sign anything”.   
 
It is important to note that not all NMPs at all times demonstrated cautiousness in relation to 
prescribing responsibility. For example, one WIC nurse described how they issued a repeat 
prescription of a medicine they had limited knowledge about because a friend had run out of their 
repeat prescription. However, whilst there are exceptions, this characterisation of NMPs’ approach 
to taking prescribing responsibility represents the attitude and behaviour of virtually all NMPs in 
this programme of research. The next section will describe the possible origins of this cautious 
approach.  
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6.2.1 Factors Influencing Overall Approach to Taking Responsibility 
Some nurse prescribers held certain attitudes in relation to prescribing practice that appeared to 
engender their cautiousness. These attitudes included lack of support from professional bodies and 
healthcare managers, NMPs’ vulnerability and the role of NMPs. These attitudes were not 
expressed by all NMPs in this research. However, even NMPs that did not express these attitudes 
were cautious about prescribing responsibility. The possible origins of their cautiousness are 
reflected upon in the discussion section of this chapter (see Section 6.6).  
 
Some of the nurse prescribers interviewed felt if they made a prescribing error they would not be 
supported by their professional body and healthcare managers to the same extent doctors are in 
similar circumstances. Some felt they would be much more likely than doctors to be “struck-off” 
from the nursing register. Other nurses felt if a nurse made a prescribing error it would be 
highlighted whereas prescribing errors made by doctors would be “concealed”. The quote below 
illustrates some of the nurses’ attitudes: 
 
“I still truly believe that nurses are still more vulnerable than doctors and always will be, so I think 
really, you’ve got to be quite safe in your practice and follow your NMC, because at the end of the 
day, you don’t follow your codes of practice, then, you know it’s, you’re only answerable to the 
coroner” (Nurse Practitioner for GP Surgery 007, Semi-structured Interview, Study 2) 
 
One nurse practitioner for a GP surgery (Nurse 006, Study 2), who did not want her interview 
recorded for confidentiality reasons, described how she was cautious putting her name to a 
prescription. She described how the “buck stopped” with her and how if a serious error was made 
with prescribing, people would think, “it was just the nurse prescribing and not the doctor”. She 
went on to say there is a “cloak of responsibility” around doctors but not nurses. By this she meant 
that doctors would be protected in cases of prescribing errors or other clinical errors. A 
dermatology specialist nurse, who was asked how her views regarding lack of professional support 
influenced her prescribing, described the impact of her views as the following: 
 
“It would make me stop and reflect sometimes before I did something, so things like, a patient not 
being able to fully understand what I’m saying to them is enough to make me think actually do I 
want to give them a prescription, or, in the situation of, of, not having a legal guardian or parent 
there, you know if I prescribe it, and something goes wrong, it’s me that has written the 
prescription” (Dermatology Specialist Nurse 012, Semi-structured Interview, Study 2) 
 
Other nurse prescribers described how their attitude, in relation to professional support, influenced 
all aspects of their practice and not just prescribing. Pharmacist prescribers did not spontaneously 
raise the issue of professional support. In fact pharmacist prescribers felt they had the necessary 
support from their professional body. Some nurse prescribers also expressed this view. 
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“I think you’ve got to, as long as you feel confident that you can justify your actions and that you 
behaved in a competent manner then, you know, you’re as protected as anybody else” (Nurse 
Practitioner for GP Surgery 027, Focus Group 2, Study 2) 
 
It was not clear from the discussions why some NMPs felt supported from their professional body 
and healthcare managers and others did not. However, it could be that past incidents or rumours of 
professional support that influenced their beliefs on this issue.  
 
A small number of nurse prescribers believed an error made by a NMP would attract strong 
criticism from the media and medical profession. In this quote below, two nurse prescribers in a 
focus group discuss how they think errors from nurses would be exaggerated by the media. Similar 
sentiments were also repeated by two other nurse prescribers throughout the course of the 
discussions in Study Two. 
 
NMP 1:“I have that paranoia anyway, if you do something wrong, you will be absolutely, you 
know, it’s about, it’s supposed to be about learning and no blame culture but, there is, and, the 
worrying thing is about prescribing is that they do say, you know, the first thing that goes wrong 
potentially serious will be blown up” (Extended Scope Practitioner 001, Focus Group 1, Study 2)  
 
NMP 2: “Well it will definitely for nurses, they’ll love it, the papers will have a field day” 
(Advanced Practitioner for Nursing Homes 004, Focus Group 1, Study 2) 
 
One epilepsy specialist nurse (Nurse 010, Study 2) felt there was a lot of criticism in the medical 
profession about non-medical prescribing. The nurse described how she had personally experienced 
negativity from doctors. As a result of this criticism she felt that non-medical prescribing had to be 
“cherished” and “protected”. Similar sentiments were also repeated by other nurse prescribers, but 
again, as with professional support, these views were not repeated by pharmacist prescribers.  
 
Nurse prescribers’ attitudes to the vulnerability of non-medical prescribing appeared to engender 
cautiousness when they were deciding whether to take responsibility for prescribing. In the quote 
below a community matron describes how the fear of making a serious prescribing error 
encourages her to highlight cases where she feels she has insufficient knowledge. The community 
nurse qualified to prescribe in 2002 and was one of the more experienced prescribers interviewed. 
Therefore, the term “new prescriber” in the quote can be taken to mean that non-medical 
prescribing is new generally, rather than she personally is a new prescriber. 
 
“As a new prescriber at this stage you’re very much aware of I don’t want to make a decision, I 
don’t want to be the first nurse that’s across the Daily Mail for killing a patient, type of thing, and I 
think, we’re very very good at looking at what we don’t know and saying I don’t know enough 
about that” (Community Matron 004, Semi-structured Interview, Study 2) 
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Some nurse prescribers felt that it was doctors’ role, rather than NMPs, to take risks in relation to 
prescribing. An advanced nurse practitioner for nursing homes explained how she felt doctors 
should be at the “forefront” and the “leaders” (Nurse 001, Study 2) of prescribing. Similar 
sentiments were also expressed by this dermatology nurse specialist: 
 
“I think GPs are more risk takers, because that is part of their role to be a risk taker, when you go 
into a GP with, err, and describe symptoms to them, they’ve got to make a decision for you” 
(Dermatology Nurse Specialist 012, Semi-structured Interview, Study 2) 
 
The attitude about risk appeared to encourage a cautious approach to taking responsibility for 
prescribing when the decision involved deviation from guidelines. 
 
“Guidelines are there to support my practice, err, always in the back of my mind, or probably in 
the forefront of my mind is the fact that I am not a GP, erm I am a nurse prescriber, and I if I, if I 
sort of vary, if I stray from the guidelines, I really need to, my practice has to be, I have to be able 
to substantiate why I have done that and there has to be a good reason for me to err to go from the 
guidelines” (Advanced Practitioner 005, In-depth Interview, Study 1) 
 
In one case a community matron described how she was more cautious about prescribing following 
the training course than before. She described how the course had outlined the legal and ethical 
aspects of prescribing issues which she had considered less before the course. The nurse described 
how it was much easier to ask a GP to sign the prescription on her behalf. This might suggest that 
the prescribing training course encourages cautiousness amongst NMPs with regards to taking 
prescribing responsibility. Exactly how long this cautiousness lasts is unknown. 
 
“When you’ve done the course you lose a lot of confidence because you learn a lot more about, you 
know the dilemmas and the ethics of prescribing and that you’ve got to know a lot more about that 
drug before you prescribe it, so then it’s actually harder to prescribe it independently” 
(Community Matron 017, Semi-structured Interview, Study 2) 
 
In addition to the views outlined there was a general sense of cautiousness amongst the majority of 
NMPs interviewed, including pharmacist prescribers. This suggests that other factors give rise to 
this cautiousness that were not identified in this research. The two quotes below illustrate this 
point: 
 
“I think as pharmacists we’ve always been a pretty cautious bunch anyway, erm I think the kind of, 
that’s been instilled in to us from the society for a very long time, so I think by breed we’re fairly 
cautious, erm we don’t tend to, kind of act too spontaneously really” (Practice Pharmacist 20, 
Semi-structured Interview, Study 2) 
 
“I do feel that within nurse prescribing people are a little bit more cautious about what they are 
prescribing anyway” (Advanced Practitioner 006, In-depth Interview, Study 1) 
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The overwhelming evidence was that NMPs adopt a cautious approach to taking responsibility for 
prescribing. For some nurse prescribers this approach was linked with their attitudes regarding 
support from the NMC and healthcare managers, NMPs’ vulnerability and the role of NMPs. 
However, not all prescribers in this research expressed these attitudes which suggest other factors 
give rise to their cautiousness. 
 
6.3 Main Influences on whether NMPs take Responsibility 
As discussed previously, there were four main categories of influences on whether NMPs took 
responsibility for prescribing. These included competency, role, practical and legal considerations, 
and ‘risk’.  
 
6.3.1 Competency 
Insufficient competency was frequently cited by NMPs as a reason for not taking responsibility for 
making a prescribing decision for a patient or issuing a prescription. Where NMPs did not feel 
competent they referred the patient to a doctor (12 incidents) or sought informal advice and support 
(nine incidents). NMPs mainly received support from GPs, but support from hospital and 
secondary care doctors and other HCPs was sometimes mentioned. The influence of competency 
on NMPs’ decisions was also apparent from NMPs’ comments in all components of Study One and 
Study Two.  
 
Nurse and pharmacist prescribers clearly felt if they were not competent they should not take 
responsibility for prescribing. This is reflected in the quote below: 
 
“Well if you’re not competent you don’t do it basically, you get the GP to do it instead” (Nurse 
Practitioner for GP Surgery 027, Focus Group 2, Study 2) 
 
This nurse practitioner used the term ‘competency’ rather that describing components of 
competency. This was also noticeable in the comments of other NMPs in Study One and Study 
Two. The importance that NMPs, both nurses and pharmacists, placed on competency in this 
programme of research reflects the guidelines provided for NMPs (Nursing and Midwifery Council 
2006; Royal Pharmaceutical Society of Great Britain 2007). Furthermore, as discussed in Section 
4.5.2, NMPs comfort with the word ‘competency’ is in contrast to the limited discussion of this 
issue in the doctors’ prescribing literature. NMPs felt they are responsible, rather than others, for 
dictating the areas they are competent enough to prescribe in. They felt that colleagues would not 
know enough about their competency to make the decision for them. 
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In some cases NMPs used other words than competency to indicate the degree to which they felt 
content to take responsibility for prescribing. For instance, NMPs talked about how when 
“uncertain”, “in doubt” or “uncomfortable” about an aspect of prescribing then they refer the 
patient or seek the support of colleagues. In many ways, these words were all used to indicate how 
competent they felt to deal with the situation.    
 
In Study One NMPs did not spontaneously expand on the meaning of competency. Therefore, one 
of the objectives of Study Two was to expand the understanding of what particular aspects of 
competency were important to NMPs when deciding whether they should take responsibility for 
prescribing. The key aspects of competency described by NMPs are discussed in relation to the 
Competency Framework initially introduced in Section 2.3.5. 
 
6.3.1.1 Competency Framework 
The aspects of competency frequently mentioned by NMPs included: background knowledge, 
ability to diagnose the patient’s complaint, the skills to interpret the results of any tests needed for 
diagnosis, the ability to select the most appropriate medicine, the skills to monitor the patient’s 
response to the medicine and the knowledge and experience to prescribe any required medicine 
safely. Many elements of competency mentioned by NMPs in this research matched those in the 
Competency Framework (National Prescribing Centre 2006). This is despite most NMPs in this 
research suggesting, when asked, that they rarely refer to the Competency Framework in their 
practice. NMPs outlined many of the competencies in the competency area ‘The Consultation’. 
Competencies from this area relating to ‘Clinical and Pharmaceutical Knowledge’, ‘Establishing 
Options’ and ‘Communicating with Patients’ were mentioned by NMPs. NMPs also mentioned 
those competencies outlined in the ‘Prescribing Safely’ section of the Competency Framework. 
However, other competencies in the ‘Prescribing Effectively’ and the ‘Prescribing in Context’ 
sections were not mentioned. 
 
It is likely that sections of the Competency Framework were not mentioned because the Framework 
was developed to maintain competency, rather than to assess whether a NMP is competent enough 
to take responsibility for prescribing in a specific scenario. For example, one statement in the 
Competency Framework states that prescribers must know how to maintain patient confidentiality 
when prescribing. It is plausible to assume that NMPs consider this before starting to prescribe but 
do not reconsider it each time they decide whether to take responsibility for prescribing.  
 
The Competency Framework provides a useful structure to describe the findings of this programme 
of research. Therefore, the description of how competency influences whether NMPs take 
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responsibility for prescribing in any given scenario is discussed under the first four headings of the 
Framework. 
 
6.3.1.2 Key Aspects of Competency 
Clinical and Pharmaceutical Knowledge 
The first aspect of competency that influenced whether NMPs took responsibility for prescribing 
was whether they possessed sufficient background clinical and pharmaceutical knowledge about 
the area of practice. This is understandable, as thorough and up-to-date background knowledge of 
the condition and viable pharmacological and non-pharmacological treatment options is needed 
before a prescriber can even contemplate making a judgement regarding prescribing.  
 
Patients would often be referred to another HCP or service if the NMP did not possess satisfactory 
background clinical and pharmaceutical knowledge. 
 
“It comes back to the competencies, you really need to know what the starting point is to know 
what’s wrong with the patient before you can actually safely go for any sort of treatment, and if 
you don’t know that then I think you’re duty bound to refer back to somebody who does” 
(Community Pharmacist 020, Semi-structured Interview, Study 2) 
 
Arguably this aspect of competency is about how NMPs define their area of clinical practice rather 
than just the situations they should and should not prescribe in. 
 
Establishing Options 
A further aspect of competency that influenced whether NMPs took responsibility for prescribing 
was whether they felt they had the competency to, if needed, make a working diagnosis from 
differential diagnosis. This was apparent from comments made when discussing critical incidents 
and from comments made by NMPs in Study One and the focus groups in Study Two. However, it 
was more apparent in the comments of nurse prescribers than pharmacist prescribers. This is most 
likely to be because more pharmacists than nurses are managing patients with conditions already 
diagnosed by a doctor. In contrast, nurse prescribers are more likely to be managing conditions 
with no previous diagnosis (See Appendix 10.0 for further details of NMPs’ roles). 
 
“Before you actually make a decision to prescribe or not, you’ve got to be safe on your assessment 
of that patient, so unless you can actually assess that patient safely, and you can actually come to a 
working diagnosis that you’re happy with, then you can’t really move on and issue a prescription” 
(WIC Nurse 009, In-depth Interview, Study 1) 
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As this quote illustrates, making a diagnosis also included possessing the skills to interpret the 
results of any tests or investigations conducted: 
 
“It’s not just a prescribing decision about the drug choice, and so on, it’s everything that comes 
before that, so, am I confident enough that I know what the problem is, is the diagnosis right and if 
I’ve made that diagnosis am I confident with it, have the investigations been done where 
appropriate and am I comfortable with the results and interpreting those results” (Practice 
Pharmacist 003, In-depth Interview, Study 1) 
 
The analysis of the critical incidents suggested if a NMP was unable to make a diagnosis then they 
would be more likely to refer the patient than prescribe in conjunction with another HCP. Out of 
the 14 critical incidents, where the NMP stated they did not have the competency to form a 
diagnosis, the NMP referred the patient to a doctor in 10 cases. In four of these 14 incidents the 
prescriber sought informal advice and support from a GP. In two of these four incidents the 
prescriber sought informal advice to avoid the patient having to make another appointment. In the 
other two other incidents, the NMP sought informal advice and guidance because they considered 
the situation high ‘risk’. The concept of a situation being high ‘risk’ is discussed further in Section 
6.3.4. 
 
NMPs also stated they would not take responsibility for prescribing in situations where they felt 
they were not competent to select the most appropriate medicine, dose and formulation for the 
patient. 
 
“I’d confidently know that a patient with a chest infection that’s coughing up green sputum would 
need an antibiotic, but I wouldn’t feel competent to know which antibiotic, and at what strength, 
and if I’ve got to look in the BNF to work that out in front of a patient then I don’t feel I want to go 
down that road” (Epilepsy Specialist Nurse 010, Semi-structured Interview, Study 2) 
 
In the majority of the seven critical incidents where the NMP did not feel they could select the most 
appropriate medicine the patient was referred to a doctor. 
 
“I am not sure what the best course of treatment would be, then erm I will refer back to the GP for 
their support” (Practice Pharmacist 020, Semi-structured Interview, Study 2) 
 
In a smaller number of incidents, the NMPs described how they sought informal advice and 
guidance from GPs. For instance, one nurse practitioner described how she asked a GP’s advice 
because she had tried most standard treatment options and was unsure what to prescribe next for 
the patient. “ACE” in the quote is referring to ACE inhibitors which are commonly used to manage 
high blood pressure. 
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“You might get a patient that’s on two or three agents for their blood pressure and it’s obvious that 
the blood pressure’s still not controlled, and there comes a point where I need to really say to, you 
know, to run by someone else and say look you know, they’re on an ACE, they’re on this, they’re 
on that, what shall we add in now” (Nurse Practitioner for GP Surgery 002, Semi-structured 
Interview, Study 2) 
 
NMPs also explained how they would be reluctant to take responsibility for prescribing unless they 
were competent to monitor the patient’s response to treatment and modify the treatment plan if 
necessary.  
 
Communicating with Patients 
 As this quote below demonstrates, some NMPs’ definition of competency also meant the capacity 
to explain to the patient what treatment they were taking, why they needed to take it and any likely 
side effects they might encounter: 
 
“Well being competent to prescribe is that you can explain how it works to the patient, so the 
patient knows what they’re taking and why they’re taking it, what potential problems they might 
encounter with it” (Practice Nurse 015, Semi-structured Interview, Study 2) 
 
Prescribing Safely 
NMPs were reluctant to take responsibility for prescribing in situations where they did not feel they 
could prescribe safely. NMPs’ perceptions of how safe they were to prescribe the medicine were 
influenced by their medicine knowledge and experience. NMPs’ definition of medicine knowledge 
varied but often included knowledge of the medicine’s interactions, any side effects, any 
contraindications, the appropriate dose of the medicine for the patient, how to adjust the dose, how 
to write the prescription, the potential harm of the medicine and the most appropriate time to give 
the medicine. 
 
In the minority of the eight critical incidents, where the NMP did not feel they possessed sufficient 
medicine knowledge to take responsibility for prescribing, the patient was referred. However, in the 
majority of the incidents the NMP sought informal support and guidance from other HCPs, most 
notably GPs and pharmacists. Guidance was often sought because the patient had co-morbidities, 
complex polypharmacy or was receiving a non-standard treatment. In half the incidents, after 
seeking guidance, the NMP went on to issue the prescription themselves.  
 
“I have quite good relationship with the pharmacist because he’s only downstairs, so I can just 
ring him up and say hi it’s [name of participant], can you just give me some advice, which I did 
this morning actually on a dexmethasone for a child, you know and he will help me, he will just say 
do that on the script or whatever” (Nurse Practitioner for GP Surgery 007, Semi-structured 
Interview, Study 2) 
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In some incidents the NMP still did not feel comfortable taking responsibility for prescribing and 
asked a doctor to issue the prescription. For example, a community matron described how she was 
uncertain about how two medicines, which she normally prescribed alone, interacted. The 
community matron sought guidance from a GP who advised her that prescribing the two medicines 
together was safe. However, even after receiving this guidance, the community matron did not feel 
comfortable issuing the prescriptions and asked a GP to do it instead. She explained the reason for 
this was that she wanted written evidence that it was safe to prescribe both medicines together 
rather than just rely on the GP’s advice. It was not entirely clear what the NMP felt might happen 
to her had she prescribed. This situation is a further example of NMPs’ cautiousness in relation to 
prescribing responsibility.  
 
“Just hearing it verbally, even from a GP, is fine, but it’s not good enough, you’ve got to also get 
the, you’ve got to see the written evidence I think really, you can’t just take verbal erm acceptance 
from a GP” (Community Matron 017, Semi-structured Interview, Study 2)  
 
As has been previously mentioned, NMPs’ perceptions of how safe they are to prescribe the 
medicine were based on their knowledge and experience. These quotes below illustrate how some 
NMPs were reluctant to prescribe medicine where they had no prior experience of doing so: 
 
“We don’t prescribe oral steroids because I don’t feel comfortable, I’ve had no experience of 
prescribing oral so I wouldn’t do it” (Dermatology Specialist Nurse 012, Semi-structured 
Interview, Study 2)  
 
“I only prescribe drugs that I know, and have used and I am comfortable with” (Practice 
Pharmacist 014, Semi-structured Interview, Study 2) 
 
Use of P-Formulary 
A p-formulary or personal-formulary is a list of medicine that the NMP feels competent to 
prescribe. The National Prescribing Centre (NPC) recommends that prescribers should aim to cover 
around 90% of routine daily prescribing requirements for the conditions they most regularly 
encounter in practice in their p-formulary. The prescriber should aim to develop good knowledge 
about the way each medicine works, likely side effects, contraindications and ideally experience 
their use in the ‘real world’ (National Prescribing Centre n.d.). For some nurse prescribers the 
medicine they felt competent to prescribe was reflected in their p-formulary. Many nurses stated it 
was a current requirement of the prescribing course to write a p-formulary. In some cases this p-
formulary was submitted on a formal basis to their PCT. The p-formulary was generally a list of 
medicine that the prescriber felt safe to prescribe. However, one nurse described how her p-
formulary was a list of medicine she feels she is not safe to prescribe. A number of nurse 
prescribers described how they would not prescribe medicines outside of their p-formulary because 
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the formulary reflects what they can safely prescribe. This quote below illustrates this sentiment. P-
list is used to refer to p-formulary in the quote. 
 
“Basically our p-list has to match up with what we’re doing, erm and then that’s when you say, 
actually no I’m not prescribing Tramadol” (Paediatric Diabetes Nurse Specialist and WIC Nurse 
030, Focus Group 3, Study 2) 
 
A small number of nurse prescribers felt they would not receive legal support if they prescribed 
something outside of their p-formulary. One nurse prescriber believed she would be open to 
litigation not backed up by the PCT. 
 
“It’s not legal to do that, you’ve got to have a p-list, and your p-list has to say what you intend to 
prescribe, and if you feel the need to prescribe something else you have to extend your p-list, can’t 
just add them and say, oh well I will give you that because that’s not what we’re here for” 
(Advanced Practitioner for School Health 029, Focus Group 3, Study 2) 
 
However, for other nurse prescribers, it was acceptable to them, and they thought their PCT would 
find it acceptable, to prescribe outside their written p-formulary where a clinical need arose. 
However, it was still important to them to possess sufficient knowledge. 
 
“The trust would accept the fact that we’re going in to things like that, I’d never prescribed before, 
but I know they need it, they’re in pain so I’m going to have to prescribe it, but it’s my duty then to 
know about the drug” (Advanced Nurse Practitioner for Nursing Homes 001, Semi-structured 
Interview, Study 2) 
 
 
For other nurse prescribers if the need arose to prescribe outside their p-formulary they would seek  
support or refer the patient to a doctor rather than taking responsibility for prescribing in that 
circumstance. However, if a need for the medicine consistently arose, nurse prescribers said they 
would consider carrying out further study of the medicine so they could add it to their p-formulary. 
 
“I still wouldn’t prescribe off my p-list, say if I went to see a child at the weekend, erm I’d phone 
somebody and get a written prescription rather than make a decision as what to give them because 
I feel that my p-list is sort of, not my protection, but what I know, and even if I looked in the BNF 
and read I wouldn’t know enough in that instance but I’d phone and get somebody to give a verbal 
message to change their medication and then if it was to come up a few times I might think it might 
be handy that to add to my p-list [others in the same focus group nod their heads in agreement]” 
(Advanced Practitioner for School Health 029, Focus Group 3, Study 2) 
 
In some cases NMPs had written a p-formulary as part of their prescribing course and felt it was 
now out-dated, and had not sought to update it because of time constraints. Furthermore, some 
NMPs had never written a p-formulary as part of their course and had not been asked or done one 
since. This was a more common occurrence amongst pharmacist prescribers. NMPs without an 
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official p-formulary often described a head-held formulary of medicine they perceived they could 
prescribe. The head-held formulary worked in much the same way as an official p-formulary with 
NMPs not willing to take responsibility for prescribing decisions that fell outside the scope of the 
medicine within their formulary. 
 
“If anyone asks me to say what I don’t prescribe, I know that I wouldn’t prescribe CDs, I know that 
I wouldn’t prescribe benzodiazepines, I know, you know where the buck stops, but no, I don’t have 
a list that says that” (Nurse Practitioner for GP Surgery 002, Semi-structured Interview, Study 2) 
 
6.3.1.3 Factors Influencing Competency 
NMPs described a number of factors that influenced the development of their competency levels. 
These factors included the availability of clinical support, opportunities to gain experience and 
training opportunities.  
 
As outlined, where NMPs did not feel competent to take responsibility for prescribing alone they 
would seek support from colleagues. NMPs described how this guidance over time would increase 
both their competency and confidence in prescribing, eventually leading them to take sole 
responsibility in similar situations in the future. In Study Two, three nurse prescribers, including a 
community matron, a paediatric continence specialist nurse and a palliative care specialist nurse, 
described how a lack of clinical support meant they found it difficult to increase their competency. 
Insufficient clinical support meant there were no mechanisms in place to prescribe in a ‘safe’ 
environment with the support of colleagues. In contrast, NMPs with adequate clinical support who 
were unsure about an aspect of a prescribing decision could seek guidance from colleagues. This 
guidance increased their competency and confidence. For example, this practice nurse explained 
how support from a GP helped her develop her competency. The abbreviation PPI in the quote 
below refers to protein pump inhibitors which are commonly used to reduce acid in the stomach. 
 
“I mean very much like becoming competent in prescribing the erm lansoprazole or the PPI, erm 
learning about it, doing it, discussing scenarios with the GP, that then gives you the competence to 
actually know when it’s safe to prescribe that, it’s like any learning isn’t it you learn by watching, 
listening, doing” (Practice Nurse 015, Semi-structured Interview, Study 2) 
 
Clinical support was not available for the three nurse prescribers mentioned. As a result they were 
finding it difficult to increase their competency. For instance, the continence specialist nurse 
(Nurse 008, Study Two) described how there were no doctors or NMPs within her team. The lack of 
support meant the nurse prescriber was underutilising her prescribing skills and not developing her 
competency in other areas of prescribing that would benefit the service. This type of problem was 
also expressed by the two other nurse prescribers, as this quote demonstrates: 
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“But I still feel I need a lot of clinical supervision which I am arranging, which I have arranged, to 
build my confidence to hopefully build on my prescribing erm medications as well, because I need 
that, because that’s the whole point is that I should be building on it” (Community Matron 017, 
Semi-structured Interview, Study 2) 
 
The continence specialist nurse felt her confidence to prescribe in her current area of prescribing 
was diminishing because of the lack of support. She described how she had experienced negative 
outcomes as a result of past prescribing decisions. As she had no one to discuss these situations 
with, her confidence lowered and she failed to take responsibility prescribing in some situations 
that followed. This was apparent in one of the critical incidents the nurse discussed in her 
interview. The nurse described how she did not prescribe an anticholinergic for a patient directly 
because of past negative outcomes (i.e. side effects) with other patients. Instead she asked the GP 
to issue the prescription even though she thought the GP would follow her request without 
examining the patient. When asked why it was better for the GP to issue the prescription she said 
“just because of the responsibility”. This example provides an in-depth examination of how 
insufficient clinical support can have a direct influence on whether a NMP takes responsibility for 
prescribing in a given scenario. This quote illustrates the difficulties faced by this NMP: 
 
“I think also someone challenging you is helpful in terms of your practice in general but I think in 
terms of making progress, I think I need someone to challenge me to say well what stop, like you’re 
doing sort of, what’s stopped you, not what, yeah what stopped you from prescribing that and 
actually do you think you’d have been better off prescribing that instead of the other” (Paediatric 
Continence Specialist Nurse 008, Semi-structured Interview, Study 2) 
 
A lack of opportunity to gain prescribing experience was mentioned by some nurse prescribers as a 
barrier to increasing competency. Two nurse prescribers mentioned it was difficult for them to gain 
experience because of their lack of contact with patients. In one case this was due to the nurse’s 
management duties and in the other case this was because the nurse’s service was being 
reorganised. 
 
“I’ve expressed that concern to my line manager that erm, but I am being pulled in a direction of 
managerial service development and my clinical is falling behind, so it’s up to me to keep that 
clinical as much as I can up-to-date” (Palliative Care Specialist Nurse, Semi-structured Interview, 
Study 2) 
 
Two pharmacist prescribers also felt opportunities to expand their prescribing practice were 
restricted by the lack of training courses and material targeted at the appropriate level for 
pharmacist prescribers. This quote below illustrates this attitude: 
 
“Expanding your prescribing may be difficult, not because of your knowledge of the drugs, but 
because there’s no training at a good enough level for the other stuff, you know, how do you 
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become competent to erm treat osteoporosis, there are no courses” (Practice Pharmacist 003, In-
depth Interview, Study 1) 
 
However, as this quote from a nurse prescriber demonstrates, lack of training could be overcome 
with sufficient opportunities to gain experience in a safe environment: 
 
“Because my background is adult and we don’t have, I don’t have any children’s qualifications so 
at first it was a bit, a bit scary with little people but the more, the more you do it the less scary it 
becomes really and you feel quite competent about doing it yeah” (Dermatology Specialist Nurse 
012, Semi-structured Interview, Study 2) 
 
Clearly NMPs’ perceptions of their competency levels in certain areas influences whether they take 
responsibility for prescribing in any given scenario. This behaviour is in line with guidance issued 
to NMPs. 
 
6.3.2 Role 
NMPs stated they would not take responsibility for prescribing if it was not within their “role” to 
do so. NMPs also used other words such as “remit” and “scope of practice” but these largely 
meant the same as role. An understanding of how NMPs define their role, and the influence it has 
on prescribing, was gathered more through the general discussion that occurred in the interviews 
and focus groups than the critical incidents. NMPs’ definition of their role appeared to be self-
generated. However, there were a number of common factors that contributed to NMPs’ definition 
which included main medical speciality, agreements with colleagues, appropriateness of alternative 
services and nature of prescribing. 
 
Some of those working as specialist nurses defined the boundaries of their role primarily by their 
main medical speciality (e.g. diabetes). These nurse prescribers described how they would be 
unwilling to take responsibility for prescribing decisions that fell outside their speciality. This role 
definition also meant there was no perceived requirement for NMPs to expand their competency 
outside their main medical speciality. 
 
“I don’t see how I would develop a competency in heart disease because it’s not my speciality so I 
wouldn’t, I wouldn’t be attempting to, there’s not an expectation either” (Palliative Care Specialist 
Nurse 018, Semi-structured Interview, Study 2) 
 
NMPs working in more general roles did not have a main medical speciality and as a result based 
the definition of their role on other factors. Two practice pharmacists in Study One, and one 
community pharmacist in Study Two, described how they had agreements with their GP colleagues 
and surgery managers about the clinical areas they could operate within. 
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“I’m answerable essentially to the doctors and the practice manager and I discuss with them the 
types of area that I’m involved with” (Practice Pharmacist 003, In-depth Interview, Study 1) 
 
In this quote below, the practice pharmacist described how his role is defined by “rules of 
engagement”. It is noteworthy that the pharmacist believes he is relatively competent in 
muscoskeletal problems but is expected to refer such patients. This clearly suggests that doctors 
have a major role in defining some NMPs’ roles. 
 
“When I start working in a practice erm I tend to sort of try and agree ground rules or rules of 
engagement, call it what you will, about what it is they want me to do, and if they’re fairly broad, 
then that’s okay, in some cases they’re fairly narrow and say outside these we prefer you to pass 
them over to us, which is also okay, erm so if I get people with muscoskeletal problems, erm which 
I’m not too bad on, but generally I pass them over in that they expect me to just sort of stay within 
my boundaries” (Practice Pharmacist 005, In-depth Interview, Study 1) 
 
Pharmacist prescribers would still only take responsibility for prescribing in an area if they felt 
competent to do so. 
 
“They did say that simple dermatology they’d be happy for me to do now I’m not really that good 
on dermatology so I’ve asked myself anything dermatology I refer on to the GP” (Community 
Pharmacist 020, Semi-structured Interview, Study 2). 
 
There is less evidence that nurses, working in GP surgeries and other general roles, have informal 
agreements outlining therapy areas where they can prescribe. This may be because nurses have 
historically had a greater role in primary and community care. 
 
The appropriateness of alternative services also shaped NMPs’ definition of their role. For instance, 
patients with more severe issues would be referred to the hospital or secondary care. In this quote, a 
dermatology specialist nurse described how she does not feel it is her responsibility to prescribe 
oral steroids for skin conditions because a need for oral steroids is an indication the patient’s 
condition is severe which requires input from other services: 
 
“We try to get our patients in the position where they don’t need them to be truthful, erm and often 
you can manage them on topical steroids, they don’t need the oral steroids and if they’re that bad 
they need to be seen by somebody else and not us” (Dermatology Specialist Nurse 012, Semi-
structured Interview, Study 2) 
 
In another example, provided in Study One, an advanced practitioner describes how she would not 
prescribe pain relief for patients with cancer as it was more appropriate for palliative care specialist 
nurses and GPs to provide that service: 
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“The palliative care will just be things like oral hygiene if we need anything for that, or say if the 
pressure areas are beginning to look suspect and we need anything for that, as far as the pain 
relief is concerned then the Macmillan and the GP really do that” (Advanced Nurse Practitioner 
003, In-depth Interview, Study 1) 
 
Similarly, a practice pharmacist described how he felt it was more appropriate for the practice 
nurses to give holiday immunisations as they do not require his level of expertise: 
 
“I don’t tend to get involved very much in vaccine holiday immunisations and so on, broadly 
because they tend not to be difficult choices, they tend to be very protocol driven and doesn’t need 
my level of expertise, that’s what our general nursing team are for” (Practice Pharmacist 003, In-
depth Interview, Study 1) 
 
Some NMPs explained how their role was more suited to some types of prescribing. For example, a 
WIC nurse was content to prescribe for one-off or acute conditions with previously undifferentiated 
diagnosis but did not feel she should initiate patients on long-term medications for conditions such 
as hypertension. She explained how this type of prescribing would be more suitable for a GP as 
WICs are not set up for long-term patient management. 
 
“At the moment I don’t feel happy to prescribe for even things like hypertension because that’s not 
my role, erm and patients obviously need not just a prescription or advice but they need further 
management” (WIC Nurse 009, In-depth Interview, Study 1) 
 
In contrast this community matron described how she would not be willing to prescribe for 
undiagnosed complaints. She perceived her role to be mainly restricted to altering medication for 
existing conditions. 
 
“It’s harder I think, initiating it for the very first time is where I wouldn’t, I might not be as 
comfortable erm because if you’re initiating a drug you need a diagnosis and if it’s a new thing 
why am I the one who is saying this is what you need for the first time” (Community Matron 017, 
Semi-structured Interview, Study 2) 
 
In general pharmacist prescribers were less involved in diagnosing patients’ conditions than nurse 
prescribers. They were however involved in altering existing treatments. The majority of NMPs 
also felt issuing repeat prescription items for patients did not fall within their role. This is discussed 
further in Section 6.5. 
 
Many factors influenced NMPs’ definition of their role and NMPs’ perceptions of their role 
influenced whether they took responsibility for prescribing in any given scenario. 
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6.3.3 Practical and Legal Considerations 
The practical issues NMPs considered when deciding whether to take responsibility for prescribing 
included whether they had access to sufficient information to enable safe prescribing, whether the 
patient would be able to obtain the medicines and whether it was more convenient for another 
service to take responsibility for prescribing. NMPs also considered the legal issues when deciding 
whether or not to take prescribing responsibility.  
 
6.3.3.1 Practical Considerations 
In five critical incidents NMPs did not take responsibility for the prescribing because of insufficient 
information. In all of these incidents the NMP postponed the prescribing decision rather than 
referring the patient to another HCP. This suggests that it would have been inappropriate for any 
prescriber to take responsibility for prescribing. Insufficient information was more often mentioned 
more by NMPs working in the community pharmacy setting, WICs, clinics and the community, but 
mentioned less by those in GP surgeries. This is presumably because NMPs in GP surgeries have 
access to patient records. 
 
Some NMPs highlighted how it could be difficult to obtain the required information from patients 
during consultations because of language barriers. One dermatology specialist nurse explained she 
was reluctant to prescribe in these cases because of difficulties obtaining a history and concerns 
that the patient would not understand the information given to them. 
 
“I can’t take a comprehensive assessment if, if erm I’m asking them questions and they’re just 
nodding and saying yes and, and I’m uneasy that they actually understand what I am asking them, 
especially around allergies and previous medications etc and previous treatments that they’ve tried, 
it just puts you in a very difficult position” (Dermatology Specialist Nurse 011, Semi-structured 
Interview, Study 2) 
 
Advanced nurse practitioners working for nursing homes also highlighted difficulty in obtaining 
information from elderly patients. This was because the elderly patient did not know the 
information themselves and the nursing home did not keep the information. If it was not possible to 
obtain the information then the NMP would make the patient as safe as possible. This may or may 
not have involved issuing a prescription. 
 
NMPs visiting patients in their own home were reluctant to provide prescriptions for patients if the 
patient would be unable to take the prescription to the pharmacy. Instead, the NMP would ask the 
patient’s GP surgery to provide the prescription to the pharmacy so the medicine could be delivered 
by the pharmacy to the patient’s home. 
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“Even if it’s an antibiotic and they’re house bound there’s no point me doing a script and handing 
it to them and they can’t get it, the surgery might as well do it and send it through to the pharmacy 
and have it delivered”(Community Matron 017, Semi-structured Interview, Study 2) 
 
NMPs felt it was more convenient for GPs to take responsibility for prescribing in cases where 
patients were given medicine in dosettes9 as any change in the prescription needed to be processed 
through the patient’s GP surgery before it could be issued anyway. 
 
“You struggle sometimes with some of the heart failure patients because they might be on medi-
dose and nomads and all of that so it doesn’t necessarily work us giving them a prescription 
because it’s got to come through the GP to change the nomads and the medi-dose and it takes 
weeks” (Practice Nurse and Specialist Nurse 012, In-depth Interview, Study 1) 
 
Similarly, some NMPs found it easier for the patient’s GP surgery to issue the prescriptions if the 
patient required a large number of medicines. Similarly, in one critical incident a palliative care 
specialist nurse described how it was easier for GPs to issue prescriptions for medicine that 
involved a large amount of paper work. This was because the nurse was employed by a private 
hospice rather than the PCT who issued the paperwork.   
 
6.3.3.2 Legal Considerations 
Given the frequency and volume of changes to non-medical prescribing legislation over the last 
few years it is understandable that NMPs considered legal issues, specifically around CDs and 
unlicensed drugs, when deciding whether or not to take responsibility for prescribing. 
 
Pharmacist prescribers conformed to the current regulations that state pharmacist prescribers 
cannot prescribe CDs independently. 
 
“I’ve got the unfortunate situation, I can’t prescribe co-codomol at the moment because there are 
the legalities of pharmacists prescribing CDs” (Practice Pharmacist 019, Semi-structured 
Interview, Study 2) 
 
In some cases, pharmacist prescribers wishing to prescribe CDs set up a CMP in line with the rules 
of SP. However, other pharmacists simply asked the GP to issue the prescription instead because 
they regarded CMPs as time consuming and the requirement of CMPs to ask patients for their 
consent, as inappropriate. 
 
Those nurse prescribers working in roles that required the use of CDs issued prescriptions of CDs 
independently. However, despite the fact all nurse prescribers are permitted to prescribe CDs there 
was very little use of them in practice. This was either because the NMP needed an agreement with 
                                                 
9
 Dosettes are are individualised box containing medicines organised into compartments by day and time. 
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the PCT, which they did not have, they did not perceive themselves to be competent to prescribe 
CDs or the use of CDs was not required within their role.  
 
When Study One took place all NMPs were unable to prescribe unlicensed medicines 
independently. Since Study One was conducted restrictions on nurse and pharmacist prescribers 
prescribing unlicensed medicines independently have been lifted. However, in Study One, NMPs 
mentioned they were not permitted to mix two licensed medicines together in a syringe driver as it 
created a product that was unlicensed. The quote below highlights the issue initially faced by nurse 
prescribers: 
 
“We can’t prescribe multiple drugs now in a syringe driver but we used to be able to, well no we 
didn’t, we thought we could at first as everybody did and then it was flagged up, hello, this is an 
unlicensed drug” (Palliative Care Specialist Nurse 010, In-depth interview, Study 1) 
 
Even though the restriction on the use of unlicensed medicines had been lifted there was no 
evidence in Study Two of NMPs prescribing medicine in this manner. This may have been because 
the NMPs taking part in Study Two did not feel they were competent to prescribe these medicines 
or because it was not part of their role to do so.  
 
A number of practical and legal issues influenced whether NMPs took responsibility for 
prescribing. NMPs only took responsibility for prescribing where they possessed sufficient 
information to do so, it was the most convenient option for the patient and where it was legal. 
 
6.3.4 Degree of Risk 
Whether NMPs took responsibility for prescribing was in some cases influenced by their 
perception of the situations ‘risk’. ‘Risk’ was mainly risk to themselves as a result of any personal 
and legal ramifications. ‘Risk’ seemed to increase when prescribing involved deviation from 
guidelines or formularies, prescribing medicine off-label and prescribing high ‘risk’ medicines or 
for high ‘risk’ patients. Nurse prescribers, more than pharmacist prescribers, seemed to associate 
high ‘risk’ with certain types of medicine and patients. However, like nurses, pharmacist 
prescribers did mention their reluctance to deviate from guidelines and formularies and to prescribe 
medicine off-label. There was some evidence that NMPs felt less competent to deal with high ‘risk’ 
situations. However, sometimes NMPs appeared reluctant to take responsibility for prescribing in 
high ‘risk’ situations regardless of their perceived competency levels. High ‘risk’ situations also led 
to feelings of unease and discomfort amongst NMPs. This also might explain why they were 
reluctant to prescribe. An understanding of how ‘risk’ influenced NMPs arose from discussion of 
the critical incidents and the general discussion in Study One and Study Two. 
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In five critical incidents the NMP’s decision of whether or not they should take responsibility for 
prescribing was influenced by the possible requirement of deviating from guidelines or formularies. 
In two of these five incidents the NMP did not take responsibility for prescribing and referred the 
patient to a doctor. In three of the incidents the NMP prescribed in conjunction with a doctor. 
Incidents such as these were provided both by nurse and pharmacist prescribers. In this quote 
below, a community pharmacist describes how the possibility of prescribing against guidelines led 
him to feel uncomfortable about taking responsibility for prescribing. This pharmacist went on to 
describe how he referred the patient to a hospital consultant. 
 
“I didn’t think it was my place to kind of initiate a very high dose script of benzodiazepines, 
although it does mention it on the clinical management plan, I really didn’t want to go against all 
local protocols and guidelines by reissuing a script for a client at high doses” (Community 
Pharmacist 020, Semi-structured Interview, Study 2)  
 
In another example, provided by a nurse practitioner in a GP surgery (Nurse 005, Study Two), a 
patient had recently been put back on a smoking cessation medicine by a GP despite the use being 
contrary to NICE guidelines. The patient then consulted the nurse prescriber for a review and asked 
to be given another prescription of the medicine. As the nurse did not want to issue a prescription 
contrary to guidance she consulted a GP in her surgery. The GP advised her to prescribe the 
medicine anyway, which she did, but she felt uneasy and uncomfortable doing so. In another 
incident, another nurse practitioner in a GP surgery (Nurse 018, Study Two) felt “uneasy”, 
“vulnerable” and “uncertain” about her use of antibiotics as she was unsure which guidance was 
preferred by the PCT. It is interesting that this nurse practitioner wished to ensure she was not only 
following guidance but the ideal guidance in the area. This incident, as well as the others provided 
by NMPs, suggests that deviating from guidelines and formularies is a source of discomfort for 
both nurse and pharmacist NMPs.  
 
Despite the fact nurse and pharmacist prescribers can legally prescribe medicines off-label 
independently they exhibited a wide range of negative emotions about prescribing them in practice. 
In one critical incident, a palliative care specialist nurse prescriber described how issuing a 
medicine off-label led to feelings of “discomfort” and “anxiety”. This was despite the fact she was 
comfortable with the clinical decision she was making and had observed use of the medicine, in 
this manner, by GPs. The nurse’s negative feelings were strongly linked to her perception that the 
pharmacist may question her decision. Although uncomfortable, the nurse prescriber did issue the 
prescription but it was clear that if a doctor had been available she would have rather the doctor 
issued the prescription. 
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“When I issued the prescription for it I must admit I personally had some anxiety thinking that the 
pharmacist was going to contact me” (Palliative Care Specialist Nurse 018, Semi-structured 
Interview, Study 2) 
 
NMPs were much more likely to seek informal guidance when they were prescribing medicine off-
label. This was apparent from two critical incidents discussed and was also supported by comments 
from nurse prescribers in the focus groups. For instance, this nurse prescriber says she would 
always get a second opinion if using melatonin off-label for children: 
 
“You know it’s just one of those things that erm and I do always speak to our consultant before I 
prescribe it, so I do get a second opinion on everything” (Paediatric Active Case Manager and 
WIC Nurse 031, Focus Group 3, Study 2) 
 
Some NMPs referred patients needing a medicine off-label to doctors. In one critical incident a 
pharmacist prescriber, prescribing malaria prophylaxis, described how if a patient needed medicine 
off-label then she would refer the patient to their GP rather than prescribe herself. There was no 
evidence of any restrictions on the pharmacist preventing the prescription of medicine off-label. 
The pharmacist’s decision did not seem to relate to issues of competency as she prescribed the 
medicine frequently in other circumstances. Instead the decision appeared to be based purely on the 
fact it was a medicine being used off-label. In a further example provided by an advanced 
practitioner for school health the nurse described how she would not prescribe a medicine off-label, 
even though she commonly prescribes the medicine in other circumstances and even though she 
knows she can legally prescribe it. The advanced practitioner uses the word license in this quote 
but it was evident from others aspects of the conversation she meant off-label. 
 
“The only thing is you can prescribe outside your license for erm Levonelle, because it’s licensed 
for 72 hours but you can give it longer,  but I’ve never prescribed it longer because I’d rather say I 
will work to the thing and then I’d refer them them to either somebody else who’ll prescribe out of 
license maybe a family planning doctor or, the coil but there are times when you can legally but I 
wouldn’t” (Advanced Practitioner in School Health 029, Focus Group 3, Study 2). 
 
Some NMPs would rather refer the patient to a GP than prescribe off-label. This nurse prescriber 
also uses the word license but it was evident from others aspects of the conversation she meant off-
label. 
 
“There is only one combination inhaler that we can actually prescribe that’s within license but a 
lot of patients tend to have the inhaler that’s not actually licensed so to prescribe that, I’d go back 
to the GP” (Advanced Practitioner 005,In-depth Interview, Study 1) 
 
The main medicine characteristics associated with high risk were those with potentially severe side 
effects, potent medicine, medicine prescribed at high doses, medicines that have systemic effects 
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on the body and medicine that could have serious interactions with others. Prescribing situations 
involving these medicine characteristics decreased the likelihood of the NMP taking full 
responsibility for prescribing and increased the likelihood the patient would be referred. Pharmacist 
prescribers did not express these sentiments. However, this is not to say pharmacists did not 
consider whether they had the competency to prescribe in situations such as these.   
 
In this quote below a dermatology specialist nurse described how she was more likely to seek input 
from GPs when required to prescribe a medicine linked with toxic side effects: 
 
“They’re quite toxic these drugs and there’s a high risk, high risk of reactions such as Steven 
Johnson’s syndrome, so in a young child with scalp infections I would always ask the GP with 
specialist interests” (Dermatology Specialist Nurse 011, Semi-structured Interview, Study 2) 
 
As this quote below demonstrates, there was also a sense of reluctance amongst some NMPs to 
take responsibility for prescribing medicine that have more complex effects on the body. The word 
“consequences” refers to adverse medicine reactions. 
 
“But anticholinergics are quite, I worry more about them because they’re a more complex drug 
and they affect more body systems than laxatives. Erm and it’s probably not just one scenario 
where I feel that I haven’t prescribed it because I worry about the consequences” (Continence 
Specialist Nurse 008, Semi-structured Interview, Study 2) 
 
Some NMPs also mentioned they were reluctant to take responsibility for prescribing when it was a 
potent medicine or the medicine needed to be prescribed at a high dose. In this quote below, the 
nurse practitioner describes her feelings about prescribing steroids: 
 
“I think it’s a very big decision to give someone oral steroids because it’s not like giving someone 
a course of antibiotics it’s a big whacking dose of steroids I have to be absolutely sure in my own 
mind that the patient needs it” (Nurse practitioner for GP Surgery 002, Semi-structured Interview, 
Study 2)  
 
Prescribing medicine that could have interactions with other medicine caused feelings of 
discomfort amongst NMPs. As this quote illustrates, in some cases, this led the NMP to defer 
responsibility for issuing the prescription to a doctor: 
 
“I’ll look for the black spots and if I see the black spot I actually say to the patient this has got a 
black spot which means I err I really need to run this past the GP, so I’m going to, I’m not going to 
write the prescription for you now I’m going to get the GP to do it” (Nurse Practitioner for GP 
Surgery 015, In-depth Interview, Study 1) 
 
The patient characteristics associated with risk were complex polypharmacy, multiple co-
morbidities and under the age of four years old.  
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NMPs were less likely to take responsibility for prescribing when the patient was taking multiple 
medicines or had multiple conditions. In the quote below, a nurse prescriber indicates that she 
would refer patients to a GP if the patient had co-morbidities or was taking other medicine, rather 
than prescribing herself: 
 
“If they’re on a lot of other drugs or they’ve got lots of other health problems I just refer it to the 
GP but if they’ve got no co-morbidities and they’re on minimal drugs I would go ahead and 
prescribe it” (Palliative Care Specialist Nurse 010, In-depth Interview, Study 1) 
 
Similarly, a nurse practitioner for a GP surgery (Nurse 006, Study Two), who did not want her 
interview recorded, also explained how she would not take responsibility for prescribing for 
patients with co-morbidities. The nurse described how she referred a patient with cancer to a GP 
because she was “worried about the consequences” of prescribing anything for the patient. 
 
Patients with co-morbidities or complex polypharmacy were not always referred. However, NMPs 
often sought informal guidance and support from others. 
 
 “I think as people get older and they’re on much more you know, you can get somebody on 20 
different medications can’t you, erm I look to our pharmacist to assist with those” (Nurse 
Practitioner for GP Surgery 015, Semi-structured Interview, Study 2) 
 
On the whole pharmacist prescribers were more comfortable prescribing for patients with complex 
polypharmacy or co-morbidities. As the quote below demonstrates, some pharmacists expressed 
unease prescribing for patients with complex needs. However, this did not often result in patient 
referral. 
 
“Yesterday I was dealing with somebody who had a renal transplant and that just makes me feel a 
bit, you know, I just feel there’s more possibility that things can go wrong in terms of the drug 
treatment” (Practice Pharmacist 019, Semi-structured Interview, Study 2) 
 
There was a general sense of unease amongst all NMPs, including both nurses and pharmacists, 
about prescribing for babies. This quote, from a WIC/OOHs nurse in Study One, demonstrates the 
unease felt by NMPs: 
 
“I have only prescribed once for a baby and that was when I ran it by the doctor, I have only ever 
prescribed four times for a child and I have been a prescriber now for three years” (WIC Nurse 
and OOHs Nurse 002, In-depth Interview, Study 1) 
 
NMPs were reluctant to take responsibility for prescribing in high risk scenarios. Risk was 
associated with deviance from guidelines or formularies, use of off-label medicine and certain 
medicine and patient characteristics. 
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6.4 Pressures 
A small number of WIC nurse prescribers described feeling pressure from other non-prescribing 
nurses to take responsibility for prescribing. Some prescribers also indicated that a lack of time 
could also influence whether or not they took responsibility for prescribing. These issues will now 
be discussed. 
 
6.4.1 Non-Prescribing Nurses 
Some WIC nurses described instances where non-prescribing nurses had asked them to provide a 
prescription for their patient. They described feeling pressure to issue prescriptions for medicine 
that fell outside their competency or role and also for patients they had not personally examined. 
Despite this pressure the nurse prescribers said they would not issue a prescription for a medicine 
they did not feel competent to prescribe. 
 
“When I am in the walk-in centre obviously they’re asking all the time, can you do this, no, 
because it’s not within your remit is it, we might have the BNF that we can prescribe from but 
we’re not competent in all that BNF are we, so basically our p-formulary has to match up with 
what we’re doing erm and then that’s when you say actually no” (Paediatric Diabetes Nurse 
Specialist and WIC Nurse 030, Focus Group 3, Study 2) 
 
Where the medicine was within their competency and role nurse prescribers were content to take 
responsibility for issuing the prescription. However, NMPs wanted to examine the patient and 
would only issue a prescription if they agreed with the non-prescribing nurse’s decision. This 
suggests nurse prescribers are not prepared to take responsibility for issuing a prescription unless 
they have involvement in the prescribing decision. This behaviour would be in line with the NMC 
standards which states prescribers should not issue prescriptions for patients they have not 
personally examined (Nursing and Midwifery Council 2006). Some nurse prescribers complained 
this has a negative impact on their workload as they have to examine other nurses’ patients as well 
as their own. However, they still insisted on examining the patient before issuing the prescription. 
Nurse prescribers described feeling uncomfortable, if on examination of the patient, they felt the 
patient did not actually require a prescription. Some described how examining the patient caused 
negative feelings between them and other non-prescribing nurses who felt their diagnostic skills 
were being questioned. 
 
“They’ll say I’ve just seen a kid next door and he’s got definite bacterial tonsillitis can you just do 
me a prescription, no sorry I can’t I’ll have to see them, well I’ve seen them and I know they have, 
but you can’t, they think that’s just awkward, you don’t trust my diagnosis, but it’s not that you 
don’t trust their diagnosis it’s that you’re responsible for your actions” (Advanced Nurse 
Practitioner for School Health 029, Focus Group 3, Study 2) 
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Some nurse prescribers felt that a minority of nurses do not believe they have genuine reasons for 
refusing to issue prescriptions. Instead they feel that others perceive them as difficult or awkward, 
as the quote below illustrates: 
 
“I think they think that you may be being difficult perhaps if you don’t prescribe something, oh it’s 
only you know, they have that kind of attitude, it’s only this come on” (Paediatric Active Case 
Manager and WIC Nurse 031, Focus Group 3, Study 2) 
 
Those who experienced pressure from other nurses felt they needed to justify their decision rather 
than just refusing to issue the prescription. Other nurse prescribers described how they needed to 
appease other nurses in order to maintain good relations. 
 
 “You have to have a rationale as to why, every time somebody else asks me to do a prescription 
for somebody, I always have to rationalise why I’m not doing it, instead of just saying nope can’t 
do it, you have to say well really I can’t do it because I don’t know the child, I haven’t seen the 
child, and there might be something else going on” (Paediatric Diabetes Nurse Specialist and WIC 
Nurse 030, Focus Group 3, Study 2) 
 
One WIC nurse described how she has put mechanisms in place to address this pressure. She 
explained how other nurses are asked not to request a prescription for a patient from her, but rather 
an opinion. 
 
“I mean it is a difficult scenario and we’ve actually got around this now and it doesn’t happen 
anymore, a colleague will never come in and ask for a prescription they will ask for an opinion” 
(WIC Nurse 009, In-depth Interview, Study 1) 
 
It may be that NMPs represent either the most convenient or possibly the only option for non-
prescribing nurses requiring a prescription. With an increase in nurse-only clinics and nurse-led 
clinics, as described by some NMPs, it might be that non-prescribing nurses, who would normally 
turn to doctors, have turned to NMPs who they find are more stringent with their prescribing 
practice. 
 
6.4.2 Time 
Time constraints were mentioned by nurse prescribers but not pharmacist prescribers. Time 
constraints influenced whether nurse prescribers took responsibility for prescribing in two different 
ways. Firstly, time restrictions encouraged nurse prescribers to take responsibility for prescribing 
when they did not feel competent doing so. For example, a nurse practitioner for a GP surgery 
described how patients, actually presenting for other complaints, sometimes complained of low 
mood. She said in these cases she would assess the patient to determine whether they required an 
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antidepressant. The nurse explained how she did not feel comfortable prescribing antidepressants 
but felt she had to because of time constraints in the consultation and because of surgery policy. 
 
“What tends to happen, is the practice policy anyway, is generally that we would start someone on 
a drug called fluoxetine, so what tends to happen, purely because I would say of time constraints 
because of course the patient is given a ten minute appointment by this time we’re probably half an 
hour in to a consultation, and then I’m going to say to the patient well actually you know I can’t 
prescribe this drug for you or whatever” (Nurse Practitioner for GP Surgery 002, Semi-structured 
Interview, Study 2) 
 
The nurse in the quote below said after double-checking a diagnosis with a GP she feels under 
pressure to sign a prescription for the required medicine: 
 
“If I’ve got somebody in the room with me and I am not sure if I’ve got the right diagnosis and I 
may not have prescribed something for that before, then I go and get a GP to double check with 
erm and I still don’t feel erm you know, I am a little bit under pressure here to sign this 
prescription” (Practice Nurse 015, Semi-structured Interview, Study 2) 
 
In contrast some nurse prescribers felt time could influence them in the opposite way to the 
sentiments described above. For instance, one nurse prescriber described how she would not issue a 
prescription if she felt under time pressure. Instead, she said, she would ask a GP to issue the 
prescription. 
 
“If I was feeling sort of like that and I felt that I was under pressure and rushed then I probably 
wouldn’t prescribe. I’d come away and ring the surgery and get the, them to issue the 
prescription” (Advanced Practitioner 005, In-depth Interview, Study 1) 
 
This behaviour suggests that whilst some NMPs are not prepared to sign prescriptions for others 
they still expect doctors to sign their prescriptions.  
 
Nurse prescribers experienced two main sources of pressure in relation to prescribing 
responsibility: pressure from non-prescribing nurses and time pressure. 
 
6.5 Repeat Prescribing 
The NMC defines repeat prescribing as a ‘partnership between patient/client and prescriber that 
allows the prescriber to authorise a prescription so it can be repeatedly issued at agreed intervals, 
without the patient/client having to consult the prescriber at each issue’ (Nursing and Midwifery 
Council 2006). The NMC and RPSGB standards state that NMPs can issue repeat prescription 
items but are responsible as the signatory of the prescription and are accountable for their practice 
(Nursing and Midwifery Council 2006; Royal Pharmaceutical Society of Great Britain 2007). 
Repeat prescribing proved to be important for NMPs in this research. Virtually all NMPs in Study 
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One and Study Two described instances where they had been asked, either by a patient or another 
HCP, to issue a repeat prescription item. The importance of repeat prescribing was also reflected in 
the nine critical incidents, highlighted by both nurse and pharmacist prescribers, which related to 
repeat prescribing. The type of repeat prescription requests that NMPs received ranged from 
requests for medicines they had originally initiated for the patient, medicines that others had 
initiated but fell within their competency or role, and medicines not within their competency or role 
and therefore not initiated by them. 
 
Through discussion of the critical incidents, as well as the general discussion in Study One and 
Study Two, it was possible to identify the factors that influence whether NMPs take responsibility 
for issuing repeat prescription items. These factors are discussed in the next part of this section.  
 
6.5.1 Factors Influencing Repeat Prescribing 
The factors that influenced whether NMPs took responsibility for issuing a repeat prescription 
mirrored those described in the initial part of this chapter. NMPs were influenced by perceptions of 
their competency, role, practical considerations and degree of risk. NMPs also described sources of 
pressure they experienced in regards to taking responsibility for issuing repeat prescriptions. 
 
The majority of nurse and pharmacist prescribers were prepared to issue repeat prescriptions for 
medicine they felt competent to prescribe. This meant if they had initiated the medicine they would 
be prepared to issue the repeat prescription. In cases where the patient was requesting medicine 
within the NMP’s competency, but was not initiated by them, generally the NMP would be 
prepared to take responsibility for issuing the repeat prescription. On the whole, NMPs were not 
prepared to take responsibility for issuing repeat prescriptions of medicines outside their perceived 
competency. However, there were some examples of some NMPs doing this. Six of the nine 
incidents relating to repeat prescribing involved a patient request for medicine the NMP did not 
feel competent to prescribe. In four of these incidents the NMP referred the patient to other 
services. This behaviour is reflected in the quote below:  
 
“I won’t sign things that you know I am not competent to sign. And I quite often will say to them, 
well I can do your you know your inhalers but I can’t do your blood pressure medications” 
(Practice Nurse 015, Semi-structured Interview, Study 2) 
 
In the other two incidents the NMP did issue the repeat prescription as a result of pressure they 
experienced (see Section 6.5.2). 
 
Many nurse prescribers and one pharmacist prescriber felt that, regardless of whether the medicine 
fell within their competency, it was still not their role to provide repeat prescriptions for patients. 
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Many felt issuing repeat prescriptions should fall within the GPs’ domain and NMPs should 
supplement existing services and not take over. As a result they were unwilling to issue repeat 
prescriptions for their patients. This view was expressed less by pharmacist and nurse prescribers 
working in GP surgeries. 
 
“I think you’ve got to have your standard, you’ve got to say to yourself whether it’s A, B or C the 
repeat comes from a GP. Even if it is something that you use regularly you’re not there to take over 
their treatment you’re there to supplement it” (Advanced Practitioner for School Health 029, 
Focus Group 3, Study 2) 
 
NMPs wanted to withstand pressures to issue repeat prescriptions so their role boundaries would be 
protected. One advanced practitioner for nursing homes felt that if she made an exception and 
prescribed outside the acute remit of her role once, in the future staff would rely on her to prescribe 
in these situations again rather than contacting a GP. 
 
“You see the more we do it to me the more reliant the nursing home become and don’t bother to 
contact the GP” (Advanced Practitioner for Nursing Homes 001, Semi-structured Interview, Study 
2) 
 
Prescribers working in GP surgeries considered issuing repeat prescriptions part of their role. So 
long as the criteria surrounding competency was met they were content issuing repeat prescription 
items for patients. However, they did not believe their role extended to signing patients routine 
monthly repeat requests and limited issuing repeat prescriptions to instances when the patient was 
actually in the consultation with them. 
 
“I don’t go to the repeat box in the morning and take out a pile and sign them like doctors do” 
(Practice Nurse and Specialist Nurse 012, In-depth Interview, Study 1) 
 
The main practical issue that influenced whether NMPs issued the repeat prescription was whether 
there was sufficient information about the patient’s medical history to ensure the prescription 
would be safe for the patient. Insufficient information issues were mentioned less by those working 
in GP surgeries and more by those working in community and clinic settings. 
 
Certain factors led NMPs to feel more comfortable about issuing repeat prescription items. For 
instance, as this quote illustrates, NMPs were more confident issuing repeat prescriptions where the 
patient had been receiving the same medicine over a long period for an established condition:  
 
“I do sign some repeat drugs that I wouldn’t commence, but where that’s been something that’s on 
a long term repeat for an existing purpose where it’s clearly identified” (Practice Pharmacist 003, 
In-depth Interview, Study 1)     
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A nurse practitioner highlighted her unease issuing repeat prescriptions for children. This was also 
a sentiment repeated by other NMPs that came in to contact with children. 
 
6.5.2 Pressures to issue Repeat Prescriptions 
NMPs described a number of pressures in relation to repeat prescriptions. These pressures fell into 
the following categories: patient need, failure of other services, time, and lack of support to uphold 
regulations. 
 
One difficulty NMPs faced, with regards to repeat prescribing, was if the patient required the 
medication they found it difficult to avoid issuing the repeat prescription regardless of their own 
concerns. This quote below demonstrates the general attitude of NMPs. This view was expressed 
less by those working in GP surgeries, presumably because if they were not comfortable issuing the 
repeat prescription, but the patient needed it, they could always approach a GP. 
 
“We tend not to use, to do repeat prescriptions, however, in an emergency situation we would, we 
would never leave patients without a prescription” (Palliative Care Specialist Nurse, In-depth 
Interview, Study 1) 
 
Even those who felt it was GPs’ role to issue all repeat prescriptions made exceptions in some 
cases. For instance, this palliative care specialist nurse prescriber described how she issued a 
prescription of morphine for a patient in exceptional circumstances: 
 
“But I shouldn’t be doing repeat prescriptions for palliative care medications anyway, they should 
be getting those through the GP, and it’s really their responsibility to ensure that they don’t run out, 
but if that scenario did happen, like the scenario happened that I mentioned before, where I walked 
in the house and they literally, they’d just broken the bottle of morphine in front of me, I wouldn’t 
see somebody without medication but I’d be explaining that in my letter, in my documentation to 
the GP” (Palliative Care Specialist Nurse 018, Semi-structured Interview, Study 2) 
 
NMPs also felt it was important to issue repeat prescriptions if there was a risk the patient’s 
condition could become worse. 
 
“So you’re in the position what, what do you do, you prescribe for them, because if they don’t use 
their treatments their skin will become worse so, and, and that’s really prescribing, there’s nothing 
clinical, nothing wrong with the clinical decision” (Dermatology Specialist Nurse 012, Semi-
structured Interview, Study 2) 
 
NMPs also felt pressure to issue repeat prescriptions for patients in cases where the GP had not 
provided or was unwilling to provide the medicine. In the example below, a nurse prescriber 
described how a patient’s GP surgery would not issue the patient a prescription for the 
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antidepressants she had lost. As a result of this, the NMP issued the repeat prescription for the 
patient. 
 
“Yesterday I encountered a lady who’s on antidepressants, a new course of antidepressants, she’d 
been in to the hospital for four days, taking them in in a tissue and lost them and when she’s rung 
the surgery for a repeat they said they’re not sure you can’t have them, which would have 
interrupted her course of treatment and I was there then I continued with another prescription for 
that” (Palliative Care Specialist Nurse 008, Semi-structured Interview, Study 1) 
 
The nurse prescriber in this quote below described how a letter she sent to the GP went missing. As 
a result, she felt she needed to issue the patient with another prescription. She describes feeling 
between a “rock and hard place” which suggests that she felt she had to issue repeat prescription 
though reluctant to. 
 
“I do occasionally get, family will phone up and say erm you know that dressing you prescribed, 
erm can you do us another one because I’ve run out, and I say well actually no I sent your GP a 
letter to ask them to put it on a repeat prescription, can you phone your GP and get a repeat and 
sometimes they’ll phone back and say the GP’s not got the prescription so then you’re stuck 
between a rock and a hard place and erm and usually I’ll just go and prescribe them, do another 
prescription, but make sure I drop the letter in at the GPs instead of faxing it over to them” 
(Paediatric Active Case Manager and WIC Nurse 031, Focus Group 3, Study 2) 
 
As this quote demonstrates, some NMPs described how time and workload pressure influenced 
their decision to issue a repeat prescription: 
 
“But this was Friday night erm where they’re desperate and they’re not going to get anybody to do 
anything erm and their patients going to be without drugs basically” (Advanced Practitioner for 
Nursing Homes 001, Semi-structured Interview, Study 2) 
 
Another source of discomfort for this advanced practitioner for nursing homes was that she was not 
sufficiently supported by managers at the PCT to follow through with the regulations regarding 
repeat prescribing. This lack of support made it difficult to resist some of the pressures discussed 
above. 
 
“It is a very difficult position to be in, erm because we’re just so regulated, and rightly so, I don’t 
think that’s wrong, erm but it’s difficult when we’re regulated, we have these rules, and we’re not 
being backed up to, err from management to say well just hang on, don’t do this, but, we shouldn’t 
be doing it” (Advanced Practitioner for Nursing Homes 001, Semi-structured Interview, Study 2) 
 
The factors that influenced whether NMPs took responsibility for issuing repeat prescriptions 
largely reflected those influencing other prescribing. NMPs described a wide range of factors that 
exerted pressure on them in relation to repeat prescribing. However, unlike the pressures discussed 
previously, they appeared to have a greater influence on the decisions NMPs took.  
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6.6 Discussion 
As Figure 6-2 depicts, the four main influences on whether NMPs took responsibility for making a 
prescribing decision for a patient or issuing a prescription were competency (see Section 6.3.1), 
role (see Section 6.3.2), practical and legal considerations (see Section 6.3.3) and risk (see Section 
6.3.4). These factors also influenced whether NMPs took responsibility for issuing a repeat 
prescription (see Section 6.5). NMPs also described a number of pressures on their decisions to 
take responsibility for prescribing (see Section 6.4 and Section 6.5.2). All NMPs displayed 
cautiousness when it came to taking prescribing responsibility (see Section 6.2). This cautiousness 
underpins all the influences on prescribing responsibility represented on Figure 6-2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
As outlined on Figure 6-2 NMPs’ perception of their competency influenced whether they took 
responsibility for making a prescribing decision for a patient or issuing a prescription. As with 
nurse prescribers in other research (Bradley et al. 2007) NMPs believed that competency should be 
self-assessed as others that they work alongside do not have the knowledge to make this assessment 
for them. It is perhaps unsurprising that competency was mentioned frequently by NMPs because 
guidelines for NMPs clearly state that they should only prescribe within their competency (Nursing 
and Midwifery Council 2006; Royal Pharmaceutical Society of Great Britain 2007) and because 
there is a strong emphasis on competency within the prescribing training course and through the 
Competency Framework (National Prescribing Centre 2006). There has not been extensive 
discussion in the literature about whether NMPs need to consider their competency levels in their 
practice or whether, by virtue of the referral pathway, they manage patients within their 
competency. This research, along with other recent research (Bissell et al. 2008), has demonstrated 
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that NMPs do regularly need to assess their competency and this assessment of their competency 
influences whether they take responsibility for prescribing. 
 
There has not been, until now, an in-depth examination of how NMPs’ perception of their 
competency influences whether they take responsibility for prescribing. This research has expanded 
this limited knowledge by identifying aspects of competency that NMPs consider on a routine basis 
in their practice before taking prescribing responsibility (see Section 6.3.1). The competency to 
form a diagnosis was mentioned more by nurse prescribers than pharmacist prescribers. This 
finding reflects the differences between the roles of nurse prescribers and pharmacist prescribers. In 
this research, pharmacist prescribers were mainly involved in medicine optimisation for patients 
with previously diagnosed conditions. Nurse prescribers were, in contrast, more involved in 
managing acute or previously undiagnosed conditions (see Appendix 10.0 for further information 
about NMPs’ roles). This finding is consistent with other research which found 74% of nurse 
independent prescribers, compared with only 22% of pharmacist independent prescribers, were 
making diagnoses on most occasions within their prescribing practice (Latter et al. 2010).  
 
It is important that NMPs consider their competency before prescribing because many prescribing 
errors are as a result of the prescribers’ failure to fulfil competencies discussed by NMPs in this 
research. For instance, Garbutt et al. reported that 34% of the prescribing errors they examined 
were as a result of incomplete knowledge of the medication (Garbutt et al. 2005). Lesar et al. found 
30% of the prescribing errors they studied were due to insufficient drug knowledge (Lesar et al. 
1997). NMPs used a p-formulary or a head-held formulary to help them assess their safety to 
prescribe certain medicine. This formulary was simply a list of medicine that the NMPs felt 
competent to prescribe. In their good prescribing guide, the World Health Organisation (WHO) 
emphasises the need for a personal formulary to promote rational prescribing (World Health 
Organisation 2000). In the UK context the NPC has reemphasised the WHO’s advice in their good 
quality prescribing guidance (National Prescribing Centre n.d.). De Vries et al. found that the 
prescribing skills of 583 medical students, from eight universities throughout the world (though not 
UK), improved using the concept of the personal formulary, compared with those using either no 
formulary or existing university formularies. However, the increase in prescribing skills was for 
students from universities with a classic rather than problem-based learning curriculum (De Vries 
et al. 2008). De Vries et al.’s research suggests that the p-formulary concept may have inconsistent 
benefits for medical students. Clearly though the p-formulary has an important role in NMPs’ 
practice as a tool to assess their competency to prescribe specific medicines. 
 
Ensuring the prescriber is competent has implications for patient safety and the NMP. However, it 
is also important that NMPs acknowledge their limitations in order to maintain the confidence of 
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their colleagues. This is because their colleagues expect them to acknowledge their limitations 
(Stenner et al. 2010). Furthermore, because patients have expressed concerns regarding some 
aspects of non-medical prescribing (Hobson et al. 2010; Stewart et al. 2009a; Watterson et al. 
2009), it is important that NMPs work, and are seen to be working, within their competency. In this 
research NMPs easily communicated their competencies. It is important that this openness is 
transmitted to both patients and colleagues alike in order to sustain good working relationships and 
quell any of their concerns. 
 
It was difficult to separate out issues of competency and certainty in this research. NMPs described 
how they would refer the patient or seek advice if they lacked competency but similarly said they 
would refer the patient or seek advice from colleagues if they were “uncertain” or “in doubt”. As 
these factors are difficult to separate they are presented together in Figure 6-2. This research found 
that NMPs’ certainty in any scenario also influenced whether they took responsibility. NMPs’ 
uncertainty led them to employ similar strategies, such as patient referral or seeking advice, to 
those used by doctors when they are uncertain or experience a dilemma (Bendtsen et al. 1999a; Di 
Caccavo and Reid 1995). The question of where the line should be drawn between competency and 
certainty is difficult to answer. One argument is that uncertainty is at the periphery of competency. 
When NMPs feel fully competent they are unlikely to be uncertain. The less competent they feel 
the more the feelings of doubt, concern and uncertainty emerge.  
 
This research has reemphasised a how lack of clinical support and insufficient opportunities to 
prescribe are barriers to NMPs employing their prescriptive authority. This finding echoes previous 
research with CNPs (Hall et al. 2006) and other NMPs (Hacking and Taylor 2010; Latter et al. 
2010). Through the use of the CIT, to explore actual prescribing scenarios, it was possible to 
understand, in more detail than current research, how a lack of support and opportunities to 
prescribe impact on whether NMPs take responsibility for prescribing in specific situations. This 
research replicates the findings of other research that active NMPs work in cohesive and supportive 
teams (Otway 2001). The importance of clinical support for NMPs is acknowledged by NMPLs 
who are putting strategies in place to manage this issue (Hacking and Taylor 2010) (see Section 
9.3). This research underlines how NMPs must also be given opportunities to prescribe regularly in 
their practice, because, as Hall et al. states, they may not overcome confidence issues and will 
remain low prescribers forever (Hall et al. 2003). 
 
There are parallels between the support requirements of NMPs and junior doctors. Post-qualifying 
junior doctors do not rate their prescribing skills very highly (Wall et al. 2006). Junior doctors learn 
safe prescribing by copying out orders written by others doctors (Garbutt et al. 2005) and seek 
guidance from more senior doctors when faced with difficult prescribing decisions (Lewis and 
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Tully 2009b). Junior doctors do not wish to feel ‘abandoned’, require opportunities to reflect on 
their practice and welcome opportunities to act independently but with assistance from more senior 
doctors when required (Iedema et al. 2010). Like junior doctors, NMPs also require support from 
doctors. However, doctors may not have time to offer support to NMPs and complete other duties 
which will include supporting less experienced doctors. Research has found that one in five doctors 
have regular contact with six or more NMPs at any one time (Hacking and Taylor 2010). 
Moreover, doctors feel working with NMPs increases their own workload (Hacking and Taylor 
2010). Community pharmacists have been found to be in a position to provide support to NMPs 
(Fisher 2009). Support for NMPs in primary and community care could therefore come from other 
avenues than doctors (see Section 9.3). 
 
How NMPs respond to inadequate support and lack of opportunities to prescribe reflects their 
perception, as well as others perception, of their role in the healthcare system. Some NMPs felt 
they were a supplement to existing practices. Furthermore, it is anticipated, and expected, by 
doctors and patients alike that NMPs should refer uncertain prescribing decisions and work within 
their competency (Stenner et al. 2010; Watterson et al. 2009). It is potentially easier for NMPs to 
‘dissolve’ prescribing responsibility to others. Doctors may not have similar opportunities and may 
take responsibility for prescribing when uncomfortable and not competent to do so. Ultimately, this 
may lead to more prescribing errors amongst doctors, particularly junior doctors, than NMPs. It 
will be important in the future to compare the number of prescribing errors made by junior doctors 
and NMPs. It will also be important to explore the reasons behind errors made (see Section 9.4.3).  
 
NMPs also considered practical and legal factors when deciding whether or not to take 
responsibility for prescribing. This influence is represented on Figure 6-2. Practical factors, 
considered most by community based prescribers, included whether they represented the most 
convenient source of a prescription for the patient. The finding echoes Hall et al.’s finding that 
CNPs would not prescribe where it was easier for GPs to prescribe for the patients as a result of 
medicine delivery arrangements or other factors, such as arrangements for repeat prescriptions 
(Hall et al. 2006). A proposed benefit of non-medical prescribing was that patients would have 
speedier access to medicine (Department of Health 1999). In some cases patients do report a more 
timely and convenient service from NMPs (Courtenay et al. 2011; Latter et al. 2010; Stewart et al. 
2008). Clearly though, NMPs do not always represent the most efficient means to provide medicine 
to patients. It is therefore expected that NMPs’ decisions of whether to take responsibility for 
prescribing are based on practical patient factors. This research clearly demonstrates that this is the 
case in practice. 
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Other practical factors considered by NMPs were whether they had sufficient information to enable 
prescribing. In some cases insufficient information, as a result of language barriers or the patient’s 
age, meant NMPs were sometimes unable to take responsibility for prescribing. There was no 
evidence that insufficient information, as a result of these issues, was unique to NMPs though. 
NMPs expressed their discomfort prescribing where there was insufficient information to do so. 
This finding replicates other research. GPs too express their discomfort prescribing with limited 
information (Bradley 1992b). Similarly, CNPs state they are more confident prescribing the more 
information they have (Luker et al. 1998).  
 
In earlier research, a lack of access to patients’ notes was found to be a barrier to community nurse 
prescribing (Hall et al. 2003). Nurse prescribers based in the community in this research also 
reported difficulties with accessing patients’ notes as they had to physically attend the patient’s GP 
surgery. However, in contrast to previous research, there was no evidence it was a barrier to 
prescribing. Nurse prescribers hoped that the computerisation of patients’ medical notes, a current 
NHS policy (NHS Choices 2010), would eliminate difficulties in this area. With insufficient 
information resulting in so many prescribing errors (Garbutt et al. 2005; Lesar et al. 1997) it is 
important that prescribers are in full possession of all information available before prescribing. This 
evidence suggests that, without the necessary available information, NMPs are reluctant to take 
responsibility for prescribing. Delaying prescribing because of insufficient information may help to 
reduce prescribing errors but it is obviously important that patients are not adversely by such a 
strategy in the short-term. 
 
The legal authority to act is clearly an issue that influences most people in the actions they take in 
their lives. It is therefore unsurprising that NMPs did not want to take responsibility for prescribing 
where it was illegal to do so. During Study One, prescribers did not issue prescriptions for 
unlicensed medicine for patients. At the time this behaviour was in line with legislation. However, 
policy on this issue has since changed (see Section 2.3.1.2). Pharmacist prescribers did not take 
responsibility for independently prescribing CDs. Some pharmacist prescribers did set-up a CMP, 
under SP, so they were able to prescribe CDs. However, some pharmacist prescribers, who were 
negative about CMPs, simply asked a doctor to issue the prescription on their behalf. The DoH 
states SP is most appropriate in circumstances where CDs are being used (Department of Health 
2006b). However, the findings of this research, as well as other research (Bissell et al. 2008), 
suggests that some pharmacists view CMPs as unworkable because of the time required to set 
CMPs up and the inconvenience to patients. If pharmacist prescribers feel competent to prescribe 
CDs independently then they should be permitted to do so. It is important that legislation enabling 
prescribing of CDs by pharmacists is changed sooner rather than later (see Section 9.3 for further 
discussion). 
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As Figure 6-2 depicts, NMPs’ decisions to take responsibility for prescribing was influenced by 
their perceptions of their role. This behaviour reflects guidance from their professional bodies 
(Nursing and Midwifery Council 2006; Royal Pharmaceutical Society of Great Britain 2007). 
NMPs’ role definition was influenced by a wide range of factors including main medical speciality, 
agreements with colleagues, appropriateness of alternative services and nature of prescribing. 
There was less evidence in this research, compared with other research (Latter et al. 2010), that 
NMPs had agreements with their PCT about their scope of practice or role. However, some NMPs, 
particularly nurses, had written p-formularies which they submitted to their PCT NMPL. The p-
formulary might be one type of ‘scope of practice’ agreement that NMPs cited in Latter et al.’s 
study. Fewer pharmacists had a p-formulary submitted to their PCT. Instead pharmacists’ role 
definitions were influenced by agreements with GP colleagues and surgery managers. Interestingly, 
in some cases, pharmacist prescribers were permitted to prescribe but selected not to because of 
insufficient competency. In other cases, pharmacists felt competent to prescribe in certain areas but 
did not because the area was not within their agreement. Clearly role and competency factors 
interlink when NMPs decide whether to take responsibility for prescribing. NMPs’ definitions of 
their roles also influenced the clinical areas they were prepared to become competent in. It is for 
these reasons the competency and role boxes are linked in Figure 6-2. 
 
As well as defining their individual role NMPs also defined the role of NMPs more generally. 
These two aspects of role are represented on Figure 6-2. For instance, many NMPs, although rarely 
those working in GP surgeries, did not feel it was their role to issue repeat prescriptions for 
patients, regardless of whether it was for medicine within their perceived competency. Some NMPs 
felt their role was to add to existing services not to replace them. Some also felt that GPs, 
traditionally the providers of long-term patient care, should remain the providers of repeat 
prescriptions. Some nurse prescribers also said doctors, rather than NMPs, should be the ones to 
take ‘risk’ in relation to prescribing. Other NMPs, including pharmacist prescribers, did not 
explicitly state these views. However, their behaviour of referring high risk situations to doctors 
suggest many NMPs hold these views anyway. In order to feel ‘safe’ when prescribing nurse 
prescribers set limits on their practice (Bradley et al. 2007). It may be that NMPs’ definition of 
their role, both individual and general, is also a way of setting limits on their practice. NMPs’ role 
may be a way of controlling their prescribing so they feel ‘measured’. Defining their role might 
also help them to resist pressures (e.g. non-prescribing nurses) that they might otherwise succumb 
to. These pressures are discussed further in this section.  
 
As Figure 6-2 highlights, NMPs’ perception of the risk of the prescribing situation influenced 
whether they took responsibility for prescribing. In high risk situations NMPs were more likely to 
refer the patient, seek advice and input from colleagues, most notably GPs, or ask a doctor to issue 
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the prescription on their behalf. Risk was associated with deviation from guidelines or formularies, 
prescribing medicine off-label and prescribing high risk medicine or prescribing for high risk 
patients. Similar factors also increased NMPs’ perceptions of risk when issuing repeat 
prescriptions. In some cases avoidance of risk was linked the prescribers’ perception of their 
competency. For example, some NMPs felt less competent to prescribe for patients with complex 
poly-pharmacy because of their lack of medicine knowledge. However, as mentioned, many NMPs 
appeared to believe it was not their role to be ‘risk-takers’ and would rather leave high risk 
situations to doctors. To reflect these links the boxes role, risk, and competency are linked on 
Figure 6-2. 
 
Invariably high risk scenarios led to feelings of discomfort in NMPs. In some cases this discomfort 
led NMPs not to take responsibility for prescribing. Research demonstrates that similar factors lead 
to discomfort in doctors and NMPs. All prescribers feel uncomfortable prescribing for patients at 
either end of the age spectrum (Bradley 1992b; Hall et al. 2003; Hall et al. 2006). NMPs feel 
uncomfortable prescribing for patients with complex poly pharmacy and those with co-morbidities 
(Bissell et al. 2008; Hall et al. 2003; Hall et al. 2006; Latter et al. 2010). Doctors, nurse 
independent prescribers and pharmacist independent prescribers feel uncomfortable departing from 
protocols, guidelines, formularies and agreed management plans (Bradley 1992b; Latter et al. 
2010). In this research, more nurses than pharmacists expressed concern prescribing for patients 
with co-morbidities and complex poly-pharmacy. However, pharmacists did also express 
discomfort in these situations. This finding replicates other research where pharmacist prescribers 
have said they are uncomfortable managing patients with co-morbidities (Bissell et al. 2008; Latter 
et al. 2010). In one study, one third of pharmacists surveyed said they felt uncomfortable managing 
these patients (Latter et al. 2010). This suggests that feelings of discomfort about managing co-
morbid patients are not just specific to nurses. This research, whilst replicating some of the 
previous findings relating to prescribing discomfort, adds that NMPs discomfort with risk 
sometimes results in them not taking responsibility for prescribing in some scenarios. 
 
Whilst some NMPs managed high risk prescribing scenarios, and subsequently any discomfort, by 
referring the patient some sought advice from doctors or asked a doctor to issue the prescription on 
their behalf. This behaviour is consistent with the findings of a recently published study that found 
when deviating from protocols, guidelines or formularies nurse and pharmacist independent 
prescribers seek colleagues’ advice (Latter et al. 2010). Furthermore, as discussed previously, 
similar strategies are used by NMPs to manage uncertainty. Junior doctors also seek advice from 
their colleagues when faced with a difficult prescribing decision as a means to reduce the 
discomfort they feel and essentially ‘pass the buck’ (Lewis and Tully 2009b). Such strategies 
appear to reduce negative feelings within the prescribers who arguably feel some responsibility for 
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the prescribing is transferred to others. It is noteworthy that, in this research, some NMPs said they 
document advice received in patients’ notes. This may also be part of absolving themselves of full 
responsibility for the prescribing. It may also be a practical way of ‘covering’ themselves in case of 
legal issues. However, in some cases, GPs advice was not sufficient to stifle negative feelings 
caused by difficult prescribing decisions, and instead, NMPs referred the patient or asked a doctor 
to issue a prescription on their behalf. 
 
The findings of this research add to the current body of research because, as yet in the literature, the 
pressures that NMPs face in relation to taking responsibility for prescribing have not been 
identified or discussed in-detail. The pressures NMPs experienced included pressure from non-
prescribing nurses, time pressures, failure of other services, patient need and lack of support to 
uphold prescribing regulations. These pressures had more influence on NMPs when issuing repeat 
prescriptions. The existence of the pressures on NMPs is represented on Figure 6-2.  
   
WIC nurse prescribers described pressure from non-prescribing nurses to issue prescriptions. This 
occurred when the non-prescribing nurse assessed a patient, decided they needed a prescription, but 
could not issue the prescription. The non-prescribing nurse would request a prescription from a 
nurse prescriber. Doctors have identified non-prescribing colleagues as a source of pressure on 
their prescribing (Lewis and Tully 2009b; Wood-Mitchell et al. 2008). It is clear from this research 
that some nurse prescribers also experience similar pressures. In this research, nurse prescribers 
said they would not issue a prescription in these circumstances unless they had assessed the patient. 
In some cases they admitted this has a negative impact on their workload. This clear refusal to issue 
prescriptions without assessing the patient is consistent with the behaviour of CNPs who have 
reported rejecting pressure from other CNPs and GPs (Fisher 2009). 
 
The nurse prescribers’ views in this research that other non-prescribing nurses viewed them as 
awkward or difficult when they refused to issue prescriptions without assessing the patient are 
consistent with non-prescribing nurses’ views. Non-prescribing nurses have described how they 
feel their professionalism and autonomy is being questioned by nurse prescribers who want to 
assess the patient themselves before issuing a prescription. Some nurses have described their 
annoyance that nurse prescribers are obliged to perform an assessment and then prescribe (Fisher 
2009). If there are uncertainties amongst non-prescribing HCPs about the legalities of prescribing, 
as some research has suggested (Fisher 2009; Stenner et al. 2009), then it is important that these are 
addressed so non-prescribing HCPs can understand NMPs’ position. However, does the pressure 
from non-prescribing HCPs stem from a lack of understanding regarding prescribing legalities or 
an expectation that all independent prescribers will ignore prescribing regulations? Nurses state 
they regularly recommend treatment to doctors and write prescriptions out for doctors to sign (Jutel 
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and Menkes 2010). Perhaps they have similar expectations of NMPs. With the introduction of 
nurse-only clinics it may not be possible to eliminate the need for non-prescribers to ask NMPs for 
prescriptions. However, it is important that non-prescribing HCPs understand that not all 
prescribers are prepared to overlook the legalities regarding prescribing. 
 
Some NMPs described how time pressure led them to take responsibility for prescribing when they 
otherwise would not have done so (e.g. because of insufficient competency). Much of the research 
with doctors has focused on how time and workload pressures encourage doctors to issue clinically 
inappropriate medicine to manage patient pressure (Lewis and Tully 2011; Petursson 2005; 
Stevenson et al. 1999). However, until now, research with NMPs had not discussed how time 
pressure could influence whether NMPs take responsibility for prescribing in any given scenario. A 
small number of NMPs described how when facing time pressures, albeit in situations which were 
inside their competency, they did not prescribe at all and asked someone else to issue the 
prescription on their behalf. This reflects other research which found in busy clinics HVs do not 
utilise their prescriptive authority (Hall et al. 2006). This research has demonstrated that deferring 
prescribing responsibility to others is not a strategy all NMPs can employ in all circumstances, and 
therefore, more must be done to reduce time pressures on prescribers. There may be serious safety 
implications of NMPs taking responsibility for prescribing just because of time pressure. This may 
be especially true where there is an absence of competency. 
 
In other research NMPs have described how they receive pressure from patients to prescribe 
outside their competency (Latter et al. 2010). This research found that much of patient pressure, in 
regards to prescribing responsibility, related to repeat prescription requests. NMPs described how 
patient need, failure of other services and time meant they felt in some circumstances they had to 
issue the prescription even though they would rather not. Furthermore, a very small number of 
nurse prescribers felt there was limited support to uphold regulations about repeat prescribing from 
managers. As far as possible GPs must continue to issue repeat prescriptions for patients so 
pressure on NMPs is limited. This is particularly important so NMPs prescribing outside their 
competency is avoided. Patient pressure in relation to repeat prescriptions may arise from patients’ 
attitudes that NMPs will be able to fulfil all their prescribing needs. It is therefore important that 
patients’ understanding of NMPs’ role is improved (see Section 9.3).   
 
One quarter of nurse prescribers and one in ten pharmacist prescribers, in recent research, said they 
were anxious about their prescribing responsibilities (Latter et al. 2010). It may therefore be 
unsurprising that, in this research, NMPs were cautious when it came to taking responsibility for 
prescribing and this cautiousness underpins all the factors presented in Figure 6-2. NMPs stated 
they were cautious about prescribing and provided examples of cautious behaviour with regards to 
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prescribing responsibility. This finding is consistent with research with nurse prescribers (Bradley 
et al. 2007). Doctors too confirm nurses’ approach to prescribing is ‘careful’ and state nurses refer 
uncertain cases to them (Stenner et al. 2009). This research suggests that pharmacist prescribers, 
like nurses, adopt a similar approach when prescribing. Nurse prescribers describe how their 
cautiousness is encouraged by the fact that prescribing is new to them (Bradley et al. 2007). In this 
research NMPs of all experience levels described a similar attitude towards prescribing. This 
suggests that even after the novelty of prescribing wears off most NMPs continue to behave in this 
manner.  
 
Why are some NMPs anxious and cautious about prescribing responsibility? This research has 
begun to uncover some of the possible reasons for this, which will be discussed in this section, but 
more focused research in this area is warranted (see Section 9.4.2). A small number of nurse 
prescribers felt that doctors would receive more support from their professional body and 
healthcare managers in the case of prescribing errors than they would. Some also felt that non-
medical prescribing needs to maintain a ‘safe’ image and be protected from criticism from both the 
media and medical profession. A small number of nurse prescribers also felt some doctors hold 
negative attitudes towards NMPs and provided specific examples of doctors’ negativity. This 
finding echoes research with CNPs who reported an unfavourable reaction amongst GPs to their 
prescriptive authority (Fisher 2009; Hall et al. 2006). Other nurse prescribers have also reported 
negative views amongst doctors (Lewis-Evans and Jester 2004; Stenner et al. 2009). As discussed 
previously, doctors express some concern about non-medical prescribing in relation to training and 
diagnosis (Blenkinsopp et al. 2008; Courtenay and Berry 2007; Crown and Miller 2005; Fisher 
2010; Lloyd et al. 2010; Stewart et al. 2009b; Tann et al. 2010; Watterson et al. 2009; Weiss et al. 
2006). Is it possible that some of these concerns are transmitted to NMPs? It may be that doctors’ 
criticism impacts NMPs in two ways. If doctors do not want NMPs to prescribe for their patients 
then NMPs are unlikely to take responsibility for prescribing in those cases. Indirectly, doctors’ 
criticism may create an underlying fear amongst NMPs who do not want to confirm any of the 
criticisms that the medical profession and in some cases, individual doctors, have levelled at them. 
 
Other factors must give rise to NMPs’ approach to prescribing though, besides from possible 
reasons discussed, as most nurse and pharmacist prescribers in this research described cautious 
behaviour or said they were cautious about prescribing. One community matron, who described 
how she was more cautious about prescribing following the training course than before, raises 
questions about the impact of the course on NMPs’ attitudes to prescribing. The prescribing 
training course leaves NMPs more aware of prescribing responsibility and accountability (Offredy 
et al. 2008) as well as more conscious of inadequacies in their own prescribing knowledge (Bradley 
et al. 2007). The PLP, required as part of the course, has also been found to enhance NMPs’ 
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understanding of doctors’ roles, the complexity of diagnosis and provide a greater understanding of 
holistic patient care. Barber et al. argued that it is the lack of teaching medical students and junior 
doctors receive about prescribing that gives rise to an attitude that prescribing issues are not really 
important (Barber et al. 2003). Once in practice junior doctors are likely to face expectations from 
other HCPs to overlook some prescribing rules and legalities (Lewis and Tully 2009b). These 
expectations can lead doctors to break prescribing rules, particularly when it helps their colleagues 
(Lewis and Tully 2009b). In contrast, NMPs receive a dedicated and specific training course 
focusing on, amongst other things, prescribing ethics and legalities. This specific training may 
contribute to cautiousness in NMPs and motivate them to reject prescribing pressure. 
 
NMPs’ cautiousness may also be as a result of them assuming legal responsibility for a task they 
could not do previously. Previously NMPs might have felt less responsibility for prescribing 
because they did not actually sign the prescription. The accountability that nurses feel post-
qualifying as a prescriber is reportedly worse than they anticipated (Lewis-Evans and Jester 2004). 
Presumably this is because they are signing the prescription and taking legal responsibility for the 
issuing of that prescription. This increased legal responsibility, combined with other issues 
discussed, may generate cautiousness in NMPs. It is noteworthy that NMPs still continue to ask 
doctors to sign their prescription requests when they feel uncomfortable prescribing. Clearly these 
HCPs new found understanding of prescribing responsibility has not influenced their expectations 
of doctors.  
 
NMPs’ cautiousness led them to seek doctors’ advice when uncertain or uncomfortable about 
prescribing. In regards to pharmacist prescribers Weiss and Sutton argue that, despite prescriptive 
authority, pharmacists still view themselves as subordinates to doctors who they require to provide 
final authorisation for prescribing decisions (Weiss and Sutton 2009). Weiss and Sutton’s 
suggestion is consistent with research that found that pharmacists avoid prescribing in fields they 
regard as the doctors’ domain (Weiss 1994). Equivalent research is not available for nurses but 
arguably NMPs’ overall approach to taking responsibility for prescribing may reflect deeply rooted 
professional boundaries in the UK healthcare system.  
 
6.6.1 Reflections on Method 
The use of the CIT in Study Two allowed an examination of the factors that influence whether 
NMPs take responsibility for making a prescribing decision or issuing a prescription. As discussed 
in Chapter Four, NMPs talked about prescribing responsibility and the factors that influence this 
decision in general terms. The CIT encouraged NMPs to think of prescribing scenarios before they 
came to the interviews and the forum to discuss these incidents in detail. This technique allowed an 
in-depth examination of actual prescribing events rather than relying on generalisations. The focus 
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groups, conducted with a larger number of NMPs, used in conjunction with the CIT were 
particularly useful in exploring some of the themes emerging from the CIT. In line with the 
limitations of the CIT, discussed in Section 5.1.2.5, a small number of NMPs did not bring any 
incidents to the discussion. However, they were reminded of the instructions regarding the 
incidents at the beginning of the interview and all managed to think of incidents during the 
discussion. 
 
The CIT provided NMPs the opportunity to reflect on aspects of their practice. A number of NMPs 
welcomed the opportunity to discuss prescribing with someone. Some stated at the end of the 
interview they had enjoyed the discussion. NMPs with limited clinical support and those struggling 
to use their prescriptive authority also appreciated the opportunity to discuss prescribing in general 
and the difficulties they faced as a prescriber. These NMPs’ motivation to take part in the research 
seemed to be linked with the difficulties they were facing. Their inclusion in this research was 
important given the issues they highlighted.  
 
The use of the CIT to study prescribing is not unique. Other research has used the CIT to study the 
sources of discomfort amongst prescribers (Bradley 1992a; Bradley 1992b; Lewis and Tully 2009a; 
Lewis and Tully 2009b). The research demonstrated that the CIT is an effective method to study 
the sources of influence on prescribing decisions. The technique, with or without the modifications 
in Section 5.1.2.5, could be used to understand the influences on other aspects of prescribing, such 
as prescribing decisions discussed in Chapter Seven. Focus groups could also be used to expand on 
some of the themes emerging from the CIT. The CIT could also be used during focus groups to 
provide an instant reading of the relevance of the themes emerging from the incidents. However, 
thought must be given to how the presence of other participants might impact the incidents 
participants provide.  
 
6.7 Chapter Summary 
This chapter has examined the factors that influence whether NMPs take responsibility for making 
a prescribing decision or issuing a prescription for a patent. The issue of prescribing responsibility 
was found, in Study One, to be particularly important to NMPs. The factors influencing whether 
NMPs took responsibility for prescribing included competency, role, practical and legal 
considerations and risk. Pressures NMPs faced to take responsibility for prescribing included time 
pressures, failures of other services, patient need and lack of support to uphold prescribing 
regulations. The next chapter discusses the influences on NMPs’ prescribing decisions.  
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Chapter Seven – Prescribing Influences 
_______________________________________________________________________________ 
 
The purpose of this chapter is to explore the factors influencing the prescribing decisions of NMPs. 
As described in Chapter Four, prescribing decisions involve the choice between a pharmacological 
versus non-pharmacological approach, the choice of medicine, formulation and dose. This chapter 
presents findings from Study One, introduced in Chapter Four, and is intended to provide a basis 
for the findings of Study Three (see Chapter Eight). The factors influencing prescribing decisions 
are discussed under seven main headings, regulatory factors, patient factors, colleagues, prescribing 
culture and professional experience, training and information sources, logistical factors and the 
pharmaceutical industry. The findings are then discussed in terms of the prescribing influences 
literature. 
_______________________________________________________________________________ 
 
7.1 Introduction 
One of the main categories of influences NMPs discussed on their prescribing decisions was 
clinical influences. Clinical influences included, but were not limited to, factors such as medical 
need, efficacy, side effects, test results, patient’s medical history, patient’s medicine history, 
allergies, co-morbidities, drug-drug interactions and patient’s symptoms. Clinical influences were 
excluded from Study Three to focus on other influences. However, it is important to highlight that 
these factors were spontaneously mentioned by all NMPs in Study One and undoubtedly play a 
very important role in their prescribing decisions. However, like Study Three, this chapter will 
focus on other influences.  
 
7.2 Regulatory Factors 
The regulatory influences discussed by NMPs as sources of influence on their prescribing decisions 
included guidelines, formularies, PGDs and cost to the NHS. 
 
7.2.1 Guidelines 
When NMPs were asked for their definition of guidelines they generally described them as step-by-
step instructions to guide treatment of a particular condition or symptom. The guidelines NMPs 
used were generally considered to be up-to-date and based on relevant research. Very few NMPs 
spontaneously mentioned cost in relation to guidelines. The guidelines mentioned by NMPs fell in 
to two main categories: national guidelines and PCT or local guidelines. As this quote illustrates, 
the recommendations of guidelines were a major consideration for NMPs when making prescribing 
decisions: 
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“Choice of drug now that would depend on various guidelines, err so you would work to say NICE 
guidelines, or you would work to local PCT guidelines” (Practice Pharmacist 004, In-depth 
Interview, Study 1) 
 
Often NMPs described how different guidelines, both national, PCT and local, informed different 
areas of their prescribing decisions. 
 
“Like if it was around contraception I’d usually use the Faculty of Family Planning, if it was 
around asthma I’d use the Thoracic Society, if it was around antibiotics I’d go by the local 
guidelines around antibiotics or you know, for skin infections, for chest”(WIC and OOHs Nurse 
002, In-depth Interview, Study 1) 
 
NMPs of all experience levels claimed to be content to deviate from guidelines in favour of their 
own judgement. However, when prompted for examples where they had deviated from guidelines, 
many NMPs said they could not think of any situations. 
 
“I’m trying to think of an example really where I haven’t erm I can’t to be honest I can’t really 
think of an example when I haven’t prescribed within guidelines erm” (Advanced Practitioner 005, 
In-depth Interview, Study 1) 
 
A small number of NMPs did provide examples of deviating from guidelines. The main reasons 
NMPs gave for deviating were that they personally had contradictory clinical experience, they 
considered the guidelines to be out-of-date or the recommended medicine was unsuitable for the 
patient (e.g. because of past treatment failure). 
 
“Let’s give an example of a urinary tract infection, first line treatment is trimethoprim but if I have 
a patient that comes to me and they’ve had several urinary tract infections and trimethoprim 
doesn’t work for them then I’m not going to give trimethoprim as a first line” (WIC Nurse 009, In-
depth Interview, Study 1) 
 
Other NMPs, when asked if they deviated from guidelines, described how their patient cases were 
not exceptional and largely fit within guidelines and formularies anyway. One advanced 
practitioner described how he was “not pushing the boundaries of any formulary or guidelines” 
(Nurse 006, Study One) when prescribing. Other NMPs described how the guidelines they used 
were sufficiently flexible to enable them to manage the majority of clinical cases. 
 
National guidelines included NICE guidelines and other guidelines from national bodies (e.g. 
British Thoracic Society, Faculty of Family Planning). The guidelines that NMPs said they 
followed depended on their speciality. Examples of local or PCT protocols or guidelines included 
WIC guidelines, local palliative care guidelines and PCT heart failure guidelines. Generally, NMPs 
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followed PCT guidance when prescribing antibiotics. Some NMPs believed their local guidelines 
were largely based on the recommendations of national guidelines. 
 
7.2.2 Formularies 
A formulary was described by NMPs as a list of medicines that are commonly used to treat a 
particular symptom or condition. Within a formulary could be recommendations as to the first, 
second and third line treatment for a particular condition or symptom. Types of formularies 
described by NMPs could be divided in to national formularies and PCT and local formularies. The 
BNF was the only national formulary mentioned by NMPs. Examples of PCT and local formularies 
included the WIC formulary, wound care formulary and palliative care formulary. A small number 
of nurse practitioners for GP surgeries and practice pharmacists also mentioned they had a GP 
surgery formulary. 
 
The recommendations of formularies, both national and local, were major considerations when 
NMPs made prescribing decisions. As with guidelines most NMPs felt formularies were based on 
research. A small number of NMPs, particularly those with a GP surgery formulary, felt cost was 
factored into the recommendations of formularies. There was a mixed response from NMPs to the 
question of whether they would prescribe a medicine not on the formulary. Some said they would 
deviate if they did not consider the recommendations of the formulary to be up-to-date. For 
instance, one nurse described how she would be prepared to follow her own clinical judgement 
about a new medicine, and prescribe it, even if it was not on the formulary: 
 
“If a new dressing has come out and we have piloted it and we have decided yes it’s good but it’s 
not yet on the formulary but it’s probably going to be then yeah I would prescribe the dressing of 
my choice” (Night Nurse Lead/WIC Nurse 003, In-depth Interview, Study 1) 
 
Some NMPs were not prepared to prescribe medicine outside the formulary. This is illustrated by 
the following quote from an OOHs and WIC nurse. The nurse is dramatic in her description of 
what she believes the consequences might be of deviating from the formulary. 
 
“I would not override [the WIC Formulary], I wouldn’t do that, I like to sleep at night and I like 
my pin number [NMC registration] and pay my mortgage. Doctors do, they do override it. But 
that’s up to them isn’t it” (OOHs and WIC Nurse 002, In-depth Interview, Study 1) 
 
7.2.3 Patient Group Directions (PGDs) 
Although NMPs can prescribe medicine outside of PGDs some described how they still consider 
the recommendations of relevant PGDs when making prescribing decisions. This was generally 
mentioned by NMPs working in OOHs centres and WICs where PGDs are commonly used by non-
prescribing HCPs. This quote from a nurse illustrates her use: 
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“The other nurses that don’t prescribe have PGDs but I can prescribe so I prescribe what the PGD 
says but I’m using prescriptions” (Practice Nurse, Specialist Nurse and WIC Nurse 013, In-depth-
Interview, Study 1) 
 
One nurse said that she had used PGDs before becoming a prescriber, and as a result, continued to 
refer to them even after qualifying. Those NMPs referring to the recommendations of PGDs felt 
they were useful, detailed, a good source of information and evidence and research based. 
 
7.2.4 Cost to the NHS 
The cost of the medicine influenced the prescribing decisions of both nurse and pharmacist 
prescribers. Generally, if after taking other factors into consideration (e.g. efficacy, anticipated 
adherence), NMPs deemed two or more medicines to be equally appropriate for the patient then 
generally they would prescribe the least expensive option. Many NMPs said that, where possible, 
they would select generic medicine over branded alternatives. Although relatively cost-conscious 
all NMPs said they would not base a prescribing decision solely on the cost of the medicine. From 
this quote below it was clear that other factors, such as patient adherence and medicine efficacy, 
took precedence over cost factors: 
 
“I think top of my priority list has got to be the other things that I’ve mentioned, is it going to work, 
are they going to take the medication, it’s no good giving the patient something that’s cheap, but 
that they’re not going to use” (WIC Nurse 009, In-depth Interview, Study 1) 
 
The initial expense of more costly medicine could be justified if NMPs felt there would be an 
overall cost saving as a result of other factors (e.g. reduced hospital admissions or increased 
adherence). 
 
“Sometimes in GP practice because it’s all very money driven they would prefer that you use 
certain inhalers because they’re cheaper but to me there’s no point in that because if they’re not 
going to use it, they’ll become unstable and they’ll end up costing a whole lot more” (Practice 
Nurse/Specialist Nurse 012, In-depth Interview, Study 1) 
 
The main sources of pressure on NMPs to reduce medicine cost came from GPs and their PCT. 
Two NMPs, one nurse and one pharmacist, described how the PCT had asked them to switch all 
their patients from one medicine to another solely for cost cutting purposes. There was no 
suggestion that their PCT was concerned with other prescribing issues such as efficacy. Many of 
those NMPs who described pressure from GPs and their PCT in relation to cost felt that if they 
could justify the prescription on other grounds they could prescribe against GPs’ or their PCT’s 
wishes. In this quote a practice pharmacist explains they favour advice from their tutors over advice 
from the PCT. This pharmacist appears to associate advice from the PCT to be purely motivated by 
cost factors but advice from his tutor to be motivated by quality and efficacy issues. 
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“But 12 months ago they [PCT] were asking us to make sure we were using a drug called 
ipratropium first line before we used a more expensive one called tiotropium treating our COPD 
patients, I completely ignored that because the literature I had read and my tutors and the 
professor I learned with say that tiotropium is far better than ipratropium even though it costs 
more so I just ignored the PCT” (Practice Pharmacist 001, In-depth Interview, Study 1) 
 
From Study One it did not appear that pharmacist prescribers were any more influenced by cost 
issues than nurses. Some pharmacist prescribers did describe how they were aware of cost issues as 
a result of their advisory roles to GP surgeries. However, the impact of cost on prescribing 
decisions was mentioned equally by nurse prescribers. 
 
7.3 Patient Factors 
As is perhaps to be anticipated a number of patient factors influenced the prescribing decisions of 
NMPs. These factors included the anticipated adherence of the patient, the patient’s social 
responsibilities, the patient’s quality of life, the patient’s relatives or carers, the patient’s financial 
situation, patient satisfaction, patients’ requests and expectations and other patient issues such as 
patient re-attendance and wider community issues. 
 
7.3.1 Adherence and Patients’ Social Responsibilities 
The anticipated adherence of the patient to the treatment was a key consideration for NMPs when 
making decisions. NMPs attempted to select medicine they felt the patient would take. In the quote 
below the prescriber uses the word concordance but it is clear from her description she means 
adherence: 
 
“Another factor is going to be concordance, it’s basically are they going to comply with what you 
prescribe them or are they going to go away use it for a day and not bother because it’s not 
suitable, don’t like it” (WIC Nurse 009, In-depth Interview, Study 1) 
 
NMPs felt that one way of increasing adherence was to incorporate patients’ views and preferences 
into their prescribing decisions. NMPs felt that if patients’ views were ignored then adherence to 
the treatment would be lower. Addressing patients’ social responsibilities (e.g. job, daily routine) 
when prescribing was thought of by NMPs as another way of improving patient adherence. 
However, NMPs described how some patients used their social responsibilities to exert pressure on 
them to prescribe inappropriately. This is discussed further in Section 7.3.6. 
 
NMPs wanted to prescribe medicine that patients would take so the patient’s condition or 
symptoms would improve. However, NMPs also highlighted how patient adherence to treatment 
reduces wasted medicine. This suggests that cost issues, other than direct medicine cost to the 
NHS, are considered by NMPs. 
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“If they are not going to take something that you prescribe then there is very little point in doing it 
really because it’s a waste of money really and they probably wouldn’t cash it anyway”, (OOHs 
and WIC Nurse 002, In-depth Interview, Study 1) 
 
7.3.2 Patient’s Quality of Life (QoL) 
As much as possible NMPs made prescribing decisions with the aim to maximise the patient’s 
QoL. This aim influenced many aspects of prescribing including whether a prescription was given 
at all, the type of medicine, the formulation and the dosing schedule. The influence of patients’ 
QoL was cited more by NMPs managing patients with chronic or long-term conditions, such as 
community matrons, palliative care nurse specialists, practice pharmacists and advanced 
practitioners, than other NMPs. The quote below illustrates how important QoL was for one 
palliative care specialist nurse: 
 
“My number one influence for prescribing, my number absolute ultimate erm aim would be that 
quality of life issue, so if by writing that prescription there and then for that patient would improve 
the quality of their life” (Palliative Care Specialist Nurse 010, In-depth Interview, Study 1) 
 
7.3.3 Patients’ Relatives or Carers 
Some NMPs provided examples of how patients’ relatives or carers influenced their prescribing 
decisions. Patients’ relatives or carers were considered a good source of information about the 
patient in question. NMPs managing patients with long-term or chronic conditions, particularly 
those working in the community, described how relatives or carers would inform them of the 
patient’s condition where it was difficult for the patient to do this themselves. This information was 
used to help inform prescribing decisions. As this quote illustrates medicine was also prescribed 
with practical issues relating to the patient’s relatives and carers in mind: 
 
“Fentanyl patches which need to be replaced every seventy two hours, so she [patient’s daughter] 
was having to get two buses to her mums to replace the patch, her mum couldn’t do it herself so I 
had a bit of a chat and basically we’ve changed it to a patch that is slightly weaker but only needs 
to go on once a week” (Advanced Practitioner 004, In-depth Interview, Study 1) 
 
NMPs managing patients with acute illness and minor ailments, such as WIC nurses, nurse 
practitioners for GP surgeries and OOHs practitioners, felt patients’ relatives or carers had little 
impact on their decisions. The majority of the NMPs interviewed did not report any pressure from 
relatives or carers. 
 
7.3.4 Patients’ Financial Situation 
The financial situation of the patient was often considered by NMPs when making prescribing 
decisions. NMPs said they would prescribe for patients who were exempt from prescription charges 
if they thought they may otherwise struggle to buy the item over-the-counter. For example, in some 
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cases NMPs wrote prescriptions for products such as ibuprofen, paracetamol and Calpol if they felt 
the parent could not afford to buy it over-the-counter for their child. As this quote illustrates, nurses 
in WICs described giving prescriptions for OTC products to homeless people because they were 
exempt from prescription charges: 
 
“The odd time you get people in who are, live on the streets, you know, I’d prescribe for them, and 
you can get those things over-the-counter because they haven’t got the money and they get free 
prescriptions” (OOHs and WIC Nurse 002, In-depth Interview, Study 1) 
 
7.3.5 Patient Satisfaction 
NMPs wanted patients to be satisfied with the prescribing decisions they made. However, this did 
not necessarily mean that NMPs prescribed what the patient wanted regardless of the clinical 
appropriateness of the decision. It did mean that patients’ views on the medicine, dose, and method 
of administration and other issues were taken into consideration when forming the eventual 
decision. As this quote illustrates, NMPs’ motivation for satisfying patients was also linked to their 
desire to increase patient adherence: 
 
“I suppose if someone’s got some really strong views about, as an example an antibiotic, if they 
say I had that it doesn’t work for me then I honestly would probably think twice about prescribing 
it because, and again, not because I believe it doesn’t work but because I believe they believe it 
doesn’t work and they’re not going to take it” (Advanced Practitioner 001, In-depth Interview, 
Study 1) 
 
It was not possible for NMPs to satisfy the patient if they felt what the patient wanted was 
clinically inappropriate. This issue is discussed in the next section of this chapter. 
 
7.3.6 Patients’ Requests and Expectations (i.e. what patient wants and/or asks for in the 
consultation) 
All of the NMPs interviewed in Study One believed they had been pressurised by patients to 
prescribe medicine they believed was clinically inappropriate. This pressure originated both from 
patients’ direct requests (i.e. what the patient asks for) and perceptions of patients’ expectations for 
medicines (i.e. what they believe the patient wants). NMPs felt pressurised to prescribe antibiotics, 
pain relief (mainly paracetamol), food supplements and antidepressants. NMPs formed views about 
patients’ expectations from non-direct verbal clues (e.g.  “I can’t have time off work at the moment 
they are making people redundant”) and non-verbal body language.  
 
It is important to note the pressure NMPs faced from patients is different to that discussed in 
Section 6.5.1. Chapter Six stated that NMPs faced pressure to take responsibility for issuing repeat 
prescriptions when the medicine fell outside their competency. However, the pressure discussed in 
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this chapter relates to how, when making prescribing decisions for patients, some NMPs feel 
pressure to prescribe a medicine for the patient. In some cases, this medicine is against the 
recommendations of guidelines or formularies. 
 
Despite their experiences of patient pressure the majority of NMPs did not feel their prescribing 
decisions were in anyway influenced by patient pressure. Most stated that unless there was a 
medical reason for a prescription they would not issue one regardless of the pressure they 
experienced. In some cases this meant the patient left the consultation dissatisfied with the 
outcome. It is noteworthy that although NMPs were keen to ensure the patient was satisfied with 
the outcome of the consultation in some circumstances (as described in Section 7.3.5) the desire for 
patient satisfaction did not extend to situations where the prescribing decision was considered 
clinically inappropriate. This quote below from one nurse illustrates NMPs’ attitude towards 
patient pressure: 
 
“A number of people want antibiotics for a chest infection that they’ve not got but they have a sats 
monitor, I examine the chest, if I don’t hear anything and the sats monitor says there’s no 
obstruction with the lungs and the pulse is fine and they are not  pyrexial I am not going to give it” 
(Night Nurse Lead/WIC Nurse 003, In-depth Interview, Study 1) 
 
NMPs placed negotiation and discussion at the core of managing patient pressure. Some NMPs felt 
this discussion was made possible by the longer time they had available for consultations 
(discussed further in Section 7.7.1). In some cases NMPs provided written information to patients 
(e.g. patient information leaflets) to help rationalise their decision not to prescribe. Part of NMPs’ 
negotiation process was also reminding patients they should return for further assessment if their 
condition worsened. 
 
“We always give them worsening advice so say well look now you’re not happy, but try this, and in 
72 hours or 24 hours depends what it is, if it’s not better or it’s worse then come back” (WIC 
Nurse 009, In-depth Interview, Study 1) 
 
Where negotiation was unsuccessful some NMPs enlisted the advice of their colleagues to help 
‘convince’ the patient that a prescription was not required. If this strategy failed patients would 
often leave the consultation dissatisfied. However, NMPs felt this only happened in a minority of 
cases. NMPs felt that dissatisfied patients leaving a consultation would simply go to their GP the 
next day. 
 
NMPs were quite stringent in their policy not to prescribe solely because the patient wanted a 
prescription. However, there were certain situations where they admitted that refusing a patient’s 
request was made more difficult. These situations included when the patient was elderly, when the 
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patient had experienced repeated exacerbations of the same condition in the past and when the 
consultation occurred before a bank holiday weekend. 
 
One reason why NMPs did not want to prescribe in reaction to patient pressure was because they 
did not want to encourage patients to re-attend with the same complaint and expectations in the 
future. Many NMPs felt that it was their role to educate patients about their condition and 
appropriate use of medicine. Additionally, some NMPs felt they had a responsibility to limit use of 
antibiotics to only clinically appropriate cases because of wider community issues such as 
antibiotic resistance. 
 
A minority of NMPs did feel their prescribing decisions could be influenced by patient pressure but 
only where the patient was very insistent they needed the requested medication. These NMPs 
described how they would issue medicine, even if they regarded it as inappropriate, but explain to 
the patient they were not happy with their decision. One nurse practitioner for a GP surgery (Nurse 
013, Study One) who said she succumbed to pressure said she felt “she had not done her job 
properly” and “deflated”. It is noteworthy that NMPs react very negatively to situations where 
they feel they have to prescribe inappropriately. Others used words such as “weak” (Nurse 009, 
Study One) to describe succumbing to patient pressure. It might be that NMPs generally do not 
give in to patient pressure to avoid negative feelings. NMPs in this research rarely discussed 
relations with patients. It might be that NMPs are less worried about upsetting patients than 
doctors, perhaps as a result of their more transient role, but are influenced by how prescribing 
inappropriately leaves them feeling on a personal level. This is discussed more in Section 7.9 of 
this chapter. 
 
Perceptions of GPs’ Behaviour 
NMPs spontaneously offered comparisons between their own and GPs’ behaviour in relation to 
patient pressure. Many NMPs felt that in comparison to themselves GPs rarely negotiate with 
patients and simply end up prescribing “what the patient wants”. When NMPs suggested patients 
would simply return to their GP, if unable to get what they wanted from them, they believed the GP 
would end up prescribing something for the patient even if inappropriate. Some NMPs felt that 
GPs’ behaviour in relation to patient pressure was as a result of time constraints on GPs because 
they did not have the time to explain to patients why the medicine requested was not appropriate. 
However, others felt that GPs prescribed simply to make life easier for themselves. Some NMPs 
also felt that GPs past behaviour in relation to patients has led to patients’ requests and expectations 
for medicines: 
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‘But antibiotics now are seen as the panacea, I’ve got a sore throat I need antibiotics. And that’s 
only really because it’s been GP led, you can go to a GP and get antibiotics it’s that simple’ 
(OOHs and WIC Nurse 002, In-depth Interview, Study 1) 
 
7.4 Colleague Factors 
The colleague factors discussed by NMPs included GPs, community pharmacists, hospital and 
secondary care practitioners, other NMPs, non-prescribing HCPs and prescribing course mentor or 
DMP. 
 
7.4.1 GPs 
GPs involvement in NMPs’ prescribing decisions varied widely. As discussed, when uncertain 
about an aspect of prescribing, NMPs actively sought input from GPs. In other cases, NMPs felt 
that GPs put unwelcome pressure on them to prescribe in a certain manner because of cost issues. 
Pressure in relation to cost arose because NMPs were managing GPs’ patients and GPs’ prescribing 
budget met the cost of any prescribing by the NMP. Some NMPs described how some GPs had 
asked them not to prescribe certain medicine because of cost. However, the palliative care 
specialist nurse in this quote below maintained, as others did, that they would still make an 
independent decision: 
 
“Some GPs who are really really budget conscious will, because obviously we use their practice 
codes so it’s going to affect budgets, will say don’t use that but I just ignore them” (Palliative Care 
Specialist Nurse 008, In-depth Interview, Study 1) 
 
None of the WIC nurse prescribers who were interviewed reported any pressure from GPs despite 
the fact their costs were also met by patients’ GPs’ budgets. This might be because they do not 
work within a close distance to GPs and have very little contact with them. However, other nurse 
prescribers and all pharmacist prescribers did not feel that GPs exerted any pressure on them to 
prescribe in a certain way. 
 
NMPs sought input from GPs in situations where they had insufficient competency or in situations 
they considered high risk. Input from GPs would take the form of informal advice. In some cases 
the patient was formally referred. Sometimes NMPs asked the GP to issue the prescription for the 
patient on their behalf. Chapter Six concentrated on GPs involvement in whether NMPs took 
responsibility for prescribing. However, this chapter focuses on how GPs actively influence NMPs’ 
prescribing decisions. The findings of Study One indicated that the nature and extent to which GPs 
were considered to influence NMPs’ eventual prescribing decision varied widely. In some cases, 
the GP’s role was simply to reassure the NMP that their decision was appropriate. In other cases, 
NMPs described how GPs advice and recommendations influenced their choice of medicine, as the 
below quote illustrates: 
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“He’d [GP] say well what would you prescribe first of all and tell me why and then we’d have that 
conversation about well no perhaps this is a better drug to use and this is the reason why” (WIC 
Nurse 007, In-depth Interview, Study 1) 
 
GPs were NMPs main source of support when faced with a difficult prescribing decision, However, 
for patient cases NMPs felt comfortable managing, GPs seemed to have little influence. This point 
is discussed further in Chapter Eight. 
 
7.4.2 Community Pharmacists 
Community pharmacists were considered a useful resource by both nurse and pharmacist 
prescribers. However, community pharmacists were mainly contacted for help with practical 
aspects of prescribing and medicine supply. Both nurses and pharmacists gave examples of where 
they contacted community pharmacists for information about medicine stocks of unusual medicine. 
Palliative care specialist nurses often built relationships with particular pharmacies on the 
understanding that certain, harder to get, medicine would be available for their patients. Some 
nurses said they contacted community pharmacists for information about OTC products their 
patients were taking. The influence this might have on NMPs eventual prescribing decision was 
uncertain. A small number of NMPs provided examples where they had contacted community 
pharmacists for help with medicine selection. However, examples such as these were few and far 
between. 
 
“I had a patient that had erm a mouth infection but she didn’t want liquid she wanted lozenges, 
and the lozenges that I knew that we used to use they don’t exist anymore so I was stuck then as 
what to prescribe and I just rang the pharmacy” (Advanced Practitioner 001 ,In-depth Interview, 
Study 1) 
 
There was some interaction between NMPs and community pharmacists. However, interaction on 
the whole was minimal with most NMPs saying they only contacted community pharmacists a few 
times at the most. 
 
“The pharmacists are a mine of information so we’d probably ring one of them you know, it’s not 
often we would do that, I have done that on one or two occasions but not a lot” (WIC Nurse 007, 
In-depth Interview, Study 1) 
 
7.4.3 Hospital and Secondary Care Practitioners 
Hospital and secondary care practitioners, normally doctors, were respected for their expert 
knowledge and experience. However, contact between these practitioners and NMPs was minimal. 
The majority of interaction took the form of formal referral letters detailing the prescriptions the 
patient should be given following discharge from hospital or secondary care. This was more 
frequently mentioned by specialist nurses and those managing long-term or chronic conditions. 
 146
“There is not a great deal of direct contact a lot of it’s through letters” (Practice Nurse and 
Specialist Nurse 012, In-depth Interview, Study 1) 
 
NMPs, normally specialists nurses and those managing long-term or chronic conditions, did 
sometimes seek guidance from hospital and secondary care doctors on specific prescribing issues. 
Usually contact occurred when the NMP was managing an unusual or complex patient who 
required specialist input. For example, as this quote illustrates, one advanced practitioner described 
how she would seek a respiratory consultant’s advice, over other colleagues, for a patient with a 
rare lung disease: 
 
“[I had] a patient with a very rare lung disease and I was wondering whether to manage her 
symptoms, to start her on a small dose of morphine, but I wouldn’t come back and discuss that 
here, I’d discuss that with her respiratory consultant” (Advanced Practitioner 005, In-depth 
Interview, Study 1)  
 
The majority of NMPs working in GP surgeries and community roles, including pharmacist 
prescribers, stated that they asked GPs to refer patients on their behalf.  
 
7.4.4 Other NMPs 
The main interaction between participants and other NMPs occurred within their working 
environment in an informal capacity. Exchanges between NMPs seemed to be informal, relaxed 
and comfortable. Some NMPs shared an office with other NMPs whilst others worked in the same 
clinic or practice. A small number of NMPs said they felt isolated from other prescribers. One WIC 
nurse described how the work rota was planned so there was only one nurse prescriber working 
with other non-prescribing nurses. As a result she had limited opportunity to interact with other 
NMPs. Other NMPs mentioned they felt isolated from others to begin with, but in recent years, 
because of the increase in the number of NMPs, the situation had improved. 
 
Other NMPs were a convenient source of advice and information when a NMP was uncertain about 
a prescribing decision. Pharmacist prescribers and nurse prescribers both said that they sought 
advice of other NMPs. However, no pharmacist prescriber mentioned that they had regular contact 
with another pharmacist prescriber. Given the relatively low number of pharmacist prescribers 
compared with nurses (see Section 2.3.3.1) it is unsurprising there are few pharmacist prescribers 
working together. The nature of the information exchanged between NMPs depended on the 
prescribers’ expertise. For example, one advanced practitioner (Nurse 001, Study One) described 
how she would seek the advice of another advanced practitioner, who was previously employed as 
a palliative care specialist nurse, on issues relating to palliative care and symptom control. 
Similarly, as the quote below illustrates, a practice pharmacist, mainly prescribing for 
cardiovascular disease, described how he would seek the advice of a nurse practitioner if the issue 
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related to respiratory conditions. He also described how the nurse practitioner would seek his 
advice on cardiovascular issues. 
 
“You know I take cues on respiratory problems from our nurse practitioners who’s, you know her 
former role as a respiratory nurse specialist, she knows more about breathing problems than I do, 
lots more, and I’m, and I will often ask her advice, what’s going on with this patient I don’t know, 
what would you recommend? Equally she’ll come to get my advice on cardiovascular issues, so 
yeah we influence each other” (Practice Pharmacist 003, In-depth Interview, Study 1) 
 
Nurses working in the community setting mentioned they sometimes contacted nurse practitioners 
working in GP surgeries, rather than seek advice from their immediate colleagues, about 
prescribing issues they regarded these nurses as having more experience of. A small number of 
NMPs mentioned that they attended non-medical prescribing group meetings offered by their PCT 
or professional body. However, they said the meetings generally offered only general support on 
issues relating to non-medical prescribing. It is clear though that other NMPs can have a role in 
prescribing decisions made by NMPs. 
 
7.4.5 Other Non-Prescribing HCPs (Except Community Pharmacists) 
WIC nurses described situations where non-prescribing HCPs exerted pressure on them to take 
responsibility for prescribing (see Section 6.4.1). In some cases non-prescribing HCPs requested 
prescriptions for medicine outside the prescribers’ competency. In these cases nurse prescribers 
were not prepared to issue the prescription at all. In some cases non-prescribing HCPs requested 
prescriptions for medicine within the prescribers’ competency. In these instances the NMP said 
they would examine the patient themselves before issuing any prescription. Chapter Six did not 
address the extent to which non-prescribing nurses’ requests for prescriptions influenced the actual 
prescribing decisions nurse prescribers made. On the one hand nurse prescribers said they would 
examine the patient and make their own independent decision. In light of these claims it might be 
assumed that non-prescribing nurses have little influence on NMPs’ prescribing decisions. 
However, the influence that a non-prescribing colleague might have, if they request a specific 
medicine, remains unclear from the discussion in Study One. Non-prescribing HCPs could 
potentially have more of an influence on NMPs than they are aware of themselves or are prepared 
to admit to. Other NMPs rarely mentioned non-prescribing HCPs, which suggests that the influence 
of other non-prescribing HCPs on NMPs’ prescribing decisions is limited. This issue is followed up 
in Chapter Eight. 
 
7.4.6 Prescribing Course Mentor or Designated Medical Practitioner 
As part of the non-medical prescribing course NMPs are required to have support from a DMP who 
provides 12 days of a PLP. Half of the NMPs interviewed in Study One still maintained contact 
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with their DMP following completion of the prescribing course. The other half of the prescribers 
did not have any contact at all. This lack of contact was mainly because either the NMP or DMP 
had moved location or because their working hours did not coincide. 
 
“I don’t have any contact now because I’ve changed jobs, so unfortunately, I did up until I 
changed my job even though I’d finished the course” (Advanced Practitioner 006, In-depth 
Interview, Study 1) 
 
NMPs with a relationship with their DMP actively sought advice and recommendations about 
prescribing issues. There was no evidence of a relationship between the length of time since 
qualifying and contact with a DMP. 
 
7.5 Prescribing Culture and Professional Experience 
The influence of prescribing culture and professional experience is discussed under the following 
headings: colleagues’ prescribing behaviour, accepted and established prescribing practice amongst 
others and prescribing experience.   
 
7.5.1 Colleagues’ Prescribing Behaviour 
There was some evidence that NMPs’ prescribing decisions were influenced by the prescribing 
practice of GPs and hospital and secondary care doctors. 
 
Some NMPs were able to observe what hospital and secondary care doctors were prescribing 
through patient discharge letters. In Study One, the influence these HCPs’ behaviour was 
mentioned more by NMPs managing chronic or long-term conditions than other NMPs. This is 
presumably because hospital practitioners have more involvement in these areas. In a direct way 
NMPs’ prescribing was influenced by hospital and secondary care doctors’ prescribing because 
they were reluctant, although not completely averse, to change the medicine started by consultants. 
This quote from one nurse prescriber illustrates how she felt about changing medicine initiated by 
hospital consultants: 
 
“Sometimes, don’t like doing it much, because it’s kind of like you, you know, you think if the 
consultant’s started it you can’t stop it” (Practice Nurse and Specialist Nurse 012, In-depth 
Interview, Study 1) 
 
There was also evidence that NMPs generally were keen to follow consultants’ prescribing 
behaviour. This quote from a nurse practitioner talking about her choice of medicine for a range of 
long-term and chronic conditions illustrates this: 
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“It also depends what’s in vogue and what’s the consultants are doing” (Nurse Practitioner for GP 
Surgery, In-depth Interview, Study 1) 
 
There was evidence that NMPs looked to GPs’ behaviour to guide their own. However, they only 
did this where they needed guidance about patient management. 
 
“What I tend to do is if I’ve had, if I’ve not been able to deal with a particular erm problem, or I’ve 
had to refer on to a GP, what I then do on the next day err or whenever that patient’s seen the GP, 
I go into the notes and see how they resolved it” (Practice Pharmacist 004, In-depth Interview, 
Study 1) 
 
There was little evidence from Study One that NMPs replicate GPs’ prescribing behaviour in all 
prescribing situations. In fact, many NMPs were critical of GPs’ own prescribing behaviour. For 
instance, some NMPs were keen to differentiate their prescribing behaviour from GPs in relation to 
patient pressure (see Section 7.3.6). Furthermore, NMPs felt GPs prescribed contrary to guidelines. 
It was evident that there was no desire to emulate GPs behaviour in this regard. 
 
“I’m possibly more aware of guidelines than they are because I review notes that often and see 
how the GPs prescribe” (Practice Pharmacist 004, In-depth Interview, Study 1) 
 
“I remember a GP (laughing), I remember a GP telling me when I was on this prescribing course 
that guidelines were for fools (laughing) and it has never really left me that  you know” (Advanced 
Practitioner 006, In-depth Interview, Study 1) 
 
Whilst NMPs were also a good source of support there was less evidence that other NMPs’ 
behaviour influenced participants’ prescribing behaviour.  
 
7.5.2 Accepted and Established Prescribing Practice amongst Others 
There was evidence in Study One that at least some NMPs’ prescribing decisions were influenced 
by whether the prescribing behaviour was ‘established’ practice and ‘accepted’ amongst others. 
NMPs judged whether the prescribing practice was ‘established’ by the length and extent of its use 
amongst other prescribers and by the extent of available research evidence. Whether the practice 
was ‘accepted’ was based on NMPs’ perception of others’ behaviour and opinions towards the 
prescribing practice. NMPs most commonly looked to the practice of GPs to inform their practice 
but hospital and secondary care doctors’ practice was also considered. This adds to the evidence 
from this research that the relationship between NMPs and GPs is complex. This quote illustrates 
the influence of GPs behaviour on NMPs: 
 
“I think it would have to be approved by GPs first and then I think that does come, it doesn’t take 
very long, because if they are dynamic enough and enthusiastic enough they make sure that they 
get their information over”(Night Nurse Lead and WIC Nurse 003, In-depth Interview, Study 1) 
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The influence of these factors was particularly apparent when NMPs discussed relatively new 
medicine. This quote from one advanced practitioner, when asked how she would feel prescribing a 
medicine new to the market, illustrates the importance of both of these issues for some NMPs: 
 
“I think I’d probably wait ‘til it was established and people were using it and see you know what 
people thought to be honest” (Advanced Practitioner 001, In-depth Interview, Study 1) 
 
This NMP, as well as other NMPs, gave the impression that the vast majority of the medicine they 
prescribe is well ‘established’ and ‘accepted’. NMPs seemed to feel uncomfortable prescribing new 
medicine because it is less well ‘established’ and ‘accepted’. 
 
“The drugs that we prescribe have been around for donkey’s years but you do get the odd new, I 
mean we’ve got some heart failure drugs that are very very new on the market, erm but I would be 
out of my comfort zone really to prescribe those” (Advanced Practitioner 004, In-depth Interview, 
Study 1) 
 
Further evidence that NMPs are reluctant to prescribe medicine that is not ‘established’ comes from 
this quote from an OOHs and WIC nurse. It is noteworthy that whilst, as will be discussed in 
Section 7.6.2, NMPs do not regularly use literature from academic and professional journals to 
inform their prescribing decisions they still place great importance on the research behind practice. 
 
“So I would not be part of that new prescribing thing unless it was sort of tried and tested and part 
of the whole package really. But it would have to be supported by robust evidence for me to sleep 
at night” (WIC and OOHs Nurse 002, In-depth Interview, Study 1) 
 
7.5.3 Prescribing Experience 
A small number of nurse and pharmacist prescribers described how the outcome of past prescribing 
decisions influenced future prescribing decisions they made. This was not, however, something 
spontaneously cited by NMPs as an influence on their prescribing decisions. In this quote the 
advanced practitioner described, in general terms, the influence of past experiences on prescribing: 
 
“Like I say lots of things that, my past experience, yeah past experiences have yeah, particularly 
around palliative care and managing symptoms, I think certainly influences my prescribing” 
(Advanced Practitioner 005, In-depth Interview, Study 1) 
 
7.6 Training and Information Sources 
7.6.1 Training 
On the whole, knowledge gained through the prescribing training course was not mentioned by 
NMPs as an on-going source of influence on individual prescribing decisions. However, some 
NMPs did recall general advice they received. For example, one NMP described how the 
 151
prescribing course emphasised the importance of medicine cost when prescribing. Other NMPs felt 
the course emphasised the importance of patient adherence when forming prescribing decisions. 
 
“The prescribing kicked off with one of the GPs there saying the best medicines are the ones that 
patients take, and I thought, I’ve not really thought about that really you know”(Advanced 
Practitioner 004, In-depth Interview, Study 1) 
 
Other training courses, such as those organised by GP surgeries, the PCT, or by pharmaceutical 
companies were also mentioned by a small number of NMPs as potential influences. Conferences 
were also mentioned by a small number of NMPs. However, the influence of these sources had a 
sporadic rather than consistent influence on their prescribing decisions. 
 
7.6.2 Information Sources 
Some NMPs mentioned that relevant information from NHS Clinical Knowledge Summaries 
(CKS) (formerly known as PRODIGY) (Clinical Knowledge Summaries NHS Evidence 2011), the 
NPC and the Medicines and Health Products Regulatory Agency (MHRA) were potential sources 
of influence on their prescribing decisions. This information was accessed through relevant 
websites or through email updates which were set-up by prescribers. NMPs felt these sources were 
evidence-based and up-to-date. These information sources were not however mentioned by all 
NMPs interviewed in the Study One. 
 
“We follow evidence-based guidelines and we usually use CKS on the computer erm that’s our err 
bible really” (WIC Nurse 007, In-depth Interview, Study 1) 
 
NMPs felt these sources assisted in keeping their prescribing practice up-to-date and evidence-
based. Information sources such as these were also used when NMPs were uncertain about how to 
prescribe medicine appropriately or how to manage particular conditions. This quote below 
illustrates this point: 
 
“I will find out about stuff that I need to know if I’m faced with it, like how to taper steroids in 
polyrheumatica, who to give antivirals to for shingles, using those kind of sources the NPC 
materials, NICE and CKS” (Practice Pharmacist 003, In-depth Interview, Study 1) 
 
 
A small number of NMPs, particularly specialist nurses and those managing long-term chronic 
conditions, stated that literature from academic and professional journals was a potential source of 
influence on their prescribing decisions. However, on the whole NMPs favoured summarised 
prescribing information (e.g. NHS CKS, NICE, PCT guidance). Two advanced practitioners and 
one specialist nurse mentioned that they refer to literature in unusual clinical cases or when they 
want to explore claims made by pharmaceutical representatives. A small number of NMPs also said 
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that they referred to literature when they were working in a new field and when training to become 
a prescriber. Some pharmacist prescribers said they refer to literature as a consequence of other 
roles beyond prescribing. However, there was no specific indication that this influenced their 
prescribing and some said they would still favour summarised information sources. Time 
constraints were cited by a small number of NMPs as a reason for not using literature to inform 
their prescribing. Furthermore, one nurse said that she likes to “keep things simple” (Nurse 007, 
Study One) another said she “is not at the cutting edge of research” (Nurse 001, Study One). These 
quotes suggest NMPs actively select not to use research findings for reasons beyond simply not 
having enough time. A number of points raised in this section are expressed in this quote below: 
 
“It can be a bit difficult keeping on the ball with all of them, this job, the heart failure job is the 
newest job to me, I’ve only been doing this since August so for my learning I’ve gone out and found 
more of the articles about the trials and erm that kind of thing because you know I want to learn, 
whereas the practice nursing and the out-of-hours I’ve done for longer so I suppose you do it while 
you do the minor illness course, while you do the prescribing course, but then you kind of, you just 
get on with it” (Practice Nurse, Specialist Nurse, WIC Nurse 013, In-depth Interview, Study 1) 
 
7.7 Logistical Factors 
7.7.1 Time 
The influence of time in Chapter Six was discussed in terms of the impact it had on whether NMPs 
take responsibility for prescribing in any given scenario. Time pressures were found, in some cases, 
to increase the likelihood that NMPs took responsibility even when they would prefer not to (e.g. 
because of insufficient competency). In this chapter, the influence of time is discussed in terms of 
how it impacts the prescribing decisions that NMPs make.  
 
The length of NMPs’ consultation time depended on the type of role they were employed in. For 
example, some NMPs, treating patients with acute or minor ailments in GP surgeries, had 10-
minute appointment slots. A 10-minute time slot is generally comparable to GPs typical practice. 
Other NMPs working in GP surgeries had 15 minute appointment slots for similar types of patients. 
Specialist nurses and those in GP surgeries managing patients with long-term or chronic diseases 
typically had 20 to 40 minute time slots for their appointments. This was so they had time to 
conduct a medicine review, conduct and/or review other tests and talk to the patient about other 
issues (e.g. lifestyle). Those working in WICs and OOHs centres had no predetermined 
appointment time slots and typically spent as much time as needed with patients. NMPs working in 
community roles, such as the advanced practitioners and community matrons, also spent as much 
time with patients as required. One advanced practitioner said her appointment times could range 
from five minutes to one-hour depending on the patient’s circumstances. Further information about 
the nature of participants’ role is presented in Appendix 10.0.  
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The majority of NMPs felt they had more time to spend with patients compared with GPs. NMPs 
considered the benefits of longer consultations to be the ability to spend more time acquiring 
necessary information from the patient, explaining their decision to the patient, answering patients’ 
questions, explaining the use of devices (e.g. inhalers) and documenting the patient’s symptoms 
and any prescribing decision. Some NMPs said they used the time to double check the accuracy of 
their prescription. This benefit was particularly important for those working in community settings 
who were handwriting their prescriptions for patients. Some NMPs felt that additional consultation 
time helped with patient adherence and satisfaction. Interestingly, even NMPs with similar 
consultation times to GPs felt they spent more time than GPs listening and explaining medicine and 
other issues to the patient. As discussed in Section 7.3.6, NMPs felt that additional time in 
consultations helped manage patient pressure as they had more time to explain to the patient why a 
prescription was not needed. NMPs compared this with GPs who they felt did not have time, but 
more importantly, did not utilise the time, to explain to the patient why a prescription was not 
needed. 
 
NMPs described workload pressure despite also saying they have additional time to spend with 
patients in consultations. This time pressure arose because of insufficient consultation time and 
general workload pressure (e.g. having too many patients to manage). 
 
“We’re very short staffed to start off with, we’re a busy walk-in centre, erm and, you know, there’s 
always a queue, it’s very rare that we’re, we’ve got a waiting room that is empty, erm  so yeah, you 
are under pressure” (WIC 007, In-depth Interview, Study 1) 
 
NMPs admitted, that in response to patient pressure, it would be sometimes easier to prescribe for a 
patient than to explain why the prescription was not needed. Despite this all NMPs were clear that 
time factors did not influence their prescribing in a negative way (e.g. by prescribing a medicine for 
a patient to speed up the consultation and “to get rid” of the patient). This quote below illustrates 
this attitude: 
 
“As far as prescribing goes it is, it is easier, it’s much much easier to write a prescription and they 
go, it takes much much longer to actually explain why they don’t need something, especially if it’s 
somebody that feels, that they need to walk out with a prescription, err it does take longer, but we 
really try not to sort of issue things when we don’t need to” (Palliative Care Specialist Nurse 008, 
In-depth Interview, Study 1) 
 
NMPs sometimes linked being a “bad” or “irresponsible” prescriber with succumbing to time 
pressure. Some NMPs emphasised how important it was for them to take their role seriously. The 
implication of this was that if they do not succumb to time pressure they are not taking their role 
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seriously. In this quote below a WIC nurse expresses similar sentiments to this and says she should 
not be a prescriber if she prescribes just to get rid of a patient: 
 
“I’ll just give them a prescription to get rid of them, I don’t think any of us would think that really, 
you know we’re all too, I think we all feel too responsible for that you know, at the end of the day 
this is my, my career on the line, this is my role on the line and you know if I’m prescribing willy 
nilly just to get rid of a patient then I shouldn’t be doing it you know, we do take it quite seriously 
really” (WIC Nurse 007, In-depth Interview, Study 1) 
 
7.7.2 Impact on Others Within and Outside own Service 
The impact of the decision on others, within and outside their own service, was rarely mentioned 
by NMPs as a source of influence on their prescribing. However, as this quote illustrates, it is 
clearly something that some NMPs reflect on when making prescribing decisions. In this case 
below the practice pharmacist mentioned he considered the impact of the prescribing decision on 
DNs’ workload: 
 
“Yes some of it’s also cost to society, you know, if we erm have someone with diabetes and they 
can manage taking tablets but they can’t self-inject because their visions poor, too poor now and 
they can’t see and you know manipulate the pen device for example, if we, if we move them off 
tablets onto insulin then there is a cost to society of having to have districting nursing visits twice a 
day to administer it” (Practice Pharmacist 003, In-depth Interview, Study 1) 
 
7.8 Pharmaceutical Industry 
NMPs main contact with the pharmaceutical industry was through pharmaceutical representatives. 
All of the NMPs interviewed had some contact with pharmaceutical representatives at some point. 
There were however three NMPs who did not have any contact in their current role. Pharmaceutical 
representatives were viewed as a valuable and an up-to-date education source. Typically, NMPs did 
not meet representatives one-on-one. However, if the representative was promoting a product that 
was relevant to the NMPs’ practice they were invited to give a presentation at team meetings, study 
and training days. In some cases the pharmaceutical company provided sponsorship for education 
and training days. 
 
“We have some interaction with [pharmaceutical] reps, it’s generally associated with sort of team 
meetings, some reps come in and see us at team meetings about various things, so we do have 
interaction with reps, we usually ask for an educational kind of approach to telling us about new 
drugs” (Advanced Practitioner 006, In-depth Interview, Study 1) 
 
Although NMPs considered pharmaceutical representatives as a useful information source they 
were still viewed as sales people. NMPs believed that pharmaceutical representatives overriding 
aim would be to promote their company’s products. In order to try and influence their decisions 
NMPs believed pharmaceutical representatives sometimes presented ‘biased’ and ‘selective’ 
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information. Free gifts, such as pens, diaries, notepads, free lunches and badge holders were 
considered as attempts to influence their prescribing decisions. However, NMPs were confident 
they were not influenced by pharmaceutical representatives at all when making prescribing 
decisions. 
 
“I’ve always found it fairly straight forward, if it’s not something I’m used to prescribing, or it’s 
not familiar to me, I won’t start using it just because somebody gave me some leaflets on it. You 
know so, and it’s like heart failure there’s a new drug on the market but it’s not really something 
we would use and yeah we’ve seen the rep but I’m not going to start prescribing it tomorrow” 
(Practice Nurse and Specialist Nurse 012, In-depth Interview, Study 1) 
 
NMPs felt confident that they were able to identify biased information. In many cases NMPs 
described how they cross referenced information provided by representatives with independent 
sources. This was particularly the case when information provided by the representative seemed 
“too good to be true”.   
 
“We had a [pharmaceutical] rep last week we did actually seek out a paper afterwards, because he 
didn’t have it with him and it just seemed a little bit too good to be true, so we did actually seek out 
that particular paper, and sure enough it was a little bit too good to be true” (Advanced 
Practitioner 004, In-depth Interview, Study 1) 
 
7.9 Discussion   
Many of the influences on NMPs’ prescribing decisions identified in Study One have been 
previously discussed in the literature in relation to doctors’ and CNPs’ prescribing. However, this 
research has provided insight into the breadth and nature of these influences on the prescribing 
decisions of nurse and pharmacist independent and supplementary prescribers which has not, as 
yet, been presented in the literature.  
 
All NMPs said the recommendations of national, local and PCT guidelines and formularies 
influenced their prescribing decisions. The recommendations of PGDs were also mentioned by a 
small number of nurse prescribers. The influence of these sources on NMPs reflects guidance for 
NMPs which states that they should consider the recommendations of relevant guidelines and 
formularies when prescribing (Manchester PCT 2009; Nursing and Midwifery Council 2006). 
NMPs in this research said they would deviate from the recommendations of these sources if 
required. This is consistent with doctors (Buusman et al. 2007; Denig et al. 2002; Higgins and 
Tully 2005; Jacoby et al. 2003; Ljungberg et al. 2007; Schumock et al. 2004; Wathen and Dean 
2004; Wood et al. 2007) and CNPs (Hall et al. 2004). Moreover, doctors appear to have a more 
liberal attitude in regards to adhering to guidelines and formularies. Doctors are sometimes not 
aware of guidelines for some conditions they prescribe for (Cavazos et al. 2008) and others feel 
guidelines are too restrictive and limit their clinical freedom (Armstrong and Ogden 2006). Some 
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doctors feel cynical about the cost saving rationale behind guidelines (Wood et al. 2007). Doctors 
recognise the benefit of formularies but show less commitment to following their recommendations 
in practice (Armstrong and Ogden 2006). In contrast, the NMPs in this research were positive 
about the role of guidelines and formularies in their prescribing practice and did not generally cite 
cost as a concern. Some NMPs in Study One said they were content deviating from guidelines and 
formularies. However, examples of them doing so were rare. This finding is consistent with Hall et 
al.’s study that indicated it was only a small minority of mainly experienced CNPs that were 
prepared to deviate from guidelines (Hall et al. 2003). It is also consistent with the findings of 
Study Two that found NMPs were uncomfortable taking prescribing responsibility when deviation 
from guidelines and formularies was required. In the US context Undeland et al. found that, when 
prescribing for a first presentation of a single pharyngitis illness, nurse prescribers adhered to 
guidelines more than doctors (Undeland et al. 2010). Undeland et al.’s study and the research 
presented in this thesis provide foundations for further research, in the UK context, which 
compares the adherence of doctors and NMPs to guidelines and formularies (see Section 9.4.1 for 
further discussion). 
 
The cost of the prescribing decision to the NHS when making decisions was cited as a source of 
influence on NMPs’ decisions. NMPs prescribed the cheaper of more than two products when they 
were equivalent on other factors (e.g. efficacy) and also prescribed generically where possible. 
Doctors as well as CNPs also consider cost when prescribing and, like the prescribers in this 
research, prescribe generically where appropriate (Greenfield et al. 2005; Hall et al. 2003; Jacoby 
et al. 2003). It is interesting that patients believe cost is a major influence on doctors’ prescribing 
decisions (Schafheutle et al. 2002). This research demonstrated, along with available literature for 
doctors (Ljungberg et al. 2007; Prosser and Walley 2006), that whilst cost is considered, 
prescribers reject the notion they would make prescribing decisions based purely on cost.   
 
It was not previously known the extent to which nurse and pharmacist prescribers experience cost 
related pressure. Previously, CNPs had not come under a lot of pressure in regards to cost issues 
because of the limited amount of prescribing they did (Hall et al. 2004). However, it would appear 
that in contrast to a decade ago, there is more pressure on NMPs to consider cost when prescribing. 
This is perhaps understandable given the increase in non-medical prescribing over recent years and 
the expansion in the range of products NMPs can prescribe. In a small number of cases NMPs 
overlooked some of the prescribing advice their PCT because they believed it to be purely driven 
by cost factors. This behaviour coincides with GPs’ attitudes that PCT managers are ‘cost cutters’ 
(Carthy et al. 2000; Prosser and Walley 2007). However, rejection of PCTs’ authority was not 
prevalent amongst NMPs. 
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The patient related factors cited by NMPs in this research (e.g. patient’s social responsibility, 
anticipated adherence) have also been found to influence the prescribing decisions of doctors and 
CNPs (Buusman et al. 2007; Carthy et al. 2000; Hajjaj et al. 2010; Hall et al. 2003; Ljungberg et al. 
2007; Luker et al. 1998). NMPs in this research wished patients to be satisfied with the prescribing 
decision they made. However, they said that this did not extend to prescribing in clinically 
inappropriate ways. NMPs felt pressure for clinically inappropriate medicine but this is not unique 
to NMPs as similar pressures have been reported by GPs, hospital doctors and CNPs (Lewis and 
Tully 2011; Luker et al. 1998; Petursson 2005; Stevenson et al. 1999). The majority of NMPs in 
this research reported that in most situations they would not prescribe just because of pressure. In 
contrast, doctors admit that they ‘give in’ to patient pressure and prescribe even when they know 
the prescription is not clinically required or evidence-based (Butler et al. 1998; Lewis and Tully 
2011; Petursson 2005; Stevenson et al. 1999). Furthermore, when doctors perceive that the patient 
expects or a prescription, or when the patient reports they expect a prescription, the patient is more 
likely to be given one (Cockburn and Pit 1997; Macfarlane et al. 1997; Webb and Lloyd 1994). 
This research suggests NMPs are able to overcome patient pressure. This could represent a 
deviation between doctors’ and NMPs’ behaviour in regards to patient pressure. 
 
What are the potential reasons behind any differences between doctors and NMPs in regards to 
managing patient pressure? Doctors give in to patient pressure because they are concerned about 
maintaining good patient relationships, wish to avoid conflict with patients, want to respond to 
patients’ suffering, have a desire to give in to patients and want to be compassionate (Butler et al. 
1998; Coenen et al. 2006; Dybwad et al. 1997). Interestingly, when a small number of NMPs 
described situations when they did issue a prescription in the face of patient pressure, they reported 
feelings of guilt. This is not unique as doctors too report feelings of guilt when issuing 
prescriptions for purely non-pharmacological reasons (Lewis and Tully 2011; Petursson 2005). 
However, perhaps for doctors, particularly GPs, negative feelings resulting from the breakdown of 
the patient-practitioner relationship or an inability to respond to the patient’s suffering out weigh 
those generated from prescribing in non evidence-based ways. NMPs may feel more negative about 
prescribing in non evidence-based ways but less negative about refusing patients’ requests. It may 
also be easier for NMPs who may have shorter and more transient relationships with patients to 
refuse medicine requests. In this research, NMPs said they managed patient pressure with 
discussion and negotiation. This involved providing patients with written information about their 
condition. NMPs’ reports of their behaviour are consistent with patients’ attitudes that they are 
provided with high quality information from NMPs (Brooks et al. 2001; Courtenay et al. 2011; 
Luker et al. 1998). It may be that NMPs manage patient pressure more effectively than doctors 
through discussion and information. It could be that the extra consultation time, some NMPs 
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reported, helps them to do this. This echoes previous claims by CNPs who said they used their 
extra time to manage patient pressure (Hall et al. 2003). 
   
This research provides a more detailed examination of how a wide range of colleagues influence 
NMPs’ prescribing decisions that is not available in the current literature. The influence of GPs, 
hospital and secondary care practitioners, community pharmacists, other NMPs, non-prescribing 
nurses and DMPs were all discussed. Both Study One and Study Two suggested that NMPs’ 
relationship with GPs is complex. GPs were NMPs main source of contact when faced with 
difficult prescribing decisions. GPs also had an important role in developing and helping to 
maintain NMPs’ competency levels. However, Study One found that GPs were rarely consulted 
when NMPs felt comfortable prescribing. Furthermore, NMPs contested that GPs do not 
‘influence’ them. In previous research CNPs also strongly denied that GPs influence their 
prescribing. They also claimed that they rarely used GPs as a resource when it came to making 
decisions (Hall et al. 2003). CNPs felt they had at least equivalent knowledge, if not more 
knowledge, than GPs about the conditions they manage (Hall et al. 2003). It was clear from Study 
One and Study Two that NMPs did require GPs’ advice on some aspects of prescribing (e.g. when 
the patient had complex poly-pharmacy). However, generally, NMPs preferred the 
recommendations of other sources to GPs. This second finding is consistent with the research with 
CNPs. This finding is also interesting because it suggests that NMPs are presented with prescribing 
decisions they are unhappy to manage independently. This explains why assessment of their 
competency is such an important part of their practice. CNPs, in contrast, need less support from 
other HCPs. This is likely to be a product of the narrow range of medicine they can prescribe (see 
Section 2.3.1.1). 
 
NMPs sometimes contacted hospital and secondary care doctors when they felt they required 
specialist advice. Specialist nurses and those managing long-term or chronic conditions mentioned 
seeking advice these practitioners more than other types of prescribers. In previous research CNPs 
also said they contacted clinical specialists when they needed help with difficult cases (Hall et al. 
2009). GPs make contact with hospital specialists through patient referral letters (Armstrong and 
Ogden 2006). Communication between NMPs in this research and hospital and secondary care 
doctors also occurred through formal discharge and referral letters. However, many NMPs in this 
research, especially those in the GP surgery setting or in a general community roles (e.g. advanced 
practitioner), said that they would ask the patient’s GPs to make referrals to hospital and secondary 
care on their behalf. The contact between NMPs and hospital and secondary care doctors might 
therefore be less than exists between GPs and these practitioners. 
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Until now, the research that has examined the interaction between community pharmacists and 
NMPs had focused on their interaction with CNPs only. Many of the findings from research with 
CNPs and doctors were replicated in this research. In this research community pharmacists’ role 
was generally limited to practical medicine support and issues of medicine supply. Doctors and 
CNPs too contact community pharmacists for practical medicine support and value the knowledge 
of pharmacists but, like NMPs, rarely use pharmacists to help with medicine selection (Carthy et al. 
2000; Hall et al. 2003; Higgins and Tully 2005; Mahoney and Ladd 2010; Pearson et al. 2002; 
Stenner and Courtenay 2008). In the hospital context, pharmacists are sometimes not considered 
‘teachers’ by junior doctors because of their low profile (Pearson et al. 2002). There is also a 
perception amongst some GPs that community pharmacists are simply ‘shop-keepers’ (Hughes and 
McCann 2003). Clearly for difficult prescribing decisions NMPs preferred the advice of a doctor 
than a community pharmacist. This may simply be as a result of practical issues of NMPs accessing 
a community pharmacist. However, it may also be that NMPs hold some similar beliefs as doctors.  
 
The interaction between NMPs and other NMPs had, until now, mainly focused on CNPs. In this 
research NMPs relationship with their peers was characterised by an informal exchange of 
information, advice and ideas. Doctors communicate with one another about prescribing issues 
(Armstrong et al. 1996; Lewis and Tully 2009b; Ljungberg et al. 2007; Prosser et al. 2003; Wood et 
al. 2007). However, some GPs sometimes feel reluctant to compare their prescribing with others 
because of lack of confidence or fear of criticism (Carthy et al. 2000). Some GPs communicate 
with each other ‘through a form of clinical etiquette’ that avoids open discussion of specific patient 
management so that ‘professional exposure or embarrassment is avoided’ (Armstrong and Ogden 
2006). The barriers between doctors did not exist between the NMPs in this research. It is 
important that the current situation, in regards to the communication between NMPs, is maintained 
so NMPs receive as much support with regards to prescribing as possible. However, more could be 
done to improve interaction between pharmacist prescribers as they currently only interact with 
nurse prescribers. This will become increasingly easier to achieve as the number of pharmacist 
prescribers continue to increase in the UK. The relationship with their peers was important for 
NMPs. However, the influence NMPs had others’ prescribing decisions appeared limited. This 
issue is explored further in the next chapter of this thesis.   
 
Other colleague factors, such as non-prescribing nurses and the influence of DMPs, were also 
discussed in Study One. There was no evidence that NMPs followed prescribing recommendations 
suggested by their DMP during training, as has been found in research with CNPs (Hall et al. 
2008). Where a relationship between the NMP and the DMP continued to exist after qualification 
the DMP was a useful resource for NMPs. However, only half of the NMPs in Study One still had 
contact with their DMP post-qualifying. One way to improve the support that NMP receive post-
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qualifying as a prescriber would be to make contact with the DMP a mandatory requirement for a 
set time period following the course (see Section 9.3). Although, as discussed in Section 6.4.1, non-
prescribing nurses placed pressure on WIC nurse prescribers to issue prescriptions for their patients 
the nurse prescribers maintained they would examine the patient themselves and form their own 
independent prescribing decision. Doctors admit that nurse pressure can be an influence on their 
prescribing behaviour (Wood-Mitchell et al. 2008). In contrast, NMPs that experienced pressure 
from nurses maintained that nurses did not influence their eventual prescribing decision. 
 
NMPs were influenced by the prescribing behaviour of both GPs and hospital and secondary care 
doctors. However, the way these HCPs influenced their prescribing differed. GPs’ prescribing 
behaviour was examined by NMPs in situations they were unable to manage the patient 
independently. This is similar to NMPs seeking GPs’ advice when faced with difficult prescribing 
decisions. However, GPs’ behaviour had little impact on them when managing patients they felt 
comfortable managing themselves. NMPs did not want to replicate or copy GPs behaviour for the 
patients they felt comfortable managing independently. Many NMPs felt that GPs prescribed 
contrary to guidelines and criticised GPs in relation to their management of patient pressure (see 
Section 7.3.6) and their submission to time pressures (see Section 7.7.1). NMPs’ attitudes 
suggested that GPs’ behaviour should not be a ‘role model’ for their own behaviour. Instead there 
was a suggestion that other sources of information were prioritised. This finding uncovers the 
complex relationship between NMPs and GPs that has not, as yet, been discussed in the literature. 
 
It was clear that hospital and secondary care doctors’ prescribing behaviour influenced NMPs. In 
one direct way NMPs were influenced by these practitioners because they were reluctant, although 
not completely averse, to change medicine initiated by hospital consultants. This echoes the 
opposition of CNPs and GPs to alter hospital prescriptions even for medicine they would not 
normally prescribe (Armstrong and Ogden 2006; Buusman et al. 2007; Hall et al. 2009). Some 
NMPs sought to replicate hospital consultants’ behaviour in their own practice. One nurse 
prescriber described this as following “what’s in vogue”. GPs have expressed similar sentiments. 
GPs feel that use of new medicine by consultants gives the medicine credibility (Jones et al. 2001). 
Moreover, hospital consultants’ behaviour influences GPs’ uptake of new medicine (Jones et al. 
2001; Prosser et al. 2003). However, even for medicine in the same class, hospital consultants 
influence GPs’ medicine selections (Buusman et al. 2007). It is an important finding that some 
NMPs in primary and community care are using the prescribing behaviour of prescribers in hospital 
and secondary care when making prescribing decisions. This is despite NMPs’ reduced interaction 
with these HCPs as a result of asking GPs to refer patients on their behalf. NMPs’ attitudes 
suggested that they did not want their behaviour to be exceptional or different in anyway. This 
meant they were keen to prescribe within prescribing practices perceived to be accepted and 
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established. These perceptions were based on both GPs’ and hospital and secondary care 
practitioners’ behaviour. This clearly adds a further dimension to NMPs already complex 
relationship with GPs.  
 
A small number of NMPs in this research described how their own prescribing experience 
influenced their current practice. However, very few NMPs spontaneously cited this as a source of 
influence. Doctors, as well as CNPs, incorporate their own past professional prescribing experience 
into their practice (Hall et al. 2008; Schwartz et al. 1989; Wood-Mitchell et al. 2008). However, 
less experienced doctors rely on their clinical experience to a lesser extent than more experienced 
colleagues (Tichelaar et al. 2010). It would be sensible to assume that less experienced practitioners 
are not as influenced by past experience because they do not have as much experience to draw 
upon. In this research prescribers of all experience levels did not spontaneously cite professional 
experience as an influence on their prescribing decisions. Study One therefore suggested that even 
NMPs with more experience continue to prioritise other sources of information (e.g. guidelines, 
colleagues, prescribing culture) over their own professional experience. 
 
NMPs described how the prescribing training course was not an ongoing source of influence on 
their prescribing decisions. This finding reflects the fact that the course is not intended to provide 
NMPs with specific advice and information about specific therapy areas but rather practical, legal 
and ethical information about prescribing. A small number of NMPs mentioned they had attended 
conferences, training courses and study days as part of ongoing CPD. Although NMPs in this 
research were positive about the opportunities for further learning, as nurse prescribers have said in 
other research (Green et al. 2009), there was little evidence that NMPs related and applied the 
information from CPD to their own prescribing practices. In contrast, education has been found to 
be important to medical students, GPs and specialists when selecting medicine for their patients 
(Tichelaar et al. 2010). NMPs working in primary care find it difficult, because of time and 
workload commitments, to access training opportunities (Hacking and Taylor 2010). Hacking and 
Taylor found that nearly 30% of 516 NMPs had no training or updates in the year before taking 
part in their research. Instead, most of the support they received in relation to prescribing came 
from doctors as well as other NMPs (Hacking and Taylor 2010). This finding may explain why 
clinical support is vital in the development and maintenance of NMPs’ competency (see Section 
6.3.1). More should be done to increase training opportunities for NMPs. This is discussed further 
in Chapter Eight and Chapter Nine. 
 
The findings of this research, in relation to the use of literature and studies from academic and 
professional journals to inform prescribing decisions, replicate previous research in two ways. 
Firstly, as has been found in other research (Banning 2005), there was variation in the extent to 
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which NMPs used this source or information in their prescribing practice. Secondly, this research 
found that prescribers with roles that involved prescribing for patients with complex, chronic or 
long-term conditions mentioned this source of influence more than other types of prescribers. This 
finding partly replicates research with doctors that found specialist doctors rely on the scientific 
literature more than their GP colleagues when prescribing (Allery et al. 1997; Tichelaar et al. 
2010). Although some NMPs did mention literature and studies from academic and professional 
journals as an influence on their prescribing it was, on the whole, rarely mentioned by prescribers. 
Difficulties interpreting and using research in practice, noted in research with acute care nurses 
(McCaughan et al. 2002), were not identified in this research. There was also no evidence to 
suggest, in contrast with research with GPs (Wood et al. 2007; Wood-Mitchell et al. 2008), that 
NMPs were rejecting research findings because of issues with ‘real-life applicability’ of the 
research. Some NMPs said they did not have time to refer to research in their practice. However, 
other NMPs actively rejected the use research findings when making prescribing decisions. 
Pharmacist prescribers said, that whilst they used research in other parts of their role, they prefer 
other sources of information when making prescribing decisions. Many of the NMPs comments 
suggested a need to be evidence-based, in line with the principles of EBM, but they considered 
other sources (e.g. guidelines, formularies, NHS CKS, MHRA, NPC) fulfilled this requirement. 
Some NMPs described how they did not consult literature because they wished to “keep things 
simple”. The findings of Study One strongly suggested that research has a low impact on NMPs’ 
prescribing decisions.  
 
NMPs described time pressure in their practice. This time pressure arose because of a limited 
consultation time and general workload pressure. Although there are a small number of studies 
with CNPs (Hall et al. 2003; Hall et al. 2006) there was little known about the time pressures that 
NMPs face in their practice and how any time pressure influences their prescribing decisions. The 
majority of NMPs claimed that time pressure was not a factor in their prescribing and, in relation to 
patient pressure, said they would rather spend time with the patient explaining why a prescription 
was not needed than prescribe. In contrast, GPs say they sometimes prescribe just to relieve 
pressure on their workload (Kumar et al. 2003; Petursson 2005) and admit these prescriptions are 
sometimes unnecessary and against available evidence (Buusman et al. 2007; Carthy et al. 2000; 
Petursson 2005). Furthermore, GPs report whether they resist patient pressure is largely as a result 
of the time they have available (Carthy et al. 2000). This research highlights a difference between 
doctors and NMPs with regards to their management of time pressure. Support for this difference, 
at least between nurses and doctors, is provided in a study where nurses claimed, in stark contrast 
to other clinicians, that their management decisions (including prescribing) were not influenced by 
time factors (Hajjaj et al. 2010). NMPs in this research took the task of resisting time pressures 
very seriously. This influenced how they dealt with time pressure and how they wished to be seen 
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to manage time pressure (see Section 7.7.1 for further details). This is clearly an important issue to 
identify in relation to understanding how time pressure, as well as other pressure, influences NMPs. 
 
Many of the attitudes expressed by NMPs in this research, with respect to pharmaceutical 
representatives, are also evident in the current literature in this field. However, in contrast with 
CNPs in earlier research (Luker et al. 1998), the majority of NMPs in this research had contact with 
representatives. This suggests that, since the early days of non-medical prescribing, the activities of 
the pharmaceutical industry have been directed towards NMPs. NMPs met with pharmaceutical 
representatives as part of a team approach but not individually. Like doctors and CNPs (Hall et al. 
2003; Prosser and Walley 2003), NMPs viewed pharmaceutical representatives as a valuable and 
an up-to-date education source. NMPs in this research acknowledged that the representatives try 
and influence their prescribing, as CNPs suggest (Hall et al. 2009), but they claimed they were not 
influenced by this themselves. This finding is consistent with much of the literature concerning 
doctors’ attitudes to the influence of the pharmaceutical industry (Carthy et al. 2000; Prosser and 
Walley 2003; Wood et al. 2007) and is also consistent with the limited research conducted with UK 
based nurse independent prescribers (Lewis-Evans and Jester 2004). However, whilst NMPs claim 
that they are not influenced by the activities of the pharmaceutical industry, further research 
beyond simply asking them, should be used to fully understand the impact of the industry on 
NMPs. Such research may become important if evidence emerges of a negative impact of the 
pharmaceutical industry on NMPs’ prescribing.  
 
7.9.1 Reflections on Method 
This chapter has presented findings from Study One which used in-depth interviews. Chapter Four 
has partly reflected on the methods used in Study One. However, it is important to reflect on the 
methods used in Study One again now the findings have been presented in full. The in-depth 
interviews allowed NMPs the opportunity to talk about the influences on their prescribing 
decisions. Interviews, such as those conducted in this research, have been used by others to explore 
influences on prescribing (Carthy et al. 2000). The in-depth interviews enabled the researcher to 
explore the nature of some of the influences. For example, participants were asked about what 
guidelines they used, how they managed patient pressure and the nature of their interaction with 
their DMP. This would have been more difficult using quantitative methods such as questionnaires. 
The in-depth interviews allowed participants to talk about the prescribing influences in their own 
words. If questionnaires had been used there might have been an inclination to ‘force’ some of the 
terms in the doctors’ prescribing literature on NMPs.  
 
It was evident from the interviews that almost any factor could be a source of influence on NMPs. 
As a result, it was difficult to gauge the relative influence of the factors on NMPs. This was made 
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even more difficult because of time constraints during the interviews. Therefore, the Q-method was 
used in Study Three in order to encourage participants to prioritise the factors that influence their 
prescribing decisions. This method grouped participants that agreed their prescribing decisions to 
be influenced by the same factors together This created perspectives amongst NMPs about the 
influences on their prescribing decisions. 
 
7.10 Chapter Summary 
This chapter has explored the influences on NMPs’ prescribing decisions. Prescribing decisions can 
be thought of as the choice between a pharmacological versus non-pharmacological approach, the 
choice of specific medicine, the choice of dosage and the choice of formulation. This decision is 
different, albeit very related, to that of prescribing responsibility which focuses on whether NMPs 
take responsibility for making a prescribing decision for a patient or issuing a prescription. The 
influences on NMPs were discussed under the following headings: regulatory factors, patient 
factors, colleague factors, prescribing culture and professional experience, training and information 
sources, logistical factors and the pharmaceutical industry. The next chapter of this thesis presents 
findings from Study Three which employed the use of the Q-method. 
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Chapter Eight – Perspectives on Prescribing Influences 
_______________________________________________________________________________ 
 
The purpose of this chapter is to describe the range of perspectives amongst NMPs about the 
sources of influence on their prescribing decisions. The findings presented in this chapter are 
derived from Study Three, which was designed using the principles of the Q-method. The chapter 
ends with a discussion of the findings and a reflection of the Q-method. 
_______________________________________________________________________________ 
8.1 Introduction 
Study Three furthered the understanding of the influences on NMPs’ decisions by asking 56 
participants to arrange statements about prescribing influences, derived from Study One as well as 
available literature, on a grid according to the extent to which they agreed with the statements for 
prescribing decisions they make. Participants were asked to think of prescribing decisions they 
make for their ‘normal patient group’. The data produced in Study Three was then analysed using 
PCA and varimax rotation analysis according to the principles of data analysis in Q-method 
studies. The aim of the analysis was to group NMPs together that ordered the statements in a 
similar manner to create perspectives about prescribing influences amongst NMPs. The 
perspectives represent NMPs that perceive their prescribing decisions to be influenced by similar 
sources of influence. The method and data analysis procedure used in Study Three has been 
discussed in extensive detail in Chapter Five. The initial part of this chapter describes how the 
output from the analysis was interpreted. 
 
8.2 Interpretation Process 
Chapter Five of this thesis provided an overview of the data analysis procedure for Study Three. As 
outlined, PCA was initially preformed on the Study Three data. The aim of PCA is to identify the 
number of natural groupings of q-sorts (the arrangement of statements on the grid) by virtue of 
their similarity to one another. PCA produces eigenvalues which can be used to determine how 
many perspectives resulting from PCA should be taken forward for varimax rotation. In Q-method 
analysis, and factor analysis more generally, these perspectives are commonly referred to as factors 
during the analysis stage. This section of the chapter will therefore use the term ‘factor’. However, 
in the findings part of this chapter and the rest of the thesis these factors are referred to as 
perspectives. 
 
As a general rule in Q-method studies, and factor analysis more generally, it is factors with 
eigenvalues of more than one that are used following PCA. This is often referred to as ‘EVG 1 
rule’, (Kaiser 1960). In this study 15 eigenvalues of more than one existed following PCA. As a 
result, the EVG 1 rule was not applied as it would have been impossible to provide a meaningful 
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interpretation of the output. Indeed, it has been argued by some authors that the EVG 1 rule leads to 
too many factors unnecessarily being retained (Patil 2008). Cattell suggests using a scree plot to 
determine the point at which the eigenvalues level off (Cattell 1996). A scree plot was produced in 
this study (see Appendix 24.0) where the eigenvalue was plotted against the number of the 
eigenvalue (factor number) in a line graph.  
 
Some authors have described the interpretation of the scree plot as an ‘art’ rather than a ‘science’ 
(Turner 1998). Indeed, this was the case in this study as there was no obvious drop off in the 
eigenvalues at any point apart from after the first eigenvalue number. After close examination it 
was felt that the eigenvalues levelled off to some extent after either the second and fifth eigenvalue 
number. Due to this ambiguity the scree plot was used as a starting point at which to begin the 
interpretation process. Eventually all possible factor solutions, up to eight factors, were examined. 
A maximum of an eight-factor solution was explored because of limitations of the PCQ software 
used and because it was felt a factor solution greater than eight would not be meaningful. The 
author followed the advice of McKeown and Thomas that ‘common sense offers the best counsel 
when determining the importance of factors, that is, their contextual significance in light or the 
problems, purposes and theoretical issues in the research project’ (McKeown and Thomas 1988, 
pg.52). The final factor solution considered other criteria suggested by Webler et al. specifically for 
Q-method studies (Webler et al. 2009). This criteria is listed in Box 8-1.  
 
A five factor solution was deemed the best solution. The five factor solution met Webler’s 
distinctness criterion because there was a low correlation between most of the factors. There was 
no difference between any of the factor solutions on the stability criterion because participant 
groups were relatively stable between all solutions. It was difficult to fulfil Webler’s clarity 
criterion with any of the viable factor solutions. The three factor solution had the least number of 
null or confounder participants, of only 13, but did not perform well on the distinctness criterion as 
there was high correlation between the factors. The concepts of ‘null’ and ‘confounder’ participants 
are discussed in Section 8.2.1. The four factor solution had the next least number of null or 
confounder participants, of 17, but this was only marginally better than the number for the five 
factor solution of 18. However, the five factor solution performed better on the simplicity and the 
distinctness criteria. The five factor solution explained 56% of the total variance of the rotated 
correlation matrix. The four factor and six factor solution explained 52% and 60% of the variance 
Box 8-1: Criteria Used to Aid Selection of Final Factor Solution (Modified from Webler et al., 2009) 
1. Distinctness: Low correlation between factors 
2. Simplicity: As low number of factors as possible without limiting meaningfulness of factors  
3. Stability: Groups of similar participants stable across factor solutions. 
4. Clarity: Large number of participants loading significantly on one of the factors, small number of 
‘null’ or ‘confounders’.  
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respectively. However, the four factor solution was not selected because it accounted for less of the 
variance within the data with only one less null or confounder participant. Whilst the six factor 
solution explained more of the variance it was difficult to interpret, especially as three of the 
factors had five or less participants significantly ‘loading’ to that factor. The concept of participants 
‘loading’ to a factor is discussed in Section 8.2.1. On Webler’s simplicity criterion, and in inline 
with McKeown and Thomas’ recommendations that common sense should drive factor selection, 
the factor five solution was selected because it made more sense and was more meaningful than 
other solutions. 
 
There is little discussion in the Q-method literature about an accepted threshold of variance that Q-
method studies should seek to explain but it is intuitive that Q-method studies should explain as 
much variance as possible in its findings. The variance reported in this study falls somewhere in the 
middle of that reported in published studies that have used the Q-method. For example, Baker 
presented three factors accounting for 44% of the variance (Baker 2006). Fairweather and 
Swaffield presented five factors accounting for 61% of the variance in their data (Fairweather and 
Swaffield 2001). Morecroft et al. et al. present five factors that accounted for 73% of the variance 
(Morecroft et al. 2006). 
 
The factors selected as a result of PCA are then taken forward for varimax rotation analysis. The 
aim of varimax rotation analysis is to yield interpretable factors by rotating the selected factors. 
This analysis results in a rotated factor loadings file which provides a correlation value (between -
1.00 and 1.00) for each participant and factor. As described in Chapter Five, in order to produce the 
final report, the researcher must first determine what factors, if any, participants significantly load 
to. The process of determining this is described in the next section.  
 
8.2.1 Determining Participant’s Significance on Rotated Factor 
In order to determine participants’ significance on each factor one must examine the factor loadings 
file (resulting from varimax rotation). This file provides a correlation value for each participant and 
factor. A correlation value of 1 would indicate perfect correlation or similarity with an overall 
factor. A low value indicates limited similarity with an overall factor and a minus value can 
indicate polarity with a factor. Those participants with a high correlation value for a factor is said to 
‘load’ to that factor. A distinction is made between participants that load to one, and only one 
factor, and participants that load on to one or more factors or none at all. Generally these groups are 
referred to as ‘defining’ participants or sorts, ‘confounders’ and ‘null’ participants or sorts 
respectively. In the analysis it is the defining sorts that help interpret the factors but examining 
confounders can be useful. In order to determine which factors participants load to it is necessary to 
determine a level at which the correlation value becomes significant. In the PCQ software the 
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significance level is set at +/- 0.45 but it can be manually overridden should you wish to change the 
level. In this study a new significance level was set using a formula, described below, which is 
commonly used in Q-method studies. This formula calculates the significance level at 99%: 
 
Significance Level = 2.58 / √N   
 
(where ‘N’ = number of statements) 
 
Based on this formula participants in this study were considered to significantly load to a factor 
when their correlation value for that factor exceeded 0.3857. In this study, of the 56 participants, 38 
participants had defining sorts as they loaded significantly to only one factor. Sixteen participants 
were confounders meaning they loaded significantly to more than one factor. In the PCQ software 
it is necessary to ‘mark’ each defining sort in order to complete the analysis. Two null participants 
loaded to none of the factors (Nurse 3 and Nurse 33). Appendix 26.0 and Appendix 27.0 provide 
the correlation values of participants with defining q-sorts and the correlation values of confounder 
participants respectively. 
 
8.2.2 Interpretation of Factors 
The loading of the participants to the factors was indicated in the PCQ software. The final analysis 
was complete by selecting the qanalyse option. This re-expresses the factors as the best estimate of 
the q-sorts or participants that represent them. The output of the qanalyse is a report which can be 
used to interpret the factors. For each factor, the PCQ software produces a z-score for each of the 
statements. Z-scores are measures of how far the position of the statement lies from the mid-point 
of the distribution (Webler et al. 2009). Essentially, z-scores provide an understanding of the 
statements that participants loading to each factor agreed and disagreed with most. This 
information is necessary to help interpret the factors. In the forthcoming description of each factor 
the six statements that received the highest positive z-score for the factor, and the six statements 
that received the lowest positive z-score for the factor have been provided. In this chapter the 
asterisks indicate if the statement received a significantly different z-score on one factor compared 
with the z-score, for the same statement, on any other factor. The significance level of 95% and 
99% are reported for each statement, indicated by: * = 95% significance ** = 99% significance, to 
distinguish between different levels of significance. 
 
The statements that received a significantly different z-score (at either 95% or 99%) on one factor 
compared with the same statements on another factor have also been provided in the description of 
each factor. Attention was also given to statements that received higher z-scores on one factor 
compared with the statement’s z-score on other factors even when it was not significant. As 
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described in Chapter Five, participants were also asked to comment on their choice of the two 
statements they placed in the most agreed with column and the two statements they placed in the 
most disagreed with column. The comments made by participants, loading significantly on the 
factor (either as a defining sort or confounder), were used to interpret the factors. The label for each 
factor was mainly derived from the differentiating statements for the factor and the six statements 
that received the highest positive z-scores. 
 
In order to discuss each of the factors in a consistent and concise way the 42 statements used in 
Study Three are discussed under seven themes. These seven themes include: regulatory factors, 
patient factors, colleague factors, prescribing culture and professional experience, training and 
information sources and logistical factors. These themes were generated following the analysis of 
Study One and were used during the statement development. The statements within each are these 
themes are outlined in Appendix 22.0. The categories provide a framework to discuss the results of 
the Q-method study. However, as mentioned previously, they did not represent a theory as to how 
participants may be divided. From this point in the chapter onwards the term factor is replaced by 
perspective. 
 
8.3 Demographic Profile of Participants Loading to each Perspective 
The demographic details of the participants loading to each perspective are described below. In the 
case of professional group, numbers are provided for defining participants and confounders. For all 
other demographic characteristics analysis is only provided for those with defining sorts. Further 
interpretation of these findings is provided in conjunction with the description of each of the five 
perspectives from Section 8.5. 
 
8.3.1 Professional Group 
As Table 8-1 shows, nearly half of nurses with defining sorts loaded significantly to Perspective 
One (P1). This compares with approximately one in 10 pharmacists. The remaining nurses with 
defining sorts loaded fairly evenly to Perspective Two (P2), Perspective Three (P3) and Perspective 
Four (P4). In total, 35% of pharmacists with defining sorts loaded significantly to P2. This 
represented the largest number of pharmacists loading to any one perspective. As with nurses, the 
remaining pharmacists with defining sorts loaded fairly evenly to P1, P3, P4 and P5. When 
examining the percentage of participants that loaded significantly to each of the perspectives as 
either a defining sorts or confounders the similar trend as that described emerges.  
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8.3.2 Role 
The number of participants with defining sorts by role employed loading significantly to each 
perspective is provided in Table 8-2. The data suggests there is no one role associated with any one 
particular perspective. However, two thirds of community matrons/active case managers loaded to 
P1. Additionally, one third of nurse practitioners for GP surgeries/practice nurses loaded to P1 and 
one third loaded to P4. 
Table 8-1: Number and Percentage of Nurse Prescribers and Pharmacist Prescribers with 
Defining Sorts Loading to Each Perspective and Number and Percentage of All Nurse 
Prescribers and Pharmacist Prescribers (Defining and Confounders) Loading to Each 
Perspective 
DEFINING SORTS DEFINING SORTS & CONFOUNDERS PERSPECTIVE 
Nurses Pharmacists Nurses Pharmacists 
P1 
PCT Driven 
Prescribers 
10 [48%] 2 [12%] 18 [56%^] 3 [14%^] 
P2 
Patient-Centred 
Driven Prescribers 
4 [19%] 6 [35%] 8 [25%^] 9 [41%^] 
P3 
Prescribing Culture 
Driven Prescribers 
2 [10%] 4 [24%] 8 [25%^] 7 [32%^] 
P4 
Evidence-Based 
Driven Prescribers 
4 [19%] 3 [18%] 10 [31%^] 6 [27%^] 
P5 
Long-term Impact 
and Logistical 
Prescribers’ 
1 [5%] 2^^ [12%] 1 [3%^] 2 [9%^] 
TOTAL 21 17 32 22 
^ Percentage calculated as number of all participants loading to perspective by all participants (either defining perspective or as 
confounder). As a result the percentages within the columns will not equal 100% and the total number of participants loading to 
each perspective will total more than the total number of participants. ^^ Includes one pharmacist loading negatively to 
perspective. 
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8.3.3 Years Experience in Prescribing Field 
The number of participants with defining sorts by years experience in their prescribing area loading 
significantly to each perspective is provided in Table 8-3. Participants with defining sorts with low 
experience loaded similarly to all five perspectives. A higher proportion of participants with 
moderate levels of experience loaded significantly to P1 and P4 compared with other perspectives. 
Almost half of those participants with a defining sort and high levels of experience loaded 
significantly to P2 compared with a quarter loading to P1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
8.3.4 Date of Qualification 
The number of participants with defining sorts by date of prescribing qualification loading 
significantly to each perspective is provided in Table 8-4. Table 8-5 and Table 8-6 provide the 
number of nurses and pharmacists with defining sorts by date of prescribing qualification loading 
significantly to each perspective. Table 8-4 shows a roughly similar percentage of participants with 
defining sorts, who qualified to prescribe between 2003 and 2005, loaded significantly to each of 
the four first perspectives. However, slightly more loaded to P4. Nearly three in five participants 
qualifying to prescribe from 2006 loaded to either P1 or P2. However, slightly more of these 
participants loaded to P1. Seven in 10 nurses who qualified to prescribe since 2006 loaded to P1 
compared with only 15% of pharmacists. The vast majority of pharmacists qualifying to prescribe 
from 2006 onwards loaded to either P2 or P3. 
 
 
 
Table 8-3: Number of Participants by Years Experience Loading to Each Perspective as 
Defining Sort 
PERSPECTIVE 
LOW 
< 4 years 
MODERATE 
> 4 years & < 
10 years 
HIGH 
> 10 years TOTAL 
P1 
PCT Driven Prescribers 3 [33%] 6 [38%] 3 [25%] 12 
P2 
Patient-Centred Driven 
Prescribers 
2 [22%] 2 [13%] 6 [46%] 10 
P3 
Prescribing Culture 
Driven Prescribers 
3 [33%] 1 [6%] 2 [15%] 6 
P4 
Evidence-Based Driven 
Prescribers 
1 [11%] 5 [31%] 1 [8%] 7 
P5 
Long-term Impact and 
Logistical Prescribers 
- 2 [13%] 1 [8%] 3 
TOTAL 9 16 13 38 
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Table 8-4: Number of Participants with Defining Sorts by Date of Prescribing 
Qualification Loading to Each Perspective as Defining Sort 
PERSPECTIVE 
 
Before 2003 
 
2003 – 2005 
 
2006 to 
Present 
 
 
TOTAL 
P1 
PCT Driven Prescribers - 3 [21%] 9 [39%] 12 
P2 
Patient-Centred Driven 
Prescribers 
- 3 [21%] 7 [30%] 10 
P3 
Prescribing Culture 
Driven Prescribers 
- 2 [14%] 4 [17%] 6 
P4 
Evidence-Based Driven 
Prescribers 
1 4 [29%] 2 [9%] 7 
P5 
Long-term Impact and 
Logistical Prescribers 
- 2 [14%] 1 [4%] 3 
 TOTAL 1 14 23 38 
 
Table 8-5: Number of Nurse Prescribers with Defining Sorts by Date of Prescribing 
Qualification Loading to Each Perspective as Defining Sort 
PERSPECTIVE 
 
Before 2003 
 
2003 - 2005 
 
2006 to 
Present 
 
 
TOTAL 
P1 
PCT Driven Prescribers - 3 [30%] 7 [70%] 10 
P2 
Patient-Centred Driven 
Prescribers 
- 2 [20%] 2 [20%] 4 
P3 
Prescribing Culture 
Driven Prescribers 
- 2 [20%] - 2 
P4 
Evidence-Based Driven 
Prescribers 
1 2 [20%] 1 [10%] 4 
P5 
Long-term Impact and 
Logistical Prescribers 
- 1 - 1 
TOTAL 1 10 10 21 
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Table 8-6: Number of Pharmacist Prescribers with Defining Sorts by Date of Prescribing 
Qualification Loading to Each Perspective as Defining Sort 
PERSPECTIVE 
 
Before 2003 
 
2003 - 2005 
 
2006 to 
Present 
 
 
TOTAL 
P1 
PCT Driven 
Prescribers 
NA - 2 [15%] 2 
P2 
Patient-Centred Driven 
Prescribers 
NA 1 [25%] 5 [38%] 6 
P3 
Prescribing Culture 
Driven Prescribers 
NA - 4 [31%] 4 
P4 
Evidence-Based Driven 
Prescribers 
NA 2 [50%] 1 [8%] 3 
P5 
Long-term Impact and 
Logistical Prescribers 
NA 1 [25%] 1 [8%] 2 
TOTAL NA 4 13 17 
 
8.3.5 Number of Prescriptions 
The number of participants with defining sorts by prescribing frequency classification loading 
significantly to each perspective is provided in Table 8-7. The percentage of participants with 
defining sorts, classified as medium or high frequency prescribers was similar across the 
perspectives. However, over two in five participants classified as low frequency prescribers loaded 
significantly to P1. 
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Table 8-7: Number of Participants with Defining Sorts by Classification of Prescribing 
Frequency Loading to Each Perspective as Defining Sort 
PERSPECTIVE 
LOW 
< 5 
Prescriptions 
MEDIUM 
> 5 and < 20 
Prescriptions 
HIGH 
>20 
Prescriptions 
 
 
TOTAL 
P1 
PCT Driven Prescribers 3 [43%] 5 [33%] 4 [25%] 12 
P2 
Patient-Centred 
Prescribers 
2 [29%] 4 [27%] 4 [25%] 10 
P3 
Prescribing Culture 
Prescribers 
1 [14%] 3 [20%] 2 [13%] 6 
P4 
Evidence-Based Driven 
Prescribers 
1 [14%] 2 [13%] 4 [25%] 7 
P5 
Long-term Impact and 
Logistical Prescribers 
- 1 [7%] 2 [13%] 3 
TOTAL 7 15 16 38 
 
8.4 Similarities 
It is important to note that there were many similarities across the perspectives. These similarities 
are discussed in this section. The positioning of some of the statements across the perspectives 
supported some of the findings described in Chapter Seven.  
 
The majority of participants perceived logistical issues to influence their prescribing decisions less 
than other influences. The following statements received high negative z-scores for all the major 
perspectives (P1, P2, P3 and P4): “the anticipated impact the prescribing decision will have on my 
service in the future (follow-up appointments, monitoring, etc)” (statement 15), “the anticipated 
impact the prescribing decision will have on other health care services of health care professionals 
outside my own service”(statement 14), “whether I feel I have sufficient time during the 
consultation” (statement 22), and “the anticipated impact of the prescribing decisions on future 
presentations to my service from the patient in question or other patients” (statement 39). The 
reasons behind participants’ agreement or disagreement with these statements, as well as the other 
statements throughout this chapter, were explained in some of the comments participants provided 
when asked to explain their choice of the two statements they most agreed with and the two 
statements they least agreed with. In regards to statement 22, some NMPs said that time was not an 
issue in their consultations, that they would prefer to “run late” than succumb to time pressures 
and that they do not want to make “rushed decisions” or “snap decisions”. They also felt part of 
being a professional is managing time pressure and that they should not be a prescriber if they 
succumb to time pressure. This last point is illustrated in the comment below:  
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(s22) “I don’t feel I should be a nurse prescriber if time saved in a consultation entered into it” 
(Practice Nurse 009, Perspective One, Study 3) 
 
The comments about time pressure supports the findings of Study One and Study Two discussed in 
Section 6.4.2 and Section 7.7.1 respectively. 
 
Participants generally thought that “recommendations from my prescribing course mentor or my 
designed medical practitioner” (statement 1), “advice from other NMPs” (statement 4), “advice 
from academic practitioners” (statement 6) and “advice from non-prescribing health care 
professionals” (statement 7) influenced their prescribing less than other influences. This finding is 
unsurprising as these HCPs were not generally mentioned by NMPs in Study One as sources of 
influence on their prescribing decisions. NMPs expressed a number of viewpoints about these 
HCPs. They said they had little or no contact with these HCPs in their practice (particularly 
statement 1, 4 and 6), they may listen to advice from these HCPs but give preference to other 
influences (particularly statement 4) and they would prefer to take advice from HCPs with similar 
levels of prescribing responsibility (particularly statement 6 and 7). This latter point is illustrated in 
the comment below: 
 
(s7) “I take general advice from non prescribing practitioners but I feel if you are taking on the 
responsibility of independent prescribing you need advice from someone who has the same 
experience of that responsibility” (Community Matron 001, Perspective Two, Study 3). 
 
There were some significant differences between perspectives in response to guideline, protocol 
and formulary statements. However, on the whole participants agreed that their prescribing 
decisions were influenced by “national guidance” (statement 20) and “recommendations of the 
BNF or other national formularies” (statement 17). NMPs said these sources consider cost 
implications, are up-to-date, evidence-based, peer reviewed, accessible and promote ‘safe’ 
prescribing behaviour. The remaining description of the perspectives generated from this analysis 
focuses mainly on the differences between perspectives. 
 
8.5 Description and Interpretation of Perspectives 
8.5.1 Perspective One – ‘PCT Driven Prescribers’ 
12 participants’ q-sorts defined P1. These 12 participants consisted of 10 nurses and two 
pharmacists. P1 represented 16% of the total variance of the rotated correlation matrix. There were 
nine confounders loading significantly on to P1 comprising eight nurses and one pharmacist.  
 
Five statements differentiated P1 from other perspectives. Each of the statements began with ‘my 
prescribing decisions are influenced by’. The following statements received a significantly higher 
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z-score on P1 than they did on the four other perspectives: “the patient’s financial situation” 
(statement 41, -0.30**), “information from my prescribing training course(s)” (statement 27, 
0.48**), and “the recommendations of my PCT’s formulary” (2.00**). The following statements 
received a significantly lower z-score on P1 than they did on the four other perspectives: 
“recommendations from my course mentor or designated medical practitioner” (statement 1, -
1.17*) and “what the patient asks for in the consultation” (statement 33, -2.06**).  
 
The six statements with the highest positive z-score and the six statements with the lowest negative 
z-score for P1 are provided in Table 8-8. Each of the statements began with ‘my prescribing 
decisions are influences by’. 
 
Table 8-8: P1: 6 Statements with Highest Positive Z-Score and 6 Statements with Highest Negative Z-Score 
18 “…the recommendations of my PCTs’ formulary” ** 2.000 
16 “…the anticipated concordance10 of the patient” 1.896 
42 “…the effect of the prescribing decision on the patient’s quality of life” 1.722 
19 “…local or PCT protocols or guidance” 1.692 
8 “…information from the medicines management team” 1.452 
17 “…the recommendations of the BNF or other national formularies” 1.425 
33 “…what the patient asks for in the consultation” ** -2.056 
22 “…whether I feel I have sufficient time during the consultation” -1.724 
39 “…the anticipated impact on the prescribing decision on future presentations 
to my service from the patient in question or other patients” 
-1.443 
11 “…other NMPs’ prescribing behaviour” -1.314 
1 “…recommendations from course mentor or DMP” * -1.175 
15 “…the anticipated impact the prescribing decision will have on my service 
in the future (follow-up appointments, monitoring, etc)” 
-1.036 
** 99% significance, * 95% significance 
 
8.5.2 Interpretation of P1 
Participants significantly loading to P1 felt their prescribing decisions were influenced by local, 
PCT and national guidance, protocols and formularies, particularly “the recommendations of the 
BNF or other national formularies” (statement 17, 1.425) and “local or PCT protocols or guidance” 
(statement 19, 1.692). Their level of agreement with statement 18, “the recommendations of my 
PCT’s formulary” (statement 18, 2.00**) differentiated P1 from other participants loading to other 
perspectives. Participants loading to P1 are supported by their PCT in relation to prescribing as 
statement 8 “information from the medicines management team” (statement 8, 1.1452) also 
received a high positive z-score. Those participants that held the view that their prescribing 
decisions were influenced by local and PCT guidance, protocols and formularies expressed a 
number of common viewpoints. Mainly, that local and PCT guidance, protocols and formularies 
                                                 
10
 It is important to note that ‘concordance’ was used rather than adherence in the statements for Study Three. This was 
done to reflect the language used by participants in Study One. As is discussed in Section 8.10.1, based on the official 
definitions of these terms, it might have been more appropriate to use ‘adherence’. However, participants used these 
terms interchangeably to mean whether the patient takes the medication. 
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were research based, up-to-date and the research contained within them is evaluated and presented 
in terms of local health needs. 
 
 (s18) “I use this guide as they have assessed the latest research and evaluated it in contact with 
local needs” (Nurse Practitioner for a GP Surgery 004, Perspective One, Study 3) 
 
Participants that loaded to P1 felt they were expected and encouraged to adhere to PCT guidance, 
protocols and formularies. 
 
(s19) “I use this every day and we are encouraged to keep to locally agreed guidelines” 
(Community Matron 006, Perspective One, Study 3) 
 
Furthermore, as the quote below by one pharmacist illustrates, many participants expressed the 
view that there was no need or justification to prescribe outside the recommendations of local and 
PCT guidance, protocols and formularies as they manage simple clinical cases. This view was also 
expressed by a number of participants in Study One (see Section 7.2.1).  
 
(s18) “We are expected to use the PCT formulary for 80% of prescribing since the group of 
patients I see are not complicated, there is no need/justification to prescribe outside of this. The 
formulary is evidence-based and peer reviewed”. (Practice Pharmacist 004, Perspective One, 
Study 3) 
 
Participants demonstrated active concern about prescribing outside PCT guidance, protocols and 
formularies. One nurse described how they would leave themselves open to question if they did not 
adhere to these recommendations: 
 
(s19) “If we don't adhere to policy then we can leave ourselves open to question and have to justify 
why we make certain decisions outside of local policy” (Practice Nurse 022, Perspective One, 
Study 3) 
 
As this comment illustrates, another nurse felt she needed to adhere to local or PCT guidance, 
protocols and formularies to be supported by her PCT: 
 
 (s19) “I feel that trust guidelines need to be adhered to ensure that you are supported by the trust 
in your clinical decisions” (WIC Nurse 018, Perspective One, Study 3) 
 
This suggests that NMPs characterising P1 were keen to prescribe within local and PCT guidance, 
protocols and formularies due to their concerns regarding appropriate legal support. Some NMPs in 
Study One and Study Two also expressed concerns about deviating from formularies and 
guidelines (see Section 6.3.4). Participants loading to P1 did not feel that their prescribing 
decisions were influenced by “the cost of the decision to the NHS” (statement 13, -0.04). This 
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suggests that participants loading to P1 were not knowingly driven by cost issues when adhering to 
guidance, protocols and formularies.  
 
Participants significantly loading to P1 agreed that their prescribing decisions were influenced by 
some patient issues such as “the effect of the prescribing decision on the patient’s quality of life” 
(statement 42, 1.722) and “the anticipated concordance of the patient” (statement 16, 1896). 
Participants loading to P1 also agreed significantly more than participants loading to other 
perspectives with statement 41 “the patient’s financial situation” (statement 41,-0.30**). However, 
it is important to note this statement did not feature in their top six statements and received a 
modest z-score. One nurse suggested they would give priority to addressing issues surrounding 
patient concordance over adhering to the PCT formulary. Whilst this is evident in this comment 
below it was not evident in the majority of the comments provided by participants loading to P1: 
 
(s18) “This formulary is up to date evidence-based and is relevant to my local clinical health care 
needs. I will consider the recommendations from this formulary when prescribing. It is not 
exclusive and issues of concordance take precedence” (Community Matron 026, Perspective One, 
Study 3)  
 
Participants loading to P1 disagreed strongly that their prescribing decisions were influenced by 
“what the patient asks for in the consultation” (statement 33, -2.056**). As the comment below 
suggests, the common reason provided by participants who placed this statement in the bottom two, 
was that often patients’ requests are inappropriate: 
 
(s33) “I do not let what the patients ask for influence my decisions as often what they are asking 
for may be inappropriate” (Community Matron 006, Perspective One, Study 3) 
 
This resistance to patients’ requests for medicine amongst some NMPs is consistent with the 
findings from Study One. It may be that these participants do not want to prescribe inappropriately 
because it would mean straying from guidance, protocols and formularies. 
 
Generally, participants significantly loading to P1 did not either strongly agree or disagree that 
their prescribing decisions were influenced by recommendations or advice from colleagues. That is 
with the exception of statement 1, “recommendations from my course mentor or DMP” (statement 
1, -1.17*), which received a significantly lower z-score on P1 than it did on the four other 
perspectives. Conversely, participants loading to P1 agreed significantly more than participants 
loading to other perspectives that their prescribing decisions were influenced by “information from 
my prescribing training course” (statement 27, 0.48**). This suggests that, for these participants, 
the training course continues to have a greater influence on their prescribing than their DMP. 
 
 180
Generally, participants significantly loading to P1 did not strongly agree or strongly disagree that 
their prescribing decisions were influenced by prescribing culture or their own prescribing 
experience. Statement 11, “other NMPs’ prescribing behaviour” (statement 11, -1.314) was placed 
in the bottom six statements by participants loading to P1. However, the z-score for this statement 
was not significantly different to its z-score on other perspectives. Some of the logistical 
statements, discussed in Section 8.4 of this chapter, were also placed in the bottom six statements. 
 
8.5.3 Demographic Profile of Participants Loading to P1 
The fact that a higher proportion of nurses loaded to P1 than pharmacists suggests nurse prescribers 
are driven more by PCT factors than pharmacist prescribers. The characteristics of P1 are more 
attributable to those recently qualified to prescribe. This is especially the case for nurse prescribers. 
The relative inexperience of these prescribers might explain why they feel more comfortable 
prescribing in accordance with PCT guidelines, protocols and formularies. It might also explain 
why the prescribing training course had more influence on their prescribing than it did on 
participants loading to other perspectives. It is noteworthy that a similar trend is not replicated for 
years experience in the prescribing field. As described in Section 8.3.5, the percentage of 
participants with defining sorts, classified as low frequency prescribers, medium frequency 
prescribers and high frequency prescribers loading to each perspective was relatively similar across 
all perspectives. However, over two in five participants (43%) classified as low frequency 
prescribers loaded to P1 compared with 29% of low frequency prescribers loading to P2. This 
might suggest that the characteristics of P1 are more attributable to low frequency prescribers than 
medium or high frequency prescribers. It may be those prescribing less regularly feel less 
comfortable deviating from the recommendations of guidelines, protocols and formularies. 
 
8.5.4 Summary: Key Attributes of P1 
Participants loading to P1: 
• Perceived their prescribing decisions to be influenced by guidelines, protocols and formularies 
particularly at the local/PCT level. These participants desire to prescribe within these 
recommendations was driven by a number of attitudes: 
o Their PCT expects them to prescribe within these recommendations 
o Their prescribing decisions may be open to question if they do not prescribe within 
these recommendations 
o They manage simple patient cases for which there is no need to prescribe outside these 
recommendations 
o They may not receive PCT support if they prescribe outside these recommendations 
o These sources are research-based, up-to-date and relevant to local health needs 
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• Perceived their prescribing decisions to be influenced by some patient issues (e.g. patient 
concordance and quality of life) but not by patients’ requests for medicine 
• Are more recently qualified to prescribe than participants loading to other perspectives, are 
more likely to be nurses and, perhaps, prescribe more infrequently than others 
 
8.6 Perspective Two – ‘Patient-Centred Driven Prescribers’ 
Ten participants’ q-sorts defined Perspective Two (P2). These 10 participants consisted of four 
nurses and six pharmacists. P2 represented 14% of the total variance of the rotated correlation 
matrix. There were seven confounders loading significantly on to P2 comprising four nurses and 
three pharmacists.   
 
Three statements differentiated P2 from other perspectives. Each of the statements began with ‘my 
prescribing decisions are influenced by’. The following statements received a significantly higher 
z-score on P2 than they did on the other four perspectives: “whether the decision fulfils the 
patient’s expectations” (statement 35, 0.83**) and “whether the patient will be satisfied with the 
prescribing decision” (statement 36, 1.42*). The following statement received a significant lower z-
score on P2 than it did for the other four perspectives: “whether the prescribing decision occurs 
before a weekend or bank holiday” (statement 23, -1.89**).  
 
The six statements with the highest positive z-score and the six statements with the lowest negative 
z-score for P2 are provided in Table 8-9. Each of the statements began with ‘my prescribing 
decisions are influenced by’ 
 
Table 8-9: P2: 6 Statements with Highest Positive Z-Score and 6 Statements with Highest Negative Z-Score 
20 “…national guidance”                                              1.789 
19 “…local or PCT protocols or guidance” 1.625 
13 “…the cost of the decision to the NHS” 1.607 
16 “…the anticipated concordance of the patient” 1.473 
36 “…whether the patient will be satisfied with the prescribing 
decision” * 
1.424 
8 “…information from the medicines management team” 1.370 
23 “…whether the prescribing decision occurs before a weekend or 
bank holiday” ** 
-1.890 
6 “…advice from academic based practitioners” -1.520 
4 “…advice from other NMPs” -1.494 
22 “…whether I feel I have sufficient time during the consultation” -1.206 
7 “…advice from non-prescribing HCPs” -1.162 
11 “…other NMPs’ prescribing behaviour” -1.120 
** 99% significance, * 95% significance 
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8.6.1 Interpretation of P2 
Participants loading to P2 agreed that their prescribing decisions were influenced by “the 
anticipated concordance of the patient” (statement 16, 1.473). Participants loading to P2 agreed 
significantly more, than other participants loading to other perspectives, that their prescribing 
decisions were influenced by “whether the decision fulfils the patient’s expectations” (statement 
35, 0.83**) and by “whether the patient will be satisfied with the prescribing decision” (statement 
36, 1.42*). The agreement with these two statements suggests that the participants loading to P2 are 
patient-centred driven prescribers.   
 
In Study One, it was apparent that NMPs wished to maximise patient satisfaction to increase the 
patients’ adherence with the treatment. This is also true of participants loading to P2. This is 
illustrated by the following comment: 
 
(s36) “If the patient is not in full concordance with you when deciding on therapy then it will have 
a detrimental effect on outcome” (Diabetes Specialist Nurse 032, Perspective Two and Perspective 
Three, Study 3) 
 
The placement of statement 16, “the anticipated concordance of the patient” (statement 16, 1.473), 
which was in the top four statements for this perspective, gives weight to this argument. However, 
it is important to note that this statement was also placed in the top six statements for two of the 
other perspectives (P1, P2). Participants in Study One also discussed how patient adherence 
reduced wasted prescriptions and medicine. It may be that participants loading to P2 also wish to 
satisfy patients to improve adherence and avoid waste. Statement 13, “the cost of the decision to 
the NHS”, received a higher z-score on this perspective compared with other perspectives. This 
suggests that cost motives partly underlie these participants desire to satisfy patients. Participants 
loading to P2 agreed more with statement 38, “what impact the decision will have on my future 
relationship with the patient” (statement 38, 0.63) than participants loading to three other 
perspectives (P1, P3 and P4). It may be that these participants are concerned about their future 
relationship with the patient when prescribing. 
 
It is noteworthy that participants loading to P2 agreed with statement 35, “whether the decision 
fulfils the patient’s expectations” (statement 35, 0.83**) and statement 36, “whether the patient will 
be satisfied with the prescribing decision”. In the cognitive interviews fulfilling patients’ 
expectations was generally regarded as negative as it was thought to be succumbing to patient 
pressure for inappropriate prescriptions. It is conceivable that participants loading to P2 interpreted 
the meaning of this statement in a similar way to statement 36. This might explain why it also 
received a high positive z-score. However, it is also conceivable that participants loading to P2 
simply wish to avoid displeasing the patient. 
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Participants loading to P2 agreed that their prescribing decisions were influenced by “national 
guidance” (statement 20, 1.789) and “local or PCT protocols or guidance” (statement 19, 1.625). 
“Information from the medicines management team” (statement 8, 1.370) also received a high 
positive z-score. Participants loading to P2 also agreed that their prescribing decisions were 
influenced by “the cost of the decision to the NHS” (statement 13, 1.607). Although this statement 
did not differentiate P2 from other perspectives, the z-score for this perspective was higher 
compared to the z-score for this statement for three other perspectives (P1, P2, and P5) and 
received a high positive z-score compared with other statements for P2. This suggests that 
participants loading to P2 believe their prescribing decisions are influenced by cost more than some 
participants loading to other perspectives. A few of the comments provided by participants reflect 
this view: 
 
(s13) “We need to have a national responsibility for what we prescribe. 20% of the entire NHS 
spend is on drugs. We need to ensure value for money” (Practice Pharmacist 008, Perspective 
Two, Study 3) 
 
Some of the logistical statements, discussed in Section 8.4 of this chapter, were placed in the 
bottom six statements for this perspective. Some of the statements relating to the advice and 
recommendations of colleagues, discussed in Section 8.4, were also placed in the bottom six 
statements. Other statements concerning the advice and recommendations of other prescribers did 
not generally have high positive or negative z-scores for P2. With the exception of statement 7, 
“other NMPs’ prescribing behaviour” (statement 7, -1.162) statements concerning prescribing 
culture and personal experience did not have high positive or negative z-scores for P2. 
Furthermore, participants significantly loading to P2 did not strongly agree or disagree that their 
prescribing decisions were influenced by information and training sources. 
 
8.6.2 Demographic Profile of Participants Loading to P2 
Nearly one fifth of nurses with a defining sort loaded significantly to P2 compared with almost two 
fifths of pharmacist prescribers. One quarter of nurse cofounders loaded to P2 compared with 
nearly half of pharmacist confounders. This suggests P2 represents both nurses and pharmacist 
prescribers’ views. However, arguably, P2 represents pharmacist prescribers to a greater extent. 
Slightly more pharmacists qualifying to prescribe from 2006 onwards loaded to P2 compared with 
other perspectives. However, this was only 38% loading to P2 compared with 31% loading to P1. 
Slightly under half of those participants with high levels of experience in their prescribing field (10 
years or more) loaded to P2. This compares with one quarter loading to P1. Participants loading to 
P2 may feel confident with prescribing, because of their experience, and are therefore able to adapt 
their prescribing to meet patients’ needs. 
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8.6.3 Summary: Key Attributes of P2 
Participants loading to P2: 
• Perceived their prescribing decisions to be driven by patient factors such as patient 
concordance, patients’ expectations and patients’ satisfaction levels. The importance of patient 
issues is driven by: 
o Participants desire to improve concordance and avoid waste 
o Participants desire to maintain a good relationship with their patient 
• Are relatively more experienced in their prescribing field compared with other participants and 
are slightly more likely to be pharmacist prescribers 
 
8.7 Perspective Three – ‘Prescribing Culture Driven Prescribers’ 
Six participant’s q-sorts defined P3. These six participants consisted of two nurses and four 
pharmacists. P3 represented 9% of the total variance of the rotated correlation matrix. There were 
nine confounders loading significantly to P3 comprising six nurses and three pharmacists.  
 
Six statements differentiated P3 from other perspectives. Each of the statements began with ‘my 
prescribing decisions are influenced by’. The following statements received a significantly higher 
z-score on P3 than they did on the four other perspectives: “what the patient asks for in the 
consultation” (statement 33, 0.03**), “whether the potential prescribing decision has been 
established amongst other prescribers” (statement 25, 1.93**) and “the level of success I have 
personally experienced with similar prescribing decisions in the past” (statement 24, 2.10**). The 
following statements received a significantly lower z-score on P3 than they did on the other four 
perspectives: “national prescribing centre” (statement 20, 0.75**), “the prescribing practice of 
hospital/secondary care based practitioners” (statement 12, -1.40**), “the anticipated impact the 
prescribing decision will have on other services or health care professionals outside own service” 
(statement 14, -1.64*).  
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The six statements with the highest positive z-score and the 6 statements with the lowest negative 
z-score for P3 are provided in Table 8-10. Each of the statements began with ‘my prescribing 
decisions are influenced by’. 
 
Table 8-10: P3: 6 Statements with Highest Positive Z-Score and 6 Statements with Highest Negative Z-Score 
24 “…the level of success I have personally experienced with similar 
prescribing decisions in the past” ** 
2.096 
25 “…whether the potential prescribing decision is established amongst 
other prescribers” ** 
1.931 
26 “…whether the prescribing decision is an accepted practice amongst 
other prescribers” 
1.931 
20 “…national guidance” 1.629 
16 “…the anticipated concordance of the patient” 1.505 
42 “…the effect of the prescribing decision on the patient’s quality of 
life” 
1.466 
14 “…the anticipated impact the prescribing decision will have on other 
services or HCPs outside own service” * 
-1.639 
22 “…whether I feel I have sufficient time during the consultation” - 1.613 
12 “…the prescribing practice of hospital/secondary care practitioners” 
** 
- 1.405 
41 “…the patient’s financial situation” - 1.375 
23 “…whether the prescribing decision occurs before a weekend or 
bank holiday” 
-1.026 
34 “…what would be best for the patient’s relatives or carers” - 1.024 
** 99% significance, * 95% significance 
 
8.7.1 Interpretation of P3 
Statement 24, “the level of success I have personally experienced with similar prescribing decisions 
in the past” (statement 24, 2.096**), statement 25, “whether the potential prescribing decision has 
been established amongst other prescribers” (statement 25, 1.931**) and statement 26, “whether 
the potential prescribing decision is an accepted practice amongst other prescribers” (statement 26, 
1.931) received the three highest z-scores for this perspective. The z-score of the first two 
statements significantly differentiated P3 from other perspectives. Participants’ response to 
statement 24 suggests that these prescribers’ prescribing decisions were influenced by the outcomes 
of their own professional experience. One participant that placed statement 24 in their top two 
statements commented: 
 
“If it works continue, if it doesn't change” (Community Pharmacist 003, Perspective Three, Study 
3). 
 
Participants loading to P3 perceived their prescribing to be influenced by whether the practice is 
‘established’ and ‘accepted’ amongst other prescribers. In Study One NMPs judged whether the 
prescribing practice was ‘established’ by the length and extent of its use amongst other prescribers 
and by the available research evidence. Whether the practice was ‘accepted’ was judged on NMPs’ 
perception of the views and behaviours of other prescribers about the prescribing practice (see 
Section 7.5.2 for further information). Participants loading to P3 can be considered prescribing 
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culture driven prescribers because they are influenced by their own and others’ prescribing 
behaviour and experiences. This argument is supported by a non-significant trend as the z-score for 
statement 9, “the prescribing behaviour of others in my service, group, clinic, etc” (statement 9, 
0.51), statement 10, “GPs’ prescribing behaviour” (statement 10, 0.08) and statement 11, “other 
NMPs’ prescribing behaviour” (statement 11, 0.01) were highest for P3 in comparison with other 
perspectives.  
 
Comments provided by participants loading to P3 illustrate the influence prescribing culture has on 
their own prescribing. For instance, a specialist nurse for palliative care commented that others’ 
experiences of using off-license drugs can be useful: 
 
(s25) “In palliative care some drugs are used off-licence and although can be well documented, 
other's experience of using them can be useful” (Specialist Nurse Palliative Care 019, Perspective 
Three, Study 3) 
 
One nurse practitioner mentioned how they would draw on others’ experience and behaviour as 
they have limited prescribing experience themselves: 
 
(s25) “I am aware that my prescribing is limited and am always keen to seek guidance” (Nurse 
Practitioner for GP Surgery 027, Perspective Three, Study 3) 
 
A quote from an OOHs and practice pharmacist illustrates how their prescribing is influenced by 
prescribing culture, particularly when the decision is not led by national guidance: 
 
(s9) “We work as a team and where I need to make a decision that isn't led by national guidance 
(and reflected in our own protocols) the next biggest influence is what the other trusted members of 
the team normally do” (OOHs Practitioner and Practice Pharmacist 013, Perspective Two and 
Three, Study 3) 
 
One community pharmacist (003, Perspective Three, Study 3) simply said that “best practice is 
important”. This suggests that participants loading to P3 are keen to adhere to prescribing ‘norms’.  
 
Participants loading to P3 did not feel their prescribing decisions were influenced by hospital or 
secondary care practitioners. Statement 12, “the prescribing practice of hospital/secondary care 
practitioners”, received a significantly lower z-score on P3 compared with its z-scores on other 
perspectives (statement 12, -1.405**). The low z-score could indicate that these participants have 
limited contact with these practitioners. However, a comment from an OOHs and practice 
pharmacist suggests that instead, hospital and secondary care practitioners’ prescribing behaviour 
challenges other prescribing ‘norms’: 
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“(s12) Secondary care does not directly influence my prescribing, more often I tend to question the 
use of certain drugs” (OOHs and Practice Pharmacist 015, Perspective Three, Study 3) 
 
 
It is not exactly clear why some NMPs might feel that hospital and secondary care practitioners’ 
prescribing behaviour challenges other prescribing norms. However, in Study One NMPs said they 
would seek input from hospital and secondary care doctors in specialist cases. Participants taking 
part in Study Three were asked to complete the exercise for their normal patient group. This 
suggests that hospital and secondary care practitioners influence NMPs in specialist cases but do 
not influence their normal practice. 
 
Some patient factors such as “the effect of the prescribing decision on the patient’s quality of life” 
(statement 42, 1.466) and “the anticipated concordance of the patient” (statement 16, 1.505) were 
perceived by participants loading to P3 to influence their prescribing decisions. Other patient issues 
such as the “patient’s financial situation” (statement 41, 1-.375) and “what would be best for the 
patient’s relatives or carers” (statement 34, -1.024) were considered to influence their prescribing 
decisions less. It is noteworthy that participants loading to P3 agreed significantly more, than 
participants loading to other perspectives, that their prescribing decisions were influenced by “what 
the patient asks for in the consultation” (statement 33, 0.03**). Although the z-score was modest 
there is an argument that participants loading to P3 are influenced more by other people, this 
includes both patients and colleagues.   
 
Participants loading to P3 did not agree that their prescribing decisions were influenced by “the 
cost of the decision to the NHS” (statement 13, -0.97). This statement received the lowest z-score 
on P3 in comparison with its z-score on other perspectives. A comment from one pharmacist 
loading to P3 illustrates the apparent rejection of cost as source of influence on their prescribing 
decisions: 
 
“The most important thing is the patient - talk of cost to the NHS winds me up the wrong way!” 
(Practice Pharmacist 012, Perspective Three, Study 3) 
 
Other than “national guidance” (statement 20, 1.629) there were no other regulatory statements 
placed in the top six statements for P3. Generally, participants loading to P3 did not either strongly 
agree or disagree that their prescribing decisions were influenced by training and information 
sources. Statement 31, “relevant updates and information from the national prescribing centre” 
(statement 31, 0.75**) did however receive a significantly lower z-score on P3 compared to its z-
score on other perspectives. Participants loading to P3 appear to reject information sources and 
regulatory influences in favour of their own experience and the prescribing culture. 
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Participants significantly loading to P3 did not strongly agree or strongly disagree that their 
prescribing decisions were influenced by advice and recommendations from colleagues. Many 
logistical statements, discussed in Section 8.4 of this chapter, were also placed in the bottom six 
statements.  
 
8.7.2 Demographic Profile of Participants Loading to P3 
P3 represents both nurses and pharmacists prescribers. All pharmacists loading to P3 qualified to 
prescribe from 2006 onwards whereas all nurses loading to P3 qualified to prescribe from 2003 to 
2005. Very few participants with high or moderate levels of clinical experience within their field 
loaded to P3. The relative inexperience of participants loading to P3 might explain why prescribing 
culture is a key source of influence on their prescribing. However, it is more difficult to explain 
why these prescribers might draw on their own relatively limited experience when prescribing. This 
is discussed further in Section 8.10 of this chapter.  
 
8.7.3 Summary: Key Attributes of P3 
Participants loading to P3: 
• Perceived their prescribing decisions were influenced by their own past prescribing 
experiences, the accepted and established prescribing practices and, with the exception of 
hospital and secondary care based practitioners, the prescribing behaviour of others 
• Perceived their prescribing decisions to be influenced by patient issues such as concordance, 
quality of life, and what the patient wants 
• Perceived regulatory influences, particularly PCT guidelines, protocols and formularies and 
cost, to influence their prescribing decisions less than other sources of influence 
• Have relatively limited experience in their prescribing field compared with other participants 
loading to other perspectives 
 
8.8 Perspective Four –‘Evidence-Based Driven Prescribers’ 
Seven participants’ q-sorts defined P4. These seven participants consisted of four nurses and three 
pharmacists. P4 represented 12% of the total variance of the rotated correlation matrix. There were 
nine confounders loading significantly to P4 comprising six nurses and three pharmacists.  
 
Four statements differentiated P4 from other perspectives. Each of the statements began with ‘my 
prescribing decisions are influenced by’. The following statements received a significantly higher 
z-score on P4 than they did on the other four perspectives: “national prescribing centre” (statement 
31, 2.02*), “advice from GPs” (statement 2, 0.93**), “advice from hospital/secondary care 
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practitioners” (statement 5, 1.00**). The following statement received a significantly lower z-score 
on P4 than it did for other four perspectives: “GPs’ prescribing behaviour” (statement 10, -1.48*).  
 
The six statements with the highest positive z-score and the six statements with the lowest negative 
z-score for P4 are provided in Table 8-11. Each of the statements began with ‘my prescribing 
decisions are influenced by’ 
 
Table 8-11: P4: 6 Statements with Highest Positive Z-Score and 6 Statements with Highest Negative Z-Score 
31 “…relevant updates and information from the national prescribing 
centre” * 
2.016 
13 “…the cost of the decision to the NHS” 1.616 
20 “…national guidance” 1.478 
30 “…relevant updates and information from NHS Clinical Knowledge 
Summaries” 
1.313 
17 “…the recommendations of the BNF or other formularies” 1.230 
29 “…what I have read about in academic and professional journals” 1.228 
34 “…what would be best for the patient’s relative or carers” -1.546 
10 “…GPs’ prescribing behaviour” * -1.482 
22 “…whether I feel I have sufficient time during the consultation” -1.402 
38 “…what impact the decision will have on future relationship with the 
patient” 
-1.342 
35 “…whether the decision will fulfil the patient’s expectations” -1.037 
9 “…the prescribing behaviour of others in my service, group, clinic, 
etc” 
-1.036 
** 99% significance, * 95% significance 
 
8.8.1 Interpretation of P4 
Participants loading to P4 perceived their prescribing decisions to be influenced by information 
sources such as “relevant updates and information from the national prescribing centre” (statement 
31, 2.016*), “relevant updates and information from NHS clinical knowledge summaries” 
(statement 30, 1.313) and “what I have read about in academic and professional journals” 
(statement 29, 1.228). Participants loading to P4 considered these information sources as 
“evidence-based”, “concise”, “up-to-date” and “useful”. The two following comments illustrate 
this attitude: 
 
(s30) “Always use CKS when it was prodigy and continued as a prescriber, rarely lets you down” 
(Practice Pharmacist 010, Perspective Three and Four, Study 3) 
 
(s31) “I have used NPC material for many years I know it is impartial evidence-based practical 
and concise” (Practice Pharmacist 001, Perspective Two and Four, Study 1) 
 
Participants loading to P4 also agreed that their prescribing decisions were influenced by “advice 
from GPs” (statement 2, 0.93*) and “advice from hospital/secondary care practitioners” (statement 
5, 1.00**) significantly more so than participants loading to other perspectives. Advice from GPs 
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and hospital and secondary care practitioners was valued. Hospital and secondary care advice was 
considered particularly useful where it coincided with patient admission to hospital. 
 
(s5) “My patients are often in and out of hospital and I base many of my decisions on advice given 
by secondary care consultants” (Community Matron 034, Perspective Four, Study 3) 
 
Participants loading to P4 agreed that their prescribing decisions were influenced by “national 
guidance” (statement 20, 1.478) and “the recommendations of the BNF or other formularies” 
(statement 17, 1.230). However, they did not agree with these statements more than participants 
loading to other perspectives. Participants loading to P4 considered these guidelines, protocols and 
formularies to be “evidence-based”. 
 
(s17) “Evidence-based up-to-date research” (Nurse Practitioner for GP Surgery 017, Perspective 
Four, Study 3) 
 
(s20) “Carry out evidence-based practice” (Practice Pharmacist 014, Perspective Four, Study 3) 
 
(s20) “Evidence-based = NICE” (Practice Pharmacist 011, Perspective Four and Four One, Study 
3) 
 
(s17) “Ensures that I am kept up to date with evidence-based clinically validated safe drug 
treatments” (Advanced Practitioner 031, Perspective Four and One, Study 3) 
 
Participants loading to P4 wanted to use sources they considered evidence-based. This led the 
participants loading to P4 to be labelled evidence-based driven prescribers. Participants loading to 
P4 agreed that their prescribing decisions were influenced by “the cost of the decision to the NHS” 
(statement 13, 1.616). The z-score on this statement did not differentiate P4 from other 
perspectives. However, these participants’ responses to these statements suggests that regulatory 
factors influence their prescribing decisions. The absence of local and PCT related statements in 
the top six statements for P4 suggests that these participants are influenced more by national 
regulatory factors than local or PCT regulation. 
 
Participants loading to P4 desire for evidence-based prescribing led them to reject prescribing 
culture as an influence on their own decisions. The z-scores for behaviour and experience 
statements were lower for P4 compared with the other perspectives. Participants loading to P4 are 
happy to seek advice from GPs and hospital and secondary care practitioners but do not feel they 
are influenced by others’ prescribing behaviour. One community nurse said they do not follow 
GPs’ prescribing behaviour because GPs do not adhere to guidelines. This attitude was also 
expressed by a number of participants in Study One (see Section 7.5.1). The perception that GPs do 
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not adhere to guidelines appears to be the underlying motivation for some NMPs’ rejection of GPs’ 
prescribing behaviour as a source of influence on their own. 
 
(s10) “Although I treat patients in conjunction with GPs I follow guidelines that many of them do 
not” (Community Nurse 034, Perspective Four, Study 3) 
 
Participants loading to P4 were clear that prescribing culture would not influence them. This 
attitude is characterised by the comment of one participant loading to P4: 
 
(s25) “Though as nurse prescribers we do prescribe in similar way as mentioned above, I  would 
not base all my prescribing practice on what my colleagues prescribe” (Nurse Practitioner for GP 
Surgery 017, Perspective Four, Study 3) 
 
One participant, in response to statement 9 “the prescribing behaviour of others in my service etc”, 
commented: 
 
(s9) “My decisions are influenced not by 'hearsay' but by evidence that has been validated” 
(Advanced Practitioner 031, Perspective Four and One, Study 3) 
 
This comment again highlights participants loading to P4 focus on evidence. Statements relating to 
patients were noticeably absent from the six statements with the highest positive z-scores on P4. 
Statement 38, “what impact the decision will have on my future relationship with the patient” 
(statement 38, -1.342), statement 34, “what would be best for the patient’s relatives or carers” 
(statement 34,-1.546) and statement 35, “whether the decision will fulfils the patient’s 
expectations” (statements 35, -1.037) were placed in the bottom six statements for this perspective. 
This suggests that participants loading to P4 are less influenced by patients when making 
prescribing decisions than other participants. Some of the logistical statements, discussed in 
Section 8.4 of this chapter, received the lowest negative z-scores.  
 
8.8.2 Demographic Profile of Participants Loading to P4 
P4 represents both nurses and pharmacist prescribers’ perspectives on prescribing influences. A 
slightly higher proportion of all participants qualifying to prescribe between 2003 and 2005 loaded 
to P4. However, it was only 29% loading to P4 compared with 21% loading to P1 and P2. Only a 
small number of participants who qualified to prescribe from 2006 onwards loaded to P4. 
Participants loading to P4 are therefore slightly more likely to have qualified to prescribe earlier 
than other participants.  
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8.8.3 Summary: Key Attributes of P4 
Participants loading to P4: 
• Perceived their prescribing decisions to be influenced by information sources (e.g. research 
findings, information from the NPC, and NHS CKS) and national guidelines and formularies. 
Participants considered these sources to be, above everything, evidence-based 
• Sought advice from GPs and hospital and secondary care based practitioners 
• Perceived their prescribing decisions to be influenced by patient factors less than participants 
loading to other perspectives 
• Rejected prescribing culture and professional experience as an influence on their own decisions 
• Are slightly more likely to have qualified to prescribe earlier than other participants 
 
8.9 Perspective Five – ‘Long-term Impact and Logistical Prescribers’ 
Three participants’ q-sorts defined P5. These three participants comprised one nurse and two 
pharmacists. However, one pharmacist that helped to define this perspective loaded negatively to 
P5. In total, P5 represented 5% of the total variance of the rotated correlation matrix. There were no 
confounders loading significantly on to P5.  
 
Seven statements differentiated P5 from other perspectives. Each of the statements began with ‘my 
prescribing decisions are influenced by’. The following statements received a significantly higher 
z-score on P5 than they did on the four other perspective: “the anticipated impact the prescribing 
decision will have on my service in the future (follow-up appointments, monitoring etc)” 
(statement 15, 1.88*), “the anticipated impact on the prescribing decision on future presentations to 
my service from the patient in question or other patients” (statement 39, 1.26**), “whether I feel I 
have sufficient time during the consultation” (statement 22, 0.57**), “the prescribing practice of 
hospital/secondary care practitioners” (statement 12, 0.93**). The following statements received 
significantly lower z-scores on P5 than they did for the four other perspectives:  “national 
guidance” (statement 20, -1.42**), “the recommendations of the BNF or other national 
formularies” (statement 17, -1.09**) and “advice from non-prescribing health care professionals” 
(statement 7, -2.21**).  
 
The six statements with the highest positive z-score and the six statements with the lowest negative 
z-score for P5 are provided in Table 8-12. Each of the statements began with ‘my prescribing 
decisions are influenced by’. 
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Table 8-12: P5 6 Statements with Highest Positive Z-Score and 6 Statements with Highest Negative Z-Score 
15 “…the anticipated impact the prescribing decision will have on my 
service in the future (follow-up appointments, monitoring etc)” ** 
1.883 
40 “…the anticipated impact of the prescribing decision on the wider 
community” ** 
1.693 
26 “…whether the potential prescribing decision is an accepted practice 
amongst other prescribers” 
1.636 
29 “…what I have read about in academic and professional journals” 1.302 
39 “…the anticipated impact of the prescribing decisions on future 
presentations to my service from the patient in question or other 
patients” 
1.264 
31 “…relevant updates and information from the national prescribing 
centre” * 
1.238 
4 “…advice from other NMPs” -1.537 
11 “…other NMPs’ prescribing behaviour” -1.475 
20 “…national guidance” ** -1.425 
6 “…advice from academic based practitioners” -1.350 
41 “…the patient’s financial situation” -1.180 
17 “…the recommendations of the BNF or other formularies” ** -1.089 
** 99% significance, * 95% significance 
 
8.9.1 Interpretation of P5 
As few participants loaded positively to P5 there was difficultly characterising this perspective. 
There were however two main findings noteworthy of discussion. Firstly, the prescribing of 
participants loading to P5 appeared to be influenced by long-term considerations more than 
participants loading to other perspectives. For example, some logistical statements received higher 
z-scores compared with the z-scores on P5 than they did on other perspectives. Other logistical 
statements also received significantly higher z-scores on P5 compared with their z-scores on other 
perspectives. 
 
The second noteworthy point is that participants loading to P5 did not agree that their prescribing 
decisions were influenced by regulatory factors. Statements such as “national guidance” (statement 
20, -1.42**) and “the recommendations of the BNF or other formularies” (statement 17, -1.00**) 
received significantly lower z-scores on P5 compared with their scores on other perspectives. 
 
There is little explanation in the comments provided by the participants loading to P5 as to why 
they believe their prescribing decisions were influenced by long-term issues and logistical issues 
but not by regulatory factors (e.g. national guidelines). However, the inclusion of this perspective 
in the analysis is important to highlight that some NMPs feel very differently about the influences 
on their prescribing. The inclusion of one participant that loaded negatively to the perspective is 
noteworthy as it indicates that the perspective is in fact the complete opposite to that held by other 
participants. In fact, in addition to the one participant that loaded negatively to this perspective, the 
correlation values of 26 other participants on this perspective were negative. This suggests that this 
perspective is by the far the most controversial of those emerging from this analysis.  
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As only three participants loaded to P5, one of which loaded negatively there is very little 
information about the profile of the participants loading to P5. 
 
8.9.2 Summary: Key Attributes of P5 
Participants loading to P5: 
• Were difficult to characterise because of their limited number 
• Perceived their prescribing decisions to be influenced by long-term logistical issues and other 
logistical issues (e.g. time in the consultation) 
• Perceived their prescribing decisions to be influenced less by national guidelines and 
formularies than participants loading to other perspectives 
 
8.10 Discussion 
Study Three used the Q-method to study prescribing influences. A reflection of the method is given 
in the next part of this section. Through exploring the perspectives generated from Study Three it 
was possible to reflect on similarities and differences between prescribers in terms of the factors 
they perceive influence their prescribing decisions. The method also facilitated an understanding of 
the relative influence of factors on NMPs’ decisions. This study has contributed to previous 
understanding by providing a systematic means to study differences between NMPs. Such methods 
have not been previously employed in this field. The findings are discussed in this section in terms 
of the current literature, with a particular focus on EBM and patient-centred medicine.  
 
PCT driven prescribers (P1) were more likely to be nurses, more recently qualified and prescribing 
less frequently compared with others. PCT driven prescribers (P1) perceived their prescribing 
decisions to be influenced by guidelines, protocols and formularies, particularly at the PCT level. It 
is important to note that other prescribers, loading to other perspectives, also perceived their 
decisions to be influenced by these sources. However, P1 prescribers were differentiated by their 
motivation to adhere to these sources because of their belief that the PCT expects them to prescribe 
within these recommendations, their prescribing decisions may be open to question from their PCT 
if they prescribe outside these recommendations and they may not receive PCT support if they 
prescribe contrary to these recommendations. The PCT driven prescribers (P1) also claimed they 
manage relatively simple patient cases where there is no need to prescribe outside PCT and local 
recommendations. Although the PCT driven prescribers (P1) considered these sources to be 
research-based the ‘safety’ that these sources provided for them personally underlined their 
motivation for following their recommendations. Nurses believe that working outside the 
traditional remit of their practice increases liability, but operating within standard protocols affords 
‘protection’ in case anything should go wrong (Rycroft-Malone et al. 2008). Nurses do admit 
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however that working to protocols might give them a ‘false-sense of security’ (Rycroft-Malone et 
al. 2008). It is important that NMPs, when following the recommendations of protocols, guidelines 
and formularies, still fully understand the rationale for their decision. After all, whilst following 
guidelines, protocols and formularies may be the best option for a NMP it may not represent the 
most appropriate prescribing decision for the patient. 
 
The PCT driven prescribers (P1) also perceived their decisions to be influenced by patients’ quality 
of life and issues of concordance. However, their desire to conform to PCT guidelines, protocols 
and formularies led them to reject patients’ requests for medicine they regarded as inappropriate 
and therefore contrary to these recommendations. There is clearly a risk that a prescriber might 
adhere to such recommendations but fail to individualise patient care. Indeed, in other research, 
Fontana et al. found that US nurse prescribers used adherence to protocols and policies to ‘avoid’ 
treating chronic pain despite patients’ clinical need (Fontana et al. 2000). The behaviour of the PCT 
driven prescribers (P1) could be considered ‘prescriber-centred’ rather than ‘patient-centred’ as 
they reject patients’ requests and prescribe within guidelines, protocols and formularies because of 
personal concerns regarding ‘safety’. It may be the relative inexperience of these prescribers, both 
because of their lack of prescribing experience post-qualification and the low number of 
prescriptions they issue per week, which promotes this behaviour. The concept of patient-centred 
medicine is a key concept in modern medical care (Bensing 2000). Bensing states patient-centred 
medicine ‘puts a strong focus on patient participation in the clinical decision making by taking into 
account the patient’s perspective, and tuning medical care to the patient’s needs and preferences’ 
(Bensing 2000, pg. 17). There is a strong argument that the PCT driven prescribers’ (P1) rejection 
of some patient influences on their prescribing makes them less patient-centred than other NMPs in 
this research. This issue is discussed further in Chapter Nine. 
 
The patient centred prescribers (P2) believed their prescribing decisions to be influenced by patient 
issues such as concordance, patients’ expectations and patients’ satisfaction levels. Participants 
characterising this perspective wished to increase adherence to medicine, reduce wasted 
prescriptions and wanted to maintain good patient relations. Doctors also make prescribing 
decisions that prioritise patients’ needs rather than reflect issues such as cost and the 
recommendations of guidelines (Prosser and Walley 2006; Wood et al. 2007). However, it is 
generally more experienced and more senior doctors that make choices such as these (Higgins and 
Tully 2005; Lewis 2006). This research also indicates that NMPs, both nurses and pharmacists, 
with relatively high levels of experience in their prescribing area, despite relatively low prescribing 
experience, feel confident to take a holistic or patient-centred approach to prescribing. This finding 
has not previously been reported for those NMPs with full prescribing rights but echoes previous 
findings that found experienced CNPs prescribe contrary to guidance in favour of patient factors 
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(Hall et al. 2004). Using this argument, it may be the relative inexperience and lack of prescribing 
experience of the PCT driven prescribers (P1) that resulted in their seemingly prescriber-focused 
rather than patient-centred approach to prescribing. 
 
In contrast to the patient-centred prescribers (P2) the evidence-based driven prescribers (P4), which 
represented both nurses and pharmacists, were concerned about adhering to the principles of EBM 
when prescribing. As outlined previously (see Section 2.4.2.7), EBM has been defined as the 
‘conscientious, explicit, and judicious use of current best evidence in making decisions about the 
care of individual patients’ (Sackett et al. 1996, pg. 71). EBM applies to all aspects of medical care 
including prescribing decisions. The principles of EBM have found to be attractive for prescribers 
and represent the ‘ideal’ (Lewis 2006). The majority of nurses, pharmacists and GPs feel it is their 
‘duty’ to keep up-to-date with current best evidence relating to practice (O'Donnell 2004). This is 
perhaps not surprising given the focus on EBM in the NHS through bodies such as NICE. The 
comments from evidence-based driven prescribers (P4) indicated their desire to conform to the 
principles of EBM. The words ‘evidence-based’ were mentioned more by participants loading to 
this perspective than any other, even when similar statements were being discussed, and they relied 
on sources they considered evidence-based. These sources included research findings, information 
from the NPC, CKS and national guidelines and formularies. This research has clearly shown that 
some NMPs actively seek to conform to the idealistic principles of EBM when prescribing. The 
attractiveness of EBM is apparent for all prescribers, including doctors (Lewis 2006),  
 
Statements relating to patients were, however, noticeably absent from the top six statements chosen 
by the evidence-based driven prescribers (P4). Furthermore, some statements concerning patient 
issues were placed in the bottom six statements. Arguably the evidence-based driven prescribers 
(P4), whilst motivated by the principles of EBM, were less patient-centred than any other group of 
prescribers. It is therefore interesting to note that EBM has been described as the opposite of 
patient-centred medicine (Bensing 2000). Bensing argues that EBM and patient-centred medicine 
‘belong to different worlds’ but both strongly influence modern medical care (Bensing 2000). 
Patients’ expectations and desires for certain medicines are cited as a barrier by GPs to practising 
EBM because patients’ requests sometimes run contrary to available evidence (McColl et al. 1998). 
Doctors, both in primary and secondary care, report discomfort and ‘a sense of failure’ if they are 
unable to convince patients to accept evidence-based prescribing decisions (Lewis 2006; Lipman et 
al. 2004). The evidence-based driven prescribers (P4) prioritised evidence over patient factors but 
other NMPs, including the patient-centred prescribers (P2), prioritised patient factors over others. 
The evidenced-based driven prescribers (P4) perspective suggests there is difficulty amongst some 
NMPs converging EBM with patient-centred medicine when prescribing. This is consistent with 
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findings from the medical literature (Lewis 2006) but has not been previously discussed in the non-
medical prescribing literature. 
 
The evidence-based driven prescribers (P4) sought advice and guidance from GPs and hospital and 
secondary care practitioners. Given their determination to practise EBM it is important to 
understand where this behaviour might fit in to their perspective. It may be that, as has been found 
in other research, multiple information sources are used as a way of endorsing prescribing 
decisions (Prosser and Walley 2006). It may also be, as has been found in other research, advice 
from colleagues is sometimes preferred over research findings because it offers ‘decision-specific 
advice’ (McCaughan et al. 2002). Some doctors reject research findings because the sample used in 
the research does not reflect the patients they manage in normal clinical practice (Wood et al. 2007; 
Wood-Mitchell et al. 2008). It may be that in some cases GPs and hospital and secondary care 
practitioners offer support to NMPs in cases where other research evidence is difficult to apply to 
individual patient cases.  
 
The evidence-based driven prescribers (P4) were actively concerned with the principles of EBM 
but other NMPs in Study Three appeared to be less concerned. The PCT driven prescribers (P1) 
perceived they were influenced by many of the same sources as the evidence-based driven 
prescribers (P4) but they rarely mentioned their explicit desire to be evidence-based. The patient-
centred driven prescribers (P2) did not, by any means, reject the principles of EBM. National, local 
and PCT formularies and guidelines featured in the top perceived influences on their prescribing 
decisions. However, it was clear that these prescribers were comfortable prioritising patient issues 
in some cases. This was most likely due to their relative experience compared with other 
prescribers. 
 
The prescribing culture driven prescribers (P3) appear most weakly aligned with the principles of 
EBM. These prescribers perceived their prescribing decisions to be influenced by their past 
treatment success or failure as opposed to other factors. Professional experience is part of the EBM 
model but is not the most favoured information source. Instead, other sources, such as systematic 
reviews, meta-analysis, randomised controlled trials, cohort studies, are preferred (Akobeng 2005). 
Both doctors and CNPs cite clinical experience as important when making prescribing decisions 
(Hall et al. 2008; Luker and Kenrick 1992; Schwartz et al. 1989; Wood-Mitchell et al. 2008) and 
some doctors prioritise their own experience over other factors, such as scientific evidence and 
cost, when prescribing (Ljungberg et al. 2007; Schwartz et al. 1989; Wood-Mitchell et al. 2008). 
However, Tichelaar et al. found that it is more experienced doctors that base their prescribing 
decisions on their own clinical experience rather than less experienced doctors (Tichelaar et al. 
2010). It may be a concern, in terms of prescribing quality, that given the relative clinical 
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inexperience of the prescribing culture driven prescribers (P3), their own experience seemingly 
takes priority over other factors. However, it is also an important finding that some NMPs feel 
confident deviating from other factors, such as guidelines and formularies, in favour of their own 
experience. These prescribers also appear to be integrating their own experience with other sources 
of information.  
 
The prescribing culture driven prescribers (P3) also perceived their prescribing decisions to be 
influenced by whether the prescribing practice was ‘established’ and ‘accepted’ amongst others. 
These prescribers also agreed that their prescribing decisions were influenced by other prescribers’ 
prescribing behaviour more than other prescribers loading to other perspectives. Doctors, nurse 
clinicians and US nurse prescribers sometimes follow informal ‘rules’ or ‘traditions’ that are not 
based on clinical need or evidence when prescribing (Bishop et al. 2011; Fontana et al. 2000; 
Ljungberg et al. 2007). It may be that the prescribing culture driven prescribers (P4) are also 
adhering to prescribing ‘norms’ with little evidence-base. Interestingly, the evidence-based driven 
prescribers (P4) rejected prescribing culture as a source of influence on their own prescribing 
because of concerns regarding other prescribers’ adherence to guidelines. Those most concerned 
with the principles of EBM are keen to reject prescribing culture as a source of influence of their 
own. This might be because they are aware that replicating others’ behaviour can lead to non 
evidence-based prescribing. ‘Clinical inertia’ refers to clinicians ‘failure to deviate from established 
prescribing patterns’ (Cavazos et al. 2008). It may be, as Cavazos et al. argues, that ‘clinician 
inertia’, arguably present in the prescribing culture driven prescribers (P3), arises from their 
disagreement with guidelines or overestimation of the quality of care provided. The lack of 
statements concerning the recommendations of guidelines and formularies in the top six, and the 
apparent rejection of some information sources, gives weight to this argument. However, it may 
also be, as Fontana et al. has argued, that insufficient formal education leads nurse prescribers to 
replicate non-evidence based prescribing practices (Fontana et al. 2000). The relatively low level of 
clinical inexperience of the prescribing culture driven prescribers (P3) might encourage this 
behaviour. This finding is important and has ramifications for the training of NMPs. It may be 
important that, because the prescribing course is generic and does not focus on what to prescribe, 
NMPs receive appropriate training about prescribing in their specific clinical area. This suggestion 
is supported further because, as Study One found, current training opportunities for NMPs do not 
currently influence their prescribing decisions.  
 
Whilst the prescribing culture driven prescribers (P3) did copy others’ prescribing behaviour they 
did not perceive their prescribing decisions to be influenced by the practice of hospital and 
secondary care practitioners. Primary care prescribers’ rejection of hospital and secondary care 
prescribing practices is evident in the literature. Though not all GPs share this view, some GPs feel 
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that too many of their own prescribing decisions are determined by hospital doctors’ decisions 
(Weiss et al. 1996). GPs feel reluctant to accept recommendations from hospital and secondary care 
doctors because of the significant differences between general practice, which typically treats a 
wide range of patients with multiple conditions, and hospital practice, which typically focuses on 
one narrow disease area (Armstrong and Ogden 2006). The prescribing culture driven prescribers 
(P3) may share similar concerns as these GPs. Additionally, these prescribers might have difficulty 
contacting hospital specialists for advice as CNPs have reported (Hall et al. 2009). They might also 
have no immediate need to contact hospital and secondary care practitioners for advice because of 
the conditions they manage. When prescribing culture driven prescribers (P3) use the behaviour of 
others to guide their own it is the behaviour of those immediately around them they prioritise. 
 
Patient statements, particularly relating to quality of life and concordance, were amongst the 
statements the prescribing culture driven prescribers (P3) agreed with most. These prescribers also 
said their prescribing decisions were influenced by “what the patient wants”. These prescribers’ 
prescribing practices may not be evidence-based because patients’ requests are often not clinically 
appropriate. However, it at least demonstrates they are more patient-centred than the PCT driven 
prescribers (P1) or the evidence-based driven prescribers (P4). The relative patient-centeredness of 
each of the four perspectives is represented visually on Figure 8-1 along with the strength of 
alignment with the principles of EBM. Figure 8-1 provides a visual representation of the findings 
from Study Three. The relative distance between the circles is not to scale and the sizes of the 
circles are not meaningful. The behaviour of the evidence-based driven prescribers (P4) was most 
aligned with the principles of EBM. The PCT driven prescribers (P1) could be considered 
‘accidental’ adherers to the principles of EBM because their motivation to confirm to guidelines, 
protocols and formularies related to personal safety concerns. As discussed, it is possible the 
prescribing culture driven prescribers (P3) were least aligned with the principles of EBM because 
of the informal prescribing practices they followed. The patient-centred driven prescribers (P2) did 
not, by any means, reject the principles of EBM but patient factors took precedent. 
 
 
 
 
 
 
 
 
 
 
 200
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The long-term impact and logistical prescribers’ perspective (P5) is not presented on Figure 8-1. 
This is because of the low number of participants positively loading to this perspective and 
difficulties characterising the perspective. The long-term impact and logistical prescribers (P5) 
represented a marked difference in comparison with the views of the other prescribers loading to 
the first four perspectives in Study Three. These prescribers were influenced by long-term and 
logistical factors but largely rejected regulatory factors as a source of influence on their prescribing 
decisions. Doctors acknowledge that logistical factors, such as time during their consultations, 
sometimes influence their prescribing decisions (Buusman et al. 2007; Carthy et al. 2000). 
However, this was largely rejected as a source of influence by other NMPs in Study One, Study 
Two and Study Three. P5 is an important finding in this research because is it highlights the 
diversity in opinion amongst a select few NMPs with regards to the influences on their prescribing 
decisions. More research would however be needed to expand the understanding of this 
perspective. It is important to reflect on why this particularly unusual perspective, compared with 
the other perspectives generated from Study Three, emerged from the analysis. Ideas for further 
research, that could help explore this perspective, are discussed in Chapter Nine. 
 
Least Patient-Centred 
Most Patient-Centred 
Weakly aligned 
with the principles 
of EBM 
Strongly aligned 
with the principles 
of EBM 
Figure 8-1: Visual Depiction of the Relative Patient-Centeredness and Strength of Alignment 
with the Principles of EBM of P1, P2, P3 and P4  
 
P2 
P3 
P4 
P1 
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8.10.1 Reflections on Method 
The Q-method provided a means to study the influences on NMPs’ decisions in a way not 
previously used in the literature. The Q-method made a valuable contribution in terms of 
understanding, in a systematic way, the similarities and differences between NMPs and the 
perceived relative influence of factors on prescribing decisions made by NMPs. However, it is 
important to acknowledge the limitations of the method in relation to understanding prescribing 
influences. The limitations of the Q-method fall into four categories which are: completeness of the 
statements, interpretation of the statements, wording of the statements and interpreting the 
perspectives.  
 
If any statements regarding prescribing influences were missing from the Q-method study then 
NMPs would not be able to adequately represent their viewpoint. As discussed in Chapter Four, the 
cognitive interviews were used to assess the breadth of the statements. The statements were found 
to be satisfactory. However, one prescriber commented at the end of the survey that they could 
think of other influences on their prescribing that were not presented. Therefore, this prescriber 
may not have been able to adequately represent their view. Given the testing of the statements in 
the cognitive interviews, and the use of interviews with NMPs and the medical prescribing 
literature to design the statements, it is likely that all the main prescribing influences were included 
in the study. But it is important to acknowledge that other influences may have been missing from 
the Q-method that could have been important for a small number of prescribers. Conducting future 
Q-method studies with more homogeneous participants (e.g. practice pharmacists only) would 
make it possible to include statements more specific to an individual type of prescriber. 
 
Participants differing interpretation of the statements may have led to differing levels of agreement. 
As discussed before, the meaning of the statements was tested in the cognitive interviews. 
Additionally, the statements were designed using the language of participants in Study One. 
Despite this it is conceivable that some participants interpreted some of the statements differently. 
This issue may be particularly relevant to this research because it included prescribers from a wide 
range of settings and professional groups. It may have been that P5, which was a particularly 
unusual perspective in comparison with the others, was a product of this differing interpretation. 
However, for the statements that received high or low agreement scores there was a lot of 
consistency in the comments provided by prescribers. This suggests that prescribers interpreted the 
statements in a similar manner.  
 
As discussed previously, the wording of the statements mirrored the language of NMPs in Study 
One. This meant that ‘concordance’ was used instead of ‘adherence’ in one of the statements. 
‘Concordance’ was used by participants in Study One to mean whether the patient takes the 
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medicine. However, a more accepted definition of concordance is whether the doctor and patient 
agree therapeutic decisions that incorporate their respective views. The definition of adherence is 
the extent to which the patient’s behaviour matches the agreed recommendations from the 
prescriber. It may therefore have been more appropriate to use ‘adherence’ in the statement in 
Study Three rather than ‘concordance’ as its use is more consistent with the official definition. An 
inspection of the comments participants provided about this statement in Study Three suggests that, 
like those in Study One, participants interpreted ‘concordance’ to mean whether the patient takes 
their medicine. It is therefore unlikely to be a major issue in this research. 
 
In the Q-method survey participants were asked to reflect on their agreement with statements 
relating to prescribing influences and then to compare their agreement with the statements to their 
agreement with all of the other statements. This process assumes that all statements can be 
compared with one another. In this research, care was taken to ensure that each statement could be 
compared with all the other statements for the purpose of ranking. However, there are subtle 
differences between the statements. For instance, the patient’s financial situation might not be 
relevant for 90% of prescribers’ patients. However, when this issue is relevant NMPs may place a 
great deal of importance on it. In contrast, the recommendations of guidelines, formularies and 
protocols may have more consistent influence leading to high agreement amongst prescribers with 
the statement. Although asking NMPs to compare these statements is still relevant and the data 
produced from this is meaningful, this limitation must be considered when interpreting the results 
of Study Three.  
 
Another potential limitation of the Q-method is the subjective nature of the data interpretation 
process. As discussed in Section 8.2, the researcher used a number of different methods and criteria 
to decide on the final perspective ‘solution’ but it is important to acknowledge that there is 
subjectivity in the decisions made. Potentially, other researchers, with their own biases and views, 
might arrive at a different solution. This issue of subjectivity in this research was addressed by 
seeking the advice of more experienced researchers who examined the plausibility of the 
perspectives emerging. A detailed description of the data interpretation process and findings can 
also provide the reader with an ability to make their own assessments about the decisions that were 
made. 
 
8.11 Chapter Summary 
The purpose of Study Three, and therefore Chapter Eight, was to explore perspectives amongst 
NMPs about the influences on their prescribing decisions. In order to do this, prescribers were 
asked to order statements about prescribing influences according to their agreement or 
disagreement with the statement. Understanding the relative agreement or disagreement with the 
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statements enabled an understanding of the relative influence of these factors. By asking 
prescribers to order statements, similarities and differences between NMPs were uncovered and 
perspectives were formed. It was clear from the results that there were differences, as well as 
similarities, between NMPs with regards to the sources of influence on their prescribing decisions. 
The findings from Study Three, along with findings from others parts of the programme of 
research, are brought together in the next and final chapter of this thesis. 
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Chapter Nine – Conclusions 
_______________________________________________________________________________ 
 
The aim of this thesis was to explore the influences on the prescribing behaviour of nurse and 
pharmacist independent and/or supplementary prescribers working in primary and community care. 
Findings arising from the programme of research have been presented and discussed in separate 
chapters. This final chapter provides an overview of the key themes emerging from the research, 
reflects upon the general limitations of the research, outlines the recommendations from these 
findings and suggests areas for further research. The chapter brings the thesis to a conclusion with 
some final thoughts. 
_______________________________________________________________________________ 
 
9.1 Conclusions 
The aim of this programme of research was to explore the influences on the prescribing 
behaviour of nurse and pharmacist independent and/or supplementary prescribers working 
in primary and community care. Through Study One it became apparent that to understand the 
influences on the prescribing behaviour of these HCPs it was important to understand the 
influences, not only on their prescribing decisions, but also on whether NMPs take responsibility 
for prescribing in the first place. The remainder of the programme of research was split into two 
studies so an in-depth picture of the prescribing influences on NMPs’ behaviour could be obtained. 
The second study, conducted as part of this programme of research, examined the influences on 
whether NMPs took responsibility for making a prescribing decision or issuing a prescription for a 
patient. The third study examined in more depth the influences on NMPs’ prescribing decisions by 
seeking to identify and explore perspectives amongst NMPs.  
 
The wide range of influences on the prescribing decisions of nurse and pharmacist prescribers in 
primary and community are better understood by considering how, and in what situations, NMPs 
take responsibility for prescribing. This chapter therefore integrates the information from all 
aspects of this programme of research. This research has demonstrated the complexity and diversity 
of the influences on NMPs’ prescribing behaviour. There were many issues that the majority of 
NMPs agreed with (e.g. time pressure, competency and cautiousness). However, there were 
differences between NMPs on some of the issues discussed and these have been outlined in 
individual findings chapters. These differences created, what appeared to be, contradictions in 
NMPs’ attitudes to prescribing influences. This complex situation makes it difficult to present one 
description of the prescribing influences on NMPs that will provide a ‘one size fits all’. This 
chapter discusses some of the key themes that have emerged from the research. These key themes 
are: ‘feeling safe’, ‘keeping it simple’, ‘code of practice’ and ‘fitting in with prescribing culture’. It 
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is important to note that these headings will apply to individual NMPs to different degrees. 
However, the author argues that it is through these headings that the influences on NMPs’ 
prescribing behaviour, outlined in this thesis, can be best discussed.  
 
9.1.1 Feeling Safe 
NMPs sought feelings of personal ‘safety’ (e.g. in terms of liability issues) when prescribing. This 
influenced many areas of their prescribing practice. NMPs need for personal safety coincides with 
the anxiety many have about their prescribing duties (Latter et al. 2010). In order to feel safe NMPs 
took a cautious approach to take prescribing responsibility (Section 6.2), did not take responsibility 
when insufficiently competent (see Section 6.3.1) even when they felt pressure to do so (see 
Section 6.4.1), did not prescribe outside their perceived role (see Section 6.3.2) and did not 
prescribe when it was illegal to do so (see Section 6.3.3.2). Some NMPs used their p-formulary, or 
equivalent head-held formulary, to control the scope of their prescribing. There was evidence that 
this formulary made them feel safer and more measured in their practice (see Section 6.3.1.2). 
Study One and Study Three found that the vast majority of NMPs adhered to the recommendations 
of guidelines, formularies and protocols when making prescribing decisions. The largest 
perspective generated from Study Three, PCT driven prescribers (P1), demonstrated how for many 
prescribers, perceptions of personal safety were increased by following the recommendations of 
such sources when making prescribing decisions (see Section 8.5.1). The perception that adherence 
to these sources equates to more personal safety was more prominent amongst nurse prescribers, 
those more recently qualified as a prescriber and those prescribing more infrequently relative to 
others. Nurses’ attitudes may be encouraged, in part, by the concerns they have about legal and 
professional support. It may therefore be helpful to reassure nurse prescribers of the support they 
are entitled to (see Section 9.3).  
   
What are the implications of NMPs’ adherence to the recommendations of guidelines, formularies 
and protocols on the appropriateness of their prescribing? Whilst this research did not directly 
address this question, inferences can be drawn from the findings of this research and the available 
literature. Fontana et al. found that US nurse prescribers sometimes followed guidelines but failed 
to individualise patient care (Fontana et al. 2000). Does NMPs’ desire to prescribe within the 
recommendations of guidelines, formularies and protocols make their prescribing less adaptive to 
patients’ circumstances? Study One and Study Two found that, in fact, many NMPs did not take 
responsibility for prescribing where deviation from guidelines or formularies was required (see 
Section 6.3.4). If NMPs do not take responsibility for these cases, the influence of the 
recommendations of these sources on the prescribing decisions they do make will be high. 
Furthermore, the patient-centred prescribers’ perspective (P2) generated from Study Three 
demonstrated, with clinical experience comes more confidence in prescribing outside of these 
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recommendations in favour of patient issues. It therefore seems unlikely, in contrast to Fontana et 
al.’s findings, that patients’ needs are overlooked by NMPs. However, given NMPs’ reliance on 
guidelines, formularies and protocols it is important they reflect best available evidence, are kept 
up-to-date, are easily accessible and are clear. If NMPs cannot access the information they require 
then many are unlikely to take responsibility for prescribing.  
 
When NMPs were uncomfortable or uncertain they used strategies to improve their perceptions of 
personal safety. These involved referring the patient to a doctor, seeking advice from doctors or 
asking a doctor to issue a prescription on their behalf. Doctors also seek colleagues’ advice as a 
way to manage discomfort or uncertainty associated with prescribing (Bendtsen et al. 1999a; Di 
Caccavo and Reid 1995; Lewis and Tully 2009b). It would be interesting to further explore how 
NMPs consider interaction with colleagues impacts the legal accountability they have for the 
prescribing task. The importance of understanding this area is discussed in Section 9.4.3. Doctors 
were, in this research, found to be central to NMPs’ support network. Other NMPs were also 
important but to a lesser extent. Where such support was lacking NMPs found it difficult to 
maintain and increase their competency. It is clearly important for NMPs to have a support 
structure. Steps should be taken to ensure this is the case for all prescribers (see Section 9.3 
recommendations).  
 
Many doctors feel that working with NMPs adds significant time to their own workload because of 
the support they need to give to NMPs (Hacking and Taylor 2010). If current trends regarding the 
number of nurses, pharmacists and AHCPs qualifying to prescribe continues, as it has done (see 
Section 2.3.3.1), then the number of NMPs requiring support from doctors is likely to increase. It 
may be helpful for doctors to receive guidance in terms of how best to support NMPs (see Section 
9.3). In the longer-term, currently trained NMPs will become more experienced and will be able to 
provide support to less experienced NMPs. In the future it is feasible that NMPs could even 
become DMPs for other trainee NMPs during the prescribing training course.    
 
It is noteworthy that generally NMPs favoured doctors’ advice when prescribing. Interactions with 
other HCPs, most notably community pharmacists, when faced with prescribing difficulties were 
limited. Similarly, in both Study One and Study Three, NMPs largely rejected the influence of 
these HCPs on their prescribing decisions (see Section 7.4 and Section 8.4). It may be that NMPs 
favour advice from doctors because they help lessen the discomfort of prescribing by increasing 
feelings of personal safety. It is important to diversify the range of support NMPs receive to ensure 
undue burden is not placed on doctors, and the skills of other HCPs are utilised. Recommendations 
regarding this are provided in Section 9.3. 
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9.1.2 Keeping it Simple 
The findings of this programme of research echo the views expressed by nurse and pharmacist 
independent prescribers in other research who said that their prescribing authority does not mean 
they can manage all patients (Latter et al. 2010). Some NMPs commented that doctors should be 
risk-takers in regards to prescribing (see Section 6.2). NMPs felt it is not their role to issue repeat 
prescriptions (see Section 6.5.1). NMPs, including both nurses and pharmacists, described referring 
patients or seeking advice when prescribing for higher risk patients (see Section 6.3.4). In the case 
of nurses this extended to their avoidance of taking prescribing responsibility for high risk patients, 
when a high risk medicine needed to be prescribed, when the decision involved deviation from 
guidelines or a formulary, or a medicine prescribing off-label. Pharmacist prescribers largely 
avoided taking prescribing responsibility for patients who needed medicine prescribing off-label or 
contrary to guidelines or formularies. It can be argued that NMPs demonstrate their wish to limit 
their prescribing to more ‘simple’ patient cases and leave the more complex or more risky patient 
cases to doctors. NMPs have a simpler role in the healthcare system compared with doctors.  
 
NMPs’ desire to keep things simple impacted on the influence of other factors on their prescribing 
decisions. Guidelines, formularies and protocols are typically written for more standard and simple 
patient cases. The recommendations of these sources are less likely to apply in more complex 
patient cases. They are therefore likely to be more applicable to the types of patients NMPs 
manage. This might explain why, as discussed in Section 7.9, these sources appear to have more 
influence on NMPs than doctors. Although some NMPs described being influenced by hospital and 
secondary care doctors overall prescribing patterns (see Section 7.5.1) generally NMPs described 
only minimal contact with these practitioners (see Section 7.4.3). Clearly, if NMPs are referring 
more complex cases to doctors, rather than taking responsibility, then there will be less need to 
seek the advice of hospital and secondary care practitioners. It is important to re-state at this stage 
that this research was with NMPs in primary and community care. Clearly, this finding may not be 
applicable to NMPs in the hospital and secondary care setting. This reinforces the need for further 
research with NMPs specifically in this setting. This is discussed more in Section 9.4  This is 
because these practitioners typically manage more complex patients that cannot be managed in 
primary and community care. NMPs also often asked GPs to refer patients to hospital and 
secondary care on their behalf. This is further evidence of the simpler role they have, and appear to 
prefer, in the healthcare system. 
 
NMPs’ prescribing practice was also simple in terms of the information sources they used. 
Although there were exceptions, generally, NMPs rejected research findings and literature as an 
influence on their prescribing decisions. This was apparent from Study One (see Section 7.6.2), and 
the general positioning of the statement relating to research findings in most of the perspectives 
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generated from Study Three. Instead, NMPs preferred summarised and digested information 
sources such as guidelines, formularies, protocols and sources such as NHS CKS. For some NMPs 
there was evidence that, even if they wanted to, they did not have time to use such sources in their 
practice. However, many NMPs actively selected not to use research findings in their practice. 
There is strong evidence from this research that the vast majority of NMPs would not feel confident 
to prescribe in line with research findings if they ran contrary to current guidelines, formularies and 
protocols anyway. The lack of desire to refer to these sources may also be a reflection of the 
‘simple’ patients NMPs take responsibility for. This is because guidelines, formularies and 
protocols and other information sources are sufficient to manage most of their patients without the 
need to seek additional information. 
 
What are the implications of NMPs’ avoidance of complex or high risk patients on overall patient 
care? Weiss et al. has argued that NMPs’ discomfort with prescribing for co-morbid patients and 
those with complex poly-pharmacy could result in fragmented care (Weiss et al. 2006). Clearly 
Weiss’ concerns are, to some extent, realised in the findings of this research as NMPs did describe 
referring such patients to doctors. NMPs’ worries about prescribing for these complex or high risk 
patients could be addressed by further training and support. However, it is important to ask whether 
it is necessary for NMPs to take responsibility for such patients. After all, doctors already benefit 
from more time to manage more complex and acute patients because of non-medical prescribing 
(Stewart et al. 2009b; Watterson et al. 2009). Additionally, doctors and patients expect NMPs to 
refer if they are uncertain about an aspect of prescribing (Stenner et al. 2010; Watterson et al. 
2009). The DoH state that non-medical prescribing should lead to the more effective use of HCPs’ 
skills (Department of Health n.d.). Currently, many NMPs do not feel they have the skills to 
manage these patients. It is unlikely to be in patients’ and prescribers’ interests for NMPs to take 
responsibility for prescribing when they do not feel comfortable doing so. If the expectations of 
NMPs change then they may need further support to allow them to take responsibility for more 
complex prescribing cases.   
 
9.1.3 Code of Practice 
NMPs have a 'code of practice' which shapes what they consider acceptable prescribing behaviour. 
This code of practice leads them to reject the influence of time and patient pressures (see Section 
7.3.6 and Section 7.7.1) that, in the medical prescribing literature, have been found to contribute to 
non evidence-based prescribing (Bradley 1992a; Carthy et al. 2000; Coenen et al. 2006; Kumar et 
al. 2003; Lewis and Tully 2011; Miller et al. 1999; Petursson 2005; Stevenson et al. 1999). In this 
research NMPs rejected the notion that non-prescribing nurses led them to take responsibility for 
prescribing outside their competency, or that they influenced their prescribing decisions (see 
Section 6.4.1). NMPs rely on doctors when faced with difficult prescribing decisions. However, it 
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is interesting that they reject the influence of GPs’ behaviour on their own prescribing. Some 
NMPs said this was because GPs prescribe outside the recommendations of guidelines (see Section 
7.5.1). Most prescribers viewed the influence of many of these pressures as negative and suggested 
that succumbing to such influences would be unprofessional and irresponsible (see Section 7.3.6, 
Section 7.7.1 and Section 8.4). NMPs reported very negative feelings when they had succumbed to 
these pressures (see Section 7.3.6). This code of practice was particularly apparent in the evidence-
based driven prescribers’ perspective (P4) generated from Study Three in which prescribers 
prioritised information sources they considered to be evidence-based (see Section 8.8).  
 
It is encouraging to find that NMPs perceive they are not influenced by factors that have been 
found to contribute to non evidence-based prescribing in the literature. It is interesting that NMPs 
spontaneously compared their rejection of these influences to that of doctors who they feel are 
influenced by such sources (see Section 7.3.6 and Section 7.7.1). This research demonstrated that, 
although NMPs feel the same pressures as doctors, they respond to them differently. In some cases 
though, NMPs perpetuated pressure on doctors for prescriptions by asking them to sign 
prescriptions on their behalf. This suggests NMPs’ code of practice is at odds with their 
expectations of doctors. Indeed many nurse prescribers said it was doctors’ roles to be risk takers. It 
may be some nurse prescribers’ concerns about legal protection that encourages their rejection of 
non evidence-based practices. It may also be the criticism they have experienced or expect to 
experience from doctors and the media in cases of prescribing error (see Section 6.2) that 
encourages their rejection of non evidence-based practices. Simply, by rejecting these sources of 
influence, NMPs might feel they are doing the ‘right thing’ in regards to prescribing which is less 
likely to attract negative consequences of any kind.  
 
How does NMPs’ rejection of patient pressure on their prescribing impact on patients’ satisfaction 
level with their care? Some NMPs did say patients left dissatisfied with their decision not to issue a 
prescription. NMPs said that generally, once they explained the rationale for their decision to the 
patient, patients left satisfied (see Section 7.3.6). Some NMPs used extra consultation time they had 
available to do this. However, even more importantly, even under time pressure, NMPs created 
time to offer an explanation about their decision to the patient. The prescribers characterising the 
evidence-based driven prescribers’ perspective (P4) in Study Three appeared the most evidence-
based but least patient-centred. As a result, there is concern that some NMPs are struggling to 
adhere to the principles of EBM and patient-centred medicine. However, although NMPs might 
appear less patient-centred in their prescribing, patients seem to be still satisfied. Furthermore, 
apart from patient pressure, other patient issues such as quality of life were considered by many 
NMPs (see Section 7.3.1, Section 7.3.2). It is clearly an important finding that NMPs have found 
 210
ways to manage patient pressure as this is an issue that has dominated discussion in the medical 
prescribing literature.  
 
9.1.3 Fitting in with the Prescribing Culture 
Some NMPs copied the prescribing behaviour of other prescribers. They were also influenced by 
what they felt was ‘accepted’ and ‘established’ practice. This was apparent in some of the 
comments in Study One (see Section 7.5.1, Section 7.5.2) and was reinforced by the emergence of 
the prescribing culture driven prescribers’ perspective (P3) in Study Three. This perspective was 
characterised by clinically inexperienced prescribers influenced by their own limited experience 
and the prescribing culture of others (see Section 8.7). It is possible that the prescribing behaviour 
NMPs are following is clinically appropriate. However, research demonstrating how doctors follow 
prescribing practices, despite lack of evidence demonstrating its effectiveness (Ljungberg et al. 
2007), opens up the possibility that some NMPs are not practising evidence-based prescribing. 
Latter et al. found that nurse and pharmacist independent prescribers do not challenge others’ 
prescribing behaviour (Latter et al. 2010). It may be the fear of criticism from doctors, highlighted 
in Study Two (see Section 6.2), that results in some NMPs’ desire to ‘fit in’ and their resulting 
alignment of their own behaviour with others. Specifically, in the case of the prescribing culture 
driven prescribers (P3), it may also be the prescribers’ lack of clinical experience that reduces their 
confidence to deviate from existing prescribing culture. 
 
There is a concern, as has been found with research in the US (Fontana et al. 2000), that NMPs 
adhere to informal prescribing rules because of a lack of formal education. This research found that 
the prescribing training course has more influence on those NMPs most recently qualified (P1) (see 
Section 8.5.1). However, it was not found to have an ongoing influence in terms of supporting 
actual prescribing decisions in specific therapy areas. Other training, study days, and conferences 
were found to have a limited influence on NMPs (see Section 7.6.1). In light of these findings, it is 
understandable why some NMPs may be particularly influenced by prescribing culture as they slip 
into accepted norms that remain unchallenged. There is clearly a need in some cases for therapy-
area specific training for NMPs in clinical areas (see Section 9.3 for recommendations). However, 
it may be important that NMPs receive this training so they can increase their confidence to 
challenge others’ prescribing practices.    
9.2 Limitations of Research 
The advantages and limitations of each of the individual data collection techniques used in this 
programme of research have been discussed previously (see Section 5.1.2.5, Section 5.2.2.5, 
Section 6.7, Section 7.9.1 and Section 8.10.1). However, there were other, more general, 
 211
limitations of the programme of research. These limitations fall in to two categories, sample and 
measuring prescribing influences. 
 
The sample of this programme of research may be limited in two respects. Firstly, participants may 
have been of a certain personality type. The NMPs that selected to take part may have done so 
because they have a special interest in this area. This may mean they hold views that are not 
reflected in the wider population. However, the sample of NMPs of this research worked in 
different areas and had wide ranging levels of experience in both prescribing and their healthcare 
field. The research used snowball sampling which might have encouraged NMPs not immediately 
wishing to take part in the research to come forward. The majority of participants were not 
exceptional and did not appear to hold exceptional views. In fact, there was a high level of 
consistency between the views of NMPs and, to some extent, the views of doctors reported in the 
literature. The critical incidents discussed in Study Two were explored with NMPs through focus 
groups. This helped to assess the ‘frequency’ of the incidents and whether they were exceptional. 
 
The second limitation with regards to the sample is the limited sample size for each of the three 
studies as well as the limited geographical locations from the sample was drawn. Moreover, only a 
small number of pharmacist prescribers took part in the research. This reflects the low proportion 
of pharmacist prescribers relative to nurse prescribers in the healthcare system. This issue relates to 
external validity which has been discussed in Section 3.2.1.3. It is generally accepted that a small 
non-random sample means that the findings cannot be generalised beyond the initial sample 
population. Although a number of strategies were used in this research to help strengthen the 
external validity (e.g. providing a ‘thick-description’ and including a wide range of NMPs) further 
research in this area could employ other data collection techniques such as questionnaires and 
surveys. Such techniques have been used by others to sample the attitudes of HCPs to prescribing 
influences (Schumock et al. 2004). These data collection techniques lend themselves to collecting 
the views of random and larger samples, which in turn increases the external validity of the 
findings. Suggestions for use of such methods are provided in Section 9.4.  
 
There are issues with exploring the influences on prescribing, including prescribing responsibility 
and prescribing decisions, by simply asking prescribers what influences them. Firstly, prescribers 
may not actually be aware of the factors that influence their decisions. NMPs are not going to be 
able to verbalise the sources of influence on their prescribing if this is the case. Even if prescribers 
are aware of the influences on their decisions they might find it difficult to explain this complex 
process. Such difficulty was evident in the interviews conducted in Study One, where NMPs 
sometimes found it difficult to provide examples of prescribing processes to which they were 
referring. In this research, prescribers were provided with various means to explain the factors that 
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influence their decisions. In Study One, participants were asked to explain the factors that influence 
their decisions in their own words. Probes were sometimes used but the participants guided the 
conversations. In Study Two, participants were provided with instructions pre-interview which 
asked them to reflect on one particular aspect of prescribing. This provided a critical reflection of 
the prescribing process beyond simply asking NMPs what influences their prescribing. In Study 
Three, participants were provided with statements about prescribing influences and were asked to 
indicate their agreement with the statements in terms of their own experiences. It was intended that 
the Q-method processes, whereby statements on prescribing influences were sorted in a quasi-
normal distribution according to the participant’s agreement, mirrored the complex prescribing 
process. It is impossible to eliminate difficulty with verbalising a process such as prescribing. It is 
hoped however that the range of methods used in this research provided NMPs with a range of 
opportunities to explain the influences on their decisions. The process by which you compare the 
data from difference sources is often referred to as ‘methods triangulation’ and is considered a way 
of increasing the validity of research findings. 
 
NMPs may have been impacted by social desirability bias when discussing their prescribing 
behaviour. Social desirability bias refers to the tendency of respondents to reply in a manner that 
will be viewed favorably by others. This will generally take the form of over reporting good 
behavior or underreporting bad behavior. To reduce this potential bias all participants were 
encouraged to be honest during the interviews, focus groups and in the Q-method survey. Despite 
these efforts, it is possible that participants in this research were not completely honest in their 
views. Social desirability bias is evident in research that has focused on the influence of the 
pharmaceutical industry on doctors’ prescribing. Doctors’ self-reported behaviour suggests a 
limited influence of the industry on their prescribing (Prosser and Walley 2003) but research, 
studying changes in prescribing data and industry activity, suggests otherwise (Muijrers et al. 2003; 
Watkins et al. 2003). As discussed in Section 6.6, some participants were particularly keen to 
‘protect’ non-medical prescribing from criticism. This may have led NMPs to over report good 
behaviour. This bias might have been a greater issue in the face-to-face interviews and focus 
groups. However, the anonymity of the Q-method survey should have reduced this bias to some 
extent. To alleviate the influence of social desirability bias, future research may want to directly 
study NMPs’ prescribing data. Research such as this was conducted by Wathen and Dean who used 
prescribing data to evaluate the influence of NICE guidance on GPs’ prescribing behaviour 
(Wathen and Dean 2004). By relying less on self-reported behaviour, and focusing on actual 
behaviour, it is possible that an additional understanding of the influences on NMPs’ behaviour 
may be obtained. However, research such as this could only focus on specific influences (e.g. 
guidelines, pharmaceutical industry) and not focus on a wide range of influences, as this research 
has done. 
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9.3 Recommendations  
The recommendations from this programme of research have been discussed briefly in various 
parts. The purpose of this section is to bring this information together as follows: 
 
• Clarify the professional and legal support nurse prescribers are entitled to receive 
A number of nurse prescribers expressed concern about the professional and legal support they 
would receive from their professional body and healthcare managers in case of prescribing 
errors. Nurse prescribers felt there is a culture of protection surrounding doctors that does not 
exist for nurses. To increase nurses’ confidence their concerns about the professional and legal 
support they are entitled to, particularly with regards to prescribing, need to be allayed. 
 
• Consider NMPs needs when designing the provision of healthcare services 
Healthcare managers have an important role in supporting NMPs when they organise the 
provision of healthcare services. It is important that they consider the following:   
o NMPs should not be isolated and where possible should have access to doctors, other 
NMPs and pharmacists. Moreover, it is important there is a critical mass of doctors and 
NMPs who can support each other.  
o NMPs should not be put in positions where they need to take responsibility for managing 
patients they are not competent to manage. Healthcare managers must therefore be aware 
of NMPs’ limitations. Where NMPs are being asked to take responsibility for new 
clinical areas they must be supported and receive the appropriate training. 
o Healthcare provision must be organised so NMPs are not continuously put in positions 
where prescribing contrary to regulations (e.g. issuing repeat prescriptions for medicine 
outside competency) is necessary for patients to receive the medication they need. 
 
• Support NMPs to uphold prescribing regulations 
Healthcare managers have an important role in supporting NMPs to uphold prescribing 
regulations. It is important that they take action, where appropriate, on the following issues: 
o NMPs face pressure from nurses to prescribe medicine they perceive to be outside their 
competency and for patients they have not examined. Nurses may have similar 
expectations of doctors and NMPs when it comes to prescribing. It is important that 
NMPs’ requirement, to only issue prescriptions for medicines they are competent to 
prescribe and for patients they have examined, is reinforced to nurses as well as other 
HCPs. This might be particularly important in nurse-only clinics, such as WICs, where 
nurse and NMPs are working independently from doctors.  
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o Because of the pressures that NMPs face in relation to repeat prescribing it is important 
that HCPs are informed of the regulations regarding repeat prescribing for NMPs. It is 
also important that the requirement of NMPs to abide by these regulations is highlighted 
to all HCPs. Given that pressure in regards to repeat prescriptions came from patients, it 
is important that patients are educated about NMPs’ roles. This may take the form of 
information leaflets or posters in clinics and surgeries.   
 
• Offer formal training within clinical fields 
This research suggests that some NMPs use general prescribing practices to inform their own 
prescribing decisions. Fontana et al. argued that insufficient formal education leads prescribers 
to replicate the prescribing practices of those around them (Fontana et al. 2000). It is not 
possible to say, based on this research, whether NMPs replicate the practice of those around 
them because they lack sufficient formal education. However, Fontana et al. raises an 
important point. What are prescribers, without formal education relating to their clinical areas, 
basing their prescribing decisions on?  NMPs may have experience from many years working 
in their field and by observing the prescribing behaviour of doctors. This may or may not be 
evidence-based. However, NMPs who have not received formal training about their area of 
practice might benefit from formal training opportunities in specific clinical areas. NMPs 
should be given the time in their practice to attend this training. In some cases training may 
reinforce current evidence-based practices. However, the training may enable NMPs to identify 
non-evidence-based practices they may want to rectify.  
 
• Increase the clinical support NMPs receive 
Latter et al. found that NMPs working in primary care feel there are insufficient opportunities 
for appraisal of their prescribing practices (Latter et al. 2010). This research reinforced Latter 
et al.’s finding by highlighting instances where some NMPs were not receiving sufficient 
clinical support. It is important that the level of support for NMPs is increased and the channels 
through which they receive this support are diversified.  
 
Currently NMPs are supported through the prescribing training course by a DMP. There is no 
requirement for NMPs to maintain any contact with their DMP post-qualifying. Only half of 
the 18 participants in Study One maintained contact with their DMP post-qualifying. Similarly 
in Study Two, a small number of participants said they no longer have contact with their DMP 
because of cost and resource issues. Clinical support might therefore be increased by making 
contact with DMPs post-qualifying a mandatory requirement of the prescribing course. Clearly 
doctors should be made aware of this requirement at the beginning of the course. If NMPs 
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change role or locations, doctors willing to fulfil the role of a DMP could be re-assigned to 
NMPs. 
 
It is also important that NMPs have the opportunity to interact with other NMPs. Currently, 
PCT led non-medical prescribing group meetings provide opportunities to do this but the 
meetings focus on practical prescribing issues rather than support at a clinical level. 
Communication between NMPs in the same PCT that are prescribing in similar clinical areas, 
but who work in isolation, could be facilitated through online forums and internet-based 
discussions. PCT non-medical prescribing group meetings could also, from time to time, focus 
on prescribing issues within specific clinical areas.  
 
Finally, as introduced by some NMPLs in the North West, a ‘buddy’ scheme where newly 
qualified NMPs are matched with a more experienced NMP could be extended to other PCTs. 
The ‘buddy’ scheme provides NMPs with informal support (Hacking and Taylor 2010). It is 
important that NMPs are matched with those prescribing in a similar field so advice can be 
provided on a clinical, as well as practical level. It would also be useful to implement this 
scheme between pharmacist prescribers as they currently have limited interaction with other 
pharmacist prescribers. 
 
• Help doctors to support NMPs  
Senior doctors are required to support junior doctors with prescribing duties (Lewis and Tully 
2009b). Moreover, doctors now also have an important role in supporting NMPs with all 
aspects of patient care including prescribing. It is important that consideration is given to the 
impact that regular contact with NMPs, particularly those recently qualified, will have on 
doctors’ workload. If may be important to evaluate the ways doctors can support NMPs. If 
doctors are overwhelmed with the demands on their time from NMPs then further support 
could come from community pharmacists. Strategies should be implemented to facilitate 
communication between these groups of HCPs. For example, NMPs could be linked with 
named community pharmacists who have agreed to help support NMPs.  
   
• Introduce legislation allowing independent prescribing of CDs by pharmacist prescribers 
A number of pharmacists were not prepared to set-up a CMP just to prescribe CDs for their 
patients. Instead, they asked doctors to issue the prescription on their behalf. It is important that 
changes in legislation allowing pharmacist prescribers to prescribe CDs are made as soon as 
possible because pharmacists are reverting back to old practices of asking doctors to sign 
prescriptions. This behaviour might have serious implications for the safety of the patient if no-
one is taking full responsibility for the decision because of reliance on their colleagues. 
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9.4 Future Research 
Ideas for future research have been discussed throughout this thesis. The purpose of this section is 
to discuss these, as well as other ideas, in further depth.  
 
9.4.1 Extensions to this Programme of Research 
This programme of research was conducted as part of a PhD. It was therefore limited, like most 
research, by time and resource constraints. Should opportunities arise the following research could 
be conducted to directly extend the findings of this programme of research with a larger number of 
NMPs across the UK. 
 
• Focus groups with Q-method participants 
The five perspectives arising from Study Three helped to understand the sources of influences 
on the prescribing decisions of NMPs. The comments NMPs made about the statements fed 
into the perspectives that were generated. However, it would be interesting in further research 
to present these perspectives to groups of NMPs as a way of increasing their validity. This is a 
form of the member validation that was used in Study Two of this programme of research (see 
Section 3.2.1.2). 
 
• Application of the Q-method with doctors 
The quantitative research completed with doctors about their prescribing influences has 
typically employed conventional survey methods. For instance, Schumock et al. asked doctors, 
clinical pharmacists and formulary committee members to rate the importance of a list of 
factors thought to influence drug prescribing (Schumock et al. 2004). The Q-method has not 
been used with doctors to understand the influences on their prescribing decisions. One key 
advantage of the Q-method, compared with conventional survey methods, is that participants 
order the statements in relation to each of the other statements. It is therefore possible to 
understand how prescribers ‘trade-off’ or ‘prioritise’ certain influences. The use of the Q-
method with doctors will add to the current understanding of doctors’ prescribing in the 
literature. Although research has explored how doctors prioritise influences over other 
influences there has not been a comprehensive and systematic study in this area. Such a study 
could be compared to the findings of this programme of research. 
 
• Further research comparing the sources of influences on NMPs and doctors prescribing 
decisions 
This research has highlighted some potential differences between how doctors and NMPs 
perceive their prescribing decisions to be influenced. However, it was only possible to compare 
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doctors prescribing with non-medical prescribing by examining the medical prescribing 
literature. A direct comparison within one research study between doctors and NMPs would 
contribute significantly to this area. This could take the form of Schumock et al.’s study, 
described above, where participants were asked to rate the importance of certain factors on the 
prescribing decisions they make (Schumock et al. 2004). Hypothesis for such research, based 
on the findings of this research, are provided in Box 9-1. Understanding the differences 
between NMPs and doctors would be important if, for whatever reason, healthcare managers 
and policy makers needed to alter the prescribing behaviour of these HCPs. The findings of this 
research could help target any intervention directly to the type of prescriber. However, the 
findings that such research would produce must be interpreted in light of the findings of this 
research about how, and in what circumstances, NMPs take responsibility for prescribing.  
 
• Hospital and secondary care settings 
Because this programme was conducted as part of a PhD it was not possible to explore the 
influences on all NMPs working in all healthcare settings. Instead, the author selected to focus 
on the prescribing decisions of those working in primary and community care. Further research 
would be beneficial to understand the influences on the prescribing behaviour of NMPs 
working in hospital and secondary care settings. This research would provide further insight 
into the training and support requirements of these HCPs. It is important not to rely on this 
research to make assumptions on the prescribing behaviour and training and support 
requirements of hospital and secondary care based NMPs because of the differences in working 
environment between the two groups. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Box 9-1: Hypotheses for Future Research Comparing the Influences on Doctors and Non-
Medical Prescribers’ Prescribing Behaviour 
 
Doctors, compared with non-medical prescribers, will be: 
 
• Less influenced by the recommendations of guidelines, formularies and protocols 
• Less influenced by information sources (e.g. NHS CKS) 
• Less influenced by patient adherence 
• More influenced by training and CPD 
• More influenced by patient pressure and maintenance of the patient-practitioner relationship 
• More influenced by hospital and secondary practitioners 
• More influenced by time and other logistical factors 
• More influenced by nurses 
• More influenced by professional experience 
• More influenced by research findings 
• The influence of cost and community pharmacists will be the same.  
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9.4.2 Professional Support and Legal Accountability 
A number of attitudes about professional support and legal accountability emerged during this 
research that may be interesting to explore in further depth.  
 
• Attitudes to professional support amongst nurses and pharmacist prescribers 
A number of nurse prescribers described how they feel doctors would receive more support in 
cases of prescribing errors than they would. One nurse practitioner described how doctors have 
a “cloak of protection” around them. It would be interesting to explore this topic with NMPs in 
more depth through interviews or focus groups. It would be important to explore the origins of 
this view and identify actual events that contributed to it. 
 
• Accountability 
In this research NMPs sought advice and guidance from doctors when they felt insufficiently 
competent to prescribe independently and when they felt uncertain or uncomfortable 
prescribing. This shared-responsibility helped some NMPs feel safe when prescribing and 
relieve their negative feelings. In some cases NMPs actually documented advice they had been 
given in patients’ notes. It would be important to explore in future research NMPs’ attitudes to 
accountability for prescribing and how, seeking others advice influences their own 
accountability for issuing a prescription. It would be important to identify if NMPs have 
incorrect perceptions of their accountability for prescribing when they have sought advice. If 
they do, issues such as this should be addressed comprehensively in the prescribing training 
course.   
 
9.4.3 Safety 
• Prescribing errors 
Clearly, it is important that HCPs prescribing behaviour is safe. Further research is required to 
evaluate the safety of non-medical prescribing. Given that NMPs only prescribe when they feel 
competent to do so, do they make any prescribing errors? Do pharmacist prescribers, with all 
their medicine knowledge, make prescribing errors? How does NMPs’ position in the 
healthcare system, of having the option to refer difficult cases, influence the amount of 
prescribing errors they make? 
 
9.5 Final Thoughts 
This programme of research has provided insight into the factors that influence the prescribing 
behaviour of nurse and pharmacist independent and/or supplementary prescribers working in 
primary and community care. This area has been until now under-researched. The research has 
 219
enabled recommendations to be made about the support and training requirements of NMPs. It has 
also made a contribution to understanding how the influences on NMPs should be researched by 
academics in the future. It has highlighted how, to understand the influences on NMPs’ prescribing 
decisions, it is important to understand how, and in what circumstances, NMPs decide to take 
responsibility for prescribing.  
 
This research is timely given the proposed changes to the NHS and the current economic situation 
in the UK. The government’s proposed changes to the NHS, that will increase GPs’ role in the 
commissioning of NHS healthcare services, may take GPs further away from providing front-line 
services to patients and increase the role of NMPs. The increased pressure on the NHS’ budget 
might also mean NMPs will have a greater role in providing prescribing services to patients. There 
may be more nurse-led, pharmacist-led or other non-doctor led services in the healthcare system. It 
is therefore important that strategies are put in place to support NMPs with their prescribing role so 
they can be a successful part of an ever evolving NHS.   
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Appendix 1.0 - Grey Literature Sources Searched in Literature 
Searches 
 
Manual searches of a number of internet sites relevant to the topic were conducted. The internet 
sites searched included the following: 
 
• Department of Health website 
• British Medical Association website 
• Nursing and Midwifery Council website 
• The General Medical Council website 
• Royal Pharmaceutical Society of Great Britain website 
• The National Prescribing Centre website  
• NHS – Business Services Authority Prescription Pricing Division website 
• The NHS Information Centre website 
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Appendix 2.0 - Databases Searched in Literature Searches 
 
The British Nursing Index (BNI) - The British Nursing Index is a bibliographic database that 
indexes articles from the most popular English language nursing journals published primarily in the 
UK. BNI is a comprehensive index covering all aspects of nursing, midwifery and community 
healthcare from 1994 to the present, and is updated monthly. 
 
PsycInfo - Is an electronic bibliographic database providing abstracts and citations to the scholarly 
literature in the psychological, social, behavioural, and health sciences.  
 
OVID Medline - MEDLINE® is the United States National Library of Medicine's bibliographic 
database providing information from the following fields: Medicine, Nursing, Dentistry, Allied 
Health, Pre-clinical sciences and Veterinary medicine.  
 
EMBASE – EMBASE consists of three separate databases: the Excerpta Medica Database 
(EMBASE), EMBASE Drugs and Pharmacology (EMDP), and EMBASE Psychiatry (EMPS). 
EMBASE is one of the most widely used biomedical and pharmaceutical databases. Approximately 
375,000 records are added each year. 
 
Allied and Complementary Medicine Database Guide (AMED) - The AMED is a unique 
bibliographic database produced by the Health Care Information Service of the British Library. It 
covers a selection of journals in complementary medicine, palliative care, and several professions 
allied to medicine. 
 
Web of Science – Includes the following: Science Citation Index Expanded, Social Sciences 
Citation Index, Arts & Humanities Citation Index, Conference Proceedings Citation Index- Science, 
Conference Proceedings Citation Index- Social Science & Humanities. 
 
OVID Books Database – Includes key medical, nursing, and pharmacy texts from a variety of 
publishers.  
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Appendix 6.0 - Study One - Participant Form 
 
Understanding The factors Influencing the Prescribing Decisions of Nurse and Pharmacist NMPs - An 
Exploratory Study 
 
If you would be willing to participate in this research please fill in the form below. The details you provide 
on this form will be used to select participants for interview and if selected you will be contacted using the 
contact details you provide. This form does not assume that you are consenting to the research and a further 
consent form will need to be signed before an interview is conducted. The information you provide on this 
form is strictly confidential.  
 
Title Dr / Mr / Ms /Other (please specify) ……………………. 
 
Name: ……………………………………………………………………………………….. 
 
Post(s): ……………………………………………………………………………………….. 
 
Details of post(s): ………………………………………………………………………………………
………………………………………………………………………………………
……………………………………………………………………………………….. 
 
Address: 
 
 
………………………………………………………………………………………
……………………………………………………………………………………….. 
 
Contact telephone 
number: 
……………………………………………………………………………………….. 
 
Email address: ……………………………………………………………………………………….. 
 
Preferred method of 
contact: 
 Telephone        
 Email 
 Letter 
 
Please indicate below which type of prescribing you are qualified to use, when you qualified and 
whether or not you use it in your current role? 
 
 Are you qualified to 
use this type of 
prescribing? 
When did you qualify to 
use this type of 
prescribing? 
Do you use this type of 
prescribing in your 
current role? 
Independent 
Prescribing 
Yes  
No    
Approx. date:  
 
OR N/A   
Yes  
No    
Supplementary 
Prescribing 
Yes  
No    
Approx. date:  
 
OR N/A   
Yes  
No    
(Nurses only) 
Community nurse 
prescribing 
Yes  
No    
Approx. date:  
 
OR N/A   
Yes  
No    
 
Thank you for taking time to fill in the questionnaire 
Please return the questionnaire in the stamped address envelope provided or email to 
clare.maddox@postgrad.manchester.ac.uk  
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Appendix 7.0 - Study One - Invitation Letter 
 
 
 
 
 
 
[Nurse/pharmacist name] 
[Address] 
 
 
[Date] 
 
 
Dear [Name of nurse/pharmacist], 
 
I am a PhD student at the University of Manchester and I am currently investigating prescribing 
decisions made by pharmacist and nurse prescribers. In particular, the research aims to identify and 
explore the factors that are thought to influence prescribing decisions made by nurse and 
pharmacist prescribers in primary care. It is hoped that, through this research, more knowledge will 
be gained about the influences on non-medical prescribing which is an area that is currently under 
researched. 
 
Participation in the study will involve a single interview lasting approximately 1 hour. It will 
involve discussion of your current role and use of prescribing and also discussion of some of the 
factors which you believe influence your prescribing. No information relating to specific patients is 
required. The interviews will be arranged for a time and location convenient for you. 
 
I am writing to ask if you would consider participating in the study. If, after reading the participant 
information leaflet, you have any questions or clarifications, please do not hesitate to contact me. If 
you are interested then please fill in the form attached and send it back to me via email or in the 
envelope that has been provided. This questionnaire provides me with background information and 
details so that you can be contacted. All questionnaires will remain strictly confidential. 
 
Thank you for your time. 
 
Kindest regards 
 
 
Clare Maddox 
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Appendix 8.0 - Study One - Participant Information Sheet  
 
Understanding The factors Influencing the Prescribing Decisions of Nurse and Pharmacist 
NMPs - An Exploratory Study 
 
Introduction 
 
You are being invited to take part in the research study. Before you decide whether or not to take 
part, it is important for you to understand why the research is being done and what it will involve. 
Please take time to read the following information and discuss it with others if you wish. The 
information provided below will hopefully give you a good understanding of what the research is 
about and how you might be able to help. However, if you have any other questions or 
clarifications, please do not hesitate to contact me on the telephone number or email address given 
below. Please take time to decide whether or not you wish to take part. 
 
What is the purpose of the study? 
 
The research aims to identify and explore the factors that are thought to influence prescribing 
decisions made by nurse and pharmacist prescribers in primary care. It is also hoped that, through 
this research, more knowledge will be gained about the influences on non-medical prescribing, 
which is an area that is currently under-investigated. 
 
Why have I been chosen? 
 
You have been chosen as you are a qualified nurse or pharmacist prescriber working in primary 
care.  
 
What will happen to me if I decide to take part? 
 
If you decide to take part in this study you may be asked to participate in a single interview. This 
interview will be conducted at a time and place suitable for you. During the interview you will be 
asked about your role and the factors that influence your prescribing decisions. It is estimated that 
the interview should take about an hour. No specific patient information is needed during the 
interview. The interview will be audio-recorded with your permission; if you object, then I will just 
take notes. You may request that the audio-recorder to be turned off or to stop the interview at any 
point. Direct quotations may be used for the purposes of disseminating the research findings, but in 
such a way as not to identify you. The audio-recordings will be stored securely and anonymised. 
The audio-recordings will be destroyed at the end of the study. 
 
At the end of the interview you may be asked if you know a colleague or friend who might like to 
take part in the study. If you do know someone, I will give you an information pack that you can 
pass on to the person. If the person wishes to participate in the study then they will be asked to 
contact me directly. Similarly, if you are not able or interested in taking part in the study but you 
know someone who might be interested, then I would be grateful if you could pass the information 
pack you have received on to them. 
 
Are there any risks or benefits to taking part? 
 
It is expected you will benefit from the process of reflection involved in the study. In the highly 
unlikely event you disclose information in the interview that may reveal a serious patient safety 
issue then confidentiality will be broken to allow details of the disclosure to be given to the 
relevant authority.  
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Do I have to take part? 
 
No, participation is entirely voluntary.  
 
Will the information about me remain confidential? 
 
Except in a situation where a serious patient safety issue has been disclosed (as described above) all 
information obtained from the interview and any other contact with you will be kept confidential. 
Other than my supervisors, your participation in the study will not be divulged to any person. In 
order to respect patient and colleague confidentiality and you will be asked to not mention patients 
or your colleagues by name during the interview. However, if identifying information is mentioned 
it will be removed from the interview data.  
 
What do I do next? 
 
If you decide you may like to take part then please complete the attached form. This form provides 
me with information about your post and also your contact details so that I can send you further 
information. It does not mean that you are agreeing to take part in this study and you may decline 
any further involvement at a later stage. It is possible that you may not be selected for the study and 
if this is the case then we will let you know by letter that no further participation is required. In this 
case your personal details will be destroyed.  
 
What if there is a problem? 
 
If, after taking part in this research, you are unhappy with any aspect of the process you can 
telephone the University of Manchester’s research governance co-ordinator on 0161 2758093 or 
email them at research-governance@manchester.ac.uk. 
 
 
Thank you for your time 
 
Clare Maddox 
Email: clare.maddox@postgrad.manchester.ac.uk 
Tel: 0161 275 2363 
1st Floor, Stopford Building 
School of Pharmacy and Pharmaceutical Sciences 
University of Manchester 
Manchester 
M13 9PT 
 
 
If you need further information please do not hesitate to contact me or if you would rather 
talk to my supervisors about this project please feel free to do so. 
Dr Mary Tully: 0161 275 4242 or email: mary.p.tully@manchester.ac.uk 
Dr Jason Hall: 0161 275 2720 or email: jason.hall@manchester.ac.uk 
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.
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at
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ra
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.
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n
u
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at
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p-
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a
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a
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m
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n
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re
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re
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u
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m
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.
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.
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ra
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re
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re
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n
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ra
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Key Details about Nurse Specialists Roles 
Role Conditions Prescribed Medicine Referrals 
Palliative Care 
Specialist/Macmillan 
Nurse 
Patients with a cancer 
diagnosis requiring 
pain relief, symptom 
control or treatment for 
other acute ailments 
 
Antibiotics, antiemetics, 
analgesics, antidepressants 
and antiepileptics 
GPs, district nurses, 
hospital practitioners 
and self/relative referral 
Diabetes (Adult and 
Paediatric) 
Diabetes and 
congestive heart 
disease 
Insulin, statins and oral 
diabetes medication 
 
GP or hospital 
practitioners 
(particularly surgeons). 
 
Heart Failure Heart failure and atrial 
fibrillation. 
ACE inhibitors, BETA 
blockers and diuretics 
GPs or hospital 
practitioners 
 
Epilepsy Epilepsy and seizure 
activity 
Anticonvulsants, anti-
inflammatory, folic acid and 
antidepressants 
Hospital consultants, 
GP referral, self/relative 
referral and employer 
referral 
 
Dermatology Scalp fungal infections, 
acne, skin lesions, 
eczema and psoriasis 
Complete emollients 
therapies, topical steroid 
preparation, 
immunomodulating creams, 
vitamin D, shampoo, 
bandages and steroid 
plasters 
GP or hospital 
consultants (including 
paediatricians 
Continence (Paediatric) Complex continence 
issues 
Laxatives, anticholinergics 
and antibiotics 
Paediatricians, GPs, 
schools nurses and 
health visitors 
 
Leg Ulcers Wounds, pressure 
ulcers, leg ulcers, 
lymphedema and 
dermatology conditions 
Wound care products, 
steroids, compression 
therapy, analgesia and 
antibiotics 
GPs, district nurses, 
other community 
nurses, nurses in 
intermediate care 
settings 
Tissue Viability Wound care, wound 
infections and cellulitis 
Antibiotics, steroid creams 
and dressings 
Community, GPs, 
nursing homes, hospital 
and self referrals 
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Appendix 11.0 - Study Two - Participant Form  
 
Factors Influencing the Decision to Prescribe 
 
If you would be willing to participate in this research please fill in the form below. The details you provide on 
this form will be used to select participants. If selected you will be contacted using the contact details you 
provide. This form does not assume that you are consenting to the research and a further consent form will need 
to be signed. The information you provide on this form is strictly confidential.  
 
Title Dr / Mr / Mrs / Miss/ Ms/Other (please specify) ……………………. 
Name: …………………………………………………… 
Post Title: …………………………………………………… 
Address: 
 
 
…………………………………………………… 
…………………………………………………… 
…………………………………………………… 
Contact tel no: …………………………………………………… 
Email address: …………………………………………………… 
Preferred method of 
contact 
 Telephone        Email          Letter 
 
Approx. no. of 
prescriptions you write 
per week: 
………………. 
Length of time in field 
you are prescribing in: 
 
………………. 
Please indicate below which type of prescribing you are qualified to use, when you qualified and 
whether or not you use it in your current role? 
 
 Are you qualified to 
use this type of 
prescribing? 
When did you qualify to 
use this type of 
prescribing? 
Do you use this type of 
prescribing in your 
current role? 
IP Yes  No    
Approx. date:  
OR N/A   
Yes   
No     
SP Yes  
No    
Approx. date:  
OR N/A   
Yes   
No     
 
Please indicate which of the following you 
would prefer to be involved in: 
 
 
 Face-to-face interview 
 Group discussion with 2 to 4 people  
 No preference 
 
 
THANK YOU 
Please return the questionnaire in the stamped address envelope provided, email to 
clare.maddox@postgrad.manchester.ac.uk or send to FREEPOST address: 
 
Miss Clare Maddox, School of Pharmacy and Pharmaceutical Sciences, University of Manchester, 
FREEPOST MR 9661, Room 1.131, 1st Floor Stopford Building, Oxford Road, Manchester, M13 9PT 
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Appendix 12.0 - Study Two - Invitation Email 
 
 
 
 
 
[Nurse/pharmacist name] 
[Address] 
 
 
[Date] 
 
 
Dear [Name of nurse/pharmacist], 
 
I am a PhD student at the University of Manchester and I am currently investigating prescribing 
decisions made by pharmacist and nurse prescribers working in primary and community care. In 
previous research I found that as well as making treatment choices NMPs often needed to decide 
whether they should issue a prescription or take responsibility for making a prescribing decision for 
a patient. In this research I am interested in exploring further how nurse and pharmacist prescribers 
decide when to prescribe and when not to prescribe and the factors that influence these decisions. It 
is hoped that through this research more knowledge will be gained about non-medical prescribing 
which is an area that is currently under researched. 
 
Participation in the study will involve a single interview OR a group discussion with 2 to 4 other 
people. Both will last approximately 1 hour. Both will involve discussion of your current role and 
use of prescribing and also some of the factors that you take into consideration when deciding 
whether or not to prescribe. If you take part in an interview you will be asked to think of some 
examples of prescribing situations before the interview takes place. The interview or group 
discussion will be arranged for a time and location convenient for you. 
 
I am writing to ask if you would consider participating in the study. If, after reading the participant 
information leaflet, you have any questions or clarifications, please do not hesitate to contact me. If 
you are interested then please fill in the form attached and send it back to me via email or in the 
envelope that has been provided. This questionnaire provides me with background information and 
details so that you can be contacted. All questionnaires will remain strictly confidential. 
 
Thank you for your time. 
 
Kindest regards 
 
 
Clare Maddox BSc 
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Appendix 13.0 - Study Two - Participant Information Sheet 
 
Factors Influencing the Decision to Prescribe 
 
You are being invited to take part in our research study. Before you decide whether or not to take 
part, it is important for you to understand why the research is being done and what it will involve. 
Please take time to read the following information and discuss it with others if you wish. If you 
have any other questions or clarifications, please do not hesitate to contact me on the details given 
below.  
 
What is the purpose of the study? 
 
Previous research has found that as well as making treatment choices NMPs often needed to decide 
whether they should take professional responsibility for issuing a prescription or for making a 
prescribing decision for a patient. This research aims to explore how nurse and pharmacist 
prescribers decide when to prescribe and when not to prescribe and the factors that influence these 
decisions. 
 
Why have I been invited? 
 
You have been invited because you are a qualified nurse or pharmacist prescriber working in 
primary or community care. 
 
Do I have to take part? 
 
No. it is up to you whether you to decide to take part in the study. If you agree to take part you will 
be asked to sign a consent form. You are free to withdraw at any time, without giving a reason. 
 
What will happen to me if I decide to take part? 
 
If you decide to take part in this study you may be asked to participate in an interview or a group 
discussion with between 2 and 4 other people (you will be asked to state your preference on the 
participant form). If you take part in an interview you will be asked to think of some examples of 
prescribing scenarios before you come to the interview (you will be given a form to note down the 
key details of these scenarios but the form will not be collected). In both the interview and group 
discussion you will be asked to talk about your current role and use of prescribing and also some of 
the factors that you take into consideration when deciding to issue a prescription or take 
responsibility for making a prescribing decision for a patient. The interview or group discussion 
will be conducted at a time and place suitable for you. It is expected that the interview and group 
discussion will last no more than 1 hour. The discussion will be audio-recorded with your 
permission; if you object, then I will just take notes. 
 
At the end of the discussion you may be asked if you know a colleague or friend who might like to 
take part in the study. If you do know someone, I will give you an information pack that you can 
pass on to the person. If the person wishes to participate in the study then they will be asked to 
contact me directly.  
 
 
Are there any risks or benefits to taking part? 
 
You may benefit from the process of reflection involved in the study. In the highly unlikely event 
you disclose information in the discussion that may reveal a serious patient safety issue then 
confidentiality will be broken to allow details of the disclosure to be given to the relevant authority. 
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However, if this was to happen this would be discussed with you before the relevant authority is 
contacted.  
 
Will the information about me remain confidential? 
 
Yes. Except in situations where a serious patient safety issue has been raised all the information 
which is collected about you during the course of the research project will remain confidential at all 
times. Audio-recordings of interviews or group discussions will be erased as soon as the findings 
have been published. The audio-recordings will be stored securely and anonymised.  
 
What will happen with the results of the study? 
 
The results of the study will be analysed and may be published in professional journals and at 
conferences. The results will also contribute to the completion of a postgraduate thesis which will 
be stored in the University of Manchester’s library. Direct quotations may be used for the purposes 
of disseminating the research findings, but in such a way as not to identify you. 
 
Who has organised and reviewed the study? 
 
The study has been organised and funded by the School of Pharmacy and Pharmaceutical Sciences 
at the University of Manchester and approved by a NHS Ethics Committee and the University of 
Manchester. 
 
What if there is a problem? 
 
If, after taking part in this research, you are unhappy with any aspect of the process you can 
telephone the University of Manchester’s research governance co-ordinator on 0161 2758093 or 
email them at research-governance@manchester.ac.uk. 
 
What do I do next? 
 
If you decide you may like to take part then please complete the participant form. This form 
provides me with information about your post and also your contact details so that I can send you 
further information. It does not mean that you are agreeing to take part in this study and you may 
decline any further involvement at a later stage. It is possible that you may not be selected for the 
study and if this is the case then we will let you know by letter that no further participation is 
required. In this case your personal details will be destroyed. 
 
Thank you for your time 
 
Clare Maddox 
Email: clare.maddox@postgrad.manchester.ac.uk, Tel: 0161 275 2363 
Address: School of Pharmacy and Pharmaceutical Sciences, University of Manchester, FREEPOST 
MR9661, Room 1.131, 1st Floor Stopford Building, Manchester, M13 9PT 
 
If you need further information please do not hesitate to contact me or if you would rather 
talk to my supervisors about this project please feel free to do so. 
Dr Mary Tully: 0161 275 4242 or email: mary.p.tully@manchester.ac.uk 
Dr Jason Hall: 0161 275 2720 or email: jason.hall@manchester.ac.uk
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Appendix 15.0 - Study Two - Discussion Guide - Semi-structured 
Interview  
 
 
Interviewer Say: As a NMP you are able to prescribe any licensed medicine out of the British 
National Formulary (as well as some CDs – nurse only). However, in reality you are unlikely to 
prescribe the entire range of products out of the BNF. This means therefore, that there will be 
instances where you have to decide whether or not to issue a prescription or take responsibility 
for making a prescribing decision for a patient. 
 
The purpose of this interview is to understand more about the factors that you take into 
consideration when deciding whether or not to issue a prescription or take responsibility for 
making a prescribing decision for a patient. I would like to do this through reflecting on two 
prescribing scenarios, the first where you felt that it was not appropriate for you to issue a 
prescription or make a prescribing decision for a patient, secondly, where you felt uncertain or 
uneasy about issuing a prescription or making a prescribing decision for a patient. 
 
Confidentiality is assured at all times and information analysed or reported from this interview 
will not enable anyone to recognise you. Patient information is not required; if however patients 
are mentioned during the interview their details will be immediately removed from all records.  
 
The interview will last approximately 1 hour and the topics to be covered include a few questions 
about your role and use of prescribing and also discussion of the two types of prescribing 
scenarios I outlined above.  
 
The interview will be audio recorded unless you oppose to this? The recordings will be kept 
securely until publication of the results.  
 
Do you have any questions before starting the discussion? 
 
 
 
Section One: Current Role and Use of Prescribing  
 
• Please tell me about your current role(s)? 
 
Prompts to be used where appropriate: 
 
⇒ Where are you based (GP practice, WIC, hospital)? 
⇒ By what method do you see patients (pre-arranged appointments, house visit, same-day 
appointments etc...)? 
⇒ What type of conditions/symptoms do you treat? 
⇒ How do patients get referred to you? 
⇒ How long have you been in your current post for? How long have you worked in the 
field you are now prescribing in? 
⇒ How many patients do you see per week/session? How many patients for each condition? 
 
• Please tell me about your use of prescribing in your current role? 
 
Prompts to be used where appropriate: 
 
⇒ How many prescriptions do you write per week/session? 
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⇒ What type/class of medicine do you often prescribe? 
⇒ What types of prescriptions do you usually give to your patients (e.g. Acute vs. repeat)? 
⇒ What type of prescribing are you operating under (e.g. independent, supplementary, 
patient group directives)? 
 
 
Section Two: Discussion of Prescribing Decisions 
 
INTERVIEWER SAY: In the letter I sent you, I asked you to make a note of two prescribing 
scenarios, firstly a situation where you felt that it was not appropriate for you to issue a 
prescription or take responsibility for making a prescribing decision for a patient, secondly, 
where you felt uncertain or uneasy about issuing a prescription or taking responsibility for 
making a prescribing decision for a patient. 
 
INTERVIEWER SAY: I would initially like to talk about the first prescribing decision you 
thought about (where you did not feel it was appropriate). I would like to remind you that 
you do not need to mention the patient’s name or names of your colleagues. 
 
• Could you please tell me about this prescribing decision? 
 
Prompts to be used where appropriate: 
 
⇒ Why did you feel it was not appropriate for you to issue the prescription or make the 
prescribing decision for the patient? 
 
⇒ What were the factors involved in this decision? 
 
⇒ What was the condition(s) or symptom(s) involved? 
 
⇒ What was the drug(s) involved? 
 
⇒ On reflection, would you do the same thing again? 
 
⇒ How did you feel about making the decision not to prescribe? 
 
⇒ What happened to the patient? Did this involve another health care professional? Who 
was this? 
 
⇒ How do you perceive the patient felt about your decision? How did this make you feel? 
 
⇒ How do you think your medical colleagues would behave in a similar situation? 
 
⇒ What leads you to think that you should not prescribe in situations such as these? 
• Guidance/protocols. If so, who from? 
• Any individual(s). If so, what did they say? 
• Training. If so, what did it say? 
 
⇒ Has this happened before?  
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INTERVIEWER SAY: I would now like to talk about the second prescribing decision you 
thought about (where you where uncertain or uneasy). 
 
• Could you please tell me about this prescribing decision? 
 
Prompts to be used where appropriate: 
 
 
⇒ Why were you uncertain or uneasy about issuing a prescription or making the prescribing 
decision for the patient?  
 
⇒ What were the factors involved in this uncertainty? 
 
⇒ What was the condition(s) or symptom(s) involved? 
 
⇒ What was the drug(s) involved? 
 
⇒ What was the final decision you made? 
 
⇒ Do you think the final decision you made was appropriate? Why was it appropriate/not 
appropriate? 
 
⇒ How did this situation make you feel? 
 
⇒ What happened to the patient? Did this involve another health care professional? Who 
was this? 
 
⇒ How do you perceive the patient felt about your decision? How did this make you feel? 
 
⇒ What does guidance/protocols/ other individuals/ training say about what you should do 
in this situation? 
 
⇒ What would help you address this uncertainty or unease in situations such as these? 
 
⇒ Has this happened before? What did you do then? 
 
INSTRUCTION: IF THE PARTICIPANT DID NOT THINK OF EXAMPLES BEFORE THEY 
CAME TO THE INTERVIEW USE THE FOLLOWING TWO QUESTIONS. 
 
• Are there any prescribing situations where you did not feel it was appropriate for you to 
issue a prescription or take responsibility for making a prescribing decision for a patient? 
Could you please tell me about this/these prescribing decision(s)? 
⇒ Use prompts above 
 
• Are there any prescribing situations where you where uncertain or uneasy about issuing 
a prescription or taking responsibility for making a prescribing decision for a patient? 
Could you please tell me about this/these prescribing decision(s)? 
⇒ Use prompts above 
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Section Three: General Discussion (If section two was very brief or not covered at all ask the 
following) 
 
• What factors do you take into consideration when deciding whether you should issue a 
prescription or take responsibility for making a prescribing decision for a patient? 
 
• Are there any situations where you do not feel that you should prescribe? What 
situations? 
 
• What do you consider a high risk situation? 
 
• Are there any situations that you cannot prescribe in? What prevents you from 
prescribing? 
 
• In which situations do you feel very confident to prescribe in? Why? 
 
• Has anyone ever asked you not to prescribe in a certain situation? Did you do this? 
 
• Have you received guidance which has directed you not to prescribe in certain situations? 
 
• Are there any situations where you feel unsure whether you should be prescribing or not? 
⇒ Why? 
 
 
Section Four: Competency and Competency Framework 
 
• What does the word ‘competency’ in relation to prescribing mean to you? 
 
• Do you believe your competency levels differ according to the: 
⇒ Patient’s age 
⇒ Patient’s condition/symptoms 
⇒ Severity of the patient’s symptoms 
⇒ Drug or likely drug required by the patient 
 
• In situations where you do not feel competent enough to prescribe what do you do? 
 
• Have you heard of the ‘competency framework’ specifically for prescribing? 
IF RELEVANT: 
⇒ When and where were you first introduced to the competency framework? 
⇒ How do you use the competency framework? 
 
 
CONCLUSON 
 
⇒ Is there anything else you would like to talk about? 
 
⇒ Is there anything that you would like to go back to? 
 
 
SWITCH OFF THE RECORDER 
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Appendix 16.0 - Study Two - Discussion Guide - Focus Groups 
 
 
Interviewer Say: As a NMP you are able to prescribe any licensed medicine out of the British 
National Formulary (as well as some CDs – nurse only). However, in reality you are unlikely to 
prescribe the entire range of products out of the BNF. This means therefore, that there will be 
instances where you have to decide whether or not to issue a prescription or take responsibility 
for making a prescribing decision for a patient. 
 
The purpose of this group discussion is to understand more about the factors that you take into 
consideration when deciding whether or not to issue a prescription or take responsibility for 
making a prescribing decision for a patient. The topics to be covered include a few questions 
about each your role and use of prescribing. We will then begin to talk about the factors that 
influence whether or not you decide to prescribe. I would firstly like to get each of your 
individual opinions on the factors you take into consideration before showing you some examples 
of prescribing scenarios which I would like you to talk about through your own experiences.  
 
Confidentiality is assured at all times and information analysed or reported from this group 
discussion will not enable anyone to recognise you. Patient information is not required; if 
however patients are mentioned during the interview their details will be immediately removed 
from all records.  
 
The discussion will be audio recorded unless anyone opposes to this? The recordings will be kept 
securely until publication of the findings.  
 
Does anyone have any questions before starting the discussion? 
 
 
 
Section One: Current Role and Use of Prescribing  
 
INTERVIEWER INSTRUCTION: ASK EACH PARTICIPANT 
 
• Please tell me about your current role(s)? 
 
Probes to be used where appropriate: 
 
⇒ What is your first name? 
⇒ Where are you based (GP practice, WIC, hospital)? 
⇒ By what method do you see patients (pre-arranged appointments, house visit, same-day 
appointments etc...)? 
⇒ What type of conditions/symptoms do you treat? 
⇒ How do patients get referred to you? 
⇒ How long have you been in your current post for? How long have you worked in the 
field you are now prescribing in? 
⇒ How many patients do you see per week/session? How many patients for each condition? 
 
• Please tell me about your use of prescribing in your current role? 
 
Prompts to be used where appropriate: 
 
⇒ How many prescriptions do you write per week/session? 
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⇒ What type/class of medicine do you often prescribe? 
⇒ What types of prescriptions do you usually give to your patients (e.g. Acute vs. repeat)? 
⇒ What type of prescribing are you operating under (e.g. independent, supplementary, 
patient group directives)? 
 
 
Section Two: General Discussion 
 
• What factors do you take into consideration when deciding whether you should issue a 
prescription or take responsibility for making a prescribing decision for a patient? 
 
• What do you consider a high risk situation? 
 
• Are there any situations where you do not feel that you should prescribe? What 
situations? 
 
• Are there any situations that you cannot prescribe in? What prevents you from 
prescribing? 
 
• In which situations do you feel very confident to prescribe in? Why? 
 
• Has anyone ever asked you not to prescribe in a certain situation? Did you do this? 
 
• Have you received guidance which has directed you not to prescribe in certain situations? 
 
• Are there any situations where you feel unsure whether you should be prescribing or not? 
⇒ Why? 
 
Section Three: Examples of Prescribing Scenarios 
 
INSTRUCTION: SHOW OR READ EXAMPLE 1 OF PRESCRIBING SCENARIO TO 
PARTICIPANTS AND ASK: 
 
• Is this something that you have experienced yourself? 
IF YES: 
⇒ Please describe when it happened to you? 
⇒ In what ways was it similar or different? 
⇒ What was the condition/symptom or drug involved? 
⇒ Is this something that happens frequently? How frequently? 
⇒ How did this prescribing situation make you feel? 
 
IF NO: 
⇒ Has anything similar happened to you? Please describe this situation. 
⇒ Why do you think this example is not relevant to you? 
 
INSTRUCTION: REPEAT ABOVE WITH ANY FURTHER EXAMPLES OF PRESCRIBING 
SCENARIOS 
 
Section Four: Competency and Competency Framework 
 
• What does the word ‘competency’ in relation to prescribing mean to you? 
 
• Do you believe your competency levels differ according to the: 
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⇒ Patient’s age 
⇒ Patient’s condition/symptoms 
⇒ Severity of the patient’s symptoms 
⇒ Drug or likely drug required by the patient 
 
• In situations where you do not feel competent enough to prescribe what do you do? 
 
• Have you heard of the ‘competency framework’ specifically for prescribing? 
IF RELEVANT: 
⇒ When were you first introduced to the competency framework? 
⇒ How do you use the competency framework? 
 
 
CONCLUSON 
 
⇒ Is there anything else you would like to talk about? 
 
⇒ Is there anything that you would like to go back to? 
 
 
SWITCH OFF THE RECORDER 
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Appendix 17.0 - Study Three - Invitation to RPSGB 
Pharmacists Only 
 
 
 
 
Dear (Name of Pharmacist prescriber) 
 
I am a PhD student at the University of Manchester. The overall aim of my research it to 
understand the factors that influence the prescribing decisions of pharmacist and nurse 
independent/supplementary prescribers.  Your name has been identified from the Society’s 
Pharmaceutical Register because you are a pharmacist prescriber working in primary and/or 
community care. 
 
I wish to invite you to take part in an online survey. The survey aims to further explore what factors 
you perceive to influence your prescribing decisions by using a technique called the Q-method. 
This method provides a new way of studying prescribing not previously used. The survey is 
expected to last no more than 35 minutes in total.   
 
I am contacting you to ask you if you would be willing to take part in the survey. Included in the 
letter is the participant information sheet that will provide more information on the study. The 
criteria for taking part in the research is that you are a pharmacist using independent and/or SP in a 
primary/community care role. If you fit this criteria and would like to take part in the survey please 
access the internet link below: 
 
www.link to survey.co.uk 
 
Then type in your unique username and password: 
 
Username: (Type in username) 
Password: (Type in password) 
 
Please contact me on clare.maddox@postgrad.manchester.ac.uk or telephone 0161 2752363 if you 
require any further information. 
 
I hope that you will consider taking part. 
 
Kind Regards 
Clare Maddox 
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Appendix 18.0 - Study Three - Invitation Letter to PCTs 
 
 
 
 
 
 
Dear Nurse and Pharmacist prescribers, 
 
I am a PhD student at the University of Manchester. Over the last two years I have been conducting 
research with NMPs from the Greater Manchester region. The aim of my research has been to 
explore what factors prescribers use to make prescribing decisions.   
 
The culmination of my programme of work is an internet survey. The hope is that a number of 
prescribers from different PCTs in the North West complete the survey. The survey aims to further 
explore what factors you perceive to influence your prescribing decisions by using a technique 
called the Q-method. This method provides a new way of studying prescribing not previously used. 
In the survey you will be asked to sort a number of statements depending on the extent of your 
agreement in relation to the prescribing decisions you make. The survey is expected to last 35 
minutes in total.  
 
Attached is the participant information sheet that will provide more information on the study. The 
criterion for taking part in the research is that you are a nurse or pharmacist using independent 
and/or SP in a primary/community care role. If you would like to take part in the survey please fill 
in the expression of interest form (attached) and email or post it back to me (using the freepost 
address provided on the form). I will then send you a username and password you can use to access 
the internet link. The survey can then be completed at a time and location that is suitable for you.  
 
Please contact me on clare.maddox@postgrad.manchester.ac.uk or telephone 0161 2752363 if you 
require any further information. 
 
I hope that you will consider taking part. 
 
Kind Regards 
Clare Maddox 
(Contact Details) 
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Appendix 19.0 - Study Three - Expression of Interest Form PCT 
 
Perspectives on Prescribing Influences amongst NMPs 
 
If you would be willing to participate in this research please fill in the form below. The details you 
provide on this form will be used to select participants. If selected you will be contacted using the 
contact details you provide. This form does not assume that you are consenting to the research and 
you can still withdraw at a later date. The information you provide on this form is strictly 
confidential.  
 
Title Dr / Mr / Mrs / Miss/ Ms/Other (please specify) ……………………. 
Name: 
…………………………………………………… 
Post Title: 
…………………………………………………… 
Address: 
 
 
…………………………………………………… 
…………………………………………………… 
…………………………………………………… 
Contact tel no: 
…………………………………………………… 
Email address: 
…………………………………………………… 
 
Once this form has been returned, I will send you details of how to access and complete the 
survey, how would you like to be sent this information? 
 Email          Letter 
Please indicate below which type of prescribing you are qualified to use, when you qualified 
and whether or not you use it in your current role? 
 
 Are you qualified 
to use this type of 
prescribing? 
When did you qualify to 
use this type of 
prescribing? 
Do you use this type 
of prescribing in your 
current role? 
IP Yes  No    
Approx. date:  
OR N/A   
Yes   
No     
SP Yes  
No    
Approx. date:  
OR N/A   
Yes   
No     
 
THANK YOU 
Please return the form via email to clare.maddox@postgrad.manchester.ac.uk or post to the 
FREEPOST address: 
 
Miss Clare Maddox, School of Pharmacy and Pharmaceutical Sciences, University of 
Manchester, FREEPOST MR 9661, Room 1.131, 1st Floor Stopford Building, Oxford Road, 
Manchester, M13 9PT 
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Appendix 20.0 - Study Three - Participant Information Sheet 
  
Perspectives on Prescribing Influences amongst NMPs 
 
You are being invited to take part in a research study. Before you decide whether or not to take 
part, it is important for you to understand why the research is being done and what it will involve. 
Please take time to read the following information and discuss it with others if you wish. If you 
have any other questions or clarifications, please do not hesitate to contact me on the details given 
below.  
 
What is the purpose of the study? 
 
The research aims to understand what factors NMPs perceive influence the prescribing decisions 
they make. It is hoped that, through this research, more knowledge will be gained about the 
influences on non-medical prescribing which is an area that is currently under-investigated.   
 
Why have I been invited? 
 
You have been invited because you are a qualified pharmacist prescriber working in primary or 
community care. 
 
Do I have to take part? 
 
No. it is up to you whether you to decide to take part in the study. You are free to withdraw at any 
time, without giving a reason. 
 
What will happen to me if I decide to take part? 
 
If you decide to take part you will be asked to access a link to an internet based survey. You have 
also been sent a unique username and password which you will need to access the internet survey. 
During the survey you will be asked to sort a number of statements according to the extent to which 
you agree with them. After sorting the statements you will be asked to briefly explain some of the 
choices you have made. The survey will end with a few questions about your role and use of 
prescribing and a few questions about how you found the survey process. It is expected the survey 
will last no more than 35 minutes.  
 
Are there any risks or benefits to taking part? 
 
I am not aware of any risks or disadvantages you may experience. However, participation may 
provide you with a chance to reflect on your practice, especially in relation to prescribing. You 
could use your experience of taking part in this study as part of your continued professional 
development (CPD).  
 
Will the information about me remain confidential? 
 
Yes. All the information which is collected about you during the course of the research project will 
remain confidential at all times. 
 
 
What will happen with the results of the study? 
 
The results of the study will be analysed and may be published in professional journals and at 
conferences. The results will also contribute to the completion of a postgraduate thesis which will 
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be stored in the University of Manchester’s library. Findings reported from the study will not 
enable anyone to recognise you. 
 
Who has organised and reviewed the study? 
 
The study has been organised and funded by the School of Pharmacy and Pharmaceutical Sciences 
at the University of Manchester and approved by a NHS Ethics Committee and the University of 
Manchester. 
 
What if there is a problem? 
 
If you have a concern about any aspect of this study, you should ask to speak to the researchers 
who will do their best to answer your questions.  If they are unable to resolve your concern or you 
wish to make a complaint regarding the study, please contact a University Research Practice and 
Governance Co-ordinator on 0161 2757583 or 0161 2758093 or by email to research-
governance@manchester.ac.uk.   
 
 
Thank you for your time 
 
 
Clare Maddox 
Email: clare.maddox@postgrad.manchester.ac.uk, Tel: 0161 275 2363 
Address: School of Pharmacy and Pharmaceutical Sciences, University of Manchester, FREEPOST 
MR9661, Room 1.131, 1st Floor Stopford Building, Manchester, M13 9PT 
 
If you need further information please do not hesitate to contact me or if you would rather 
talk to my supervisors about this project please feel free to do so. 
Dr Mary Tully: 0161 275 4242 or email: mary.p.tully@manchester.ac.uk 
Dr Jason Hall: 0161 275 2720 or email: jason.hall@manchester.ac.uk 
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Appendix 22.0 – Study Three - Statements 
 
Colleague Factors 
1. My prescribing decisions are influenced by.... recommendations from my prescribing course 
mentor or my designated medical practitioner. 
2. My prescribing decisions are influenced by.... advice from General Practitioners. 
3. My prescribing decisions are influenced by.... information from community pharmacists. 
4. My prescribing decisions are influenced by.... advice from other NMPs. 
5. My prescribing decisions are influenced by.... advice from hospital/secondary care practitioners. 
6. My prescribing decisions are influenced by.... advice from academic based practitioners. 
7. My prescribing decisions are influenced by.... advice from non-prescribing health care 
professionals. 
 
Regulatory Factors 
8. My prescribing decisions are influenced by.... information from the medicines management 
team. 
13. My prescribing decisions are influenced by.... the cost of the decision to the National Health 
Service. 
17. My prescribing decisions are influenced by.... the recommendations of the British National 
Formulary or other national formularies.  
18. My prescribing decisions are influenced by.... the recommendations of my primary care trust's 
formulary. 
19. My prescribing decisions are influenced by.... local or primary care trust protocols or guidance. 
20. My prescribing decisions are influenced by.... national guidance. 
21. My prescribing decisions are influenced by.... the recommendations of patient group directives.     
 
Patient Factors 
16. My prescribing decisions are influenced by.... the anticipated concordance of the patient.   
33. My prescribing decisions are influenced by.... what the patient asks for in the consultation. 
34. My prescribing decisions are influenced by.... what would be best for the patient’s relatives or 
carers. 
35. My prescribing decisions are influenced by.... whether the decision will fulfil the patient’s 
expectations.   
36. My prescribing decisions are influenced by.... whether the patient will be satisfied with the 
prescribing decision.  
37. My prescribing decisions are influenced by.... whether the prescribing decision will 
accommodate the patient’s social responsibilities (job, holiday, etc).  
38. My prescribing decisions are influenced by.... what impact the decision will have on my future 
relationship with the patient.  
41. My prescribing decisions are influenced by.... the patient’s financial situation. 
42. My prescribing decisions are influenced by.... the effect of the prescribing decision on the 
patient’s quality of life. 
40. My prescribing decisions are influenced by.... the anticipated impact of the prescribing decision 
on the wider community (antibiotic resistance, herd immunity, etc).  
 
Prescribing Culture and Professional Experience 
9. My prescribing decisions are influenced by.... the prescribing behaviour of other prescribers 
working in my service, group, clinic, etc. 
10. My prescribing decisions are influenced by.... general practitioners' prescribing behaviour. 
11. My prescribing decisions are influenced by... other NMPs' prescribing behaviour. 
12. My prescribing decisions are influenced by.... the prescribing practice of hospital/secondary 
care practitioners. 
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24. My prescribing decisions are influenced by.... the level of success I have personally 
experienced with similar prescribing decisions in the past. 
25. My prescribing decisions are influenced by.... whether the potential prescribing decision has 
been established amongst other prescribers (both medical and non-medical).  
26. My prescribing decisions are influenced by.... whether the potential prescribing decision is an 
accepted practice amongst other prescribers (both medical and non-medical).  
 
Training and Information sources  
27. My prescribing decisions are influenced by.... information from my prescribing training 
course(s). 
28. My prescribing decisions are influenced by.... information from training courses, study days 
and conferences.    
29. My prescribing decisions are influenced by.... what I have read about in academic and 
professional journals. 
30. My prescribing decisions are influenced by.... relevant updates and information from NHS 
Clinical Knowledge summaries. 
31. My prescribing decisions are influenced by.... relevant updates and information from the 
National Prescribing Centre.    
32. My prescribing decisions are influenced by.... relevant updates and information from the 
Medicines and Healthcare products Regulatory Agency.   
 
Logistical Factors 
14. My prescribing decisions are influenced by.... the anticipated impact the prescribing decision 
will have on other health care services or health care professionals outside my own service.    
15. My prescribing decisions are influenced by.... the anticipated impact the prescribing decision 
will have on my service in the future (follow-up appointments, monitoring, etc). 
22. My prescribing decisions are influenced by.... whether I feel I have sufficient time during the 
consultation.                                                                                                 
23. My prescribing decisions are influenced by.... whether the prescribing decision occurs before a 
weekend or bank holiday. 
39. My prescribing decisions are influenced by.... the anticipated impact of the prescribing decision 
on future presentations to my service from the patient in question or other patients. 
 
 272
Appendix 23.0 – Study Three - Survey 
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Appendix 25.0 - Study Three - Correlation Values of Defining 
Participants 
** A factor loading at significance level 0.01 (99%). An italic values indicate a negative loading to a factor. 
 
 
 
 
 
 
 PERSPECTVE 
ONE 
PCT Driven 
Prescribers 
PERSPECTIVE 
TWO 
Patient-Centred 
Driven 
Prescribers 
PERSPECTIVE 
THREE 
Prescribing 
Culture  
Driven 
Prescribers 
PERSPECTIVE 
FOUR 
Evidence-Based 
Driven 
Prescribers 
PERSPECTIVE 
FIVE 
Long-term 
Impact and 
Logistical 
Prescribers 
Nurse 4 0.7474 ** - - - - 
Nurse 6 0.6769 ** - - - - 
Nurse 8 0.5914 ** - - - - 
Nurse 9 0.5568 ** - - - - 
Nurse 11 05463 ** - - - - 
Nurse 18 0.5171 ** - - - - 
Nurse 22 0.7232 ** - - - - 
Nurse 23 0.6773 ** - - - - 
Nurse 25 0.6251 ** - - - - 
Nurse 26 0.7258 ** - - - - 
Pharmacist 2 0.5467 ** - - - - 
Pharmacist 4 0.7937 ** - - - - 
Nurse 1 - 0.5389 ** - - - 
Nurse 7 - 0.5097 ** - - - 
Nurse 15 - 0.6125 ** - - - 
Nurse 29 - 0.6880 ** - - - 
Pharmacist 5 - 0.6565 ** - - - 
Pharmacist 6 - 0.6966 ** - - - 
Pharmacist 8 - 0.4930 ** - - - 
Pharmacist 18 - 0.7359 ** - - - 
Pharmacist 19 - 0.6637 ** - - - 
Pharmacist 20 - 0.6155 ** - - - 
Nurse 19 - - 0.4608 ** - - 
Nurse 27 - - 0.5653 ** - - 
Pharmacist 3 - - 0.7039 ** - - 
Pharmacist 12 - - 0.6529 ** - - 
Pharmacist 15 - - 0.4107 ** - - 
Pharmacist 21 - - 0.5455 ** - - 
Nurse 2 - - - 0.5560 ** - 
Nurse 13 - - - 0.5802 ** - 
Nurse 17 - - - 0.4044 ** - 
Nurse 34 - - - 0.6624 ** - 
Pharmacist 14 - - - 0.6480 ** - 
Pharmacist 16 - - - 0.5622 ** - 
Pharmacist 22 - - - 0.4751 ** - 
Nurse 30 - - - - 0.7050 ** 
Pharmacist 7 - - - - -0.5716** 
Pharmacist 17 - - - - 0.6428 ** 
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Appendix 26.0 -  Study Three - Correlation Values of 
Confounder Participants 
 
* A factor loading at significance level 0.01 (99%) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 PERSPECTVE 
ONE 
PCT Driven 
Prescribers 
PERSPECTIVE 
TWO 
Patient-Centred 
Driven 
Prescribers 
PERSPECTIVE 
THREE 
Prescribing 
Culture  
Driven 
Prescribers 
PERSPECTIVE 
FOUR 
Evidence-Based 
Driven 
Prescribers 
PERSPECTIVE 
FIVE 
Long-term 
Impact and 
Logistical 
Prescribers 
Nurse 16 0.4247 * 0.5274 * - - - 
Nurse 20 0.4745 * 0.4117 * - - - 
Nurse 21 0.4123 * 0.4577 * - - - 
Nurse 24 0.5713 * - 0.4477 * - - 
Nurse 5 0.5435 * - - 0.6024 * - 
Nurse 12 0.4753 * - - 0.4300 * - 
Nurse 28 0.4096 * - - 0.6576 * - 
Nurse 31 0.5513 * - - 0.5677 * - 
Pharmacist 11 0.4058 * - - 0.7135 * - 
Nurse 32 - 0.4865 * 0.4475 * - - 
Pharmacist 9 - 0.5481 * 0.4315 * - - 
Pharmacist 13 - 0.5806 * 0.4806 * - - 
Pharmacist 1 - 0.6700 * - 0.4258 * - 
Nurse 10 - - 0.4081 * 0.5704 * - 
Nurse 14 - - 0.4422 * 0.4051 * - 
Pharmacist 10 - - 0.5683 * 0.4232 * - 
